<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source></source><date></date><key></key><document><id>PMC-2412842-sec-03</id><passage><offset>0</offset><text>Competing interests
The authors declare that they have no competing interests.
</text></passage></document><document><id>PMC-2535566-caption-18</id><passage><offset>0</offset><text>Click here for additional data file.
</text></passage></document><document><id>PMID-12663827</id><passage><offset>0</offset><text>Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children.
Cerebral blood flow (CBF) was measured with continuous arterial spin-labeling perfusion magnetic resonance (MR) imaging in 14 children with sickle cell disease and seven control subjects. Mean CBF values were higher in patients (P &lt;.005) than in control subjects in all cerebral artery territories. Three patients had decreased CBF in right anterior and middle cerebral artery territories compared with CBF on the left, and one patient had a profound decrease in CBF in all three territories in the right hemisphere. Baseline CBF was significantly decreased in territories seen as unaffected on conventional MR images and MR angiograms in four children with sickle cell disease.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="229" length="11"></location><text>sickle cell</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="359" length="15"></location><text>cerebral artery</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="98" length="5"></location><text>blood</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="588" length="16"></location><text>right hemisphere</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="144" length="8"></location><text>arterial</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="747" length="11"></location><text>sickle cell</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="424" length="14"></location><text>right anterior</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="450" length="15"></location><text>cerebral artery</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="0" length="11"></location><text>Sickle cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="89" length="8"></location><text>Cerebral</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="32" length="8"></location><text>arterial</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation></passage></document><document><id>PMID-8898364</id><passage><offset>0</offset><text>Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
Terminal cell differentiation involves permanent withdrawal from the cell division cycle. The inhibitors of cyclin-dependent kinases (CDKs) are potential molecules functioning to couple cell cycle arrest and cell differentiation. In murine C2C12 myoblast cells, G1 CDK enzymes (CDK2, CDK4, and CDK6) associate with four CDK inhibitors: p18INK4c, p19INK4d, p21, and p27Kip1. During induced myogenesis, p21 and its associated CDK proteins underwent an initial increase followed by a decrease as cells became terminally differentiated. The level of p27 protein gradually increased, but the amount of total associated CDK proteins remained unchanged. p19 protein decreased gradually during differentiation, as did its associated CDK4 protein. In contrast, p18 protein increased 50-fold, from negligible levels in proliferating myoblasts to clearly detectable levels within 8-12 h of myogenic induction. This initial rise was followed by a precipitous increase between 12 and 24 h postinduction, with p18 protein finally accumulating to its highest level in terminally differentiated cells. Induction of p18 correlated with increased and sequential complex formation--first increasing association with CDK6 and then with CDK4 over the course of myogenic differentiation. All of the CDK6 and half of the CDK4 were complexed with p18 in terminally differentiated C2C12 cells as well as in adult mouse muscle tissue. Finally, kinase activity of CDK2 and CDK4 decreases as C2C12 cells differentiate, whereas the CDK6 kinase activity is low in both proliferating myoblasts and differentiated myotubes. Our results indicate that p18 may play a critical role in causing and/or maintaining permanent cell cycle arrest associated with mature muscle formation.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="115" length="4"></location><text>cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="292" length="4"></location><text>cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="175" length="4"></location><text>cell</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="599" length="5"></location><text>cells</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1185" length="5"></location><text>cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="314" length="4"></location><text>cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="346" length="20"></location><text>C2C12 myoblast cells</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1570" length="11"></location><text>C2C12 cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1659" length="9"></location><text>myoblasts</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1688" length="8"></location><text>myotubes</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1793" length="4"></location><text>cell</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1462" length="11"></location><text>C2C12 cells</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1834" length="6"></location><text>muscle</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1500" length="13"></location><text>muscle tissue</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="929" length="9"></location><text>myoblasts</text></annotation></passage></document><document><id>PMID-3993849</id><passage><offset>0</offset><text>Management of the tortuous internal carotid artery.
The tortuous internal carotid artery as the basis of cerebral vascular insufficiency is a controversial entity, as such lesions frequently occur without neurologic symptoms. However, some tortuous vessels are associated with significant carotid atherosclerotic disease requiring a specific surgical approach. This formed the basis of our report. Symptoms of cerebrovascular insufficiency in association with a tortuous internal carotid artery was encountered in 27 of 853 carotid endarterectomies over a 22 year period. Stenosis of hemodynamic significance was noted in nine patients and irregularities or ulceration were noted in the rest. With the standard technique of carotid endarterectomy, removal of plaque from a tortuous vessel leads to loss of the stenting effect provided by the plaque such that angulation occlusion is likely to occur. The optimal reconstruction in our experience is eversion endarterectomy by transection and lower reimplantation of the internal carotid artery on the common carotid artery. Our experience with 17 such procedures in 15 patients has been presented.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="18" length="32"></location><text>tortuous internal carotid artery</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="105" length="17"></location><text>cerebral vascular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="56" length="32"></location><text>tortuous internal carotid artery</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="410" length="15"></location><text>cerebrovascular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="462" length="32"></location><text>tortuous internal carotid artery</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="172" length="7"></location><text>lesions</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="240" length="16"></location><text>tortuous vessels</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="773" length="15"></location><text>tortuous vessel</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="759" length="6"></location><text>plaque</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="842" length="6"></location><text>plaque</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1019" length="23"></location><text>internal carotid artery</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="524" length="7"></location><text>carotid</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1050" length="21"></location><text>common carotid artery</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="724" length="7"></location><text>carotid</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="289" length="7"></location><text>carotid</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="205" length="10"></location><text>neurologic</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation></passage></document><document><id>PMC-2955004-caption-06</id><passage><offset>0</offset><text>Click here for file
</text></passage></document><document><id>PMID-18440619</id><passage><offset>0</offset><text>Sciatic nerve repair by microgrooved nerve conduits made of chitosan-gold nanocomposites.
BACKGROUND:
To better direct the repair of peripheral nerve after injury, an implant consisting of a multicomponent micropatterned conduit seeded with NSC was designed.
METHODS:
The mechanical properties of the chi-Au nanocomposites were tested. In vitro, the effect of chi-Au on cell behavior (NSC and glial cell line C6) and the influence of micropattern on cell alignment were evaluated. In vivo, the micropatterned conduits with/without the preseeded NSC were implanted to bridge a 10-mm-long defect of the sciatic nerve in 9 male Sprague-Dawley rats. The repair outcome was investigated 6 weeks after the surgery.
RESULTS:
Based on the dynamic modulus, chitosan with 50 ppm or more gold was a stronger material than others. In vitro, gold at 25 or 50 ppm led to better cell performance for NSC; and gold at 50 ppm gave better cell performance for C6. On the microgrooved substrate, the NSC had elongated processes oriented parallel to the grooves, whereas the NSC on the nonpatterned surfaces did not exhibit a particular bias in alignment. In vivo, the number of regenerated axons, the regenerated area, and the number of blood vessels were significantly higher in the NSC-preseeded conduit.
CONCLUSION:
Modification of the chitosan matrix by gold nanoparticles not only provides the mechanical strength but also affects the cellular response. The preliminary in vivo data demonstrated that the biodegradable micropatterned conduits preseeded with NSC provided a combination of physical and biological guidance cues for regenerating axons at the cellular level and offered a better alternative for repairing sciatic nerve transactions.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="37" length="5"></location><text>nerve</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="370" length="4"></location><text>cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="133" length="16"></location><text>peripheral nerve</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="393" length="18"></location><text>glial cell line C6</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="450" length="4"></location><text>cell</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="241" length="3"></location><text>NSC</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="385" length="3"></location><text>NSC</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="885" length="3"></location><text>NSC</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="942" length="2"></location><text>C6</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="921" length="4"></location><text>cell</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="981" length="3"></location><text>NSC</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="545" length="3"></location><text>NSC</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1055" length="3"></location><text>NSC</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="601" length="13"></location><text>sciatic nerve</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1218" length="13"></location><text>blood vessels</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="221" length="7"></location><text>conduit</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1265" length="3"></location><text>NSC</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="0" length="13"></location><text>Sciatic nerve</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1544" length="3"></location><text>NSC</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="864" length="4"></location><text>cell</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1629" length="5"></location><text>axons</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1642" length="8"></location><text>cellular</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1704" length="13"></location><text>sciatic nerve</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1421" length="8"></location><text>cellular</text></annotation></passage></document><document><id>PMC-2939889-sec-15</id><passage><offset>0</offset><text>Animals
STOP null mice and their WT littermates were generated on a mixed BALBc/129 SvPas and on a pure 129 SvPas background as previously reported by Andrieux et al. [4]. All animals used in the study underwent immunohistochemistry for the detection of STOP protein, resulting in no staining in STOP null mice, and genotyping by PCR as described by Andrieux et al. [4]. All mice were kept under standard housing conditions with a 12-hour/12-hour dark-light cycle. The experiments were carried out in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC), and the French Department of Agriculture (License Ndegrees 67-95). The protocol was approved by the ethical Animal Research Committee of Louis Pasteur University (CREMEAS #AL/01/19/10/07).
In a first experiment, we searched for differences in glomerular ultrastructure and peripheral neurogenesis between WT and STOP null mice: a first group of 24 mice, 3- to 6- month-old, was used for ultrastructural study of the OBs; a second group of 13 animals was used to analyse proliferation and apoptosis in the OE and VNE on paraffin sections in 3-month-old mice. In a second experiment we analysed, in WT and STOP null mice, the effect of OE regeneration on glomeruli structure and ultrastructure and on peripheral neurogenesis at two age times (3 and 10 months).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1247" length="9"></location><text>glomeruli</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1106" length="3"></location><text>VNE</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1228" length="2"></location><text>OE</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="837" length="10"></location><text>glomerular</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1099" length="2"></location><text>OE</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1113" length="17"></location><text>paraffin sections</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMID-3593589</id><passage><offset>0</offset><text>Measurement of serum glycosylated proteins and glycosylated low density lipoprotein fraction in diabetes mellitus.
A simple method was developed for estimating serum glycosylated protein levels using gel filtration with Bio-Gel P6 by determining the protein and sugar content in the void volume fraction. The glycosylated protein levels (GSP) correlated well with fasting blood sugar levels and glycosylated albumin level (G-ALB) determined by affinity chromatography with Blue Sepharose CL6B. The glycosylation level of heparin-citrate precipitable fraction of serum which predominantly contained low density lipoprotein (G-LDL) also correlated well with GSP and LDL-cholesterol levels. Significantly different values were obtained for GSP, G-ALB, and G-LDL between normals and diabetics.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="562" length="5"></location><text>serum</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="15" length="5"></location><text>serum</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="372" length="5"></location><text>blood</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="160" length="5"></location><text>serum</text></annotation></passage></document><document><id>PMID-21140139</id><passage><offset>0</offset><text>Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.
OBJECTIVE:
Oxycodone is widely used for the treatment of cancer pain, but little is known of its pharmacokinetics in cancer pain patients. The aim of this study was to explore the relationships between ordinary patient characteristics and serum concentrations of oxycodone and the ratios noroxycodone or oxymorphone/oxycodone in cancer patients.
METHODS:
Four hundred and thirty-nine patients using oral oxycodone for cancer pain were included. The patients' characteristics (sex, age, body mass index [BMI], Karnofsky performance status, "time since starting opioids", "oxycodone total daily dose", "time from last oxycodone dose", use of CYP3A4 inducer/inhibitor, "use of systemic steroids", "number of medications taken in the last 24 h", glomerular filtration rate (GFR) and albumin serum concentrations) influence on oxycodone serum concentrations or metabolite/oxycodone ratios were explored by multiple regression analyses.
RESULTS:
Sex, CYP3A4 inducers/inhibitors, total daily dose, and "time from last oxycodone dose" predicted oxycodone concentrations. CYP3A4 inducers, total daily dose, and "number of medications taken in the last 24 h" predicted the oxymorphone/oxycodone ratio. Total daily dose, "time from last dose to blood sample", albumin, sex, CYP3A4 inducers/inhibitors, steroids, BMI and GFR predicted the noroxycodone/oxycodone ratio.
CONCLUSION:
Women had lower oxycodone serum concentrations than men. CYP3A4 inducers/inhibitors should be used with caution as these are predicted to have a significant impact on oxycodone pharmacokinetics. Other characteristics explained only minor parts of the variability of the outcomes.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="947" length="5"></location><text>serum</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1510" length="5"></location><text>serum</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="533" length="6"></location><text>cancer</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="354" length="5"></location><text>serum</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="902" length="5"></location><text>serum</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="232" length="6"></location><text>cancer</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="601" length="4"></location><text>body</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1349" length="12"></location><text>blood sample</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="857" length="10"></location><text>glomerular</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="98" length="6"></location><text>cancer</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="444" length="6"></location><text>cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="172" length="6"></location><text>cancer</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation></passage></document><document><id>PMC-3213245-sec-16</id><passage><offset>0</offset><text>Outcomes
The primary outcomes of this study are smoking abstinence rates post release as well as number of days to first cigarette after release. Seven day point-prevalence abstinence will be determined by combining self-reported tobacco use over the prior seven days and urine cotinine assays (below 200 ng/ml versus 200 or above). Participants with self-reported abstinence and cotinine levels below the cut-off will be classified as abstinent. Participants lost to follow-up will be considered non-abstinent. A secondary analysis will examine the effect of length of forced abstinence on quit rates.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="272" length="5"></location><text>urine</text></annotation></passage></document><document><id>PMID-7982854</id><passage><offset>0</offset><text>Comparison of image (CAS 200) and flow cytometry determined DNA content of paraffin-embedded Hodgkin's disease tissue.
To assess the reliability of DNA estimation using image cytometry, deparaffinized lymph nodes from 70 patients with Hodgkin's disease were examined and the results obtained were compared with those from flow cytometry. Image analysis without discriminating between the various cell types, as found in Hodgkin's disease, revealed no separate aneuploid peak. Selecting on morphologically defined nuclear types DNA aneuploidy was detected in 20% of the cases (14/70). The aneuploid populations were limited to the population of nuclei defined as Reed-Sternberg (RS)-like or medium-sized lymphocytes. Benign lymph nodes DNA aneuploidy was not found in any of the controls. Comparison of DNA histograms obtained by image and flow cytometry showed aneuploid peaks using image cytometry in 4 of 30 diploid and 10 of 40 aneuploid flow histograms. In conclusion, image analysis using the CAS 200 system as compared to flow cytometry is more time-consuming and less sensitive to assess ploidy status, although it may provide extra information in some selected cases. Evidence is obtained that DNA aneuploidy in Hodgkin's disease is preferentially expressed by cells with the RS/H-like and medium-sized lymphocyte morphology.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="703" length="11"></location><text>lymphocytes</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="716" length="18"></location><text>Benign lymph nodes</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="513" length="7"></location><text>nuclear</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="644" length="6"></location><text>nuclei</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1269" length="5"></location><text>cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1311" length="10"></location><text>lymphocyte</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="93" length="24"></location><text>Hodgkin's disease tissue</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="396" length="4"></location><text>cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="201" length="11"></location><text>lymph nodes</text></annotation></passage></document><document><id>PMC-1519587-sec-01</id><passage><offset>0</offset><text>Images
FIGURE 2.
</text></passage></document><document><id>PMC-3113360-caption-08</id><passage><offset>0</offset><text>Importing citations in different formats using Google Scholar
</text></passage></document><document><id>PMC-2769146-sec-05</id><passage><offset>0</offset><text>3.2.
Cell line and culture
DU145 (prostate cancer) cell line was used in this assay. DU145 was grown in DMEM/F-12 medium (Gibco BRL Life Technologies, San Diego, CA., USA) supplemented with 10% fetal calf serum and kept in a humidified 37 degreesC, 5% CO2 incubator.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="205" length="5"></location><text>serum</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="194" length="5"></location><text>fetal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5" length="9"></location><text>Cell line</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="85" length="5"></location><text>DU145</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="27" length="33"></location><text>DU145 (prostate cancer) cell line</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMC-2968135-sec-03</id><passage><offset>0</offset><text>Crystal data
C16H20N4
M r = 268.36
Monoclinic, 
a = 12.819 (4) A
b = 8.441 (3) A
c = 13.310 (4) A
beta = 95.462 (5)degrees
V = 1433.7 (8) A3
Z = 4
Mo Kalpha radiation
mu = 0.08 mm-1
T = 298 (2) K
0.33 x 0.28 x 0.21 mm
</text></passage></document><document><id>PMC-2719750-sec-10</id><passage><offset>0</offset><text>Quantitative reverse transcription PCR
Reverse transcription was performed using 0.2 mug of total RNA from muscle of 10 week-old and 19 month-old C57Bl6 mice (five animals per group), a Core kit (RT-RTCK-03, Eurogentec) according to manufacturer's instruction and a mix of random primers (9 mers) and oligodT. qPCR was performed on SDS7900HT (Applied Biosystem) using Mesagreen qPCR kit for SYBR (Eurogentec) and the following primers: 
PPARbeta: 5'-AGATGGTGGCAGAGCTATGACC-3'; 5'-TCCTCCTGTGGCTGTTCC-3'.
Catalase: 5'-GGATCCTGACATGGTCTGGG-3'; 5'-TGGAGAGACTCGGGACGAAG-3'.
PDK4: 5'-GCATTTCTACTCGGATGCTCAATG-3'; 5'-CCAATGTGGCTTGGGTTTCC-3'.
36B4: 5'-TCCAGGCTTTGGGCATCA-3'; 5'-CTTTATCAGCTGCACATCACTCAGA-3'.
Data were all normalised using 36B4 as housekeeping gene.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="107" length="6"></location><text>muscle</text></annotation></passage></document><document><id>PMC-464911-sec-25</id><passage><offset>0</offset><text>Abbreviations
Ac-DEVD-AMC = N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin; Ac-DEVD-CHO = N-acetyl-Asp-Glu-Val-Asp-aldehyde; COX = cyclooxygenase; Deltapsim = mitochondrial membrane potential; DAPI = 4',6-diamidino-2-phenylindole; DMEM = Dulbecco's modified Eagle's medium; ELISA = enzyme-linked immunosorbent assay; FCS = fetal calf serum; FLS = fibroblast-like synoviocytes; IL = interleukin; JC-1 = 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazole carbocyanide iodide; MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PBS = phosphate-buffered saline; PGE2 = prostaglandin E2; RA = rheumatoid arthritis.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="326" length="5"></location><text>fetal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="344" length="3"></location><text>FLS</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="162" length="22"></location><text>mitochondrial membrane</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="350" length="28"></location><text>fibroblast-like synoviocytes</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="337" length="5"></location><text>serum</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T4" role=""></node><node refid="T3" role=""></node></relation></passage></document><document><id>PMID-19000097</id><passage><offset>0</offset><text>Are former female elite athletes more likely to experience urinary incontinence later in life than non-athletes?
The aim of the present study was to investigate whether former female elite athletes are more likely to experience urinary incontinence (UI) later in life than non-athletes and to assess possible risk factors for UI in athletes. Three hundred and thirty-one former elite athletes (response rate 81%) and 640 controls replied to a postal questionnaire including validated questions on UI. While competing in sport, 10.9% and 2.7% of the former elite athletes reported stress urinary incontinence (SUI) and urge incontinence, respectively. Presently, 36.5% of the former elite athletes and 36.9% of the controls reported SUI. 9.1% and 9.4% reported urge incontinence. Among former elite athletes, those with two or three children were more likely than nulliparous women to have UI now. Also, among former athletes, UI was more common in women with vs those without UI while competing (odds ratio 8.57, 95% confidence interval: 3.55-20.71). Age, menopause and being regularly physically active now were not associated with UI in either group. Based on this study, the prevalence of UI does not seem to be higher in former athletes than in controls. However, the results indicate that UI early in life, as reported during elite sport, is a strong predictor of UI later in life.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="59" length="7"></location><text>urinary</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="587" length="7"></location><text>urinary</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="228" length="7"></location><text>urinary</text></annotation></passage></document><document><id>PMC-3256136-sec-15</id><passage><offset>0</offset><text>Discussion
We estimated the future acceptability of PrEP, examining the attitudes and preferences of potential user groups from different countries towards hypothetical and known PrEP attributes. Our results show that participants were generally willing to accept PrEP and adopt it as soon as it becomes available. Surprisingly, participants were also willing to take PrEP even when reminded of potential side effects, cost, condom use, and frequent HIV testing. These findings indicate participants' motivation to overcome barriers which can have a considerable impact on uptake. In contrast, participants mentioned that the thought of taking PrEP made them feel anxious, although they also indicated that taking PrEP would not be embarrassing and they would want their partner or partners to know. Participants' anxiety may be explained by the hypothetical nature of most of the presented PrEP characteristics, the stigma associated with HIV [34], and in some settings, the criminalization of sex work, injected drug use and homosexuality [35]. Most participants, nonetheless, subsequently indicated that PrEP would give them hope, which suggests that their initial willingness to take it remained largely unscathed.
Female participants indicated a higher level of willingness to take PrEP than male participants, which may be explained by women's difficulty negotiating the use of condoms and awareness of their and/or their partners' risk of becoming infected with HIV [36]. We also found that younger participants and those with fewer children, those who reported adherence to past medication, more frequent condom usage, having been tested for HIV in the past and never injecting drugs, reported greater willingness to take PrEP. These promising findings suggest that those who are currently bearing the brunt of HIV [1], have higher perceived risk, and are most likely to adhere to a comprehensive PrEP program, are also the most motivated to enroll. Yet, while participants stated not being interested in selling PrEP, the majority reported intentions to share it. Therefore, information and counseling about the risks of sharing PrEP should be readily available as part of any implementation program.
Results from the conjoint analysis reveal trends in participants' preferences which deserve consideration. PrEP route of administration was the most important attribute, and bi-monthly and monthly injections were the preferred alternatives. This finding is encouraging from a policy perspective if such modalities become available; since it may reduce users' likelihood of sharing, selling or forgetting to take PrEP, but it also raises questions regarding participants' willingness to take oral PrEP. HIV testing was the second most important attribute, and a test every six months was, as expected, the preferred alternative. Interestingly, dispensing sites were more important than any other attribute for some groups, particularly in Africa. This may indicate concerns about social stigma and access [37]. However, it is encouraging that most participants were willing to receive PrEP at a healthcare facility, which can facilitate synergies between PrEP and other existing prevention services. Time spent obtaining PrEP and frequency of pick up, which we used as a proxy measure for cost-opportunity, were generally less important, consistent with participants' willingness to pay for PrEP.
Our findings are broadly consistent with the work of Guest et al. and Galea et al [18], [19]. However, specific comparisons are not advisable as the composition and size of the samples, recruitment methods, measures and statistical analyses differ greatly. Previous work on PrEP implementation suggests that delivery programs will need to meet a number of requirements in order to be effective, including: prioritization of groups at higher risk of infection; delivery of PrEP in combination with other prevention services, including risk reduction and medication adherence counseling, condoms provision, diagnosis and treatment of other sexually transmitted infections, and frequent HIV testing; and monitoring of side effects, adherence and risk behaviors [8], [38], [39], [40], [41], [42]. Our results provide valuable clues that can help countries to deliver PrEP more effectively, should they decide to implement it, by focusing their efforts on the aspects that need more attention.
This is the first multinational study, to our knowledge, that integrates different disciplines to shed light on a question that we believe is of global importance. Our study complements previous work on PrEP by examining potential users' perspective and offering insights into their attitudes and preferences. We note that it may not be possible to generalize the observed PrEP acceptability to other settings and our results should be considered within the context of this study's limitations. Given the sensitive nature of the addressed questions, and despite all our efforts to reduce social desirability bias, there is an unavoidable risk that participants may have felt at times compelled to provide what they felt was the "right" answer. Additionally, our data collection took place in urban areas, where HIV incidence is normally higher, thus current findings may not be generalizable to rural settings. Finally, examining acceptability among users enrolled in pilot programs is much deserving, as actual acceptability may differ from potential willingness to take PrEP, especially if relevant attributes of a product or program are modified, as observed in other comparable interventions [43].

</text></passage></document><document><id>PMC-3150795-sec-01</id><passage><offset>0</offset><text>Introduction
During the weaning period and transition to solid foods in the first year of life, infants take a critical step in their eating behavior and need to meet high nutrient requirements [1, 2]. They are exposed to new foods and food combinations, which should ensure a smooth transition to the family diet later in life. At this stage, either homemade or commercially prepared foods may be fed. It is worth noting that in prosperous countries the modern diet differs considerably from that of previous generations, now dominated by products that have been processed, stored, and transported over great distances. Traditional, cold-pressed vegetable oils of the highest nutritional quality, e.g. extra virgin olive oil, may therefore constitute an important part of the modern diet [3, 4].
In Poland, many infants do not receive any traditional homemade foods and even fruits come from purchased jars. Commercial baby foods are regarded by some parents and medical professionals to be more appropriate for several reasons: they undergo intense screening for contaminants in comparison to foods sold for the general population, contain no additives of certain types, and are thought to be designed to help infants meet nutrient requirements [5]. The process of peeling, however, was identified as the most effective, and simple, procedure in reducing residues, e.g. pesticides, in fruits and vegetables [6]. Moreover, contrary to homemade food, which does not contain furan, the highest average content of this chemical was found in ready-to-eat baby foods with pasta meals, followed by vegetable meals and meals with meat [7]. Furan is considered to be potentially hazardous chemical and is classified as a possible carcinogen. The problem of this chemical in homemade food may only arise if meals with potatoes are stored and then hardly re-heated [7].
There is a growing body of evidence that flavor experiences and dietary patterns in childhood influence these patterns later in life [1, 8, 9]. It is most likely early in life that culture-specific flavor preferences are initiated [10, 11]. Consequently, exposure to flavors and smells of transitory foods may serve to heighten preferences for "known tastes" in the family diet later in adulthood. Moreover, adopting elements of childhood dinner patterns was recognized to be an important part of the social reproduction of family identities across generations [12].
Processing industries have been successful in manufacturing and marketing jarred baby foods on a commercial scale. Available products contain different ingredients and depend on the manufacturer, country, traditional cuisine, income rate, and lastly, personal beliefs and values of parents [9, 11]. Jarred foods with vegetables, meats, and desserts may contain added fat from a variety of sources: vegetable oils, cow milk butter, or cream. Manufacturer advertising makes the majority of consumers feel safe, causing them to believe that they are doing the best possible in buying given products [11]. A noteworthy fact is that many types of baby foods produced by international manufacturers are, in essence, the same mixtures with different names; this procedure aims to exploit the specifics of local markets without delivering any new, real value [11].
In the book, How to Eat Well and Stay Well the Mediterranean Way by Keys [13] first used the term "good Mediterranean diet" to describe the eating patterns of populations dwelling in southern Europe, where the olive tree (Olea europaea) is an emblematic species [4, 14]. There is variation between the exact diet in different parts of the Mediterranean region. However, generalized and distinctive dietary patterns do exist, including olive oil as the main source of visible fat, employed both in cooking and as a dressing, moderate fish and poultry but low red meat consumption, high intake of vegetables, fruits, legumes, nuts, and whole-grain cereals [4, 14-16]. When dietary fats are added, in accordance with the traditional Mediterranean diet, olive oil is the choice for children [17]. It has been repeatedly observed that individuals applying the Mediterranean diet have reduced risks of type 2 diabetes and other diseases associated with the metabolic syndrome, autoimmunological diseases, and certain forms of cancer [18]. Moreover, considerable evidence exists that the Mediterranean diet increases quality of life in the course of ageing, as well as longevity [13, 19]. The health benefits of olive oil have been attributed to two main constituents: a high oleic acid (monounsaturated fatty acid, 18:1n-9) content (70-85%) and a large amount of antioxidant compounds, which also possess antiviral, antibacterial, and immunomodulating effects [3, 4, 14, 16]. Polyphenols found in virgin olive oil are linked to both its flavor and its remarkable stability [3].
The introduction of solid foods in infancy is one of the primary matters often discussed by parents with their child's pediatrician. However, many parents do not feel that the diet of their child may be linked to poor health outcomes in the future. Parents should be educated about the interplay of environmental and genetic influences on children, specifically during the early years of development when the child is maturing and taking control of its own diet [11]. Nutrition educators should increase the critical awareness of parents in relation to their child's solid food choices. It is important to emphasize to parents the fundamental role that the Mediterranean diet and consumption of foods with olive oil play in a healthy life style [14, 20]. Parental management of the family food environment may be complicated by numerous mitigating factors, e.g. health literacy, time availability, and financial resources. Considering the role baby food manufacturers play in the infant's contextual environment, their products, as well as the manufacturers themselves, should also be viewed as key players and central agents in establishing dietary habits. Consequently, we attempted to survey manufacturer claims concerning added fat in jarred infant foods supplied to the Polish market.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="647" length="14"></location><text>vegetable oils</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="876" length="6"></location><text>fruits</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="722" length="3"></location><text>oil</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1398" length="10"></location><text>vegetables</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1593" length="9"></location><text>vegetable</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1387" length="6"></location><text>fruits</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="3892" length="6"></location><text>fruits</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2757" length="5"></location><text>meats</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2826" length="14"></location><text>vegetable oils</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2846" length="4"></location><text>milk</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="3843" length="8"></location><text>red meat</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1624" length="4"></location><text>meat</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="3880" length="10"></location><text>vegetables</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2745" length="10"></location><text>vegetables</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="3909" length="4"></location><text>nuts</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3956" length="12"></location><text>dietary fats</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1880" length="4"></location><text>body</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="4041" length="3"></location><text>oil</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3726" length="3"></location><text>oil</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="4305" length="6"></location><text>cancer</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="5569" length="3"></location><text>oil</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="4496" length="3"></location><text>oil</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="4789" length="3"></location><text>oil</text></annotation><relation id="A30"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T21" role=""></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A31"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T22" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A9"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A29"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T21" role=""></node></relation><relation id="A28"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T20" role=""></node></relation><relation id="A27"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T20" role=""></node></relation><relation id="A26"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T19" role=""></node></relation><relation id="A25"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T19" role=""></node></relation><relation id="A24"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T17" role=""></node></relation><relation id="A23"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T17" role=""></node></relation><relation id="A22"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation><relation id="A21"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T15" role=""></node></relation><relation id="A20"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T15" role=""></node></relation><relation id="A19"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T14" role=""></node></relation><relation id="A18"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T14" role=""></node></relation><relation id="A11"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A10"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A13"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A12"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A15"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation><relation id="A32"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T22" role=""></node></relation><relation id="A14"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T10" role=""></node></relation><relation id="A17"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T13" role=""></node></relation><relation id="A16"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation></passage></document><document><id>PMID-19163807</id><passage><offset>0</offset><text>Heart sound and electrocardiogram recording devices for telemedicine environments.
There is currently a worldwide trend to bring healthcare services as close as possible to the patient, either through home healthcare systems, or telemedicine. There is thus a general need for equipment that can capture patient data electronically for automated review or analysis by a medical practitioner. This paper presents prototype systems that were developed with the ultimate aim for use in telemedicine settings in rural Africa. These devices can be used to electronically capture data on patients from several sensors in a quick an easy manner. In our presented cases we focus on cardiovascular information. One of the main advantages of the proposed systems is that the data are captured simultaneously from multiple sensors. The data can be stored and sent electronically for review and analysis, and knowledge-based systems or neural network type models can be used in the future for semi-autonomous screening of the recordings, before a patient is referred to a specialist.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="0" length="5"></location><text>Heart</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="673" length="14"></location><text>cardiovascular</text></annotation></passage></document><document><id>PMID-17054099</id><passage><offset>0</offset><text>Hypocholesterolaemic and antioxidant effects of Glycyrrhiza glabra (Linn) in rats.
The hypocholesterolaemic and antioxidant effects of Glycyrrhiza glabra (GG) root powder were examined in hypercholesterolaemic male albino rats. A 4-week administration of GG root powder (5 and 10 gm% in diet) to hypercholesterolaemic rats resulted in significant reduction in plasma, hepatic total lipids, cholesterol, triglycerides and plasma low-density lipoprotein and VLDL-cholesterol accompanied by significant increases in HDL-cholesterol levels. Furthermore, significant increases in fecal cholesterol, neutral sterols and bile acid excretion along with an increase in hepatic HMG-CoA reductase activity and bile acid production were observed in these animals. The root powder administration to hypercholesterolaemic rats also decreased hepatic lipid peroxidation with a concomitant increase in superoxide dismutase (SOD) and catalase activities and total ascorbic acid content. Thus, the hypocholesterolaemic and antioxidant effects of GG root appeared to be mediated via (i) accelerated cholesterol, neutral sterol and bile acid elimination through fecal matter with an increased hepatic bile acid production and (ii) improving the activities of hepatic SOD, catalase and increasing the ascorbic acid content. The normo-cholesterolaemic animals when fed with GG root powder at 10 gm% level, registered a significant decline in plasma lipid profiles and an increase in HDL-cholesterol content. The antioxidant status of these animals also was improved upon treatment.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="360" length="6"></location><text>plasma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="421" length="6"></location><text>plasma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="368" length="7"></location><text>hepatic</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="660" length="7"></location><text>hepatic</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="575" length="5"></location><text>fecal</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="756" length="4"></location><text>root</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="828" length="7"></location><text>hepatic</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1031" length="4"></location><text>root</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="159" length="4"></location><text>root</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="258" length="4"></location><text>root</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1173" length="7"></location><text>hepatic</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1239" length="7"></location><text>hepatic</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1355" length="4"></location><text>root</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1420" length="6"></location><text>plasma</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1142" length="12"></location><text>fecal matter</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T10" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T17" role=""></node></relation></passage></document><document><id>PMC-3212267-sec-05</id><passage><offset>0</offset><text>Refinement
R[F 2 &gt; 2sigma(F 2)] = 0.052
wR(F 2) = 0.132
S = 1.02
3804 reflections
229 parameters
67 restraints
H-atom parameters constrained
Deltarhomax = 0.56 e A-3
Deltarhomin = -0.38 e A-3
</text></passage></document><document><id>PMID-16408118</id><passage><offset>0</offset><text>Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury.
We reported previously that various radiocontrast media cause apoptosis in porcine proximal tubular (LLC-PK(1)) cells, in which reduction in B-cell lymphoma (Bcl)-2 expression and caspase-3 activation are implicated. In the present study, we investigated a role for ceramide in radiocontrast media-induced apoptosis in renal tubular cells. LLC-PK(1) cells were exposed to radiocontrast media for 30 min, followed by incubation for 24 h in normal medium. Cell viability was assessed by 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt assay, while apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling stain. Immunofluorescent stains were performed using antibodies against phosphorylated Akt (pAkt) and cAMP response element binding protein (CREB) (pCREB), and ceramide. The mRNA expression and protein content of Bcl-2 were determined by reverse transcriptase-polymerase chain reaction and enzyme immunoassay, respectively. In vivo model of contrast-induced renal injury was induced in mice with unilateral renal occlusion. The cell injury induced by the nonionic radiocontrast medium ioversol was reversed by inhibiting de novo ceramide synthesis with fumonisin B(1) (FB(1)) and L-cycloserine, but not by suppressing sphingomyelin breakdown with D609. FB(1) reversed ioversol-induced decrease in the immunoreactivities of pAkt and pCREB, reduction in Bcl-2 expression and caspase-3 activation. Like ioversol, C2 ceramide and the Akt inhibitor Src homology-6 induced apoptosis by reducing pAkt and pCREB-like immunoreactivities, lowering Bcl-2 expression and enhancing caspase-3 activity. Indeed, various radiocontrast media, excluding iodixanol which showed the least nephrotoxicity, enhanced ceramide-like immunoreactivity. The role for de novo ceramide synthesis was also shown in the in vivo model of radiocontrast nephropathy. We demonstrated here for the first time that the enhancement of de novo ceramide synthesis contributes to radiocontrast nephropathy.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="548" length="4"></location><text>Cell</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1147" length="5"></location><text>renal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="413" length="19"></location><text>renal tubular cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="434" length="15"></location><text>LLC-PK(1) cells</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1196" length="5"></location><text>renal</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1217" length="4"></location><text>cell</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="67" length="18"></location><text>renal tubular cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="177" length="34"></location><text>proximal tubular (LLC-PK(1)) cells</text></annotation></passage></document><document><id>PMID-16210037</id><passage><offset>0</offset><text>Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils.
Thrombotic complications are frequently observed in patients with polycythemia vera (PV) and essential thrombocythemia (ET). Abnormalities of red blood cells and platelets arising from the clonal rearrangement of hematopoietic cells have been considered, although causal relationships between any of these specific abnormalities and thrombosis have not been clearly established. The involvement of neutrophils and macrophages, which participate in thrombosis and hemostasis, has been insufficiently explored in PV and ET. Persistent activation of circulating neutrophils was recently demonstrated in ET and PV patients, in parallel with an increase in plasma concentrations of endothelial damage-derived and prothrombotic substances. Other studies have explored whether the augmentation of adhesion of neutrophils may affect neutrophil/platelet interaction since a significant increase in circulating neutrophil/platelet aggregates is found in ET and PV. This review summarizes the current knowledge of the pathogenesis of thrombosis in PV and ET, with emphasis on the role of neutrophils in hemostasis and their possible involvement in the mechanisms of the acquired thrombophilia of these patients. Available data suggest that these hemostatic markers deserve to be included in prospective clinical studies aimed at identifying their predictive role in the vascular complications of patients with ET and PV.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="91" length="11"></location><text>neutrophils</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="266" length="9"></location><text>platelets</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="246" length="15"></location><text>red blood cells</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="518" length="11"></location><text>macrophages</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="663" length="11"></location><text>neutrophils</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="317" length="19"></location><text>hematopoietic cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="502" length="11"></location><text>neutrophils</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="906" length="11"></location><text>neutrophils</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="929" length="10"></location><text>neutrophil</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="940" length="8"></location><text>platelet</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1005" length="10"></location><text>neutrophil</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="756" length="6"></location><text>plasma</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1016" length="8"></location><text>platelet</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="781" length="11"></location><text>endothelial</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1181" length="11"></location><text>neutrophils</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1463" length="8"></location><text>vascular</text></annotation></passage></document><document><id>PMID-3763732</id><passage><offset>0</offset><text>Unsatisfactory forehead scar following face lift.
The W-plasty scar revision technique has been found to be effective in the repair of the difficult and cosmetically unsatisfactory hairline scar following the ill-advised face lift technique that excises forehead skin.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="254" length="13"></location><text>forehead skin</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="181" length="13"></location><text>hairline scar</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="221" length="4"></location><text>face</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="15" length="13"></location><text>forehead scar</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="63" length="4"></location><text>scar</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="39" length="4"></location><text>face</text></annotation></passage></document><document><id>PMC-3194540-sec-04</id><passage><offset>0</offset><text>Conclusions
This is the first prospective evaluation of parents' preferences in newly diagnosed juvenile idiopathic arthritis patients participating in the BeSt for Kids trial. Within the limitations of the small amounts, patients clearly preferred initial combination therapy with etanercept and disliked taking prednisone. After actual exposure and follow up, this questionnaire will be repeated to see if preferences remain the same.
</text></passage></document><document><id>PMC-3158436-sec-06</id><passage><offset>0</offset><text>2.1.3
Pixel Classification
The feature vector of a grid, which consists of nine features, is normalized to [0, 1], and the position features are scaled by the weighting coefficient wpos. Then, taking the nine dimensional vector of each grid as the input of the classifier, the ROI and non-ROI background in ultrasonic breast tumor images can be distinguished.
In this section, the self-organizing feature map neural network (SOMNN) [25], proposed by Kohonen according to characteristics of the nervous system, is used for the classification of these grids to detect the ROI automatically. The SOM is trained by the unsupervised learning to produce a low-dimensional discretized representation of the input space of the training samples, and it uses a neighborhood function to preserve the topological properties of the input space, which makes it different from other artificial neural networks.
In this way, the SOM is able to classify the sub-blocks into n clusters only by the unsupervised learning. In our study, the output layer number n is set to 2 (ROI and non-ROI output) and the feature vector extracted from each grid is taken as the input. To map the sorted sub-blocks back to the size of the original ultrasonic images, the initial result of ROI detection can be represented by a binary image as shown in Fig. (2d), where white areas indicate the ROI candidates while black areas the non-ROIs.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="318" length="12"></location><text>breast tumor</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="494" length="14"></location><text>nervous system</text></annotation></passage></document><document><id>PMID-9804526</id><passage><offset>0</offset><text>Detection of total assist and sucking points based on the pulsatility of a continuous flow artificial heart: in vivo evaluation.
Our novel control strategy for a continuous flow artificial heart by detecting the total assist and sucking points based on pump pulsatility was evaluated in acute animal experiments using beagle dogs and our mixed flow pump. The pump was installed as a left ventricular (LV) bypass through a left thoracotomy. To change LV contractility, the left coronary arteries were occluded for 30 min, followed by a 120 min reperfusion. To change LV end diastolic pressure (LVEDP), dextran solution was rapidly infused. To estimate the pump pulsatility without any specific sensor, we calculated the index of current amplitude (ICA), which was obtained from the amplitude of the motor current waveform divided by the simultaneous mean value. To investigate the basic characteristics of the ICA, the pump speed was changed temporarily from 2,300 rpm to 5,000 rpm. In 92% of all measurements, the ICA plotted against the pump speed had a peak point (t-point) that corresponded highly with the turning point from partial to total assistance. The ICA also had a trough (s-point) that corresponded with the beginning of severe sucking in most cases. Only preload significantly influenced pump flow rate at the t-point from among preload (LVEDP), afterload (SAoP), and contractility (max LV dP/dt), by which we can simulate Starling's law of the natural heart. We concluded that a continuous flow artificial heart could be well controlled by detecting the t-point and s-point.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="450" length="2"></location><text>LV</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="566" length="2"></location><text>LV</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="383" length="16"></location><text>left ventricular</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1401" length="2"></location><text>LV</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="401" length="2"></location><text>LV</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1467" length="5"></location><text>heart</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="477" length="17"></location><text>coronary arteries</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T4" role=""></node><node refid="T5" role=""></node></relation></passage></document><document><id>PMID-9209451</id><passage><offset>0</offset><text>Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reaction.
Interferon alpha (IFN-alpha) induces cytogenetic responses of variable degree in patients with CML. We sought to establish the relationship between BCR-ABL transcript numbers measured by competitive two-step reverse transcription polymerase chain reaction (RT-PCR) and cytogenetic status in CML patients treated with IFN-alpha. All 398 samples from 163 patients investigated by RT-PCR were positive for BCR-ABL transcripts. In order to standardize results for variability in RNA and cDNA quality, we quantified total ABL transcripts in each sample as internal control. The BCR-ABL/ABL ratios correlated with the cytogenetic results. Quantitative nested PCR allowed the detection of residual BCR-ABL transcripts in all complete cytogenetic responders on IFN-alpha. We conclude that competitive PCR with internal controls is a reliable method for monitoring patients on IFN-alpha and reduces the need for repeated marrow investigations.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1055" length="6"></location><text>marrow</text></annotation></passage></document><document><id>PMID-15464487</id><passage><offset>0</offset><text>Flow dynamics of the internal thoracic and radial artery T-graft.
BACKGROUND:
Complex use of arterial conduits has resurrected concerns about the adequacy of conduit flow. The T-graft is the extreme example of this trend. Our purpose was to identify the limitation of single source inflow and to compare flow capacity with completion coronary flow.
METHODS:
Between February 1999 and November 2001, 372 patients underwent total arterial revascularization with the T-graft alone. Intraoperative flows were recorded for each limb of the T-graft before and after distal anastomoses in 204 patients. Independent predictors of T-graft flow were identified by multivariate analysis.
RESULTS:
Free flow for the radial arterial (RA) limb was 161 +/- 81 mL/min, the internal thoracic artery (ITA) limb 137 +/- 57 mL/min (combined 298 +/- 101 mL/min) versus simultaneous limb flow of 226 +/- 84 mL/min giving a flow restriction of 24% +/- 14%. Completion coronary flow was 88 +/- 49 mL/min for the RA, 60 +/- 45 mL/min for the ITA, and 140 +/- 70 mL/min for both limbs simultaneously to give a flow reserve (vs simultaneous free flow) of 160% or 1.6. Independent predictors of completion RA limb flow are RA proximal diameter (p = 0.005), number of anastomoses (p = 0.018), and target stenosis (p = 0.005).
CONCLUSIONS:
A flow reserve of 1.6 compares favorably with an ITA flow reserve of 1.8 at 1-month postoperatively and 1.8 for both the ITA T-graft and the ITA/RA T-graft at 1-week postoperatively as reported by others. Proximal RA diameter and competitive coronary flow influence completion T-graft flow. These data quantitate the limitation of single source inflow of the T-graft configuration and support its continued use.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="43" length="13"></location><text>radial artery</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="158" length="7"></location><text>conduit</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="93" length="17"></location><text>arterial conduits</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="704" length="25"></location><text>radial arterial (RA) limb</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="757" length="35"></location><text>internal thoracic artery (ITA) limb</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="334" length="8"></location><text>coronary</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="428" length="8"></location><text>arterial</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1053" length="5"></location><text>limbs</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1178" length="7"></location><text>RA limb</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1195" length="2"></location><text>RA</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="861" length="4"></location><text>limb</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1359" length="3"></location><text>ITA</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="945" length="8"></location><text>coronary</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1017" length="3"></location><text>ITA</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="21" length="17"></location><text>internal thoracic</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="988" length="2"></location><text>RA</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1431" length="3"></location><text>ITA</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1451" length="6"></location><text>ITA/RA</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="523" length="4"></location><text>limb</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1524" length="2"></location><text>RA</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1552" length="8"></location><text>coronary</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T25" role="Arg1"></node><node refid="T1" role="Arg2"></node></relation></passage></document><document><id>PMID-12748830</id><passage><offset>0</offset><text>Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.
Positron emission tomography (PET) has now gained a place in the management of patients with cancer, including those with Hodgkin's disease and non-Hodgkin's lymphoma. Restaging studies and those addressing the monitoring of response to treatment are especially in focus. Most of the knowledge gained has been achieved with dedicated BGO-based PET technology, but there are a number of developments that will impact on the use of this metabolic imaging technique in the investigation of patients with lymphoma. The challenges ahead are determined by the need for high-quality whole-body imaging associated with increased patient throughput and the need to investigate the role of new labelled ligands. The latter are likely to yield new insights into tumour cell characterisation, tumour behaviour and tumour outcome assessment. The study of new radiolabelled ligands will impose further demands for rapid dynamic data acquisition and accurate tracer quantification. Current and future developments in PET technology range from the use of new detector materials to different detector geometries and data acquisition modes. The search for alternatives to BGO scintillation materials for PET has led to the development of PET instruments utilising new crystals such as LSO and GSO. The use of these new detectors and the increased sensitivity achieved with 3D data acquisitions represent the most significant current developments in the field. With the increasing demands imposed on the clinical utilisation of PET, issues such as study cost and patient throughput will emerge as significant future factors. As a consequence, low-cost units are being offered by the manufacturers through the utilisation of gamma camera-based SPET systems for PET coincidence imaging. Unfortunately, clinical studies in lymphoma and other cancers have already demonstrated the limitations of this technology, with 20% of lesions &lt;15 mm in size escaping detection. On the other hand, the recent development of combined PET/CT devices attempts to address the lack of anatomical information inherent with PET images, taking advantage of further improvement in patient throughput and hence cost-effectiveness. Preliminary studies using this multimodality imaging approach have already demonstrated the potential of the technique. Although the potential exists, certain technical issues with PET/CT require refinement of the methodology. Such issues include organ movement (such as respiratory motion), which strongly influences the image fusion of a rapidly acquired CT scan with the slower acquisition of a PET dataset, and the derivation of CT-based attenuation coefficients in the presence of contrast agents or metallic implants. The application of the technology for radiotherapy planning also poses a number of associated challenges. Finally, the development of dedicated PET systems based on planar detector arrangements with new detector components has the potential to improve clinical throughput by over 100%, but clinical trials using such systems have still to be carried out in order to establish the associated whole-body image quality.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="75" length="8"></location><text>lymphoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="262" length="22"></location><text>non-Hodgkin's lymphoma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="211" length="6"></location><text>cancer</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="899" length="6"></location><text>tumour</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="920" length="6"></location><text>tumour</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="619" length="8"></location><text>lymphoma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="869" length="11"></location><text>tumour cell</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2020" length="7"></location><text>lesions</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2552" length="5"></location><text>organ</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1919" length="8"></location><text>lymphoma</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="3226" length="4"></location><text>body</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="2576" length="11"></location><text>respiratory</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1938" length="7"></location><text>cancers</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation></passage></document><document><id>PMID-15510029</id><passage><offset>0</offset><text>Neurologic diagnosis and treatment in patients with computed tomography and nasal endoscopy negative facial pain.
OBJECTIVE:
To determine the helpfulness of specialist neurology referral for patients with facial pain, a normal sinus computed tomography (CT) scan, and normal nasal endoscopy findings.
STUDY DESIGN:
Prospective identification of patients and analysis of data approved by the Institutional Review Board.
METHODS:
The data of 104 consecutive patients presenting with facial pain, a normal sinus CT scan, and normal nasal endoscopy findings were reviewed. The patients presented to a single rhinologist in a tertiary care institution. All patients were referred for specialist neurologic evaluation and potential treatment. Further information was obtained from a patient survey.
RESULTS:
Of the 104 patients, 81 were women and 23 were men. The average age was 46 years (range, 22-85). Fifty-six had clear CT scans, 48 had minimal change, and all had negative endoscopies. Twenty-nine had previous unsuccessful sinus surgery. The average follow-up period was 10.5 months. Forty of 75 patients seeing a neurologist were seen on multiple occasions. Four percent of patients seen by a neurologist had an unsuspected serious intracranial diagnosis. The most common diagnoses were migraine (37%), rebound headache (17%), chronic daily headache (17%), and obstructive sleep apnea (16%). Overall, 58% improved on medical therapy; 60% of those with a clear CT scan improved, and 53% of those with minimal change on CT scan improved (P = .749).
CONCLUSIONS:
Facial pain remains a difficult symptom to diagnose and treat in rhinologic practice. Patients often undergo surgery without help. Most patients with facial pain, a normal sinus CT scan, and normal endoscopy findings benefit from neurologic consultation. Serious intracranial pathologic conditions can be excluded and diagnosis-specific pharmacogenetic therapy instituted with improvement in more than 50%.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1024" length="5"></location><text>sinus</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1734" length="5"></location><text>sinus</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="227" length="5"></location><text>sinus</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="76" length="5"></location><text>nasal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="503" length="5"></location><text>sinus</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="275" length="5"></location><text>nasal</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="529" length="5"></location><text>nasal</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1562" length="6"></location><text>Facial</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1712" length="6"></location><text>facial</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1234" length="12"></location><text>intracranial</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1825" length="12"></location><text>intracranial</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="101" length="6"></location><text>facial</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="481" length="6"></location><text>facial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="205" length="6"></location><text>facial</text></annotation></passage></document><document><id>PMC-3086171-sec-12</id><passage><offset>0</offset><text>CONCLUSION
Intra-operative monitoring of partial pressure of tissue oxygen (PtiO2 ) is a very sensitive method of detecting the decrease of oxygen for cell utilization, due to decreased blood flow, during temporary clipping and after definitive clipping, in middle cerebral artery incidental unruptured aneurysm surgery. "Basal values", obtained without the influence of subarachnoid blood, were lower than expected in "uninjured" brain, and this fact, although unexplained, should be kept in mind in future investigation in this field. Although values that could be predictive of brain ischemia could not be established, an incomplete recovery or continuous decrease in PtiO2 values after definitive clipping should be considered an indicator of high risk for the development of post-operative brain infarction, and, therefore, an indication for verification of the position of the clip.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="371" length="18"></location><text>subarachnoid blood</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="431" length="5"></location><text>brain</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="265" length="15"></location><text>cerebral artery</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="303" length="8"></location><text>aneurysm</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="581" length="5"></location><text>brain</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="795" length="5"></location><text>brain</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="61" length="6"></location><text>tissue</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="186" length="5"></location><text>blood</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="151" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMID-1945393</id><passage><offset>0</offset><text>[Incidence of fungal infection in surgical diseases of the pancreas].
Recently the number of mycotic infections has increased significantly. Authors have observed 13 mycotic infections on operated patients suffering pancreatic diseases between 1984 and 1990. 9 of 13 patients had pancreatic abscesses as well. The risk factors of fungal infections are analysed. It is important to take differentiation between fungal colonisation and septicaemia caused by yeasts. Repeated microbiological examinations can promote recognising of the fungal invasion. The base of the therapy is to avoid risk factors of infections and to use antifungal medication in time.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="59" length="8"></location><text>pancreas</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="280" length="20"></location><text>pancreatic abscesses</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="216" length="10"></location><text>pancreatic</text></annotation></passage></document><document><id>PMID-11370224</id><passage><offset>0</offset><text>[H. pylori infection. Our experience with the quadruple and triple therapy as first pharmacologic approach].
For now the most used pharmacological treatment of first instance to eradication of Hp foresees utilization of triple therapy (PPI + two antibiotics). In our study we have compared this kind of treatment with the quadruple therapy (PPI + three antibiotics), that have showed a taller percentage of eradication at the end of first therapeutical cycle with a shorter time and lower price of treatment.
</text></passage></document><document><id>PMC-3274927-sec-07</id><passage><offset>0</offset><text>Supplementary Material
Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536812002796/hg5166sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536812002796/hg5166Isup2.hkl
Additional supplementary materials: crystallographic information; 3D view; checkCIF report
</text></passage></document><document><id>PMID-14525939</id><passage><offset>0</offset><text>The presence of nitrite during UVA irradiation protects from apoptosis.
Nitrite occurs ubiquitously in biological fluids such as blood and sweat, representing an oxidation product of nitric oxide. Nitrite has been associated with a variety of adverse effects such as mutagenicity, carcinogenesis, and toxicity. In contrast, here we demonstrate that the presence of nitrite, but not nitrate, during irradiation of endothelial cells in culture exerts a potent and concentration-dependent protection against UVA-induced apoptotic cell death. Protection is half-maximal at a concentration of 3 mM, and complete rescue is observed at 10 mM. Nitrite-mediated protection is mediated via inhibition of lipid peroxidation in a similar manner as seen with butylated hydroxytoluene, a known inhibitor of lipid peroxidation. Interestingly, nitrite-mediated protection is completely abolished by coincubation with the NO scavenger cPTIO. Using electron paramagnetic resonance (EPR) spectroscopy or Faraday modulation spectroscopy, we directly prove UVA-induced NO formation in solutions containing nitrite. In conclusion, evidence is presented that nitrite represents a protective agent against UVA-induced apoptosis due to photodecomposition of nitrite and subsequent formation of NO.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="413" length="17"></location><text>endothelial cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="527" length="4"></location><text>cell</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="103" length="17"></location><text>biological fluids</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="139" length="5"></location><text>sweat</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="129" length="5"></location><text>blood</text></annotation></passage></document><document><id>PMC-2267190-sec-04</id><passage><offset>0</offset><text>Background
Potato late blight, a disease caused by the oomycete pathogen Phytophthora infestans, is one of the world's most devastating crop diseases. World-wide losses due to late blight exceed several billion dollars annually [1]. Most of the potato cultivars currently grown in the United States are highly susceptible to late blight and control of this disease relies almost exclusively on fungicide applications. The most effective and environmentally sound way for controlling late blight is to incorporate natural resistance into potato cultivars. The pedigrees of many potato cultivars currently used in different countries include late blight resistant germplasm derived from Solanum demissum, Solanum andigena, and other wild species. However, most of the resistance derived from these wild species is controlled by single dominant resistance genes (R genes). These R genes are only effective in preventing the development of late blight if the invading P. infestans race contains the corresponding avirulence genes. This R gene-mediated resistance is often short-lived and is rapidly overcome by new races of the late blight pathogen.
Solanum bulbocastanum (2n = 2x = 24) is a diploid species that has adapted in the same environment as the late blight pathogen. This wild species was characterized as possessing durable resistance against P. infestans, even under high disease pressure [2,3]. Two resistance genes, RB (Rpi-blb1) and Rpi-blb2, have been cloned from S. bulbocastanum [4-6]. Both genes confer broad-spectrum resistance against a wide range of known P. infestans races. Transgenic potato lines containing a single RB gene showed a high-level resistance in the Toluca Valley, Mexico, where the potato fields are naturally intensively infested with the most diversified P. infestans populations [7]. Most interestingly, transgenic RB plants did not show total immunity to late blight, but instead showed a marked delay in both onset of symptoms and development of lesions. Such rate-limiting resistance may put less selection pressure on the P. infestans populations and protect the durability of this resistance gene. The RB gene therefore provides an excellent model to study the mechanism of broad-spectrum and rate-limiting disease resistances. An understanding of the underlying mechanism of this type of resistance is important for developing strategies to breed durable and sustainable disease resistance.
Several genes have been implicated in the regulation of R gene function. Of these genes, Rar1 and Sgt1 are among the most extensively studied genes. The Rar1 (required for Mla12 resistance) gene was first identified for its essential role in the function of a subset of Mla genes that confer resistance to barley powdery mildew [8]. The RAR1 protein contains two highly similar but distinct cysteine- and histidine-rich (CHORD) Zn2+-binding domains and was proposed to play a role in stabilizing R proteins in a confirmation that is implicated in receiving pathogen signals [9]. The Sgt1 gene (suppressor of the G2 allele of skp1) is an essential gene with multiple functions in yeast. SGT1 protein was initially identified as a RAR1-interacting partner in a yeast two-hybrid screen [10]. SGT1 may play a role in R protein accumulation [11]. Rar1 and Sgt1 genes are required in various R-gene mediated resistance against viral, bacterial, oomycete or fungal pathogens [12]. However, none of the previously studied R genes showed a race-non-specific and rate-limiting resistance phenotype as the RB gene. In addition, the role the Rar1 and Sgt1 genes are not universal and these genes are not essential for resistance involving some R genes [12,13].
Besides the two broad-spectrum resistance genes RB and Rpi-blb2, several race-specific late blight resistance genes have also been cloned [14-16]. Numerous late blight resistance genes have recently been mapped in various potato species or populations [17-25]. However, there is almost no information available about the resistance pathways mediated by any of these genes. As an initial effort to understand the RB-mediated late blight resistance pathway, we silenced the Rar1 and Sgt1 genes using an RNAi-based approach in a potato line containing the RB gene. We demonstrated that SGT1, but not RAR1, is essential for the RB-mediated broad-spectrum resistance to potato late blight.
</text><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1987" length="7"></location><text>lesions</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMID-20855870</id><passage><offset>0</offset><text>Acute ablation of Langerhans cells enhances skin immune responses.
Understanding the function of Langerhans cells (LCs) in vivo has been complicated by conflicting results from LC-deficient mice. Human Langerin-DTA mice constitutively lack LCs and develop exaggerated contact hypersensitivity (CHS) responses. Murine Langerin-diphtheria toxin receptor (DTR) mice allow for the inducible elimination of LCs and Langerin(+) dermal dendritic cells (dDCs) after administration of diphtheria toxin, which results in reduced CHS. When Langerin(+) dDCs have partially repopulated the skin but LCs are still absent, CHS returns to normal. Thus, LCs appear to be suppressive in human Langerin-DTA mice and redundant in murine Langerin-DTR mice. To determine whether inducible versus constitutive LC ablation explains these results, we engineered human Langerin-DTR mice in which diphtheria toxin ablates LCs without affecting Langerin(+) dDCs. The inducible ablation of LCs in human Langerin-DTR mice resulted in increased CHS. Thus, LC-mediated suppression does not require their absence during ontogeny or during the steady-state and is consistent with a model in which LCs actively suppress Ag-specific CHS responses.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="18" length="16"></location><text>Langerhans cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="97" length="16"></location><text>Langerhans cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="44" length="4"></location><text>skin</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="240" length="3"></location><text>LCs</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="402" length="3"></location><text>LCs</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="115" length="3"></location><text>LCs</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="177" length="2"></location><text>LC</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="529" length="16"></location><text>Langerin(+) dDCs</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="577" length="4"></location><text>skin</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="586" length="3"></location><text>LCs</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="637" length="3"></location><text>LCs</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="410" length="34"></location><text>Langerin(+) dermal dendritic cells</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="787" length="2"></location><text>LC</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="446" length="4"></location><text>dDCs</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="895" length="3"></location><text>LCs</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="917" length="16"></location><text>Langerin(+) dDCs</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="961" length="3"></location><text>LCs</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1025" length="2"></location><text>LC</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1163" length="3"></location><text>LCs</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T3" role=""></node><node refid="T4" role=""></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T8" role=""></node><node refid="T9" role=""></node></relation></passage></document><document><id>PMC-2710092-sec-01</id><passage><offset>0</offset><text>SUMMARY
This is a prospective study carried out to determine the outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. Sixty-three patients were evaluated between 1995 and 2001 who declined to undergo a planned cystectomy because they achieved a complete clinical response to neoadjuvant cisplatin-based chemotherapy. Herr assessed patient, tumor and treatment features for a median follow- up of 86 months, all patients being followed-up for more than 5 years. Forty patients (64%) survived, with 54% of them having an intact functioning bladder. The number and size of invasive tumors were strongly associated with the overall survival. The most significant treatment variable predicting better survival was complete resection of the invasive tumor on restaging transurethral resection (TUR) before starting chemotherapy. Of 23 patients (36%) who subsequently died of disease, 19 (30%) relapsed with invasive cancer in the bladder. Over 90% of the surviving patients had solitary, small and low-stage invasive tumors completely resected and 83% survived without relapses in the bladder.[1]
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="976" length="6"></location><text>cancer</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="990" length="7"></location><text>bladder</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="645" length="6"></location><text>tumors</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="810" length="5"></location><text>tumor</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1077" length="6"></location><text>tumors</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1145" length="7"></location><text>bladder</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="152" length="30"></location><text>muscle-invasive bladder cancer</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="604" length="7"></location><text>bladder</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="406" length="5"></location><text>tumor</text></annotation></passage></document><document><id>PMID-1482802</id><passage><offset>0</offset><text>Outcomes of cefazolin versus ceftriaxone therapy in treating lower respiratory tract infections in adults.
OBJECTIVE:
To determine whether choice of a first- versus third-generation cephalosporin as initial therapy for lower respiratory tract infections in hospitalized adults affects the course and duration of care, both of which may influence antimicrobial treatment cost.
DESIGN:
Retrospective analysis of discharge abstracts and hospital pharmacy records.
SETTING:
Forty-eight US acute-care hospitals.
PATIENTS:
One thousand ninety-two hospitalized adults (aged &gt; 17 y) with principal diagnoses of lower respiratory tract infections (DRGs 79-80, 89-90).
INTERVENTIONS:
Cefazolin or ceftriaxone, given as sole antimicrobial therapy for at least one day.
MAIN OUTCOME MEASURES:
(1) The number of patients who received another parenteral antibiotic anytime prior to hospital discharge; (2) the number of days during which patients received any parenteral antibiotic while in the hospital; and (3) the number of days patients remained hospitalized following the start of antibiotic therapy.
RESULTS:
Patients treated with cefazolin (n = 763) were more likely to receive another parenteral antibiotic while in the hospital (30.3 vs. 20.7 percent; p &lt; 0.001) and received more total days of therapy (7.2 vs. 6.7 d; p &lt; 0.05) than those treated with ceftriaxone (n = 329). Although the time to hospital discharge did not differ in the full sample (9.2 d for both groups), it was greater among those receiving cefazolin (8.6 vs. 8.0 d; p &lt; 0.05) when patients with lengths of stay exceeding 24 days were excluded from both groups.
CONCLUSIONS:
In addition to acquisition cost, differences in course and duration of care should be considered when determining the most cost-effective choice for antimicrobial therapy.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="219" length="23"></location><text>lower respiratory tract</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="61" length="23"></location><text>lower respiratory tract</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="603" length="23"></location><text>lower respiratory tract</text></annotation></passage></document><document><id>PMC-2822164-caption-01</id><passage><offset>0</offset><text>Demographic data of subjects
</text></passage></document><document><id>PMID-16201626</id><passage><offset>0</offset><text>Polybrominated diphenyl ethers in indoor dust in Ottawa, Canada: implications for sources and exposure.
Polybrominated diphenyl ethers (PBDEs) are widely used as additive flame retardants in plastics, soft furnishings, electrical and electronic equipment, and insulation in the indoor environment, and may be released indoors via volatilization or as dusts. The penta-and octa-brominated mixes are now banned in most parts of Europe, and phasing out of their use has recently begun in North America. This study follows a previous investigation into indoor air levels of PBDEs. House dust was analyzed from the family vacuum cleaners of 68 of the same 74 randomly selected homes, in Ottawa, Canada during the winter of 2002-2003. PBDEs, comprising on average 42% BDE-209, were found in all samples. The levels were log-normally distributed with a geometric mean sigmaPBDE of 2000 ng g(-1), and a median of 1800 ng g(-1) dust. The levels in dust did not correlate with questionnaire information on house characteristics. Correlations were found between pentamix congener levels in dust and in air from the same homes, but not for congeners of the more highly brominated mixes. Exposure scenarios are presented for mean and high dust ingestion rates, and compared against exposures from other pathways, for both adults and toddlers (6 months-2 years). Assuming a mean dust ingestion rate and median dust and air concentrations, adults would be exposed to ca. 7.5 ng sigmaPBDE d(-1) via the dust ingestion pathway, which represents approximately 14% of total daily exposure when compared to diet (82%) and inhalation (4%). However, for toddlers the equivalent intakes would be 99 ng d(-1), representing 80% of their daily PBDE exposure. At high dust ingestion rates these values increase to 180 ng d(-1) (80% daily intake) for adults and 360 ng d(-1) (89% daily intake) for toddlers. The data give a clearer picture of sources of PBDE exposure in the home environment and suggest that dust could be a significant exposure pathway for some individuals, particularly children.
</text></passage></document><document><id>PMC-2959669-sec-16</id><passage><offset>0</offset><text>Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (A2)
x y z Uiso*/Ueq
C1 0.3043 (3) 0.1779 (4) 0.79280 (13) 0.0445 (6)
C2 0.4358 (4) 0.1697 (5) 0.84058 (17) 0.0604 (8)
H2 0.4201 0.1476 0.8809 0.072*
C3 0.5911 (4) 0.1953 (6) 0.8269 (2) 0.0783 (12)
H3 0.6811 0.1914 0.8584 0.094*
C4 0.6130 (4) 0.2267 (6) 0.7670 (2) 0.0773 (11)
H4 0.7180 0.2427 0.7582 0.093*
C5 0.4818 (5) 0.2344 (5) 0.7202 (2) 0.0746 (10)
H5 0.4980 0.2547 0.6798 0.090*
C6 0.3257 (4) 0.2121 (4) 0.73293 (15) 0.0562 (7)
H6 0.2360 0.2200 0.7015 0.067*
C7 0.1252 (3) 0.3838 (4) 0.90059 (11) 0.0400 (6)
C8 0.2051 (4) 0.5522 (4) 0.90920 (13) 0.0484 (6)
H8 0.2132 0.6288 0.8758 0.058*
C9 0.2725 (4) 0.6041 (4) 0.96827 (15) 0.0558 (7)
C10 0.2645 (4) 0.4935 (4) 1.01861 (14) 0.0590 (8)
H10 0.3122 0.5293 1.0582 0.071*
C11 0.1830 (4) 0.3278 (4) 1.00819 (13) 0.0534 (7)
C12 0.1118 (3) 0.2699 (4) 0.95062 (12) 0.0480 (6)
H12 0.0561 0.1577 0.9451 0.058*
N1 0.0494 (3) 0.3297 (3) 0.84009 (10) 0.0441 (5)
H1N 0.038 (4) 0.418 (3) 0.8138 (12) 0.053*
O1 -0.0021 (3) 0.1298 (3) 0.74998 (9) 0.0527 (5)
O2 0.1112 (3) -0.0066 (3) 0.85135 (10) 0.0574 (6)
Cl1 0.37237 (16) 0.81541 (13) 0.97944 (5) 0.0927 (4)
Cl2 0.16462 (15) 0.18752 (15) 1.07089 (4) 0.0834 (4)
S1 0.10584 (7) 0.14095 (9) 0.80800 (3) 0.0412 (3)
</text></passage></document><document><id>PMC-2713402-sec-09</id><passage><offset>0</offset><text>Statistical Analysis
Mitochondrial DNA haplogroup frequencies were calculated by counting from the observed genotypes. The Pearson chi-square test and the chi-square test for linear-by-linear association were used to analyze the significances between the prevalence of haplogroups and different age groups. SPSS software (version 10.0) was used.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="21" length="13"></location><text>Mitochondrial</text></annotation></passage></document><document><id>PMID-10463077</id><passage><offset>0</offset><text>Antisense technologies have a future fighting neurodegenerative diseases.
Our growing understanding of the role that unfavorable patterns of gene expression play in the etiology of neurodegenerative disease emphasizes the need for strategies to selectively block the biosynthesis of harmful proteins in the brain. Antisense technologies are ideally suited to this purpose. Tailor-designed to target specific RNA, antisense oligonucleotides and ribozymes offer tools to suppress the production of proteins mediating neurodegeneration. Although technical limitations must still be overcome, the antisense approach represents a novel and exciting strategy for intervention in diseases of the central nervous system.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="307" length="5"></location><text>brain</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="689" length="22"></location><text>central nervous system</text></annotation></passage></document><document><id>PMC-2666640-sec-27</id><passage><offset>0</offset><text>Authors' contributions
CM, JRH, HJP, and JH carried animal studies. CM performed the statistical analysis. JLK conceived of the study, participated in its design and coordination, and drafted and edited the manuscript. All authors read and approved the final manuscript.
</text></passage></document><document><id>PMC-2709655-sec-17</id><passage><offset>0</offset><text>Discussion
Because Netherton syndrome exhibits allergic phenotype, it is reasonable to speculate that SPINK5, which is mutated in Netherton syndrome, may act as a candidate gene for asthma and other allergic diseases [9]. An extensive search for single nucleotide polymorphisms in the SPINK5 led to the identification of a number of SNPs, including six nonsynonymous SNPs in coding region that might perturb its immune function. Subsequent genotyping of three nonsynonymous SNPs, A1103G, G1156A and G1258A in two independent panels of British families showed a significant association between SNP G1258A (Glu420Lys) and atopy, atopic dermatitis, elevated serum IgE levels and asthma [10]. This association was confirmed in a large German population and two Japanese populations [16-18]. Kato et al analyzed eight SNPs in exon 13 and 14 of the SPINK5 including G1258A (Glu420Lys), and found a positive association of seven SNPs with atopic dermatitis in a Japanese study sample using a case-control study design [16]. Nishio et al surveyed five of six previously reported nonsynonymous SPINK5 SNPs in Japanese atopic families identified through asthmatic children or subjects with atopic dermatitis and found that SPINK5 was associated with development of atopic dermatitis but not asthma [17]. Kabesch M et al. analyzed G1258A (Glu420Lys) in a German population of school children, and found its association with asthma as well as a concomitant occurrence of asthma and atopic dermatitis [18]. However, two subsequent studies failed to replicate the original SPINK5 findings for allergic diseases [19,20]. Folster-Holst et al genotyped four nonsynonymous SNPs (Asp106Asn, Asn368Ser, Asp386Asn, and Glu420Lys), and detected no association between SPINK5 and atopic dermatitis in populations of Northern German origin [20]. Jongepier H et al. failed to detect any association between SPINK5 and asthma, atopic phenotypes and atopic dermatitis in a Dutch population [19]. These discordant findings probably reflect different genetic and environmental backgrounds in various populations. To determine whether nonsynonymous SNPs of the SPINK5 are involved in the pathogenesis of asthma in the Chinese Han population, we performed a case-control study by genotyping four nonsynonymous SNPs in the SPINK5. We did not detect any significant association between these nonsynonymous SNPs and asthma in our Chinese samples. With our sample size, we expected a power of at least 80% in detecting an effect of OR &gt;=1.3 for each of these SNPs. Therefore, our failure to detect an association for these 4 SNPs was not due to the sample size. These results suggest that the polymorphisms in the coding region of the SPINK5 are unlikely to contribute to asthma risk in the Chinese Han population. However, because our patients were ascertained for asthma, we could not exclude a role of the coding SNPs of the SPINK5 in atopic dermatitis in our population.
The variations in the regulatory sequences of genes may determine risks to common diseases by causing different levels of expression. Therefore, the identification and functional evaluation of polymorphisms in promoter region are of great value in understanding the genetic susceptibility to asthma. In order to determine the role of the SPINK5 promoter polymorphism in the pathogenesis of asthma, we genotyped a promoter polymorphism, -206G&gt;A, in 422 asthma patients and 410 controls, and found a marginal association. The frequency of allele G was significantly higher in asthmatic patients than that in controls (p = 0.022). To confirm the association, additional 267 asthma patients and 301 controls newly recruited from the same hospital were genotyped, and the -206G&gt;A polymorphism remained significantly associated with asthma (P = 0.001), even after Bonferroni correction(adjusted P = 0.01). To our knowledge, this is the first report of an association of -206G&gt;A polymorphism with asthma. We further examined the potential functional role of this promoter polymorphism, and found that the G to A substitution at -206 generated a GATA-3 transcription factor binding site.
Major transcription factors controlling Th1 and Th2 development, such as T-box transcription factor and GATA3, are possibly involved in asthma and atopic diseases. GATA-3, a transcription factor specifically expressed in T helper 2 (Th2) cells, plays a critical role in the differentiation of Th2 cells from uncommitted CD4+ lymphocytes. In addition, GATA-3 is essential for the expression of the cytokines IL-4, IL-5 and IL-13 that mediate allergic inflammation [23]. Our luciferase reporter assay confirmed that SNP -206G&gt;A is associated with the transcriptional activity of SPINK5. The G allele was associated with decreased transcriptional activity of the SPINK5. The mechanism by which the -206G&gt;A SNP affects SPINK5 expression may be explained by the potential differential transcription factor binding of GATA binding factor, since -206G&gt;A is located at the core sequence of GATA binding factor binding site. Electrophoretic mobility shift assay confirmed that the A to G substitution at -206 significantly reduced the binding efficiency of nuclear proteins to this element. Our data suggest that loss of GATA transcription factor regulation with the -206G may decrease the SPINK5 expression and thereby potentially perturb the immunosuppressive function of LEKTI.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="5168" length="7"></location><text>nuclear</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="655" length="5"></location><text>serum</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4341" length="22"></location><text>T helper 2 (Th2) cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4440" length="16"></location><text>CD4+ lymphocytes</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4413" length="9"></location><text>Th2 cells</text></annotation></passage></document><document><id>PMID-385804</id><passage><offset>0</offset><text>The origin of yolk-DNA in Xenopus laevis.
Xenopus laevis serum and plasma was found to contain an average of 25 microgram DNA/ml. Isolated X. laevis oocytes incubated in medium containing 25 microgram DNA/ml labeled with either 125I, 32P or 14C and from three different sources (bovine, E. coli and X. laevis), incorporated the label at an average rate of 0.11 ng.mm-2.hr-1. Sucrose gradient fractionation of oocytes revealed that 40-75% of the acid-precipitable label incorporated was associated with the yolk platelets. Additional incubations of oocytes in unlabeled medium demonstrated that the DNA incorporated into the yolk platelets was undergoing turnover; only 20% of the yolk-associated DNA was still present after a one-week incubation. Our data suggest that yolk-DNA arises by the adventitious uptake of DNA present in the maternal serum by vitellogenic oocytes.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="506" length="14"></location><text>yolk platelets</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="548" length="7"></location><text>oocytes</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="149" length="7"></location><text>oocytes</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="769" length="4"></location><text>yolk</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="409" length="7"></location><text>oocytes</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="843" length="5"></location><text>serum</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="865" length="7"></location><text>oocytes</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="624" length="14"></location><text>yolk platelets</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="680" length="4"></location><text>yolk</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="57" length="5"></location><text>serum</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="14" length="4"></location><text>yolk</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="67" length="6"></location><text>plasma</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation></passage></document><document><id>PMC-3248638-caption-17</id><passage><offset>0</offset><text>(iii) HIV testing response rate by educational attainment and gender.
</text></passage></document><document><id>PMC-2811192-caption-03</id><passage><offset>0</offset><text>Electrostatic interaction energies between the SNARE complex and fusing membranes.
(A) Schematic diagram and definitions of intermolecular interaction energies presented in (B) and (C). In (A) through (C), only the SNARE core complex is considered. Interaction free energies are calculated for (B) a series of SNARE/membrane distances and (C) different membrane lipid compositions. Arrow in (B) indicates the most physiologically relevant distance when the closest points between SNARE and membranes are 3 A, the thickness of a layer of water.[19] In (D) through (F), TMDs of VAMP and syntaxin are present and embedded in membranes. Furthermore, the C-terminus of the SNARE motif is partially unraveled into individual alpha-helices by molecular dynamics simulations to represent trans-SNARE complex. Interaction free energies are then calculated for (E) a series of SNARE motif C-terminus separation distances and (F) different lipid compositions of the membranes. Conclusions drawn from both groups of studies are essentially the same. V (circles): Interaction energies between the SNARE complex and the v-membrane. T (squares): Interaction energies between SNARE and the t-membrane. VT (triangles): Interaction energies between the v- and the t-membranes if the SNARE complex were extracted.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="955" length="9"></location><text>membranes</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1106" length="10"></location><text>v-membrane</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="490" length="9"></location><text>membranes</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1246" length="11"></location><text>t-membranes</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="622" length="9"></location><text>membranes</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1174" length="10"></location><text>t-membrane</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1235" length="2"></location><text>v-</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="72" length="9"></location><text>membranes</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="353" length="8"></location><text>membrane</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="316" length="8"></location><text>membrane</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T9" role="Arg1"></node><node refid="T10" role="Arg2"></node></relation></passage></document><document><id>PMC-2780376-sec-29</id><passage><offset>0</offset><text>Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2377/9/57/prepub
</text></passage></document><document><id>PMC-3039624-sec-11</id><passage><offset>0</offset><text>The importance in identifying genes involved in spinal curvature
Spinal curvature is a prevalent and costly deformity among humans and teleosts. The estimated annual cost of treating children hospitalized with idiopathic scoliosis (IS) in the United States alone is over $3 billion. This cost estimate does not consider Scheuermann kyphosis, or adults with idiopathic-type spinal curvature who suffer from chronic back pain, contributing to the estimated $849 billion cost of treatment and lost wages associated with musculoskeletal disease [24]. Among teleosts, spinal column deformities reduce total production in the aquaculture industry substantially [12]. In contrast to humans, teleost curve phenotypes are less well characterized; although heritable curves are acknowledged to account for many cases among cultured stocks, whether these cases are from congenital defects or are idiopathic-type is often not known.
Despite the prevalence and impact of this type of deformity, the genetic architecture and specific genes involved are unknown. The current view is that human idiopathic-type scoliosis is a complex genetic disorder with multiple genes segregating in the population exhibiting complex genotype by environment interactions [25-30]. In aquaculture stocks, inheritance for spinal curvature has been described as Mendelian recessive or dominant, as well as polygenic, depending on how well the phenotype is characterized and what stock is considered (reviewed in [13], [16]). The guppy curveback phenotype has been extensively characterized so that the lineage can be applied as a model for understanding the biological context of heritable spinal curvature [1,7-9]. Future studies can use approaches to map QTL affecting shape based on digital photos [31,32], rather than the qualitative scale used in the present study. The identification of QTL in this study is a first step in understanding the genetics of this type of deformity and will lead to the identification of biological pathways associated with spinal integrity.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="563" length="13"></location><text>spinal column</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1289" length="6"></location><text>spinal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="373" length="6"></location><text>spinal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="517" length="15"></location><text>musculoskeletal</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1656" length="6"></location><text>spinal</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2024" length="6"></location><text>spinal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="48" length="6"></location><text>spinal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="414" length="4"></location><text>back</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="65" length="6"></location><text>Spinal</text></annotation></passage></document><document><id>PMC-2673471-sec-01</id><passage><offset>0</offset><text>1. Introduction
Phase I clinical trials of new anticancer agents have been commonly conducted using the method of modified Fibonacci [1]. In brief, 3 patients are treated at a starting dose which is typically one tenth of the dose that is lethal to 10% of animals defined in preclinical studies. If none of the 3 patients experiences DLT, then the next 3 patients will be treated at the next higher dose. If DLT is observed, additional patients will be treated at the same or lower dose level to determine MTD according to a predetermined schema. The MTD is defined as the highest dose reached for which the incidence of DLT occurs in less than 33% of the subjects. Typically, intrapatient dose escalation is not allowed.
There are several shortcomings associated with the modified-Fibonacci design. It has long been recognized that a substantial number of patients are likely to be treated at subtherapeutic doses [2, 3]. This is particularly true for drugs with potential anticancer activity. Since the primary purpose of phase I trials is to determine DLT and MTD, the efficacy of the drug may not be evident for certain tumor types as there are only a small number of patients enrolled into the trial. Furthermore, the modified-Fibonacci design does not take into account individual variations in therapeutic and toxicologic responses due to genomic polymorphisms [4, 5]. In addition, since there is a limit of 3 subjects allowed for each cohort, a waiting period of up to four weeks is commonly required before enrollment of the next cohort of subjects. This latter requirement creates anxiety of waiting for eligible patients.
Several alternative phase I designs have been proposed which limit the number of patients accrued at each dose level and accelerate the dose escalation process [1, 6]. There has also been an increase in the number of clinical trials that include a component of intrapatient dose escalation although no formal validation with the modified-Fibonacci approach has been reported [7-9]. We have pioneered a population-based design to maximize therapeutic efficacy, to provide preliminary efficacy information and to allow derivation of a pMTD for subsequent phase II trials.
Irinotecan and cisplatin have been shown to have promising efficacy in patients with small-cell lung cancer in phase III trial where irinotecan was given on a weekly schedule [10]. We wished to perform a population-based phase I trial of irinotecan, given every 3 weeks, and carboplatin, a platinated anticancer drug which is generally better tolerated than its cisplatin analog.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1124" length="5"></location><text>tumor</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2288" length="22"></location><text>small-cell lung cancer</text></annotation></passage></document><document><id>PMC-394315-caption-04</id><passage><offset>0</offset><text>Collaxa BPEL Server Screenshot of Collaxa's bpelz design tool, building a choreography of GetHAPI and GetUMLS web services
</text></passage></document><document><id>PMID-17537580</id><passage><offset>0</offset><text>Long-term immunosuppression in burned patients assessed by in vitro neutrophil oxidative burst (Phagoburst).
OBJECTIVE:
To assess the duration and magnitude of immunosuppression induced by burns as measured by the neutrophil oxidative burst in vitro.
DESIGN:
Prospective exploratory cohort study.
SETTING:
Tertiary referral unit, University Hospital, Linkoping, Sweden (National Burn Unit). PATIENTS AND HEALTHY VOLUNTEERS (CONTROLS): Twenty-eight subjects consecutively admitted to the Burn Unit. The mean total burn surface area (TBSA%) was 36 (range 13-87) and mean age 44 years (range 14-89). Patients' data were collected prospectively in the burn unit, which also included sequential organ failure assessment (SOFA) score.
INTERVENTIONS:
None.
MEASUREMENTS AND RESULTS:
To assess the changes in the oxidative capacity of neutrophils after the burn, blood samples for the Phagoburst analysis were taken on admission and at least once every second week for the duration of stay in hospital and thereafter monthly up to 12 months after the burn. Neutrophils were stimulated in vitro by Escherichia coli, phorbol 12-phorbol myristate 13-acetate (PMA), and peptide N-formyl-Met-Leu-Phe (fMLP). Oxidative burst was measured by flow cytometry. Oxidative capacity of the neutrophils decreased similarly for all three stimulants: there was a pathological decrease shortly after admission, with the lowest value occurring between days 7 and 10, followed by a gradual recovery during the ensuing months. Full recovery (to the values of the controls) was seen first 3.5 months after the burn. Using multiple regression, we found that only age and time since the burn significantly (p&lt;0.05) affected the oxidative burst. White cell count (WCC) and C-reactive protein (CRP) values returned to reference ranges long before the oxidative burst.
CONCLUSIONS:
This study provides evidence that immunosuppression in those injured by burns, as assessed by the in vitro oxidative burst of neutrophils, remains long after the event of the burn (up to 3.5 months after burn). Absence of correlations to TBSA%, FTB%, blood transfusion, opiates provided, and multiple organ failure score and laboratory infection variables together with the finding that decreased oxidative burst was uniform after the injury, suggesting that this immunosuppression is primarily due to the general metabolic response rather than recurring infections.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1049" length="11"></location><text>Neutrophils</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1269" length="11"></location><text>neutrophils</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="827" length="11"></location><text>neutrophils</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2099" length="5"></location><text>blood</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="855" length="13"></location><text>blood samples</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2149" length="5"></location><text>organ</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1714" length="10"></location><text>White cell</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1974" length="11"></location><text>neutrophils</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="68" length="10"></location><text>neutrophil</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="690" length="5"></location><text>organ</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="214" length="10"></location><text>neutrophil</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation></passage></document><document><id>PMID-19269647</id><passage><offset>0</offset><text>Handling within run retention time shifts in two-dimensional chromatography data using shift correction and modeling.
The use of PARAFAC for modeling GC x GC-TOFMS peaks is well documented. This success is due to the trilinear structure of these data under ideal, or sufficiently close to ideal, chromatographic conditions. However, using temperature programming to cope with the general elution problem, deviations from trilinearity within a run are more likely to be seen for the following three cases: (1) compounds (i.e., analytes) severely broadened on the first column hence defined by many modulation periods, (2) analytes with a very high retention factor on the second column and likely wrapped around in that dimension, or (3) with fast temperature program rates. This deviation from trilinearity is seen as retention time-shifted peak profiles in subsequent modulation periods (first column fractions). In this report, a relaxed yet powerful version of PARAFAC, known as PARAFAC2 has been applied to handle this shift within the model step by allowing generation of individual peak profiles in subsequent first column fractions. An alternative approach was also studied, utilizing a standard retention time shift correction to restore the data trilinearity structure followed by PARAFAC. These two approaches are compared when identifying and quantifying a known analyte over a large concentration series where a certain shift is simulated in the successive first column fractions. Finally, the methods are applied to real chromatographic data showing severely shifted peak profiles. The pros and cons of the presented approaches are discussed in relation to the model parameters, the signal-to-noise ratio and the degree of shift.
</text></passage></document><document><id>PMID-9239276</id><passage><offset>0</offset><text>[Treatment of acute liver failure in children].
Among the main causes of acute liver failure (ALF) in children, metabolic diseases (especially in infants), viral and toxin or drug induced hepatitis are the most frequent. The cause remains, however, undetermined in about 30% of the cases. Management must be conducted in a pediatric hepatology unit or intensive care unit in relation with a pediatric transplant team in order: 1) to perform urgent etiological diagnosis; 2) to initiate specific therapy and symptomatic treatment; 3) to evaluate the severity and prognosis of liver disease for selection of children for emergency liver transplantation; 4) to evaluate contraindications to liver transplantation. The overall survival of post-emergency liver transplantation for ALF in children averages 65%.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="20" length="5"></location><text>liver</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="688" length="5"></location><text>liver</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="750" length="5"></location><text>liver</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="79" length="5"></location><text>liver</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="629" length="5"></location><text>liver</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="575" length="5"></location><text>liver</text></annotation></passage></document><document><id>PMID-8989261</id><passage><offset>0</offset><text>Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency.
Isolated GnRH deficiency is a heritable condition characterized by a functional deficit in GnRH secretion. Familial cases with different modes of inheritance have been described, and the gene responsible for the X-linked form (KAL-1) has been identified. However, sporadic cases with no documented family history of GnRH deficiency account for the majority of the affected patients. For this reason, we sought to determine the frequency with which KAL-1 gene mutations occur in patients with sporadic GnRH deficiency. Only 1 of 21 patients with sporadic GnRH deficiency was found to bear a defect in the KAL-1 gene (a deletion of 14 bases starting at codon 464). Three types of polymorphic single base substitutions with no apparent correlation with GnRH deficiency were also detected in several patients. In each of 3 different patients with an X-linked mode of inheritance, 3 genetic defects, 2 point mutations and a small intragenic deletion, were detected. These defects consist of a single base mutation introducing a stop codon at position 328, a single base mutation resulting in a phenylalanine to leucine substitution at position 517, and a 9-base deletion at the 3'-exon-intron splice site of exon 8, respectively. All identified genetic defects occur within the fibronectin type III repeats of the predicted protein encoded by the KAL-1 gene. In conclusion, our study indicates that the incidence of genetic defects within the coding region of the KAL-1 gene in patients with sporadic GnRH deficiency is low (5-8%), thus supporting the idea that the X-linked form of inheritance represents the least common form of the disease.
</text></passage></document><document><id>PMID-8102531</id><passage><offset>0</offset><text>Epilepsy in Down syndrome: clinical aspects and possible mechanisms.
Although epilepsy is more common in persons with trisomy 21 (Down syndrome) than in the general population, the mechanisms by which seizures are generated in this population have received little attention. It is likely that this increased seizure susceptibility is due to a combination of medical risk factors and inherent neurologic abnormalities characteristic of Down syndrome. In this review clinical aspects of seizures among individuals with Down syndrome were described and possible mechanisms by which the trisomy 21 brain may generate seizures were explored.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="392" length="10"></location><text>neurologic</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="594" length="5"></location><text>brain</text></annotation></passage></document><document><id>PMID-9503276</id><passage><offset>0</offset><text>Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.
In patients with Parkinson' disease and dopaminergic psychosis, clozapine treatment is recommended as the drug is free from extrapyramidal side effects and does not worsen motor symptoms of the underlying disease. The use of clozapine, however, is limited due to its hematotoxic side effects. For treatment of clozapine-induced agranulocytosis, granulocyte colony-stimulating factors (G-CSF) are recommended. We report the case of a 72-years-old male patient with clozapine-induced agranulocytosis and thrombopenia. Neutropenia was successfully treated with G-CSF, but thrombopenia persisted and resolved spontaneously after 14 days. Bone marrow toxicity of clozapine is not restricted to white cell maturation, but may also impair thrombocytopoesis.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="727" length="11"></location><text>Bone marrow</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="782" length="10"></location><text>white cell</text></annotation></passage></document><document><id>PMID-18953948</id><passage><offset>0</offset><text>[The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
OBJECTIVE:
To investigate the clinical and laboratory features of acute promyelocytic leukemia (APL).
METHODS:
513 APL patients in the last two decades were retrospectively analyzed in this research. We investigated the clinical features including age, sex, abnormality of peripheral hemogram before treatment, therapeutic effect and follow-up and laboratory data such as morphology, immunology, cytogenetics and molecular biology (MICM).
RESULTS:
The median age of the APL patients was 33 years old and the ratio of male and female was 1.21:1. Before treatment, the median level of WBC was 4.3 x 10(9)/L and the detection rate of abnormal promyelocyte on blood film was 85.8%; with immunophenotypic detection, the expression levels of CD117, CD34, HLA-DR, CD7, CD14 and CD19 in APL were found to be lower and the expression levels of CD2, CD33 and MPO higher than those in other subtypes of acute myelocytic leukemia (AML) (both P &lt; 0.01). Specific abnormal chromosome t (15;17) was detected in 91.7% of the patients, of whom 75.9% had standard translocation of t (15;17), being the most common one and 15.8% of the patients had t (15;17) with additional abnormal chromosome. There was only 7.5% of the patients with normal karyotype. However, the presence of both simple translocation and complex translocation was seldom seen. With molecular biological detection, PML/RARalpha fusion gene positive rate was 99.6%. In a relatively long clinical follow-up, we found that the complete remission (CR) rate in APL patients was 84.7%, incidence of DIC was 13.4% and five-year survival rate was 30.7%. The median count of WBC in CR group was lower than that non-remission group (P &lt; 0.01). There were no significant differences on expressions of CD34 and CD2 and changes of cytogenetics between the two groups (P &gt; 0.05).
CONCLUSIONS:
Comprehensive evaluation of MICM could be of important significance in the diagnosis and prognosis judgment for APL patients. The CR rate in these patients with high WBC count was considerable low.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1263" length="10"></location><text>chromosome</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1716" length="3"></location><text>WBC</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="754" length="5"></location><text>blood</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1057" length="10"></location><text>chromosome</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2095" length="3"></location><text>WBC</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="738" length="12"></location><text>promyelocyte</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="681" length="3"></location><text>WBC</text></annotation></passage></document><document><id>PMC-3181428-caption-05</id><passage><offset>0</offset><text>Absolute responder rates for medical management recommendations.
</text></passage></document><document><id>PMID-1683740</id><passage><offset>0</offset><text>Changes of lymphocyte subsets in leukemia patients who received allogenic bone marrow transplantation.
Proportional changes of lymphocyte subsets in the peripheral blood were monitored by two-color flow-cytometry in seven leukemia patients who had received allogenic bone marrow transplantation (BMT). Lymphocyte counts, and proportions of T and B-cells returned to normal ranges between the 2nd and 12th months after BMT. Activated T-cells prominently increased after BMT, and the values gradually returned toward normal. As to lymphocyte subsets, the proportions of CD 4+ cells had remained low, while those of CD 8+ cells high for a whole observation period after BMT. The changes of CD 4+ cells were caused by the decrease of suppressor-inducer T-cells (CD 4+ Leu 8+). High proportion of CD 8+ cells was mainly associated with increased suppressor T-cells (CD 8+ CD 11+). Among natural killer (NK) cells, highly active NK cells (CD 16+ CD 57-) markedly increased shortly after BMT, and gradually returned to normal. CD 16 -CD 57+ NK cells increased beyond normal ranges after the 2nd month. The incidence or degree of acute and chronic graft-versus-host diseases (GVHD) did not correlate with the changes of any lymphocyte subsets. The present results suggest that the increase of activated T-cells shortly after BMT reflects lymphocyte reconstitution. The prolonged immune deficiency after BMT might be related to either deficient expression of homing receptor (Leu 8 antigen) on CD 4+ cells or increased suppressor T-cells (CD 8+ CD 11+). In addition, the early increase of NK cells after BMT may compensate for the immune deficiency in BMT patients.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="302" length="10"></location><text>Lymphocyte</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="340" length="1"></location><text>T</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="153" length="16"></location><text>peripheral blood</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="267" length="11"></location><text>bone marrow</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="346" length="7"></location><text>B-cells</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1140" length="5"></location><text>graft</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="433" length="7"></location><text>T-cells</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1580" length="8"></location><text>NK cells</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1510" length="18"></location><text>suppressor T-cells</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1485" length="11"></location><text>CD 4+ cells</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1330" length="10"></location><text>lymphocyte</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1295" length="7"></location><text>T-cells</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1216" length="10"></location><text>lymphocyte</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="11" length="10"></location><text>lymphocyte</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="127" length="10"></location><text>lymphocyte</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="74" length="11"></location><text>bone marrow</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="529" length="10"></location><text>lymphocyte</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="568" length="11"></location><text>CD 4+ cells</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="613" length="11"></location><text>CD 8+ cells</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="687" length="11"></location><text>CD 4+ cells</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="730" length="26"></location><text>suppressor-inducer T-cells</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="792" length="11"></location><text>CD 8+ cells</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="841" length="18"></location><text>suppressor T-cells</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="882" length="25"></location><text>natural killer (NK) cells</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="923" length="8"></location><text>NK cells</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1020" length="22"></location><text>CD 16 -CD 57+ NK cells</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T8" role="Arg2"></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T26" role=""></node></relation></passage></document><document><id>PMC-3191169-sec-14</id><passage><offset>0</offset><text>ERK signaling is involved in decreasing BDNF-induced gene activity via Eph receptors
Data provided so far suggest that ephrin-A5 might counteract BDNF-mediated gene expression and growth cone responses via decreasing ERK activity and nuclear localization (Figs. 2 and 3). To test this hypothesis more directly, we analyzed whether Eph forward signaling can still suppress BDNF-stimulated IEG induction and growth cone collapse when ERK kinase activity was experimentally raised. For this, ERK activity was elevated by expressing constitutively-active MEK1 (CA-MEK1), an ERK upstream activator, in cortical neurons (Fig. S3). Subsequently, neurons were subjected to either an ephrin-A5 mediated growth cone collapse assay (Fig. 5) or stimulated with guidance cues for 20 minutes and IEG mRNA levels were quantified via qRT-PCR (Fig. 6).
10.1371/journal.pone.0026089.g005 Figure 5
Constitutively-active MEK1 blocks ephrin-A5 mediated growth cone collapse.
Wild-type neurons were electroporated with vectors expressing GFP (control; A, C, E) or expressing a FLAG-tagged constitutively-active MEK1 (CA-MEK1; B, D, F). Neurons were treated with ephrin-A5-Fc for 30 min followed by visualization of GFP (A, C, E) or CA-MEK-1 (green in B, D, F), F-actin and betaIII tubulin. (A, B) Overexpression of CA-MEK1 (B) reduces mean neurite length compared to a control GFP-expressing neuron (A). (C-F) A control growth cone without ephrin-A5 application (C) typically protrudes multiple filopodia (arrow). CA-MEK-1 expressing growth cones (D) were indistinguishable from a GFP-expressing growth cone. Note that CA-MEK1 was expressed in a dot-like pattern in the growth cone (arrowheads in D and F). Upon ephrin-A5 application, a control growth cone (E) collapsed resulting in only few filopodia. In contrast, a CA-MEK1 expressing growth cone (F) was only partially collapsed and many filopodia structures were preserved after ephrin-A5 induction. (G) Quantification of average neurite length. (H, I) Quantification of growth cone area (H) and filopodia number/growth cone (I) in the four conditions. Ephrin-A5 induces a growth cone collapse, resulting in reduced growth cone area and filopodia number in GFP but not CA-MEK1 expressing neurons. Scale-bar (A, B) = 10 microm; (C-F) = 2 microm.
10.1371/journal.pone.0026089.g006 Figure 6
Ephrin-A5 suppresses BDNF-induced IEG responses via MAP kinase signaling.
Wild-type cortical neurons, mock-electroporated (black bars) or with a vector expressing constitutively-active MEK1 (white bars), were treated with guidance cues for 20 minutes as depicted, followed by mRNA quantification. In mock-electroporated neurons, BDNF induced an IEG response of c-fos (A), Egr1 (B), Egr2 (C) and Arc (D). Co-application of ephrin-A5 and BDNF reduced mRNA levels of all four IEGs in mock-electroporated neurons (A-D). In contrast, expression of constitutively-active MEK1 prevented Eph forward signaling from suppressing BDNF-evoked IEG responses. This was most evident for the IEGs Egr1 (B) and Egr2 (C).
First of all, we analyzed the impact of CA-MEK1 on neurite outgrowth and ephrin-A5 mediated growth cone responses (Fig. 5). The average neurite length of neurons overexpressing CA-MEK1 (Fig. 5B) was clearly reduced compared to control GFP expressing neurons (Fig. 5A; see quantification in (G)). Growth cones of GFP (C) and CA-MEK1 expressing neurons were similar and protruded many filopodia (arrows in Fig. 5C-F). CA-MEK1 expression in growth cones was confined to individual dot-like structures (arrowheads in Fig. 5D, F). Ephrin-A5 application on a GFP expressing control growth cone (Fig. 5E) resulted in a growth cone collapse as revealed by reduced overall growth cone area and filopodia number (quantified in Fig. 5H, I). In contrast, in neurons overexpressing CA-MEK1 (Fig. 5F), ephrin-A5 induced only a partial growth cone collapse. Thus, growth cone area and filopodia number were not reduced (see Fig. 5H, I). This result suggests that an ephrin-A5 induced signaling cascade targets MAP kinase signaling to exert a full growth cone collapse. This result is in contrast to a recent report [46] which excluded ERK signaling downstream of an ephrin-A5 mediated growth cone collapse.
Next, we tested whether ephrin-A5 signaling suppresses ERK kinase signaling also to interfere with BDNF-mediated gene expression (Fig. 6). In agreement with previous results (Fig. 4), in mock-electroporated neurons, ephrin-A5 incubation reduced the BDNF-mediated up-regulation of c-fos (Fig. 6A), Egr1 (Fig. 6B), Egr2 (Fig. 6C) and Arc (Fig. 6D) mRNA. In contrast, in neurons over-expressing CA-MEK1, ephrin-A5 could not suppress BDNF-induced IEG responses to the same degree. Particularly Egr1 (Fig. 6B) and Egr2 (Fig. 6C) mRNA levels were almost identical when comparing neurons treated with BDNF alone and neurons with BDNF and ephrin-A5 together.
Thus, ephrin-A5 represses gene activity elicited by BDNF at least in part via MAP kinases.
Besides IEGs, we inspected the influence of both guidance cues on cytoskeletal genes, whose gene products might modulate cytoskeletal dynamics evoked by ephrin-As and/or neurotrophins (Fig. S4). Therefore, the filamentous actin (F-actin) stabilizing tropomyosins (Tpm1 and Tpm2), the F-actin cross-linker alpha-actinin 1 (Actn1) and the motor protein dynein light chain 1 (Dnal1) were analyzed. mRNA levels of other cytoskeletal genes were not altered by any of the guidance cues (i.e. cofilin, filamin A, mena, vinculin and smooth muscle actin; data not shown). Short-term stimulation with guidance cues did not result in major alterations of cytoskeletal mRNA levels except for upregulation of Tpm1 by ephrin-A5 (Fig. S4A). At 16h of incubation, both tropomyosin genes were induced by BDNF and ephrin-A5 alone and both together (Fig. S4B, D). Actn1 levels were induced by individual application of ephrin-A5 and BDNF and by co-application of both (Fig. S4F). A similar profile was observed for the dynein light chain (Fig. S4H).
Taken together, cytoskeletal gene expression was modulated by ephrin-A5 and BDNF. In contrast to the antagonistic impact on the IEG gene response (Figs. 4 and 6), ephrin-A5 and BDNF resulted in rather synergistic action on cytoskeletal gene expression. This difference might be due to short-term (i.e. 20 minutes) vs. long-term (i.e. 16h) exposure of both guidance cues in the IEG and cytoskeletal gene response, respectively.
</text><annotation id="T29"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3161" length="7"></location><text>neurite</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3117" length="11"></location><text>growth cone</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3076" length="7"></location><text>neurite</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2822" length="7"></location><text>neurons</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2641" length="7"></location><text>neurons</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2170" length="9"></location><text>filopodia</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2149" length="11"></location><text>growth cone</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2106" length="11"></location><text>growth cone</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2029" length="9"></location><text>filopodia</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2046" length="11"></location><text>growth cone</text></annotation><annotation id="T62"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1512" length="12"></location><text>growth cones</text></annotation><annotation id="T63"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1963" length="7"></location><text>neurite</text></annotation><annotation id="T38"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3771" length="7"></location><text>neurons</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3710" length="9"></location><text>filopodia</text></annotation><annotation id="T39"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3846" length="11"></location><text>growth cone</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3601" length="11"></location><text>growth cone</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3463" length="12"></location><text>growth cones</text></annotation><annotation id="T36"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3689" length="11"></location><text>growth cone</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3637" length="11"></location><text>growth cone</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3179" length="7"></location><text>neurons</text></annotation><annotation id="T61"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3321" length="12"></location><text>Growth cones</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3368" length="7"></location><text>neurons</text></annotation><annotation id="T60"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="180" length="11"></location><text>growth cone</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3275" length="7"></location><text>neurons</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1318" length="7"></location><text>neurite</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1370" length="6"></location><text>neuron</text></annotation><annotation id="T49"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="5169" length="11"></location><text>filamentous</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="964" length="7"></location><text>neurons</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1114" length="7"></location><text>Neurons</text></annotation><annotation id="T48"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="5080" length="12"></location><text>cytoskeletal</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1473" length="9"></location><text>filopodia</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1574" length="11"></location><text>growth cone</text></annotation><annotation id="T43"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="4195" length="11"></location><text>growth cone</text></annotation><annotation id="T42"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="4057" length="11"></location><text>growth cone</text></annotation><annotation id="T41"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3895" length="9"></location><text>filopodia</text></annotation><annotation id="T40"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3874" length="11"></location><text>growth cone</text></annotation><annotation id="T47"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="5025" length="12"></location><text>cytoskeletal</text></annotation><annotation id="T46"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4826" length="7"></location><text>neurons</text></annotation><annotation id="T45"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4790" length="7"></location><text>neurons</text></annotation><annotation id="T44"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4585" length="7"></location><text>neurons</text></annotation><annotation id="T50"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="5375" length="12"></location><text>cytoskeletal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="234" length="7"></location><text>nuclear</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="639" length="7"></location><text>neurons</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="597" length="16"></location><text>cortical neurons</text></annotation><annotation id="T59"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3408" length="9"></location><text>filopodia</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="406" length="11"></location><text>growth cone</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="694" length="11"></location><text>growth cone</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="932" length="11"></location><text>growth cone</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1398" length="11"></location><text>growth cone</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1648" length="11"></location><text>growth cone</text></annotation><annotation id="T52"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="5484" length="13"></location><text>smooth muscle</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1723" length="11"></location><text>growth cone</text></annotation><annotation id="T51"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="5603" length="12"></location><text>cytoskeletal</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1771" length="9"></location><text>filopodia</text></annotation><annotation id="T54"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="6213" length="12"></location><text>cytoskeletal</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1816" length="11"></location><text>growth cone</text></annotation><annotation id="T53"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="6006" length="12"></location><text>cytoskeletal</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1870" length="9"></location><text>filopodia</text></annotation><annotation id="T56"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4424" length="7"></location><text>neurons</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2004" length="11"></location><text>growth cone</text></annotation><annotation id="T55"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="6375" length="12"></location><text>cytoskeletal</text></annotation><annotation id="T58"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2221" length="7"></location><text>neurons</text></annotation><annotation id="T57"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2405" length="16"></location><text>cortical neurons</text></annotation></passage></document><document><id>PMID-21822531</id><passage><offset>0</offset><text>Massive osteolysis in a dog resembling Gorham's disease in humans.
An eight-month-old mixed-breed dog was presented with a history of sudden onset pelvic limb lameness. Radiographic and computed tomographic examinations demonstrated an osteolytic process involving the lumbar spine and pelvis. A comprehensive work-up including serial radiographic skeletal survey, biopsy, routine laboratory investigation and evaluation of parathyroid hormone (PTH) and 25-hydroxy-vitamin D levels failed to reveal any underlying cause for the osteolysis. Conservative treatment using the bisphosphonate drug alendronate and oral analgesic medications resulted in a return to nearly normal long-term function, despite massive lumbar and pelvic osteolysis. The clinical, radiological and histopathological features in this dog are reported, and similarities with the human condition known as Gorham's disease are discussed.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="348" length="8"></location><text>skeletal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="147" length="11"></location><text>pelvic limb</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="286" length="6"></location><text>pelvis</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="269" length="12"></location><text>lumbar spine</text></annotation></passage></document><document><id>PMC-3072624-caption-03</id><passage><offset>0</offset><text>Encoding methods of SOLiDzipper.
Notes: A) The quality value in QV files from ABI SOLiD system ranges from -1 to 40, which requires 6 bit space. The remaining 2 bit space out of 1 byte can be used for storing another quality value in part. B) Csfasta files contain the sequence information in four digits, '0123', which require 2 bit space. Provided that '0', 1 byte character in csfasta files, is mapped as binary data '00', '1' as '01', '2'as '10', '3' as '11', 4 byte data '0113' can be encoded into 1 byte character 0x17(00010111) through shift operation. C) Sequence IDs are extracted from QV and csfasta files, combined, and compressed using the general purpose compression methods. D) Encoded data are stored as data blocks of fixed size. This allows for selective decoding.
</text></passage></document><document><id>PMC-2701282-sec-04</id><passage><offset>0</offset><text>2.2.
Iris and Ciliary Body
Serotonin is present in mammalian iris-ciliary body complex (ICB) at higher concentration that in non-mammalian species [5, 45, 73, 129, 137]. Moreover, the presence of serotonergic nerves has been demonstrated in studies conducted on the ICB of various species [102, 137, 138]. Experimental evidence and radioligand analyses have defined the presence at this level of three different types of serotonin receptors [10, 28, 85, 136, 137], i.e. 5-HT1A, 5-HT2A/2C and 5-HT7 [98], one linked to a stimulation of inositol phosphates (5-HT2 subtype), while the others two are linked to cAMP activity.
The plausibility of the existence of more than one 5-HT receptor type in the ciliary body is confirmed by intraocular pressure (IOP) experiments. Topical application of serotonin has been reported to both elevate [84] and lower [88] IOP in rabbit. A large number of reports have shown that serotonin agonists and antagonists can produce increases and decreases in IOP when given orally, topically to the eye or when they are directly injected in the anterior chamber [10, 26, 34, 35, 64, 75, 84, 87, 88, 112, 113, 126, 136, 137]. A rationale for such apparently contradictory results may be due to the different sites of action, i.e. which class of serotonin receptor is activated. In fact, in rabbit the administration of 5-methyl-urapidil (a combined 5-HT1A agonist/alpha1 adrenoreceptor antagonist) and 8-OH-DPAT (8-hydroxydypropylaminotetralin, a 5HT1A agonist) reduces IOP, while the administration of 5-CT (5-carboxamidotryptamine, a 5-HT1A and 5-HT7 agonist) increases IOP [36, 84, 99].
Chidlow, Le Corre and Osborne [28] have recently demonstrated that, in section taken through the whole eye and ciliary body, prominent 5-HT1A and 5-HT7 receptor messenger ribonucleic acid signals were obtained. These signals were evident in both the pigmented and non-pigmented epithelial cell layers of the pars plicata region of the ciliary processes, but not in the pars plana or in the ciliary musculature. 5-HT1A and 5-HT7 signals were apparent in the posterior processes but not in the iris processes. The presence of both receptors in the ciliary body would certainly provide an explanation for the shallow displacement curves observed in [3H]5-HT binding studies with the tissue [110], since this ligand can be used to label both receptors. Because the ciliary epithelium of the pars plicata is responsible for the secretion of aqueous humor, an obvious function for these two receptors would be an involvement in the control of aqueous production and, consequently, of the IOP level. Further, the almost identical distribution of the 5-HT1A and 5-HT7 messengers ribonucleic acid indicate that the receptors may be co-localized in epithelial cells. The presence of two serotonin receptors with opposing effects on cAMP in the same cell layer prompts the suggestion that they could act antagonistically. The agonism of 5-HT1A receptors, negatively coupled to cAMP, reduces IOP by decreasing the production of aqueous humor, like beta-receptor antagonists which, diminishing the content of cAMP at the postjunctional site, lowers the aqueous humor secretion with a consequent decrease in IOP [98]. On the contrary, the administration of 5-CT induces a rise in IOP, which is partly or entirely caused by an increase in aqueous humor secretion mediated by 5-HT7 receptors [84].
The other type of serotonin receptor present in the ICB is a 5-HT2 type. Serotonin stimulates the accumulation of inositol phosphates in the ICB and this effect is partially counteracted by the 5-HT2 antagonists ketanserin, methysergide and mianserin [98]. Studies with ketanserin have demonstrated that, when orally or topically applied, it lowers IOP in animals, healthy volunteers and in glaucomatous patients [26, 34, 37, 64, 75, 88, 113, 126]. It has been emphasized that ketanserin also possesses an affinity for alpha1-adrenoreceptors [27, 36, 139], and for this reason the effects of ketanserin on IOP may not be entirely caused by its action on 5-HT2 receptors. However, data from human studies conducted after oral or topical administration of ketanserin, in which were determined the variations of IOP, total outflow facility and pupil diameter, demonstrated that the alpha1-adrenoreceptor blocking effect exerted by ketanserin should represent a further aspect of its mechanism of action, probably due to a functional sharing of these receptors [64, 87]. Lastly, already in 1992 Martin and co-workers showed the occurrence of a significant correlation between the content of serotonin in the aqueous humor and IOP in the human eye [85].
In 1981, Moro and his collaborators found that intravitreal injection of 5, 6-dihydroxytryptamine, a serotonergic neurotoxin, causes miosis [91]. The identification of 5-HT7, but not of 5-HT1 receptors in the rabbit iris, suggests that this population of serotonergic receptors is involved in the relaxation of the sphincter of the pupil. In fact, one of the function correlate to 5-HT7 receptor activation includes smooth muscle relaxation observed in a variety of isolated tissue preparations, in which elevation of cAMP concentration was also detected [3, 44]. Further evidence for the mediation of the relaxant response via the 5-HT7 receptor is provided by the localization of messenger ribonucleic acid transcripts encoding the 5-HT7 receptor in many blood vessels [67]. This hypothesized mechanism of action is also supported by the fact that various other receptor types, also positively coupled to cAMP, in the iris cause relaxation of the sphincter muscle [1, 28].
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="266" length="3"></location><text>ICB</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="699" length="12"></location><text>ciliary body</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="88" length="3"></location><text>ICB</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="209" length="6"></location><text>nerves</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="5063" length="13"></location><text>smooth muscle</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4979" length="5"></location><text>pupil</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="4962" length="9"></location><text>sphincter</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="728" length="11"></location><text>intraocular</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4863" length="4"></location><text>iris</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1072" length="16"></location><text>anterior chamber</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="4637" length="3"></location><text>eye</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4239" length="5"></location><text>pupil</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="3539" length="3"></location><text>ICB</text></annotation><annotation id="T40"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2855" length="4"></location><text>cell</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="3450" length="3"></location><text>ICB</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2403" length="12"></location><text>pars plicata</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="2377" length="18"></location><text>ciliary epithelium</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="14" length="12"></location><text>Ciliary Body</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="61" length="25"></location><text>iris-ciliary body complex</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5" length="4"></location><text>Iris</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1719" length="3"></location><text>eye</text></annotation><annotation id="T38"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3348" length="5"></location><text>humor</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1727" length="12"></location><text>ciliary body</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3164" length="5"></location><text>humor</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1894" length="15"></location><text>epithelial cell</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1924" length="12"></location><text>pars plicata</text></annotation><annotation id="T39"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="4610" length="5"></location><text>humor</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1951" length="7"></location><text>ciliary</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2755" length="16"></location><text>epithelial cells</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1985" length="10"></location><text>pars plana</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="5596" length="16"></location><text>sphincter muscle</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2006" length="19"></location><text>ciliary musculature</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2108" length="4"></location><text>iris</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1026" length="3"></location><text>eye</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2162" length="12"></location><text>ciliary body</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="5122" length="6"></location><text>tissue</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="2296" length="6"></location><text>tissue</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5567" length="4"></location><text>iris</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5404" length="13"></location><text>blood vessels</text></annotation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T27" role="Arg1"></node><node refid="T28" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T20" role="Arg1"></node><node refid="T21" role="Arg2"></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T3" role=""></node><node refid="T4" role=""></node></relation></passage></document><document><id>PMC-2652060-sec-11</id><passage><offset>0</offset><text>Results

</text></passage></document><document><id>PMC-1933192-sec-01</id><passage><offset>0</offset><text>INTRODUCTION
Comparing genomic sequences across related species is a fruitful source of biological insight. Functional elements such as exons tend to exhibit significant sequence similarity due to purifying selection, whereas regions that are not functional tend to be neutrally evolving and thus less conserved. The first step in comparing genomic sequences is to align them--to map the letters of the sequences to each other. After an alignment is computed, visualization frameworks become essential to enable users to interact with the sequence and conservation data, especially in the context of longer DNA sequences or whole genomes. Visualization frameworks should be easy to understand by a biologist and provide insight into the mutations that a particular genomic locus has undergone.
The VISTA portal is a comprehensive comparative genomics resource that provides biomedical scientists with a single unified framework to generate and download multiple sequence alignments, visualize the results in the context of existing annotations and analyze comparative results in search for important sequence signals in alignments. The VISTA suite of programs has been in development and continued use since 2000 (1-4). It was originally developed for the alignment and comparative analysis of long genomic sequences and later was expanded to pair-wise and multiple alignment of vertebrate genomes. VISTA has popularized the visualization of the level of conservation in the format of a continuous curve based on the conservation in a sliding window. This concept proved to be extremely successful due to the easy interpretation of the resulting plots.
VISTA was built through a close collaboration between computational and biological scientists, resulting in a product that is robust, efficient and powerful, yet simple to use for a person without extensive computer experience, as is illustrated by more than 1000 citations to the various VISTA-associated tools (according to http://scholar.google.com).
In the last 2 years the VISTA portal has seen many significant improvements. In addition to updating the whole genome alignments, computed using recent assemblies of vertebrate, insect, plant and microbial genomes, we have added significant new functionality and resources to the Genome Browser and other tools, including: 
A novel multiple whole genome alignment algorithm.
A new server for whole-genome alignment of bacterial genomes.
Base-pair level visualization ability within the VISTA browser.
Visual access to the results of the prediction of potential deleteriousness of non-synonymous Single Nucleotide Polymorphisms (SNPs) by the algorithm PolyPhen (5).
A novel conservation track, Rank-VISTA, to show the statistical significance of conserved regions computed by the Gumby algorithm (6).
Whole-genome rVISTA, that allows for evaluation of which conserved transcription factor binding sites (TFBS) are over-represented in a group of genes.
</text></passage></document><document><id>PMC-137449-sec-08</id><passage><offset>0</offset><text>Competing interests
None declared.
This article is the third in an ongoing, educational review series on medical statistics in critical care. Previous articles have covered 'presenting and summarising data' [3] and 'samples and populations' [4]. Future topics to be covered include power calculations, comparison of means, comparison of proportions, and analysis of survival data to name but a few. If there is a medical statistics topic you would like explained contact us on editorial@ccforum.com .
</text></passage></document><document><id>PMID-8064416</id><passage><offset>0</offset><text>Imaging techniques for the assessment of body composition.
Three imaging methods, ultrasound imaging (UI), computer-assisted axial tomography (CAT) and magnetic resonance imaging (MRI), are widely used in medicine. Their application to the assessment of body composition in nutrition research is still being explored and developed. Ultrasound imaging yields poor image quality but, because it is cheap and safe, deserves further exploration. Both CAT and MRI can produce images with good discrimination among bone, muscle and adipose tissue. Movement artifacts tend to be more serious in MRI than in CAT due to the longer imaging time. On the other hand, the X-ray exposure in CAT is likely to limit its use in human nutrition research. Repeated measurements of tissue volumes by CAT and MRI give similar CV. In both CAT and MRI, intra-abdominal adipose tissue presents greater problems of measurement than subcutaneous adipose tissue. Validation studies with 77-kg pigs of MRI, using 13 slices, predicted total body lipid with residual standard deviation of 1.9%. In validating any of these methods, account should be take of the extent to which the information they give can augment that given by more simple measures like age and weight.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="907" length="27"></location><text>subcutaneous adipose tissue</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="41" length="4"></location><text>body</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="762" length="6"></location><text>tissue</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="836" length="24"></location><text>abdominal adipose tissue</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="254" length="4"></location><text>body</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1012" length="4"></location><text>body</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="509" length="4"></location><text>bone</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="526" length="14"></location><text>adipose tissue</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="515" length="6"></location><text>muscle</text></annotation></passage></document><document><id>PMC-2646243-sec-01</id><passage><offset>0</offset><text>Background

</text></passage></document><document><id>PMC-1828719-sec-06</id><passage><offset>0</offset><text>Mass casualty estimation on a geographic basis
The Defense Threat Reduction Agency (DTRA) has expended considerable effort to develop models for calculating mass casualties from a nuclear detonation. In order to specifically evaluate urban medical systems vulnerability we are employing the PC based Consequence Assessment Tool Set (CATS) v6, with ESRI's ArcGIS9 [14], CATS/JACE (Joint Assessment of Catastrophic Events) v5 with ESRI's ArcView 3.3, Hazard Prediction and Assessment Capability (HPAC) V4.04SP3 [15], as well as custom GIS and database software applications. HPAC does excellent Chemical Biological and Nuclear (CBN) modeling, although output could provide more flexibility. Additionally, results can be exported to CATS for further analysis and display. All three programs can access the current weather data from both classified and unclassified weather servers. Examples of uses of CATS/HPAC are hurricane, tidal surge and earthquake damage, prediction of the results from nuclear, biological and chemical releases, assessment of persons and infrastructure affected and at risk (e.g. which hospitals and pharmacies are under a CBN plume and are thus out of commission), and mobilization of surviving and nearby infrastructure outside the plume that would be needed to address healthcare and other emergency response needs of the community.
These models have been, and continue to be, developed with a view to better estimating the impact of WMD weapons in an offensive setting. However, recent DTRA enhancements and our modifications have facilitated their use in helping estimate potential casualties from a WMD terrorist incident. One area of intense interest, and somewhat of a vacuum in public health planning, has been the utility of this approach in estimating medical care vulnerabilities in such an attack, and for the calculation of the distribution of surviving medical care resources. While much work has already occurred in estimating the impact of chemical weapons (due to the dual use in chemical spill management from transportation and industrial accidents), or in nuclear power plant accident management, much less research and development has gone into estimating the impact on our civilian population of a nuclear weapon detonation from a terrorist incident in a large urban area. The models already calculate such factors as the impact of blast, thermal effects and fallout, but results are often not available at the detail level needed for civil defense purposes, casualty management, and planning the use of scarce health resources in response to a nuclear weapon detonation. Furthermore, the models do not readily facilitate the calculation of injuries from multiple effects such as burns and blast with fallout or prompt radiation. The complexity of the urban three-dimensional landscape and its local impact on thermal, blast and radiation is also poorly understood. Additionally, given their traditional world-wide focus, and the increased sensitivity to providing information on the U.S.A. of use to terrorists, the models do not provide detailed or current data that exists for the United States that would help provide better casualty estimates and response. The models can be customized locally and data updated if the user has sufficient expertise. However, there is often a significant duplication of effort due to overlapping jurisdictions and the lack of data sharing due to security and other considerations.
CATS and HPAC are also useful for creating realistic scenarios for training and planning before a disaster strikes, thus enabling responders to drill and exercise so they know roughly what to expect and how to react. Contingency plans can be created using comprehensive national and more detailed population and infrastructure data. Should disaster strike, the affected population and the impact on critical facilities can be quickly assessed, although efforts frequently need to be expended to ensure regional and local databases are current and useful.
</text></passage></document><document><id>PMC-3165302-sec-13</id><passage><offset>0</offset><text>Pharmacokinetic-pharmacodynamic analysis.
The mean (90% CI) slope estimate from the linezolid concentration-R-R interval analysis was -0.0017 (-0.0022 to -0.0011) ms/ng/ml. This translates to mean (90% CI) predicted decreases in heart rate of approximately 1.5 (1.0 to 2.0) and 3.0 (2.1 to 4.1) beats/min at the mean Cmax following the administration of 600- and 1,200-mg linezolid doses, respectively.
The study-specific mean correction factor estimated from baseline data was 0.278, which is slightly less than Fridericia's correction (0.333). Evaluation of the various correction factors showed that QTcF most appropriately resolves the relationship between the QT interval and the heart rate in the baseline data from the present study. This is evident upon inspection of Fig. 4, since the slope between the QTcF interval and the R-R interval is closest to zero when this correction is applied.
Fig. 4.
Evaluation of various heart rate correction factors for the QT interval versus the R-R interval. The predicted line in each figure represents the fit from a linear mixed-effect model with R-R interval as a fixed effect and subject-specific random effects for intercept and slope.
The results from the concentration-QTcF analysis are graphically depicted in Fig. 5. The mean (90% CI) slope estimate from the linezolid concentration-QTcF analysis was -0.0145 (-0.0768 to 0.0477) ms/mug/ml. At the geometric mean Cmax following the infusion of linezolid at 600 mg (14.9 mug/ml) and 1,200 mg (30.5 mug/ml), the mean (90% CI) predicted placebo-adjusted changes from the baseline QTcF were -0.217 (-1.14 to 0.710) and -0.444 (-2.34 to 1.45) ms, respectively, thus confirming a lack of a relationship between linezolid concentrations and QTc interval.
Fig. 5.
QTcF interval versus plasma linezolid concentrations.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1781" length="6"></location><text>plasma</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="229" length="5"></location><text>heart</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="929" length="5"></location><text>heart</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="685" length="5"></location><text>heart</text></annotation></passage></document><document><id>PMID-20570920</id><passage><offset>0</offset><text>Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer.
PURPOSE:
We previously found that cellular FLICE-inhibitory protein (c-FLIP), caspase 8, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor 2 (DR5) are major regulators of cell viability and chemotherapy-induced apoptosis in colorectal cancer. In this study, we determined the prognostic significance of c-FLIP, caspase 8, TRAIL and DR5 expression in tissues from patients with stage II and III colorectal cancer.
EXPERIMENTAL DESIGN:
Tissue microarrays were constructed from matched normal and tumor tissue derived from patients (n = 253) enrolled in a phase III trial of adjuvant 5-fluorouracil-based chemotherapy versus postoperative observation alone. TRAIL, DR5, caspase 8, and c-FLIP expression levels were determined by immunohistochemistry.
RESULTS:
Colorectal tumors displayed significantly higher expression levels of c-FLIP (P &lt; 0.001), caspase 8 (P = 0.01), and DR5 (P &lt; 0.001), but lower levels of TRAIL (P &lt; 0.001) compared with matched normal tissue. In univariate analysis, higher TRAIL expression in the tumor was associated with worse overall survival (P = 0.026), with a trend to decreased relapse-free survival (RFS; P = 0.06), and higher tumor c-FLIP expression was associated with a significantly decreased RFS (P = 0.015). Using multivariate predictive modeling for RFS in all patients and including all biomarkers, age, treatment, and stage, we found that the model was significant when the mean tumor c-FLIP expression score and disease stage were included (P &lt; 0.001). As regards overall survival, the overall model was predictive when both TRAIL expression and disease stage were included (P &lt; 0.001).
CONCLUSIONS:
High c-FLIP and TRAIL expression may be independent adverse prognostic markers in stage II and III colorectal cancer and might identify patients most at risk of relapse.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="602" length="6"></location><text>normal</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="613" length="12"></location><text>tumor tissue</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="343" length="17"></location><text>colorectal cancer</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1139" length="5"></location><text>tumor</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="553" length="6"></location><text>Tissue</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1277" length="5"></location><text>tumor</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1842" length="34"></location><text>stage II and III colorectal cancer</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="876" length="17"></location><text>Colorectal tumors</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="469" length="7"></location><text>tissues</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1069" length="13"></location><text>normal tissue</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="290" length="4"></location><text>cell</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1538" length="5"></location><text>tumor</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="496" length="34"></location><text>stage II and III colorectal cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="56" length="34"></location><text>stage II and III colorectal cancer</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T7" role="Arg2"></node></relation></passage></document><document><id>PMC-2725788-sec-03</id><passage><offset>0</offset><text>2.1.
Biological samples
Placental tissues from the first trimester legally induced abortions (8-12 weeks of gestation) were obtained from the Department of Obstetrics and Gynecology at the Broussais, Saint Vincent de Paul and Cochin Hospitals. Second trimester placental tissues were collected at the time of termination of pregnancy at 15 and 25 weeks of gestation (in weeks of amenorrhea) in trisomy 21-affected pregnancies. Fetal Down syndrome was diagnosed by karyotyping of amniotic fluid cells. The indication of amniocentesis was the maternal age. Term placentas were obtained after elective cesarean section from healthy mothers near term with uncomplicated pregnancies. With written informed consent of the pregnant woman, the following samples were collected at term: a fragment of the placenta, umbilical cord fetal blood and maternal blood. The placenta biopsy sample was collected at a depth of 1 cm and at a distance of 8 cm from the edge of the placenta, with the maternal side facing upward. The use of these biological samples was approved by local ethical committee. Villous cytotrophoblastic cells were isolated by sequential enzymatic digestion of chorionic villi from the first trimester, second trimester and term placenta and purified on a discontinuous percoll gradient, as described previously.47-49 These cells were positively stained for cytokeratin 7 at 95%, indicating the cytotrophoblastic origin of the cells. Placental fibroblasts were isolated by prolonged enzymatic digestion from first trimester chorionic villi as in Malassine et al.50 Fibroblastic cells (1.25 x 105 cells/mL) were plated on 35-mm plastic dishes (TPP, Switzerland) and cultured for 48 h, and the culture medium was changed daily. These cultured fibroblasts were characterized using immunocytochemistry. It was found that 98% of the cells were vimentin positive and also positive for a monoclonal antibody against specific fibroblast antigen (clone ASO2, Dianova, Hamburg, Germany). Owing to the limited amount of cells, only DNA was extracted.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="24" length="17"></location><text>Placental tissues</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="427" length="5"></location><text>Fetal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="261" length="17"></location><text>placental tissues</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="796" length="8"></location><text>placenta</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="780" length="8"></location><text>fragment</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="479" length="20"></location><text>amniotic fluid cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="560" length="9"></location><text>placentas</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="857" length="22"></location><text>placenta biopsy sample</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="960" length="8"></location><text>placenta</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1085" length="31"></location><text>Villous cytotrophoblastic cells</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1236" length="8"></location><text>placenta</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="806" length="26"></location><text>umbilical cord fetal blood</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1331" length="5"></location><text>cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="846" length="5"></location><text>blood</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1441" length="21"></location><text>Placental fibroblasts</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1434" length="5"></location><text>cells</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1168" length="15"></location><text>chorionic villi</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1531" length="15"></location><text>chorionic villi</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2016" length="5"></location><text>cells</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1572" length="18"></location><text>Fibroblastic cells</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1925" length="10"></location><text>fibroblast</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1748" length="11"></location><text>fibroblasts</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1835" length="5"></location><text>cells</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T6" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T10" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A11"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T13" role=""></node></relation><relation id="A10"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation><relation id="A9"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T10" role=""></node></relation><relation id="A13"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation><relation id="A12"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation><relation id="A14"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T15" role=""></node></relation></passage></document><document><id>PMID-21913457</id><passage><offset>0</offset><text>[Rubella in Poland in 2009].
In Poland, 7,587 cases of rubella were registered in 2009 (incidence 19.9 per 100,000 population). According to a new rubella case definition, introduced in 2009, 7 (0.1%) cases were classified as confirmed cases, 30 (0.4%) as probable. One case of congenital rubella syndrome was reported. The incidence in men (26.6) was 1.9-times higher than in women (13.6). The highest incidence was observed in children aged 7 and 8 years (180.3 and 175.6, respectively). No rubella deaths were registered. An improvement of laboratory diagnosis of reported cases is necessary to assess the impact of 2-dose immunization implemented in 2003 on rubella epidemiology in Poland.
</text></passage></document><document><id>PMID-491661</id><passage><offset>0</offset><text>Absence of effect of prenatal ethanol on adult emotionality and ethanol consumption in rats.
Lower peak blood ethanol concentrations after 1 and 2 g of ethanol per kg were found in pregnant rats than in virgin females. No significant differences in adult "emotionality" or ethanol consumption were found in rats exposed to prenatal alcohol and in pair-fed and untreated controls.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="104" length="5"></location><text>blood</text></annotation></passage></document><document><id>PMC-2323032-sec-05</id><passage><offset>0</offset><text>Basilar papilla
The basilar papilla is found in a recess that opens into the saccular space at one end, and is limited by a thin contact membrane at the other. The contact membrane separates the endolymphatic fluid in the papillar recess from the perilymphatic fluid at the round window (Lewis and Narins 1999; Wever 1985). The recess perimeter is roughly oval in shape; in the bullfrog, Rana catesbeiana, its major axis is approximately 200 mum long, while the minor axis measures approximately 150 mum (Van Bergeijk 1957). In the leopard frog, Rana pipiens pipiens, it is of similar size (personal observation, RLMS &amp; JMS).
The oval perimeter of the lumen is formed from limbic tissue; a substance unique to the inner ear, and similar to cartilage (Wever 1985). The sensory epithelium is approximately 100 mum long. It occupies a curved area that is symmetrical in the major axis of the elliptical lumen. It contains approximately 60 hair cells (measured in Rana catesbeiana), from which the stereovilli protrude into the lumen and connect to the tectorial membrane (Frishkopf and Flock 1974). Typically the orientation of the hair cells, as defined by the direction to which the v-shape of the stereovilli bundle points (Lewis et al. 1985), is away from the sacculus in Ranidae.
The tectorial membrane spans the lumen of the papillar recess. It occludes about half the lumen, and consequently takes an approximately semi-circular shape when viewed from the saccular side (Frishkopf and Flock 1974; Wever 1985). The membrane has pores at the surface closest to the epithelium, into which the tips of the hair bundles project (Lewis and Narins 1999).4
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="195" length="19"></location><text>endolymphatic fluid</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="222" length="8"></location><text>papillar</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="129" length="16"></location><text>contact membrane</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="164" length="16"></location><text>contact membrane</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1606" length="4"></location><text>hair</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1567" length="10"></location><text>epithelium</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1518" length="8"></location><text>membrane</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="247" length="19"></location><text>perilymphatic fluid</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1460" length="8"></location><text>saccular</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="652" length="5"></location><text>lumen</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1372" length="5"></location><text>lumen</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1328" length="8"></location><text>papillar</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1315" length="5"></location><text>lumen</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1286" length="18"></location><text>tectorial membrane</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1261" length="8"></location><text>sacculus</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1197" length="11"></location><text>stereovilli</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="0" length="15"></location><text>Basilar papilla</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="77" length="14"></location><text>saccular space</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="20" length="15"></location><text>basilar papilla</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="673" length="13"></location><text>limbic tissue</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="714" length="9"></location><text>inner ear</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="740" length="9"></location><text>cartilage</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="768" length="18"></location><text>sensory epithelium</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="889" length="16"></location><text>elliptical lumen</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="936" length="10"></location><text>hair cells</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1024" length="5"></location><text>lumen</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="994" length="11"></location><text>stereovilli</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1049" length="18"></location><text>tectorial membrane</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1129" length="10"></location><text>hair cells</text></annotation></passage></document><document><id>PMC-3089218-caption-02</id><passage><offset>0</offset><text>View of the structure of the title compound along the a axis displaying chains alternating with amine groups.
</text></passage></document><document><id>PMID-7088434</id><passage><offset>0</offset><text>Verrucous carcinoma of the endometrium--a unique neoplasm with long survival.
A case of verrucous carcinoma of the endometrium with long survival is described. It represents the first of its type to be recorded in this site. The literature on verrucous carcinoma and on other cases of squamous carcinoma of the endometrium is briefly reviewed.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="243" length="19"></location><text>verrucous carcinoma</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="285" length="18"></location><text>squamous carcinoma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="88" length="19"></location><text>verrucous carcinoma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="115" length="11"></location><text>endometrium</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="311" length="11"></location><text>endometrium</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="0" length="19"></location><text>Verrucous carcinoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="49" length="8"></location><text>neoplasm</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="27" length="11"></location><text>endometrium</text></annotation></passage></document><document><id>PMID-7624335</id><passage><offset>0</offset><text>Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription.
NGFI-A (also called Egr1, Zif268, or Krox24) and the closely related proteins Krox20, NGFI-C, and Egr3 are zinc-finger transcription factors encoded by immediate-early genes which are induced by a wide variety of extracellular stimuli. NGFI-A has been implicated in cell proliferation, macrophage differentiation, synaptic activation, and long-term potentiation, whereas Krox20 is critical for proper hindbrain segmentation and peripheral nerve myelination. In previous work, a structure/function analysis of NGFI-A revealed a 34-aa inhibitory domain that was hypothesized to be the target of a cellular factor that represses NGFI-A transcriptional activity. Using the yeast two-hybrid system, we have isolated a cDNA clone which encodes a protein that interacts with this inhibitory domain and inhibits the ability of NGFI-A to activate transcription. This NGFI-A-binding protein, NAB1, is a 570-aa nuclear protein that bears no obvious sequence homology to known proteins. NAB1 also represses Krox20 activity, but it does not influence Egr3 or NGFI-G, thus providing a mechanism for the differential regulation of this family of immediate-early transcription factors.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="677" length="8"></location><text>cellular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="982" length="7"></location><text>nuclear</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="396" length="8"></location><text>synaptic</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="510" length="16"></location><text>peripheral nerve</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="295" length="13"></location><text>extracellular</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="368" length="10"></location><text>macrophage</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="348" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMID-6229539</id><passage><offset>0</offset><text>Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits.
Phosphorylation of purified phospholamban isolated from canine cardiac sarcoplasmic reticulum vesicles decreased the electrophoretic mobility of the protein in sodium dodecyl sulfate (SDS)-polyacrylamide gels. Different mobility forms of phospholamban in SDS gels were visualized both by direct protein staining and by autoradiography. Unphosphorylated phospholamban migrated with an apparent Mr = 25,000 in SDS gels; maximal phosphorylation of phospholamban by cAMP- or Ca2+-calmodulin-dependent protein kinase increased the apparent Mr to 27,000. Partial phosphorylation of phospholamban by either protein kinase gave intermediate mobility forms of molecular weights between 25,000 and 27,000, suggesting that more than one phosphorylation site was present on the holoprotein for each activity. Boiling of phospholamban in SDS dissociated the holoprotein into an apparently homogeneous class of low molecular weight "monomers." Only two mobility forms of monomeric phospholamban were observed in SDS gels after phosphorylation by cAMP-dependent protein kinase, corresponding to 9-kDa dephospho- and 11-kDa phosphoproteins. All of the 9-kDa protein could be phosphorylated and converted into the 11-kDa mobility form, suggesting the presence of only one site of phosphorylation on a single type of monomer for cAMP-dependent protein kinase. Simultaneous phosphorylation of monomeric phospholamban by cAMP-dependent protein kinase and Ca2+-calmodulin-dependent protein kinase gave an additional mobility form of the protein, suggesting that different sites of phosphorylation were present for each activity on each monomer. Incomplete dissociation of the holoprotein by boiling it in a relatively low concentration of SDS facilitated the detection of five major mobility forms of the protein in SDS gels, and the mobilities of all of these forms were decreased by phosphorylation. We propose that the high molecular weight form of phospholamban is a multimer of electrophoretically indistinguishable monomers, each of which contains a different phosphorylation site for cAMP-dependent protein kinase activity and Ca2+-calmodulin-dependent protein kinase activity. Phosphorylation of phospholamban at multiple sites is responsible for the various mobility forms of the holoprotein detected in SDS-polyacrylamide gels.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="259" length="39"></location><text>cardiac sarcoplasmic reticulum vesicles</text></annotation></passage></document><document><id>PMC-2774332-sec-09</id><passage><offset>0</offset><text>Target volumes' coverage
The mean PTV1 and PTV2 volumes were 452 cm3 (range 276-1074 cm3) and 300 cm3 (range 137-567 cm3) respectively. A mean of &gt;98% (range 92-100%) of the PTV1 received 100% of the prescribed dose in all planning methods. A mean of 95.5% and 95.7% of the PTV2 received 100% of the prescribed dose with TOMO and IMRT plans respectively. A mean of 94% and 92% of the PTV2 received 100% of the prescribed dose with IB and 3D treatment plans, respectively. The mean IB and 3D plans PTV2 coverage was significantly inferior then the IMRT and TOMO plans (p &lt; 0.02, for all comparisons).
The mean Inhomogeneity Coefficient (IC) was significantly lower (better) with the TOMO plans, compared to all other plans for both PTV1 and PTV2 (p &lt; 0.0003 for all comparisons) (figure 3). The mean IC of the IMRT plans was significantly higher (worse) than the mean IC of the 3D plans regarding PTV 1 (p &lt; 0.02) and higher (worse) then the mean IC of the IB plans regarding PTV2 (p &lt; 0.03) (figure 3). No significant difference was found between the means of the IC of the 3D and IB plans.
Figure 3
The mean Inhomogeneity Coefficient (IC) achieved by the different planning methods. The mean of the Inhomogeneity Coefficient is a measure of dose inhomogeneity in the target volumes. The closer the IC to zero, the more homogenous the dose is.
</text></passage></document><document><id>PMC-2779440-caption-01</id><passage><offset>0</offset><text>All-cause mortality in RALES and EPHESUS (adapted from [4] and [5]). Mean follow-up period is 24 months in RALES and 16 months in EPHESUS
</text></passage></document><document><id>PMC-3242184-sec-02</id><passage><offset>0</offset><text>Methods
We studied 3,574 Canadian children, aged 7-8 yr, enrolled in a population-based birth cohort. Standardized questionnaires were completed by the children's parents, and data were analyzed by multivariate logistic regression.
</text></passage></document><document><id>PMID-12975002</id><passage><offset>0</offset><text>[Community intervention on hypertension and stroke].
OBJECTIVE:
To evaluate the community-based intervention on reduction of hypertension and stroke in different age groups and subtypes hypertension.
METHODS:
In 6 cities, 2 geographically separated communities with a registered population about 10 000 of each were selected as either intervention or control communities. A cohort containing 2 700 subjects, 35 years or older, and free of stroke were sampled from each community. The baseline survey was conducted to screen the subjects for intervention. In each city, a program for control of hypertension, heart diseases and diabetes was initiated in the intervention cohort and health education was provided to the whole intervention community. A follow-up survey was conducted 3 years later.
RESULTS:
Within 3 years, the prevalence of hypertension increased in both intervention and control cohorts, as well as in the middle and elderly cohorts, especially in the middle aged in control group. Among hypertensives in the intervention cohort, the rates of awareness, treatment and control of hypertension got improved. The incidence of stroke was 29% lower (HR = 0.71, 95% CI: 0.58 - 0.87) and mortality of stroke was 40% lower (HR = 0.60, 95% CI: 0.42 - 0.86) in the intervention cohort than the control cohort. The intervention was most effective in reduction of stroke for those with isolated systolic hypertension and combined systolic and diastolic hypertension (All P &lt; 0.05). Meanwhile, all-cause mortality was 11% lower (HR = 0.89, 95% CI: 0.78 - 0.99) in the intervention cohort than in the control cohort.
CONCLUSION:
The community-based intervention was effective in controlling the development of hypertension and stroke, while the elderly people benefit more than the middle aged people from the intervention.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="608" length="5"></location><text>heart</text></annotation></passage></document><document><id>PMID-12604762</id><passage><offset>0</offset><text>Rural/urban differences in access to and utilization of services among people in Alabama with sickle cell disease.
OBJECTIVE:
This study examined relationships between socioeconomic factors and the geographic distribution of 662 cases of sickle cell disease in Alabama in 1999-2001.
METHODS:
Measures of community distress, physical functioning, and medical problems were used in analyzing utilization differences between individuals with sickle cell disease living in urban and rural areas.
RESULTS:
Utilization of comprehensive sickle cells disease services was lower for individuals with sickle cell disease living in rural areas than for those living in urban areas. Rural clients reported significantly more limitations than urban clients on several measures of physical functioning. The results also suggest that utilization of services was higher for those with more medical problems and those who lived in high distress areas, although these findings did not meet the criterion for statistical significance.
CONCLUSIONS:
Conclusions based on statistical evidence that geographic location and socioeconomic factors relate to significantly different health care service experience bear important implications for medical and health care support systems, especially on the community level.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="530" length="12"></location><text>sickle cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="591" length="11"></location><text>sickle cell</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="94" length="11"></location><text>sickle cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="439" length="11"></location><text>sickle cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="238" length="11"></location><text>sickle cell</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation></passage></document><document><id>PMC-3003815-caption-03</id><passage><offset>0</offset><text>Correlation matrix for ear (E) traits in 2006; data from water stress plots (lower left) and well-watered plots (upper right) of 350 maize inbreds
</text></passage></document><document><id>PMC-3106860-sec-04</id><passage><offset>0</offset><text>Conclusions
Myocardial ischaemia during DCMR is independently predictive of cardiac events among patients with previous myocardial revascularisation.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="12" length="10"></location><text>Myocardial</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="76" length="7"></location><text>cardiac</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="120" length="10"></location><text>myocardial</text></annotation></passage></document><document><id>PMC-3168770-caption-05</id><passage><offset>0</offset><text>Challenges to creating and implementing a perioperative glycemic control protocol.
</text></passage></document><document><id>PMID-18578357</id><passage><offset>0</offset><text>Intraoperative handling and wound healing of arthroscopic portal wounds: a clinical study comparing nylon suture with wound closure strips.
This prospective, single-centre study compared wound closure methods in patients undergoing arthroscopy. Closure of arthroscopic portal wounds with sterile adhesive strips is effective and convenient for wound management. The method was associated with a reduced potential for infection, faster renewal of tensile strength, greater cost effectiveness, and better cosmetic effects comparing with suture closure. This method of wound closure may also reduce the incidence of needle stick injury in the theatre environment. Thereby the incidence of percutaneous exposure following a surgical procedure may not facilitate transmission of blood borne pathogens such as human immunodeficiency virus (HIV), hepatitis C virus and hepatitis B virus. As a result it may reduce litigation in today's changing healthcare climate.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="344" length="5"></location><text>wound</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="566" length="5"></location><text>wound</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="187" length="5"></location><text>wound</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="276" length="6"></location><text>wounds</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="774" length="5"></location><text>blood</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="28" length="5"></location><text>wound</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="118" length="5"></location><text>wound</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="65" length="6"></location><text>wounds</text></annotation></passage></document><document><id>PMID-8640445</id><passage><offset>0</offset><text>Cell surface binding characteristics correlate with consensus type I interferon enhanced activity.
The binding characteristics of a genetically engineered consensus interferon with unusually high biologic activity were compared to the characteristics of recombinant interferon-alpha 2. Both interferon-alpha 2 and the consensus interferon produced typical biphasic Scatchard plots, indicating multiple independent binding sites. The consensus interferon, which exhibited a biologic potency more than 10-fold greater than all other type I interferons, also exhibited binding site affinities greater than those for IFN-alpha 2b. In addition, a larger number of high, and low-affinity cell surface sites were recognized by the consensus interferon, resulting in equivalent numbers of sites at reduced molar concentrations compared to IFN-a2b. Thus, at any given biologic activity, similar numbers of sites were bound by the consensus interferon and IFN-alpha 2, despite differences in their molar concentrations. No differences in internalization kinetics were identified between the two interferons, indicating that the differences in cell surface binding may be sufficient to produce the differences in biologic activity.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="0" length="12"></location><text>Cell surface</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1133" length="12"></location><text>cell surface</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="682" length="12"></location><text>cell surface</text></annotation></passage></document><document><id>PMC-3041925-caption-05</id><passage><offset>0</offset><text>Intact mass analysis of a mixed population of proteins. A mixture of the membrane protein KCNJ12, the soluble TEV protease used to cleave the fusion tag, and the membrane protein HVCN1, which occurred as a contaminant from an earlier analysis on the same LC column.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="73" length="8"></location><text>membrane</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="162" length="8"></location><text>membrane</text></annotation></passage></document><document><id>PMC-2703643-sec-15</id><passage><offset>0</offset><text>Sex and age distributions of confirmed cases
Of 480 confirmed cases, 56% (269/480) were male patients and 44% (211/480) were female, respectively. The percentage of male cases was higher than that of females in all groups except for the group aged 31-40 (chi2 = 42.4, P &lt; 0.001). 278 (57.9%) cases were in the group aged 21-50, followed by 102 (21.3%), 79 (16.5%) and 21 (4.4%) cases in the group aged 51-70, 0-20, and &gt;= 71, respectively. The youngest and oldest cases were 1.5 and 81 years old, respectively (Table 2).
Table 2
Age and occupational distributions and activities (1-3 weeks prior to symptom appearance) of confirmed cases
Cases (%) (Male: Female, %)
Age (Years)
0-10 46 (9.6) (76:24)
11-20 33 (6.9) (79:21)
21-30 78 (16.3) (51:49)
31-40 99 (20.6) (46:54)
41-50 101 (21.0) (56:44)
51-60 47 (9.8) (55:45)
61-70 55 (11.5) (53:47)
&gt;= 71 21 (4.4) (52:48)
Occupation
Children at preschool age 20 (4.2) (75:25)
Pupils 50 (10.4) (78:22)
Farmers 408 (85.0) (52:48)
Others 2 (0.4) (50:50)
Activities
Farm work 325 (67.7) (53:47)
Play on grassland 65 (13.5) (75:25)
Recreation 20 (4.2) (65:35)
Housework 25 (5.2) (8:92)
Unknown 45 (9.4) (71:29)
</text></passage></document><document><id>PMC-3267723-sec-02</id><passage><offset>0</offset><text>Results

</text></passage></document><document><id>PMC-2941963-sec-01</id><passage><offset>0</offset><text>INTRODUCTION
For several years now, virtual microscopy has been utilized in medical teaching, research, proficiency testing, American Board of Pathology examinations, pathology meetings and conferences, and quality assurance programs. In diagnostic practice, it is most widely and routinely used in image analysis. Some practices are beginning to use it internally (within their group) for frozen section intraoperative consultations and subspecialty consultations due to geographic and time constrains.
Although diagnostic consultation for expert second opinion is a well-established practice in pathology for glass slides, similar consultation via virtual microscopy poses multiple controversial issues such as licensing, liability, security, reimbursement, and scanning quality and its validation. Regulations and standardization are not yet in place that pathologists can use to allay these fears. Nevertheless, if the virtual microscopy scans are of optimal quality, these can be simply substituted for glass slides and a microscope while maintaining all other practice guidelines for second opinion consultation. Additionally, the cost and maintenance of scanning equipment is not currently affordable to most practitioners and consultants.
A practice model that offers tertiary consultation in gastrointestinal (GI) and liver pathology is presented that eliminates the cost and maintenance of scanners by the consultants and clients, minimizes the need for review of glass slides, facilitates clinicopathological and radiological correlation and serves the need of clients who need timely help with challenging liver and GI cases and to obtain expert opinion for dysplasia in Barrett's and ulcerative colitis surveillance biopsies required by the American Gastroenterology Association (AGA). This model has been practiced for 3 years and applied to over 2000 cases by small pathology practices in the 50 United States and a single consultant GI and liver pathologist.
</text><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1949" length="2"></location><text>GI</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1618" length="5"></location><text>liver</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1628" length="2"></location><text>GI</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1956" length="5"></location><text>liver</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1301" length="16"></location><text>gastrointestinal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1327" length="5"></location><text>liver</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1319" length="2"></location><text>GI</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T1" role=""></node><node refid="T2" role=""></node></relation></passage></document><document><id>PMID-8078269</id><passage><offset>0</offset><text>[Preliminary results of observing 18 cases of retinoblastoma carried within the international research program RICS].
In the years 1988-1989, the Ophthalmological Clinic in Cracow took part in the International Research Programme on Retinoblastoma as one of 28 clinical centres in 14 countries. The study included 18 children with retinoblastoma, in most cases in the advanced stadium of the disease. As a rule, the eyes filled with tumours were enucleated, and the less advanced cases were treated with combined methods applying radiation with 60Co plaques with xenon arc photocoagulation, cryopexy, and chemotherapy. In 18 treated children 23 eyes were enucleated (in 5 children both eyes, in 6 children with bilateral retinoblastoma 1 eye, and 7 eyes in all unilateral cases). Six eyes with less advanced lesions were treated with combined methods. One child died because of metastases to the brain. The obtained data reveal that retinoblastoma is diagnosed too late, which decreases the chance of cure and causes great danger for the life of the child.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="46" length="14"></location><text>retinoblastoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="331" length="14"></location><text>retinoblastoma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="233" length="14"></location><text>Retinoblastoma</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="749" length="4"></location><text>eyes</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="784" length="4"></location><text>eyes</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="721" length="14"></location><text>retinoblastoma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="738" length="3"></location><text>eye</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="645" length="4"></location><text>eyes</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="686" length="4"></location><text>eyes</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="416" length="4"></location><text>eyes</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="433" length="7"></location><text>tumours</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="896" length="5"></location><text>brain</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="808" length="7"></location><text>lesions</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="933" length="14"></location><text>retinoblastoma</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="878" length="10"></location><text>metastases</text></annotation></passage></document><document><id>PMID-765945</id><passage><offset>0</offset><text>Central nervous system infection with Eikenella corrodens: report of two cases.
Two cases of central nervous system infections from which E. corrodens has been isolated are reported. The portals of entry, clinical course, and antimicrobial responses conform to other reports in the literature. The importance of obtaining careful anaerobic cultures is emphasized.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="0" length="22"></location><text>Central nervous system</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="93" length="22"></location><text>central nervous system</text></annotation></passage></document><document><id>PMID-3609047</id><passage><offset>0</offset><text>Torsade de pointes during loading with amiodarone.
Torsade de pointes represents a potential complication of chronic amiodarone therapy. Several reports have emphasized the need for a loading dose in order to achieve therapeutic blood levels rapidly. We report a case of torsade de pointes following a single oral dose of amiodarone (1400 mg or 30 mg kg-1) administered after short intravenous loading for prevention of paroxysmal atrial flutter. Torsades de pointes were preceded and associated with marked QT prolongation and bradycardia. This report suggests that careful monitoring of patients undergoing oral amiodarone loading is necessary.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="229" length="5"></location><text>blood</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="431" length="6"></location><text>atrial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="382" length="11"></location><text>intravenous</text></annotation></passage></document><document><id>PMID-3830071</id><passage><offset>0</offset><text>Clinical evaluation of radiotherapy for Graves' ophthalmopathy.
Seventeen patients with moderately severe ophthalmopathy due to Graves' disease were treated by cobalt or supervoltage radiotherapy. All patients complained of diplopia. The mean proptosis value was 21.4 mm. Three patients (18%) showed good response, 7 (41%) moderate and 7 minimal or no response. Improvement was noted mainly in soft tissue changes and diplopia, while proptosis decreased in only 5 patients. All except one patient who had marked extraocular muscle involvement revealed by computed tomography responded to treatment. These data indicate that radiotherapy may be indicated in patients with progressive ophthalmopathy, especially in those who are associated with extraocular muscle enlargement.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="394" length="11"></location><text>soft tissue</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="743" length="18"></location><text>extraocular muscle</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="512" length="18"></location><text>extraocular muscle</text></annotation></passage></document><document><id>PMID-17101038</id><passage><offset>0</offset><text>Multicentre study on peri- and postoperative central venous oxygen saturation in high-risk surgical patients.
INTRODUCTION:
Low central venous oxygen saturation (ScvO2) has been associated with increased risk of postoperative complications in high-risk surgery. Whether this association is centre-specific or more generalisable is not known. The aim of this study was to assess the association between peri- and postoperative ScvO2 and outcome in high-risk surgical patients in a multicentre setting.
METHODS:
Three large European university hospitals (two in Finland, one in Switzerland) participated. In 60 patients with intra-abdominal surgery lasting more than 90 minutes, the presence of at least two of Shoemaker's criteria, and ASA (American Society of Anesthesiologists) class greater than 2, ScvO2 was determined preoperatively and at two hour intervals during the operation until 12 hours postoperatively. Hospital length of stay (LOS) mortality, and predefined postoperative complications were recorded.
RESULTS:
The age of the patients was 72 +/- 10 years (mean +/- standard deviation), and simplified acute physiology score (SAPS II) was 32 +/- 12. Hospital LOS was 10.5 (8 to 14) days, and 28-day hospital mortality was 10.0%. Preoperative ScvO2 decreased from 77% +/- 10% to 70% +/- 11% (p &lt; 0.001) immediately after surgery and remained unchanged 12 hours later. A total of 67 postoperative complications were recorded in 32 patients. After multivariate analysis, mean ScvO2 value (odds ratio [OR] 1.23 [95% confidence interval (CI) 1.01 to 1.50], p = 0.037), hospital LOS (OR 0.75 [95% CI 0.59 to 0.94], p = 0.012), and SAPS II (OR 0.90 [95% CI 0.82 to 0.99], p = 0.029) were independently associated with postoperative complications. The optimal value of mean ScvO2 to discriminate between patients who did or did not develop complications was 73% (sensitivity 72%, specificity 61%).
CONCLUSION:
Low ScvO2 perioperatively is related to increased risk of postoperative complications in high-risk surgery. This warrants trials with goal-directed therapy using ScvO2 as a target in high-risk surgery patients.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="45" length="14"></location><text>central venous</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="629" length="9"></location><text>abdominal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="128" length="14"></location><text>central venous</text></annotation></passage></document><document><id>PMID-6920468</id><passage><offset>0</offset><text>Relationship of self-concept during late pregnancy to neonatal perception and parenting profile.
Thirty-one gravidas were studied to examine the relationship between a woman's feelings about herself during late pregnancy, her perception of her newborn, and her profile of parenting. The Tennessee Self-Concept Scale was completed during the third trimester of pregnancy, the Neonatal Perception Inventory I at one-to-two days postpartum, and the Neonatal Perception Inventory II and the Michigan Screening Profile of Parenting at four-to-six weeks postpartum. When considered separately, no positive significant relationships were found between scores on these variables. However, all subjects with negative scores on both self-concept and neonatal perception had negative scores on at least two subscales of the parenting profile.
</text></passage></document><document><id>PMC-1925142-sec-12</id><passage><offset>0</offset><text>Results
Here we include data obtained from active, oscillatory brain slices as well as from recordings during cortical slow oscillations in anesthetized animals. All recordings included in this study were obtained from the visual cortex of the ferret (in vitro), cat (in vivo) and from barrel cortex of the rat (in vivo). Twenty-nine neurons recorded from ferret cortical slices are included in this study (22 regular spiking (RS); 5 chattering (CH) and 2 intrinsic bursting (IB)), 27 neurons from cat visual cortex in vivo (14 RS; 5 CH; 2 IB; 3 fast spiking (FS); plus 3 non classified) and 14 neurons from rat barrel cortex in vivo (12 RS; 1 CH; 1 IB). Synaptic potentials were evoked by electric shocks (intracortical or thalamocortical connections) or by means of sensory (visual or whisker) stimulation. The main results are: 1) Synaptic potentials show more paired pulsed facilitation and synaptic augmentation in active than in silent cortical networks and 2) Synaptic potentials occurring during up or activated states of the cortex increased their amplitude with respect to those occurring during down states.

</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="63" length="12"></location><text>brain slices</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="286" length="13"></location><text>barrel cortex</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="223" length="13"></location><text>visual cortex</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="485" length="7"></location><text>neurons</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="502" length="13"></location><text>visual cortex</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="334" length="7"></location><text>neurons</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="363" length="15"></location><text>cortical slices</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="655" length="8"></location><text>Synaptic</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="834" length="8"></location><text>Synaptic</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="895" length="8"></location><text>synaptic</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="942" length="8"></location><text>cortical</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="595" length="7"></location><text>neurons</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="967" length="8"></location><text>Synaptic</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="612" length="13"></location><text>barrel cortex</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1034" length="6"></location><text>cortex</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="110" length="8"></location><text>cortical</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMC-2883578-sec-04</id><passage><offset>0</offset><text>Introduction
Tea (Camellia sinensis L.) is one of the most widely consumed beverages in the world. (-)-Epigallocatechin-3-O-gallate (EGCG), which is the major green tea catechin present in the leaves, is believed to the compound most responsible for the health benefits attributed to tea. EGCG was reported to have antioxidative [1], [2], antimutagenic [3], anti-inflammatory [4], and anticarcinogenic activities [5].
Although the EGCG concentrations required to elicit the anticancer activity have been shown to be more than 1 microM, the blood level of EGCG after consuming the equivalent of 2-3 cups of green tea was 0.1-0.6 microM and for an equivalent of 7-9 cups was still lower than 1 microM [6], [7]. In a cohort study, daily consumption of ten cups of green tea was required for the cancer preventive effect [8]. Moreover, adverse effects of green tea, mainly hepatitis, by consumption of high doses of green tea have been reported [9]. Therefore, it is important to enhance the pharmacologic effect of EGCG to obtain the health benefit in reasonable concentration in daily life.
We have reported that the cell-surface binding of EGCG and its derivatives is involved in their biological activities [10]-[15]. We have identified the 67-kDa laminin receptor (67LR) as a cell surface receptor for EGCG that mediates the anticancer activity of EGCG [16]. 67LR has been shown to be overexpressed on the cell surface of various tumor cells [17]. It was postulated that 67LR plays a significant role in the tumor progression and speculated that studies conducted to define the function of 67LR could provide a new approach to cancer prevention. Indeed, expression of 67 LR confers EGCG responsiveness to tumor cells in vivo [18].
Vitamin A, also known as retinol, participates in physiological activities related to the immune system, maintenance of epithelial and mucosa tissues, growth, reproduction, and bone development. It comes from animal sources, such as eggs, meat, milk, cheese, cream, liver, kidney, cod and halibut fish oil. In vitro and in animal models, it has been demonstrated that vitamin A is involved in the regulation and promotion of growth and differentiation of many cells [19]. The visual function of vitamin A depends on its natural and synthetic derivatives, retinoids [20]. All-trans-retinoic acid (ATRA), the active derivative of vitamin A, has been well documented as a growth and differentiation factor in many tissues and cells, and proved to be an effective treatment to many diseases including cancers [21], [22].
Retinoids exert their physiological activities through retinoid receptor nuclear proteins that belong to the superfamily of steroid/thyroid hormone receptors, of which there are two classes, retinoic acid receptors (RARs) and the retinoic-X receptors (RXRs), each of which has three subtypes, alpha, beta, and gamma [23], [24]. The natural ligands for the RARs are ATRA and its stereoisomers 9-cis-RA and 13-cis-RA, whereas RXRs are activated by 9-cis-RA only. ATRA acts through RAR to transcriptionally activate target genes, such as cytochrome P450 and CRABI [24].
This study was designed to identify a food component that could be effectively used in combination with EGCG and to investigate the mechanism of action of this combination. By using in vitro and in vivo systems involving a highly metastatic mouse B16 melanoma cell line [25], we found that ATRA enhances the antitumor activity of EGCG by upregulating the 67 LR expression through RAR.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1277" length="12"></location><text>cell surface</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1407" length="12"></location><text>cell surface</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="540" length="5"></location><text>blood</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1115" length="12"></location><text>cell-surface</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2455" length="5"></location><text>cells</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1431" length="11"></location><text>tumor cells</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="2443" length="7"></location><text>tissues</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1509" length="5"></location><text>tumor</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="3428" length="5"></location><text>tumor</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3363" length="22"></location><text>B16 melanoma cell line</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2622" length="7"></location><text>nuclear</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2529" length="7"></location><text>cancers</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2192" length="5"></location><text>cells</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2034" length="3"></location><text>oil</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="193" length="6"></location><text>leaves</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="792" length="6"></location><text>cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="478" length="6"></location><text>cancer</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1628" length="6"></location><text>cancer</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1706" length="11"></location><text>tumor cells</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1852" length="10"></location><text>epithelial</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1867" length="14"></location><text>mucosa tissues</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1909" length="4"></location><text>bone</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1965" length="4"></location><text>eggs</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1971" length="4"></location><text>meat</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1977" length="4"></location><text>milk</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1998" length="5"></location><text>liver</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2005" length="6"></location><text>kidney</text></annotation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T12" role="Arg1"></node><node refid="T13" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T8" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T18" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T24" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T19" role=""></node></relation></passage></document><document><id>PMC-1550851-caption-02</id><passage><offset>0</offset><text>Inflammation-modulating effect of antithrombin on the endothelium. Ligation of heparan sulfate proteoglycans (HSPGs) of endothelium with antithrombin (AT) induces cellular signalling events that alter the cell's biochemical and functional responses to inflammatory stimuli (e.g. bacterial lipopolysaccharide [LPS]). Changes include reduced release of inflammatory and procoagulatory mediators (e.g. interleukin [IL]-1, IL-6, tumour necrosis factor-alpha[TNF]), tissue factor (TF), adenosine diphosphate (ADP) and cellular adhesion molecules (not shown), as well as increased release of anticoagulatory prostacyclin (prostaglandin [PG]I) or CD39/ATPDase. In neuronal tissue, protective mechanisms may by mediated via the release of calcitonin gene-related peptide and nitric oxide with the potential to affect prostacyclin release [55].
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="513" length="8"></location><text>cellular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="657" length="15"></location><text>neuronal tissue</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="205" length="4"></location><text>cell</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="54" length="11"></location><text>endothelium</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="163" length="8"></location><text>cellular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="120" length="11"></location><text>endothelium</text></annotation></passage></document><document><id>PMID-10191918</id><passage><offset>0</offset><text>[Epidemiology of respiratory allergy in children].
Epidemiology of paediatric respiratory allergic disorders allows the approach to causal and preventive risk factors by studying groups or sub groups of children in different locations and under different conditions. This is, however, complicated by the lack of consensus on disease definitions, which renders comparisons between studies difficult. Atopy is usually defined by the presence of positive skin tests (wheal size of at least a mean diameter &gt; or = 3 mm), by the presence of specific IgE, or by the presence of increased total IgE (&gt; or = 100 UI/mL). Infantile asthma is not well defined, complicated by the high prevalence of bronchiolitis; one thus questions between wheezing or wheezy bronchitis. Prevalence is high: among early wheezers, two populations will be defined by the medium term evolution: transient wheezers and persistent wheezers. Risk factors for these two conditions are different. Childhood asthma may be defined by the diagnosis of asthma (specific but fairly non-sensitive), by asthmatic symptoms (wheezing, waking by an attack of shortness of breath) (sensitive but not very specific), or by the combination of symptoms and airway hyperresponsiveness. The ISAAC study has standardised a questionnaire to assess the prevalence of asthma. The preliminary results show that there are wide variations across the world. The prevalence is low in Africa and Asia, intermediate in Europe, and high in Anglo-Saxon countries. The prevalence of asthma has gradually increased over the past 20 years in developed countries. Asthma and atopy are closely associated in children. Risk factors are genetic, associated with sex and environmental factors. Among these, allergic sensitisation is associated with the degree of exposure to allergens. Westernization of way of life is associated with increased prevalence of atopy, allergic rhinitis and asthma. Atopy seems inversely correlated to certain infections. Passive smoking is clearly associated with early wheezing. This and atmospheric pollution aggravate childhood asthma. However, the inducing role of pollution on asthma is still controversial.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="17" length="11"></location><text>respiratory</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="78" length="11"></location><text>respiratory</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1208" length="6"></location><text>airway</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="452" length="4"></location><text>skin</text></annotation></passage></document><document><id>PMC-2259298-sec-18</id><passage><offset>0</offset><text>Authors' contributions
All authors contributed to the development of the methodology. CY and NZ led method conceptualization and prepared the original draft, which was revised by JR. CY and VD performed most implementations. All authors read and approved the final manuscript.
</text></passage></document><document><id>PMC-1868021-caption-04</id><passage><offset>0</offset><text>Additional File 1
Appendix 1. Indications for liver function tests with no obvious liver disease, and consequent investigations
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="46" length="5"></location><text>liver</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="83" length="5"></location><text>liver</text></annotation></passage></document><document><id>PMID-899346</id><passage><offset>0</offset><text>[Considerations regarding two cases of macromastia (author's transl)].
Two cases of macromastia have been shown; one which appeared during puberty, the other during menopause. Histopathological examination has demonstrated for the both cases a cystic degeneracy of the glandular tissue with a hyperplazia and hypertrophy of the conjunctive tissue. The pathogeny of macromastia is being discussed and it is demonstrated both the role of hypophysis hormones (prolactine and growth hormone) and of ovarian hormones (estrogens). The treatment was surgical for the both cases.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="269" length="16"></location><text>glandular tissue</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="495" length="7"></location><text>ovarian</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="328" length="18"></location><text>conjunctive tissue</text></annotation></passage></document><document><id>PMC-2268729-sec-08</id><passage><offset>0</offset><text>Ovariectomy
Based on the uterine weight, we determined seven unsuccessful OVXs. The rats concerned were removed from further analyses, which left nine rats in the control group, five in the OVX group, seven in the OVX and late ZOL group, and eight in the OVX and early ZOL group. For each animal, we determined the percentage change in structural parameters compared to the values at week 0. Figure 1 shows the average percentage change and upper standard deviation for all groups for BV/TV, Conn.D, SMI, Tb.N, Tb.Th, and Tb.Sp. The OVX group without treatment showed large changes in structural parameters, indicating the development of OVX-induced bone loss (Figs. 1 and 2). Paired Student's t-test indicated significant changes within 2 weeks after OVX for all structural parameters. BV/TV, Conn.D, and Tb.N decreased during the experiment and SMI and Tb.Sp increased. Both Tb.Th and Tb.N decreased within 2 weeks, indicating that both thinning and complete resorption of trabeculae started directly after OVX. The initial rapid loss of bone and connectivity was largely accompanied by trabecular thinning, while secondary, slower loss of bone was concomitant with a decrease in Tb.N. While BV/TV, Conn.D, SMI, Tb.N, and Tb.Sp showed continuous changes in the same direction throughout the experiment, Tb.Th initially decreased significantly until 4 weeks after OVX and then increased again until after 16 weeks Tb.Th was significantly higher than in the control group. 
Fig. 1
Average percentage change in structural parameters in the metaphyseal proximal tibia and upper standard deviation for all groups at all time points. Brackets indicate P &lt; 0.05 at week 16
Fig. 2
Same slice of an unprocessed CT scan of the same rat in the OVX group taken at weeks 0 (a), 2 (b), 4 (c), 8 (d), 12 (e), and 16 (f). Images show typical trabecular bone loss due to OVX in the metaphysis. Green line shows the analyzed metaphyseal bone
The absolute average values and standard deviations for all structural parameters of all measurements are shown in Table 1. At the starting point, some differences in the values between the groups were present. This was due to the fact that some animals, which mostly had a relatively low BV/TV, were removed from the study because they did not respond to the OVX. However, since we compared the relative changes in each animal, the results were most likely not affected by the difference in absolute values. 
Table 1
Mean values and standard deviation of all structural parameters of all groups at the start of the experiment
Group BV/TV (1) Conn.D (1/mm) SMI (1) Tb.N (1/mm) Tb.Th (mum) Tb.Sp (mum)
Control 0.17 (0.056) 41 (47) 1.52 (0.53) 1.89 (1.38) 105 (49) 613 (368)
OVX 0.26 (0.055) 141 (76) 1.22 (0.39) 3.77 (1.66) 84 (10) 335 (174)
OVX + late ZOL 0.23 (0.062) 86 (66) 1.23 (0.34) 2.77 (1.55) 89 (13) 482 (227)
OVX + early ZOL 0.17 (0.056) 38 (21) 1.70 (0.39) 1.86 (0.80) 95 (7) 647 (207)
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="650" length="4"></location><text>bone</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1828" length="15"></location><text>trabecular bone</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1142" length="4"></location><text>bone</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1560" length="5"></location><text>tibia</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1921" length="4"></location><text>bone</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="25" length="7"></location><text>uterine</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1089" length="10"></location><text>trabecular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1040" length="4"></location><text>bone</text></annotation></passage></document><document><id>PMC-2844379-caption-01</id><passage><offset>0</offset><text>Magnetic resonance imaging of axial plan with intravenous contrast gadolinium-BOPTA demonstrating a mass adherent to the right ventricular wall.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="46" length="11"></location><text>intravenous</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="127" length="16"></location><text>ventricular wall</text></annotation></passage></document><document><id>PMC-3192753-sec-05</id><passage><offset>0</offset><text>Introduction
Yeast infections cause significant mortality in critically ill and immunocompromised patients. In particular, Candida species are the 4th most common cause of nosocomial bloodstream infections in the United States, and Cryptococcus neoformans, the commonest cause of fungal meningitis worldwide [1], [2]. Whilst Candida albicans remains the leading pathogenic yeast, infections due to non-C. albicans species such as Candida glabrata, as well as previously rare opportunists such as Trichosporon and Geotrichum species, are increasingly reported [1], [3]-[6]. Novel pathogenic Candida species such as Candida nivariensis and Candida bracarensis have also been described [7]. Since many non-C. albicans Candida and non-Candida yeasts are resistant or less susceptible to antifungal agents, rapid accurate species identification is central to timely, effective antifungal therapy [3]-[6], [8], [9].
Conventional phenotypic-based methods for yeast identification, however, are slow (24-72 h), insensitive and often unable to identify more unusual species. Various molecular techniques including real-time PCR, DNA sequence analysis, microarray analysis, and fluorescence in-situ hybridization provide accurate identification [10], [11] but are expensive, require substantial specimen processing time (hours to a day) and are not easily implemented as routine techniques in the clinical laboratory.
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a powerful and rapid tool for the identification of bacterial and yeast pathogens [12]-[17]. Using MALDI-TOF MS, the protein spectral "fingerprint" of an isolate is compared to a reference spectral database for identification [18]. Previous studies have reported species identification rates of 92-99% amongst collections of yeasts and yeast-like organisms [14]-[17], [19], [20]. However, taken collectively, the results may not be directly comparable since these studies have used different approaches to assign species - from comparing spectra from test organisms to reference spectra in MALDI-TOF MS databases [16], [20], to enhancing these databases, and in some instances developing study-specific databases, with "in-house" spectral signatures [14], [15]. There also is a continuing need to extend the repository of reference spectra in MALDI-TOF MS databases.
We therefore undertook the present study to evaluate the utility of the MALDI Biotyper 2.0 Microflex LT spectrometer (Bruker Daltonik GmbH; Bremen, Germany) with its current spectral database in comparison with phenotypic-based methods for the identification of a broad range of yeasts in a diagnostic laboratory. The first part of the study comprised testing of reference and clinical strains from our culture collection. The second was a blinded prospective analysis of freshly-collected yeast isolates recovered during routine laboratory work flow; discrepant results between MALDI TOF MS and phenotypic methods were resolved using sequence analysis of the fungal internal transcribed spacer (ITS) regions [21], [22]. Results obtained by preparation of yeasts by extraction of fungal proteins and by direct application of yeast colonies onto the MALDI TOF MS plate were also compared.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="183" length="5"></location><text>blood</text></annotation></passage></document><document><id>PMC-2949661-caption-02</id><passage><offset>0</offset><text>Summary of instrument characteristics
</text></passage></document><document><id>PMC-2945143-sec-13</id><passage><offset>0</offset><text>Definition of pathogens
It remains difficult to determine whether the organisms detected by the DNA Detection Kit are true pathogens. This also applies, although to a much lesser degree, to conventional blood culture analysis. However, detected organisms were considered to be pathogens if the results of culture tests from samples of the suspected infectious sites coincided with the results of DNA Detection Kit or blood culture analysis. The culture data of sputum, urine, pus and drainage fluid were used to define the pathogens.
A decision as to whether an identified organism was a pathogen was taken based on the decision tree shown in Figure 1. Thus, when the same organism was detected by both DNA Detection Kit and blood culture analysis, the detected organism was considered an infectious pathogen. If there was a discrepancy between the organism that was detected by SeptiFast analysis and that detected by blood culture analysis, or if an organism was only detected in one of these tests, then other samples taken from the infection site were analyzed. If this second culture test of the suspected infectious site revealed the presence of the same organism, this organism was considered to be a pathogen. If the microbial strain was only detected once for a sample, we then checked the second culture results in the suspected infectious sites. If this result identified the same strain as that identified by SeptiFast analysis then it was decided that this strain was a pathogen. However, if the strain was still only detected in some of the assays, we next determined if the patient involved suffered from sepsis. Sepsis is defined as SIRS caused by infection. The definition of sepsis that we used was based on the International Sepsis Forum Definition of Infection at the ICU Consensus Conference [7]. However, if the underlying disease is acute lymphoma leukemia (ALL), malignant lymphoma (ML), or acute myelogenous leukemia (AML), the definition of infection is defined as the ability to detect infectious organisms by blood culture analysis. If the patient was not defined as having sepsis when whole blood was administered to the patient, we decided that the strain detected by subsequent DNA Detection Kit or blood culture analysis was not a pathogen.
Figure 1
Flowchart for pathogen decision.
Samples were defined as negative for pathogens if a pathogen could not be detected by any method of analysis within seven days, and if another type of culture test did not detect this pathogen but could detect other organisms.
CoNS bacteria, which are represented by the Staphylococcus epidermidis (S. epidermidis) and Streptococcus spp. are indigenous bacteria and often cause contamination in assays of pathogens. Therefore, when CoNS or Streptococcus spp. were detected by blood culture and SeptiFast analysis, the following criteria were applied to define whether these strains represented a pathogenic infection: (1) Tests were performed at least twice within 48 hours before and after CoNS were detected by blood culture or SeptiFast analysis; (2) CoNS or Streptococcus spp. were detected in two different blood culture tests that were separately performed twice within 48 hours; and, (3) CoNS or Streptococcus spp. were detected twice or more in tests that were performed three times [11-15]. If a sample's results met any of these three criteria, then the sample was evaluated as a pathogen.
The distinction between pathogen and contamination was also determined for CoNS or Streptococcus spp. from the crossing point (Cp) obtained using the LightCycler analysis software v4.05. The Cp represents the point in the amplification cycle where the amplification curve crosses the detection threshold. When CoNS or Streptococcus spp. were detected using the LightCycler analysis software v4.05, a Cp of less than 20 was defined as indicating a pathogen and a Cp of over 20 was defined as contamination by checking the amplification curve.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="493" length="5"></location><text>fluid</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="725" length="5"></location><text>blood</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="469" length="5"></location><text>urine</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1887" length="18"></location><text>malignant lymphoma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="476" length="3"></location><text>pus</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1907" length="2"></location><text>ML</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2037" length="5"></location><text>blood</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2114" length="11"></location><text>whole blood</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="919" length="5"></location><text>blood</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2230" length="5"></location><text>blood</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2791" length="5"></location><text>blood</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3028" length="5"></location><text>blood</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3127" length="5"></location><text>blood</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3379" length="6"></location><text>sample</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="203" length="5"></location><text>blood</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="461" length="6"></location><text>sputum</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="417" length="5"></location><text>blood</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T10" role=""></node><node refid="T11" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T18" role=""></node></relation></passage></document><document><id>PMC-2596116-sec-09</id><passage><offset>0</offset><text>Authors' contributions
OK and MG analyzed and interpreted the patient data regarding his hospitalization. SP and PK performed the coronary angiography, and were the major contributors in writing the manuscript. All authors read and approved the final manuscript.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="130" length="8"></location><text>coronary</text></annotation></passage></document><document><id>PMID-8925114</id><passage><offset>0</offset><text>Functional model of benign paroxysmal positional vertigo using an isolated frog semicircular canal.
Bull frogs posterior semicircular canals (psc) wee used to simulate the condition of benign paroxysmal positional vertigo (BPPV). The psc was isolated in frog Ringer's solution, and the saccular otoconia were used as a responsible material to stimulate the cupula. When the otoconia were placed on the cupular surface to mimic the condition of cupulolithiasis, the psc ampullary nerve action potentials instantaneously changed according to the direction of the gravity produced by otoconia. When the otoconia were dropped into the canal to mimic the condition of moving otoconia in the canal, the action potentials changed together with the otoconial flow after a latent period. Both cupulolithiasis and moving otoconia are possibly valid mechanisms of BPPV, since they effectively stimulate the cupula. However, moving otoconia with a latent period would better explain clinical features of BPPV.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="80" length="18"></location><text>semicircular canal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="142" length="3"></location><text>psc</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="111" length="29"></location><text>posterior semicircular canals</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="357" length="6"></location><text>cupula</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="374" length="8"></location><text>otoconia</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="234" length="3"></location><text>psc</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="286" length="17"></location><text>saccular otoconia</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="581" length="8"></location><text>otoconia</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="600" length="8"></location><text>otoconia</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="631" length="5"></location><text>canal</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="670" length="8"></location><text>otoconia</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="402" length="15"></location><text>cupular surface</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="686" length="5"></location><text>canal</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="465" length="19"></location><text>psc ampullary nerve</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="741" length="9"></location><text>otoconial</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="811" length="8"></location><text>otoconia</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="896" length="6"></location><text>cupula</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="920" length="8"></location><text>otoconia</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T2" role=""></node><node refid="T3" role=""></node></relation></passage></document><document><id>PMC-2946569-sec-02</id><passage><offset>0</offset><text>2. Methods

</text></passage></document><document><id>PMC-2707216-sec-06</id><passage><offset>0</offset><text>Luciferase Assay
For Fig. 1, 10 ng of TORC1, 5 ng of TORC2, and 15 ng of PKAalpha expression plasmids were transfected into HEK293 cells. For Fig. 2, 800 ng of total DNA consisted of 200 ng of the pMLHoxb1ARE luciferase reporter and 100 ng of each expression plasmid. A lacZ reporter was co-transfected to normalize transfection efficiency. For Fig. 3A, the amounts of pENTR T2i shRNA (TORC2 shRNA) are given within the panel. For Fig. 3B, 25,000 cells per well were plated in 48-well plates and transfected using Lipofectamine 2000 with the following vectors: 40 ng of pML5xUAS, 40 ng of pGAL-DBD or pGAL-MEIS1A(335-390), 40 ng of pRSV-PBS or pRSV-PKA, 40 ng of pENTR U6 (control shRNA) or pENTR T2i shRNA (TORC2 shRNA), and 100 ng of pRSV-beta-galactosidase. At 48 h post-transfection, cell lysates were prepared using 100 mul per well of lysis buffer (1% Triton X-100, 1 mm dithiothreitol, 92.8 mm K2HPO4, pH 7.8, 9.2 mm KH2PO4, pH 7.8) and centrifuged for 5 min at 4 degreesC. A 20-mul aliquot of the supernatant was added to 12.5 mul of assay buffer (20 mm ATP, 40 mm MgCl2, 0.4 m Tris-Cl, pH 7.8). The mixture was immediately quantified for luciferase activity using a Lumat LB 9507 luminometer (EG&amp;G Berthold) that dispensed 100 mul per reaction of luciferin solution, which contains 1 mm d-(-)-luciferin (catalogue number 11626353001, Roche) and 0.1 m Tris-Cl, pH 7.8.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1005" length="11"></location><text>supernatant</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="93" length="8"></location><text>plasmids</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="124" length="12"></location><text>HEK293 cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="788" length="12"></location><text>cell lysates</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="447" length="5"></location><text>cells</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation></passage></document><document><id>PMC-3181729-sec-08</id><passage><offset>0</offset><text>Biochemical traits

</text></passage></document><document><id>PMID-10357269</id><passage><offset>0</offset><text>Enterococci at the crossroads of food safety?
Enterococci are gram-positive bacteria and fit within the general definition of lactic acid bacteria. Modern classification techniques resulted in the transfer of some members of the genus Streptococcus, notably some of the Lancefield's group D streptococci, to the new genus Enterococcus. Enterococci can be used as indicators of faecal contamination. They have been implicated in outbreaks of foodborne illness, and they have been ascribed a beneficial or detrimental role in foods. In processed meats, enterococci may survive heat processing and cause spoilage, though in certain cheeses the growth of enterococci contributes to ripening and development of product flavour. Some enterococci of food origin produce bacteriocins that exert anti-Listeria activity. Enterococci are used as probiotics to improve the microbial balance of the intestine, or as a treatment for gastroenteritis in humans and animals. On the other hand, enterococci have become recognised as serious nosocomial pathogens causing bacteraemia, endocarditis, urinary tract and other infections. This is in part explained by the resistance of some of these bacteria to most antibiotics that are currently in use. Resistance is acquired by gene transfer systems, such as conjugative or nonconjugative plasmids or transposons. Virulence of enterococci is not well understood but adhesins, haemolysin, hyaluronidase, aggregation substance and gelatinase are putative virulence factors. It appears that foods could be a source of vancomycin-resistant enterococci. This review addresses the issue of the health risk of foods containing enterococci.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1304" length="23"></location><text>nonconjugative plasmids</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1079" length="13"></location><text>urinary tract</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1289" length="11"></location><text>conjugative</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="377" length="6"></location><text>faecal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="886" length="9"></location><text>intestine</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="544" length="5"></location><text>meats</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T5" role="Arg1"></node><node refid="T6" role="Arg2"></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMC-2989791-sec-04</id><passage><offset>0</offset><text>Measurement of IgA1 content
IgA1 content in the supernatant from each culture well was measured in duplicate using enzyme-linked immunosorbent assay (ELISA). All incubations were performed at room temperature except for capture antibody coating. Briefly, 96-well immunoplates (Thermo Fisher Scientific, Waltham, MA, USA) were coated with 5 microg/mL of F(ab')2 fragment goat anti-human IgA antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA), in phosphate-buffered saline (PBS) at 4degreesC overnight. After three washes with PBS containing 0.05% Tween-20 (PBST), plates were blocked by adding PBS containing 1% bovine serum albumin (BSA) to the wells for 90 min. Next, 50 microL of supernatant sample or standard human IgA1 (CALBIOCHEM, La Jolla, CA, USA) was added to the reaction wells and then incubated for 90 min. After three washes, 0.75 microg/mL alkaline phosphatase conjugated goat anti-human IgA (Southern Biotechnology Associates, Birmingham, AL, USA) in 1% BSA/PBS was added to the reaction wells and then incubated for 90 min. Plates were washed three times and developed with a substrate solution of 1 mg/mL p-nitrophenyl phosphate disodium salt (SIGMA, St. Louis, MO, USA) in 0.1 M glycine buffer containing 1 mM MgCl2, 1 mM ZnCl2, pH 10.4. The optical density at 405 nm was determined in a microplate reader (Benchmark PlusTM Bio-Rad Laboratories, Hercules, CA, USA). IgA1 concentration in unknown duplicate samples was determined by interpolation of the respective optical density into the appropriate standard curve. IgG and IgM contents in the supernatant were measured using sandwich ELISA (IMMUNOtek(R), ZeptoMetrix Corporation, Buffalo, NY, USA) according to the manufacturer's instructions.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="699" length="18"></location><text>supernatant sample</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1580" length="11"></location><text>supernatant</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="48" length="11"></location><text>supernatant</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="635" length="5"></location><text>serum</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation></passage></document><document><id>PMID-9380745</id><passage><offset>0</offset><text>Blind separation of auditory event-related brain responses into independent components.
Averaged event-related potential (ERP) data recorded from the human scalp reveal electroencephalographic (EEG) activity that is reliably time-locked and phase-locked to experimental events. We report here the application of a method based on information theory that decomposes one or more ERPs recorded at multiple scalp sensors into a sum of components with fixed scalp distributions and sparsely activated, maximally independent time courses. Independent component analysis (ICA) decomposes ERP data into a number of components equal to the number of sensors. The derived components have distinct but not necessarily orthogonal scalp projections. Unlike dipole-fitting methods, the algorithm does not model the locations of their generators in the head. Unlike methods that remove second-order correlations, such as principal component analysis (PCA), ICA also minimizes higher-order dependencies. Applied to detected-and undetected-target ERPs from an auditory vigilance experiment, the algorithm derived ten components that decomposed each of the major response peaks into one or more ICA components with relatively simple scalp distributions. Three of these components were active only when the subject detected the targets, three other components only when the target went undetected, and one in both cases. Three additional components accounted for the steady-state brain response to a 39-Hz background click train. Major features of the decomposition proved robust across sessions and changes in sensor number and placement. This method of ERP analysis can be used to compare responses from multiple stimuli, task conditions, and subject states.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="838" length="4"></location><text>head</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1215" length="5"></location><text>scalp</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="453" length="5"></location><text>scalp</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="718" length="5"></location><text>scalp</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1461" length="5"></location><text>brain</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="43" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="403" length="5"></location><text>scalp</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="156" length="5"></location><text>scalp</text></annotation></passage></document><document><id>PMID-15604153</id><passage><offset>0</offset><text>TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids.
TBX21 encodes for the transcription factor T-bet (T-box expressed in T cells), which influences naive T lymphocyte development and has been implicated in asthma pathogenesis. Specifically, the T-bet knockout mouse spontaneously develops airway hyperresponsiveness and other changes consistent with asthma. Because airway responsiveness is moderated by the use of inhaled corticosteroids in asthma, it is conceivable that genetic variation in TBX21 may alter asthma phenotypes in a treatment-specific fashion. Here we demonstrate that the nonsynonymous variation in TBX21 coding for replacement of histidine 33 with glutamine is associated with significant improvement in the PC(20) (a measure of airway responsiveness) of asthmatic children in a large clinical trial spanning 4 years. We note that this increase occurs only in the children randomized to inhaled corticosteroids and that it dramatically enhances the overall improvement in PC(20) associated with inhaled corticosteroid usage. The average PC(20) at trial end for subjects on inhaled corticosteroids possessing a variant allele was in the normal range for nonasthmatics. In cellular models, we show that the TBX21 variant increases T helper 1 and decreases T helper 2 cytokine expression comparably with wild type. TBX21 may thus be an important determinant pharmacogenetic response to the therapy of asthma with inhaled corticosteroids.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1321" length="10"></location><text>T helper 2</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="414" length="6"></location><text>airway</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1296" length="10"></location><text>T helper 1</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="796" length="6"></location><text>airway</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="202" length="12"></location><text>T lymphocyte</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="337" length="6"></location><text>airway</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="169" length="7"></location><text>T cells</text></annotation></passage></document><document><id>PMC-3150645-caption-02</id><passage><offset>0</offset><text>a, b Radiographs of the left elbow and forearm 5 months after the surgery
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="29" length="5"></location><text>elbow</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="39" length="7"></location><text>forearm</text></annotation></passage></document><document><id>PMID-9635525</id><passage><offset>0</offset><text>Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis.
BACKGROUND:
Epstein-Barr virus (EBV) infection in nonsmall cell lung carcinoma (NSCLC) has been demonstrated in some ethnic groups. The pathobiology and the role of EBV and oncoprotein expression in these tumors have not been studied extensively. In this study, the authors investigated EBV-encoded RNA-1 (EBER1) transcripts by in situ hybridization and the expression of latent membrane protein-1 (LMP-1) and bcl-2 protein by immunohistochemistry in NSCLC patients from Taiwan, where nasopharyngeal carcinoma is endemic.
METHODS:
A total of 127 cases of NSCLC (43 cases of squamous cell carcinoma [SCC], 67 cases of adenocarcinoma [AD], 12 cases of large cell carcinoma [LCC], and 5 cases of lymphoepithelioma-like carcinoma [LE]) were included. A sensitive polymerase chain reaction-derived, digoxigenin-labeled DNA probe for in situ detection of EBER1 transcripts was performed for the detection of EBV. Immunohistochemistry using the avidin-biotin-immunoperoxidase method was also performed to evaluate the expression of bcl-2 and LMP-1.
RESULTS:
EBER1 was detected in 11 of the 127 NSCLC cases (8.7%; 6 SCC cases and 5 LE cases). All 5 LE cases were EBV-positive, whereas only 6 of the 43 SCC cases (14%), 0 of 67 AD cases, and 12 LCC cases were EBV-positive (P &lt; 0.05). All five LE cases showed diffuse, strong, positive staining of tumor cells; five of the six SCC cases showed diffuse but weak staining. Among the nontumor epithelial cells, there was no EBER1 staining of any of the 11 EBER1-positive cases. The mean age of the LE patients was 10 years younger than that of the patients with other histological types. All 5 LE patients were nonsmokers, whereas 3 of the 6 patients with EBER1-positive SCC (50%) were smokers. EBER1 expression did not correlate with the 2-year survival rate of overall cases, but all 5 LE patients were alive without clinical evidence of disease at last follow-up. Gender, lymph node or distant metastasis, and clinical stage were not found to have any correlation with EBER1 expression (P &gt; 0.05). All LE cases had bcl-2 oncoprotein expression (100%). This frequency was significantly different from other histologic types (P &lt; 0.05). The LMP-1 detection rate was low and demonstrated no correlation with bcl-2 expression.
CONCLUSIONS:
In this study, the authors found that the primary LE of the lung is associated with young age, a history of not smoking, high bcl-2 immunoreactivity, and better survival rate. These characteristics demonstrate that EBV-associated LE of the lung is a unique entity. The findings of the current study suggest that EBV infection may play a different role in the tumorigenesis of primary LE of the lung than it does in other EBER1-positive NSCLCs.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="607" length="5"></location><text>NSCLC</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="641" length="24"></location><text>nasopharyngeal carcinoma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="236" length="5"></location><text>NSCLC</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="361" length="6"></location><text>tumors</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2199" length="2"></location><text>LE</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2069" length="10"></location><text>lymph node</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1982" length="2"></location><text>LE</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="711" length="5"></location><text>NSCLC</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1865" length="3"></location><text>SCC</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="730" length="23"></location><text>squamous cell carcinoma</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1788" length="2"></location><text>LE</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1692" length="2"></location><text>LE</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1578" length="25"></location><text>nontumor epithelial cells</text></annotation><annotation id="T40"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1495" length="11"></location><text>tumor cells</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1524" length="3"></location><text>SCC</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1441" length="2"></location><text>LE</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1297" length="2"></location><text>LE</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="30" length="28"></location><text>nonsmall cell lung carcinoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="206" length="28"></location><text>nonsmall cell lung carcinoma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="77" length="34"></location><text>"lymphoepithelioma-like" carcinoma</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="755" length="3"></location><text>SCC</text></annotation><annotation id="T38"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2827" length="4"></location><text>lung</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="773" length="14"></location><text>adenocarcinoma</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2817" length="2"></location><text>LE</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="789" length="2"></location><text>AD</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="806" length="20"></location><text>large cell carcinoma</text></annotation><annotation id="T39"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2854" length="21"></location><text>EBER1-positive NSCLCs</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="828" length="3"></location><text>LCC</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1264" length="3"></location><text>SCC</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="849" length="32"></location><text>lymphoepithelioma-like carcinoma</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1243" length="5"></location><text>NSCLC</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="883" length="2"></location><text>LE</text></annotation><annotation id="T36"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2673" length="4"></location><text>lung</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1350" length="3"></location><text>SCC</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1280" length="2"></location><text>LE</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1375" length="2"></location><text>AD</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2483" length="2"></location><text>LE</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1392" length="3"></location><text>LCC</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2663" length="2"></location><text>LE</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2493" length="4"></location><text>lung</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T3" role=""></node><node refid="T4" role=""></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T9" role=""></node><node refid="T10" role=""></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T11" role=""></node><node refid="T12" role=""></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T13" role=""></node><node refid="T14" role=""></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T15" role=""></node><node refid="T16" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T40" role=""></node></relation></passage></document><document><id>PMC-3245051-caption-01</id><passage><offset>0</offset><text>The growth in the number of database publications per year. Each bar shows the number of research articles with the keyword 'database' appearing in the article title in the given year. The count only covers articles indexed in PubMed. The increase shows an exponential trend that will produce nearly 2000 database publications per year by 2015.
</text></passage></document><document><id>PMC-3212698-sec-01</id><passage><offset>0</offset><text>Objectives
Evaluate relationships between MRI and clinical/laboratory/radiographic findings in rheumatoid arthritis (RA).
</text></passage></document><document><id>PMID-9776783</id><passage><offset>0</offset><text>Lack of developmental and reproductive toxicity of 2,3,3',4, 4'-pentachlorobiphenyl (PCB 105) in ring-necked pheasants.
Mono-ortho PCBs are global contaminants of wildlife with the potential to produce toxicity by an aryl hydrocarbon receptor (AhR)-mediated mechanism. To determine the potency of 2,3,3',4, 4'-pentachlorobiphenyl (PCB 105) for producing reproductive and developmental toxicity, adult ring-necked pheasant hens (Phasianus colchicus) were orally dosed with 0, 0.06, 0.6, or 6 mg PCB 105/kg hen/week for 10 weeks to achieve cumulative doses of 0, 0.6, 6, or 60 mg PCB 105/kg hen after which hens were bred with untreated roosters once per week for 8 weeks. Except at week 6 of the egg-laying period when cumulative egg production in the 6 mg PCB 105/kg hen group was greater than controls, fertilized egg production was not significantly different between treatment groups. Embryo mortality and chick mortality were not significantly different between treatment groups. Total body and heart weights of all chicks 1 day posthatch (dph) were not different between groups, however, liver weights of chicks from the 60 mg/kg treatment group were greater than controls at 1 dph. The first chick to hatch from each hen was reared to 21 dph and among these birds, the total body, liver, and heart weights were not different between groups. There were no dose-related malformations of the beak or limbs, and no signs of subcutaneous edema, ascites, or pericardial edema in chicks at 1 or 21 dph. Hepatic microsomal monooxygenase activities [ethoxyresorufin-O-dealkylase (EROD), benzyloxyresorufin-O-dealkylase (BROD), and methyloxyresorufin-O-dealkylase (MROD)] were significantly elevated in chicks at 1 dph from hens given a cumulative PCB 105 dose of 6 mg/kg and in chicks at 21 dph from hens given a cumulative PCB dose of 60 mg/kg. These results indicate that a cumulative PCB 105 dose up to 60 mg/kg hen does not decrease the production of fertilized eggs or increase embryo or chick mortality in ring-necked pheasants, but does increase chick hepatic monooxygenase activity.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="695" length="3"></location><text>egg</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="815" length="3"></location><text>egg</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="729" length="3"></location><text>egg</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="999" length="5"></location><text>heart</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1093" length="5"></location><text>liver</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="888" length="6"></location><text>Embryo</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="990" length="4"></location><text>body</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1298" length="5"></location><text>heart</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1395" length="4"></location><text>beak</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1403" length="5"></location><text>limbs</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1426" length="18"></location><text>subcutaneous edema</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1281" length="4"></location><text>body</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1446" length="7"></location><text>ascites</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1287" length="5"></location><text>liver</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1458" length="17"></location><text>pericardial edema</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="1963" length="4"></location><text>eggs</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="1980" length="6"></location><text>embryo</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2056" length="7"></location><text>hepatic</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T14" role=""></node></relation></passage></document><document><id>PMID-17409033</id><passage><offset>0</offset><text>Determination of eprosartan in human plasma and urine by LC/MS/MS.
A protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method has been developed and validated for the determination of eprosartan in human plasma and urine. The solvent system also served as a protein precipitation reagent. The chromatographic separation was achieved on a CAPCELL PAK C18 column (50 mmx2.0 mm, 5 microm, Shiseido). A mobile phase was consisted of 0.5% formic acid in water and 0.5% formic acid in acetonitrile (72:28). Detection was by positive ion electrospray tandem mass spectrometry on a Sciex API3000. The standard curves, which ranged from 5 to 2000 ng/mL in human plasma and from 0.25 to 50 microg/mL in urine, were fitted to a 1/x weighted quadratic regression model. The method proved to be accurate, specific and sensitive enough to be successfully applied to a pharmacokinetic study.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="724" length="5"></location><text>urine</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="246" length="5"></location><text>urine</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="684" length="6"></location><text>plasma</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="37" length="6"></location><text>plasma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="235" length="6"></location><text>plasma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="48" length="5"></location><text>urine</text></annotation></passage></document><document><id>PMC-2922337-sec-10</id><passage><offset>0</offset><text>RNA extraction and reverse transcription
Total RNA were extracted from cells using either Trizol reagent (Invitrogen) or RNeasy kit (Qiagen) and treated with DNaseI reagent (Macherey-Nagel) for 30 min at room temperature. Reverse transcriptions were performed using 1microg total RNA and the High capacity cDNA reverse transcription kit with RNase Inhibitor (Applied Biosystems).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="71" length="5"></location><text>cells</text></annotation></passage></document><document><id>PMID-8369040</id><passage><offset>0</offset><text>Chelation treatment of neurological Wilson's disease.
The results of chelation treatment of 137 patients presenting with neurological Wilson's disease are described, together with the more commonly observed toxic reactions to the various drugs employed. Fifty-seven patients made an excellent response to treatment and became symptom free. Thirty-six patients made a good recovery, but were left with some minor neurological deficit. Twenty-four patients had a poor response: although the disease process was arrested they were left more or less disabled. Twenty patients died: nine had little or no treatment, but 11 died despite apparently adequate chelation therapy. There was no obvious reason for this failure. The liver copper level was estimated in six of these patients: it was still significantly elevated in only one, but in all four in whom it was possible to make the determination, the concentration of copper in the basal ganglia was in excess of 45 micrograms/g wet weight. It was not apparent why adequate therapy failed to remove copper from the brains of these patients. There was no obvious clinical, histological or biochemical indicator of failure to respond to treatment. Initial deterioration before improvement was seen in 30 patients: the prognosis for a useful recovery was not necessarily worse than that in patients who did not show this phenomenon.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1063" length="6"></location><text>brains</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="720" length="5"></location><text>liver</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="930" length="13"></location><text>basal ganglia</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="23" length="12"></location><text>neurological</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="412" length="12"></location><text>neurological</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="121" length="12"></location><text>neurological</text></annotation></passage></document><document><id>PMID-2947053</id><passage><offset>0</offset><text>Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agents.
Various approaches to hormonal treatment of prostate carcinoma are discussed. Eighty-one patients with prostatic carcinoma, eight with stage B, nine with stage C, and 64 with stage D disease, were treated subcutaneously daily for 3 months with the LH-RH agonist D-Trp-6-LH-RH (Decapeptyl) in order to evaluate the incidence of remissions according to WHO recommendations for oncologic trials. The findings were compared to those obtained with other hormonal therapies of prostatic carcinoma according to the statistical method of "expected response rate" as adapted by Lee and Wesley for phase II trials. Treatment with D-Trp-6-LH-RH greatly reduced serum LH and testosterone levels without raising serum prolactin. After 1-2 weeks of therapy, there was relief of subjective symptoms and a reversal of the signs of prostatism as well as a marked decrease in bone pain. At 90 days 52 patients had complete relief of prostatism and 21 had only mild signs and symptoms. Seventy patients were experiencing no bone pain and an additional six had only mild pain. Prostatic size, evaluated by rectal examination and transabdominal ultrasonography, reverted to normal in 26.4% of patients (complete remission) and was reduced by more than 50% in an additional 17.6% (partial remission), the overall rate of complete plus partial regression of prostatic enlargement being 44%. Scans showed a major improvement of bone lesions in 14.8% of cases. This response increased to 37% after more than 6 months of follow-up. Prostatic acid phosphatase levels were decreased by more than 50% in 61% of the patients, but this test appears to be a less valid marker than the lipid-associated sialic acid (LASA). The increase in LASA before treatment and a reduction after treatment can frequently be correlated with the objective volume of the neoplasms. No flare-up of the disease was encountered, and there were no side effects except for impotence. Statistical analyses of results by the method of Lee and Wesley indicated that the incidence of complete and partial regression (CR and PR) observed with D-Trp-6-LH-RH was not significantly different from that recorded in previous studies for another LH-RH analog, Buserelin. However, CR and PR obtained with D-Trp-6-LH-RH (44%) were significantly higher than with subcapsular orchiectomy (22%). Hormonal effects and some other actions of D-Trp-6-LH-RH were compared and contrasted with those produced by castration, estrogens, antiandrogens, and progestogens.(ABSTRACT TRUNCATED AT 400 WORDS)
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="37" length="19"></location><text>prostatic carcinoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="200" length="19"></location><text>prostatic carcinoma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="141" length="18"></location><text>prostate carcinoma</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="796" length="5"></location><text>serum</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="955" length="4"></location><text>bone</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="568" length="19"></location><text>prostatic carcinoma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="747" length="5"></location><text>serum</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1432" length="9"></location><text>prostatic</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1501" length="12"></location><text>bone lesions</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1603" length="9"></location><text>Prostatic</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1919" length="9"></location><text>neoplasms</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1102" length="4"></location><text>bone</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1206" length="14"></location><text>transabdominal</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1154" length="9"></location><text>Prostatic</text></annotation></passage></document><document><id>PMC-2151581-sec-12</id><passage><offset>0</offset><text>Ca2+ Dependence of Slob57 Modulation of the Voltage Dependence of Activation of dSlo
Ca2+ plays a fundamental role in regulating the dSlo response to membrane depolarization. One of the three known Ca2+ binding sites (Xia et al., 2002; Bao et al., 2002; Zeng et al., 2005b), known as the calcium bowl (Schreiber and Salkoff, 1997), contributes to the high-affinity Ca2+ sensitivity of the channel (Schreiber and Salkoff, 1997; Schreiber et al., 1999; Braun and Sy, 2001; Bao et al., 2002; Niu and Magleby, 2002; Xia et al., 2002; Bao et al., 2004; Zeng et al., 2005b). We used a mutated dSlo channel with substitution of Asp966-Asp970 by Asn966-Asn970 within its calcium bowl, which greatly reduces the channel's calcium sensitivity (Bian et al., 2001), to determine whether Ca2+ participates in Slob57 modulation of dSlo. This mutated channel, dSloD5N5, still binds to full-length and truncated Slobs (Fig. 1 B, lanes 4-6). During a 350-ms test pulse (Fig. 7 E), Slob57 causes dSloD5N5 inactivation (Fig. 7 B), consistent with our previous finding that the inactivation caused by Slob57 is Ca2+ independent (Zeng et al., 2005a). After deletion of the amino-terminal residues 2-6 of Slob57, the inactivation of dSloD5N5 is eliminated (Fig. 7 C), and further truncation of Slob57 to Arg16 also eliminates the inactivation (Fig. 7 D), just as observed with wild-type dSlo (Fig. 2, C and D).
Figure 7.
Slob57 causes inactivation of dSloD5N5. Same as Fig. 2, except that the mutated channel dSloD5N5 was used instead of wild-type dSlo. (A) dSloD5N5 alone, (B) dSloD5N5 together with Slob57, (C) dSloD5N5 together with Slob57DeltaN5, (D) dSloD5N5 together with Slob57DeltaN15, (E) pulse protocol.
We next used a 100-ms test pulse (during which no inactivation occurs) to measure the voltage dependence of activation of dSloD5N5 in the presence of 110 muM free Ca2+, as only at high concentrations of free Ca2+ can tail current saturation be achieved with the mutant channel (Fig. 8). As shown in Fig. 8, Slob57 does not rightward shift the conductance-voltage relationship of dSloD5N5. Because dSloD5N5 can still respond to an increment of free Ca2+ at high concentration (Bian et al., 2001), we then increased the concentration of free Ca2+ to 300 muM. As shown in Fig. 8, the conductance-voltage relationship of dSloD5N5 shifts to less depolarized voltages when the concentration of free Ca2+ is increased from 110 to 300 muM, but again the V1/2 is not modulated by Slob57.
Figure 8.
Conductance-voltage relationships for dSloD5N5. Same protocol as Fig. 6, except that the mutated channel dSloD5N5 was used in the presence (circles) or absence (squares) of Slob57, and the concentration of free Ca2+ was either 110 muM (filled symbols) or 300 muM (open symbols).
We next measured the voltage dependence of activation of wild-type dSlo, in the presence or absence of Slob57, at free Ca2+ concentrations ranging from 20 to 300 muM. As shown in Fig. 9 A (and by many previous investigators), in the absence of Slob57, the voltage-conductance relationship of dSlo shifts to less depolarized voltages as the free Ca2+ concentration is increased in this range. The V1/2 decreases from 85 to -22 mV, a change of 107 mV, when the concentration of free Ca2+ is increased from 20 to 300 muM. In contrast, when dSlo is coexpressed with Slob57, this increment of free Ca2+ concentration shifts the V1/2 to a much lesser extent (Fig. 9 B and Fig. 10 A). Note also that the effect of Slob57 on the V1/2 is more apparent at higher free Ca2+ concentrations (Fig. 10 A). To illustrate this better, we plotted the V1/2 change evoked by Slob57 (DeltaV1/2) as a function of the free Ca2+ concentration (Fig. 10 B) to demonstrate that the magnitude of the modulatory shift in V1/2 evoked by Slob57 itself is calcium dependent.
Figure 9.
Effect of calcium on dSlo voltage dependence of activation in the absence or presence of Slob57. Same as Fig. 6, except that the measurements of dSlo expressed alone (A) or together with Slob57 (B) were performed in the presence of different concentrations of free Ca2+: 20 muM (diamonds), 40 muM (inverted triangles), 80 muM (triangles), 110 muM (squares), and 300 muM (circles).
Figure 10.
Interaction between Slob57 and calcium. The V1/2 (A) of the conductance-voltage relationship for dSlo expressed alone (O) or together with Slob57 (*), taken from Fig. 9, and the difference in V1/2 (DeltaV1/2) evoked by Slob57 (B) are plotted as a function of the concentration of free Ca2+.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="150" length="8"></location><text>membrane</text></annotation></passage></document><document><id>PMC-2721088-sec-10</id><passage><offset>0</offset><text>Chicken CCN3 expression in embryonic and extraembryonic tissues
Expression of CCN3 in axial structure becomes visible in the presegmentation stage and reaches to the highest level at the beginning of somitogenesis (HH stage 7, Fig. 1a). Strong similarity between CCN3 and Sonic Hedgehog was observed for the expression pattern in axial structure (notochord and floor plate), in which the left-right asymmetrical pattern in the node area is also conserved (Fig. 1b). However, Sonic Hedgehog expression is slightly broader than that of CCN3. Since CCN3 stimulates Notch signaling (Sakamoto et al. 2002), we investigated the expression of Notch signal genes. Among them, Serrate1, a ligand of Notch is unique because its expression is apparently a right deviated pattern in the node area (Fig. 1c). Another Notch ligand, Delta1 shows a right deviated pattern, but is more caudal area of the node extending to the primitive streak (data not shown). The expression of CCN3 in axial structure was followed by the presomitic mesoderm although it is diminished (Sakamoto et al. 2002). 
Fig. 1
Expression of mRNA in early stage chicken embryo; CCN3 (a), Sonic Hedgehog (b) and Serrate1 (c) at the beginning stage of somitogenesis (Hamburger and Hamilton (HH) Stage 7). Arrowheads indicate Hensen's node. Demonstrates the schematic view of tissue organization at this stage (d). Expression of CCN3 mRNA in blood islands of chicken extraembryonic tissue (HH stage 10) (e). Ventral part of the endothelial precursor cells in blood islands is positive for CCN3 expression. Coloration was stopped before the background staining started in sense probes (negative control)
There is accumulating evidence of CCN3 commitment to hematopoiesis and therefore we investigated the CCN3 expression in extraembryonic tissues. Blood islands are formed in the yolk sac mesodermal area just between the visceral endodermal and ectodermal layers, which supply the red blood cells at the primary stage. The cells in blood islands are called hemangioblasts since they also differentiate into the endothelial cells of extraembryonic blood vessel structure. In chicken embryo, differentiating endothelial cells in the ventral part of blood islands express CCN3 from the initial stage (Fig. 1e). Erythroblasts in the center of blood islands (spherical cells in Fig. 1e) weakly express CCN3 and their expression is mildly enhanced in later stage (data not shown).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1421" length="21"></location><text>extraembryonic tissue</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1482" length="27"></location><text>endothelial precursor cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1330" length="6"></location><text>tissue</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1513" length="13"></location><text>blood islands</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1462" length="7"></location><text>Ventral</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1396" length="13"></location><text>blood islands</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2185" length="7"></location><text>ventral</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1777" length="22"></location><text>extraembryonic tissues</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2318" length="5"></location><text>cells</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2293" length="13"></location><text>blood islands</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2262" length="13"></location><text>Erythroblasts</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2201" length="13"></location><text>blood islands</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2160" length="17"></location><text>endothelial cells</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2136" length="6"></location><text>embryo</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="27" length="9"></location><text>embryonic</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="1127" length="6"></location><text>embryo</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="41" length="22"></location><text>extraembryonic tissues</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1801" length="13"></location><text>Blood islands</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1833" length="19"></location><text>yolk sac mesodermal</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1875" length="19"></location><text>visceral endodermal</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1899" length="17"></location><text>ectodermal layers</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1935" length="15"></location><text>red blood cells</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1977" length="5"></location><text>cells</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1986" length="13"></location><text>blood islands</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2011" length="14"></location><text>hemangioblasts</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2065" length="17"></location><text>endothelial cells</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2086" length="37"></location><text>extraembryonic blood vessel structure</text></annotation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T12" role="Arg1"></node><node refid="T13" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T21" role="Arg1"></node><node refid="T26" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T1" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T13" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation><relation id="A11"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T10" role=""></node></relation><relation id="A10"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A9"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A13"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T24" role=""></node></relation><relation id="A12"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T22" role=""></node></relation></passage></document><document><id>PMC-2875696-sec-02</id><passage><offset>0</offset><text>2. Methods
We conducted a systematic study of patients hospitalized from August 2006 until September 2007 at the Yerevan City and the Republican Dispensaries, the two reference TB hospitals in Armenia. Following focus group discussions and pilot testing to refine the survey instrument, patient interviews began in the fall of 2006 and were conducted by trained students in the public health program of the American University of Armenia. Students received training by the study designer (SO) on principles of interview ethics and interviewing processes.
Most patient interviews were conducted at the Republican Dispensary in Abovian Marz, the national TB diagnostic and treatment facility to which all suspected cases throughout the country are referred for diagnostic confirmation. In the past several years, strong financial support has been provided to Armenia by a number of international organizations, such as the German Gesellschaft fur Technische Zusammenarbeit (GTZ), the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Red Cross, which has enabled both microscopic and culture examinations for each TB case to be performed at the National Reference Laboratory located at the Republican TB Dispensary. All culture-confirmed TB cases are admitted as in-patients while undergoing the initial phase of therapy. Because all confirmed TB patients in Armenia are referred to one of these dispensaries for treatment, this population represents all known TB cases in the country. Therefore, all culture-confirmed TB in-patients present at the time of the interviewer visits were eligible for inclusion in the study (the study group included both new and relapsed patients). Our systematic sample of the inpatient TB population--in which interviewers visited every hospital room to identify patients willing to participate--yielded a participation rate of approximately 80% (a total of 240 patients).
Interviewers collected demographic information and asked each patient to recall when they first began to feel ill, what symptoms they experienced, how long after symptom onset they waited to see a doctor, their reasons for delaying medical evaluation, the type of facility at which they first sought care, the initial diagnosis, if they had been referred for further evaluation, and their adherence to treatment once diagnosed with TB. In 2006, 129 of the planned 250 surveys were completed. Data collection resumed in the fall of 2007 and a total of 240 interviews were conducted.

</text></passage></document><document><id>PMID-17607547</id><passage><offset>0</offset><text>Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-alpha, IL-1beta and IL-1Ra.
OBJECTIVES AND DESIGN:
To study the consequences of mast cell activation in human synovial tissue.
METHODS:
Synovial tissue was obtained from 18 RA patients and mast cells was selectively activated in synovial tissue explant cultures. Expression of TNF-alpha, IL-1beta and IL-1Ra were determined and tissue distribution of IL-1beta was studied.
RESULTS:
Compared to untreated synovia, selective activation of synovial mast cells increased significantly the production of TNF-alpha (0.49 +/- 0.88 vs. 4.56 +/- 3.18 pg/mg wet tissue, p &lt; 0.001) and IL-1beta (0.058 +/- 0.032 vs. 2.55 +/- 1.98 pg/mg wet tissue, p = 0.013). The expression of TNF-alpha and IL-1beta mRNA increased significantly (19-fold (p = 0.009) and 13-fold (p = 0.031), respectively). Mast cell activation induced IL-1beta expression in particular in nearby CD68 positive synovial macrophages. Secretion of IL-1Ra was also increased but to a lesser degree than that of IL-1beta.
CONCLUSIONS:
Synovial mast cells produce proinflammmatory cytokines and may thus contribute to the inflammation in RA.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="24" length="10"></location><text>mast cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="174" length="9"></location><text>mast cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="38" length="26"></location><text>rheumatoid synovial tissue</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="283" length="10"></location><text>mast cells</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="323" length="15"></location><text>synovial tissue</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="204" length="15"></location><text>synovial tissue</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="230" length="15"></location><text>Synovial tissue</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="531" length="19"></location><text>synovial mast cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="874" length="9"></location><text>Mast cell</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="947" length="34"></location><text>CD68 positive synovial macrophages</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1081" length="19"></location><text>Synovial mast cells</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="422" length="6"></location><text>tissue</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="498" length="7"></location><text>synovia</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMC-3052097-caption-01</id><passage><offset>0</offset><text>The asymmetric unit of the title compound with the atomic labelling scheme.Displacement are drawn at the 50% probability level. H atoms are represented as small spheres of arbitrary radii. Hydrogen bonds are shown as dashed lines.
</text></passage></document><document><id>PMC-2646714-caption-02</id><passage><offset>0</offset><text>Sealant application criteria for molar fissures
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="33" length="5"></location><text>molar</text></annotation></passage></document><document><id>PMC-2074286-sec-01</id><passage><offset>0</offset><text>Images
Figure 1
</text></passage></document><document><id>PMID-10744669</id><passage><offset>0</offset><text>Genuine monovalent ligands of TrkA nerve growth factor receptors reveal a novel pharmacological mechanism of action.
Developing small molecule agonistic ligands for tyrosine kinase receptors has been difficult, and it is generally thought that such ligands require bivalency. Moreover, multisubunit receptors are difficult to target, because each subunit contributes to ligand affinity, and each subunit may have distinct and sometimes opposing functions. Here, the nerve growth factor receptor subunits p75 and the tyrosine kinase TrkA were studied using artificial ligands that bind specifically to their extracellular domain. Bivalent TrkA ligands afford robust signals. However, genuine monomeric and monovalent TrkA ligands afford partial agonism, activate the tyrosine kinase activity, cause receptor internalization, and induce survival and differentiation in cell lines and primary neurons. Monomeric and monovalent TrkA ligands can synergize with ligands that bind the p75 subunit. However, the p75 ligands used in this study must be bivalent, and monovalent p75 ligands have no effect. These findings will be useful in designing and developing screens of small molecules selective for tyrosine kinase receptors and indicate that strategies for designing agonists of multisubunit receptors require consideration of the role of each subunit. Last, the strategy of using anti-receptor mAbs and small molecule hormone mimics as receptor ligands could be applied to the study of many other heteromeric cell surface receptors.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="607" length="13"></location><text>extracellular</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="890" length="7"></location><text>neurons</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1507" length="12"></location><text>cell surface</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="867" length="10"></location><text>cell lines</text></annotation></passage></document><document><id>PMID-6653557</id><passage><offset>0</offset><text>Purification and characterization of various esterases from rat liver.
The major rat liver microsomal esterases acting on o-nitrophenylacetate with isoelectric points 5.0, 5.5, 6.1 and 6.4 were resolved by isoelectric focusing. Molecular weights were determined by sedimentation analysis in isokinetic gradients of sucrose and, after purification, in sodium dodecyl sulphate/polyacrylamide gel electrophoresis. Their subunit molecular weights were between 57 000 and 60 000. They behaved as monomers except the pI-6.1 enzyme which behaved as a trimer. Esterases of pI 5.0, pI 6.1 and pI 6.4 behaved like glycoproteins of the polymannose type in the presence of 125I-labelled concanavalin A. Preparations of the pI-5.0 enzyme contained two esterases of highly homologous structure. Antibodies directed against this preparation did not inhibit but precipitated pI-5.0 esterase activity quantitatively. They did not react with the pI-6.1 and pI-6.4 esterases but precipitated several nonimmunologically related esterases. Two of these enzymes were inducible by phenobarbital. Total activity was very low in 3-day-old animals. Individual esterase activities rose at different rates during development; the enzyme focusing near pI 5.0 was about three times more active in adult females than in males. All microsomal esterases are located on the luminal side of the endoplasmic reticulum.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="64" length="5"></location><text>liver</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1360" length="21"></location><text>endoplasmic reticulum</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="85" length="16"></location><text>liver microsomal</text></annotation></passage></document><document><id>PMID-17627146</id><passage><offset>0</offset><text>Neurohypophyseal granulomatous germinoma invading the right cavernous sinus: case report and review of the literature.
We encountered a rare case of neurohypophyseal germinoma with a prominent granulomatous reaction, which invaded the right cavernous sinus. The neuroimaging and histopathology features in this case were unique, distinguishing it from other types of suprasellar lesions. A 13-year-old boy presented with loss of appetite and polyuria; both symptoms were present for 1 year, and headache, general fatigue and blurred vision present for the prior 2 months. On admission, neurological examination indicated bitemporal hemianopsia and optic atrophy. Endocrinological exam showed panhypopituitarism. Tumor markers such as alpha-fetoprotein, human growth hormone, carcinoembryonic antigen, and placental alkaline phosphatase were negative. Brain CT revealed a suprasellar tumor with calcification. MR T(1)-weighted and T(2)-weighted images showed the tumor to be isointense to normal brain parenchyma and to be enhanced densely. The tumor also involved the right cavernous sinus, so that a biopsy was performed by the transsphenoidal approach. On pathologic examination of the specimen, typical large tumor cells with lymphocytic cell infiltration and prominent granulomatous reaction were observed. Neurohypophyseal granulomatous germinoma was diagnosed. Radiotherapy was performed with a total dose of 51 Gy and the tumor shrank remarkably. The patient returned to school under hormone replacement therapy.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="0" length="40"></location><text>Neurohypophyseal granulomatous germinoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="149" length="26"></location><text>neurohypophyseal germinoma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="54" length="21"></location><text>right cavernous sinus</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="712" length="5"></location><text>Tumor</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="235" length="21"></location><text>right cavernous sinus</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="367" length="19"></location><text>suprasellar lesions</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="871" length="17"></location><text>suprasellar tumor</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="962" length="5"></location><text>tumor</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="995" length="5"></location><text>brain</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="805" length="9"></location><text>placental</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1044" length="5"></location><text>tumor</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1068" length="21"></location><text>right cavernous sinus</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="851" length="5"></location><text>Brain</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1129" length="15"></location><text>transsphenoidal</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1212" length="11"></location><text>tumor cells</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1229" length="16"></location><text>lymphocytic cell</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1311" length="40"></location><text>Neurohypophyseal granulomatous germinoma</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1429" length="5"></location><text>tumor</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation></passage></document><document><id>PMC-1635332-sec-23</id><passage><offset>0</offset><text>Nf and GA-1 DNA polymerases couple polymerization to strand displacement processively
The results presented in this paper clearly indicate that Nf and GA-1 DNA polymerases can account for their genome replication without the assistance of unwinding and processivity factors, in contrast to most replicative DNA polymerases which require their physical association to processivity factors and DNA unwinding proteins (1,70). Strand displacement capacity has also been shown for other protein-primed DNA polymerases as those of bacteriophages phi29 (10), Cp-1 (71) and PRD1 (72,73). On the contrary, adenovirus DNA polymerase, although processive, cannot couple polymerization to strand displacement, requiring the DNA unwinding activity of the adenovirus DBP to perform strand displacement (74,75).
Whereas it was possible to obtain GA-1 DNA replication by using exclusively the GA-1 TP and DNA polymerase, Nf DNA polymerase, although provided with competent strand displacement and processivity features, required the presence of Nf DBP for an effective in vitro replication of Nf TP-DNA. Results presented here show that Nf DBP strongly stimulates the formation of the TP-dAMP initiation complex by decreasing the Km for dATP and facilitates the transition from initiation to elongation, as it occurs in phi29 (76). These results point to either a specific and direct contact between DBP and DNA polymerase that promotes conformational changes at the polymerization active site or to an effect of DBP in conferring the optimal template structure to direct initiating nucleotide insertion. A similar role has been proposed for adenovirus DBP, a DNA unwinding protein (77). As in the case of phi29 and Nf DBP, this protein stimulates the rate of initiation also by decreasing the Km for the initiating nucleotide (74). The fact that an adenovirus DBP mutant defective in unwinding can still stimulate initiation precludes the unwinding role as the one responsible for such an activation (77,78). In this case, contacts between DBP and pTP/DNA polymerase complex have been reported (77).
The effect of Nf DBP in promoting elongation of the initiation products could be due to a decrease of the Km also for the incorporation of the dNMPs during the transition stage from initiation to elongation, to a different type of contact with the DNA polymerase that helps transition to elongation, or both. The similarity in replication rates when comparing M13 DNA replication, performed in the absence of DBP (2400 nt/min), with Nf TP-DNA replication in the presence of DBP (2260 nt/min), suggests that the DBP stimulatory role is restricted to the first phases of Nf TP-DNA replication.
</text></passage></document><document><id>PMID-20525074</id><passage><offset>0</offset><text>Acoustic trauma evokes hyperactivity and changes in gene expression in guinea-pig auditory brainstem.
Hearing loss from acoustic trauma is a risk factor for tinnitus. Animal models using acoustic trauma have demonstrated hyperactivity in central auditory pathways, which has been suggested as a substrate for tinnitus. We used a guinea-pig model of unilateral acoustic trauma. Within the same animals, measurements of peripheral hearing loss, spontaneous activity of single neurons in the inferior colliculus and gene expression in cochlear nucleus and inferior colliculus were combined, acutely and after recovery from acoustic trauma. Genes investigated related to inhibitory (GABA-A receptor subunit alpha 1; glycine receptor subunit alpha 1) and excitatory neurotransmission (glutamate decarboxylase 1; glutamate receptor AMPA subunit alpha 2; glutamate receptor NMDA subunit 1), regulation of transmitter release (member of RAB family of small GTPase; RAB3 GTPase activating protein subunit 1) and neuronal excitability (potassium channel subfamily K member 15). Acoustic trauma resulted in unilateral hearing loss and hyperactivity bilaterally in inferior colliculus. Changes in expression of different mRNAs were observed in ipsilateral cochlear nucleus and in ipsi- and contralateral inferior colliculus, immediately after acoustic trauma, and after 2 and 4 weeks' recovery. Gene expression was generally reduced immediately after trauma, followed by a return to near normal levels or over-expression as recovery time increased. Different mechanisms appear to underlie the spontaneous hyperactivity observed. There is evidence of down-regulation of genes associated with neuronal inhibition in the contralateral inferior colliculus, whereas in ipsilateral cochlear nucleus, competing actions of inhibitory and excitatory systems seem to play a major role in determining overall excitability.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1003" length="8"></location><text>neuronal</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1153" length="19"></location><text>inferior colliculus</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="489" length="19"></location><text>inferior colliculus</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1679" length="8"></location><text>neuronal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="553" length="19"></location><text>inferior colliculus</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1720" length="19"></location><text>inferior colliculus</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1764" length="16"></location><text>cochlear nucleus</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1244" length="16"></location><text>cochlear nucleus</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1292" length="19"></location><text>inferior colliculus</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="91" length="9"></location><text>brainstem</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="532" length="16"></location><text>cochlear nucleus</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="474" length="7"></location><text>neurons</text></annotation></passage></document><document><id>PMC-3135183-sec-06</id><passage><offset>0</offset><text>4.2. Histological Findings
Microscopy revealed features of a diffusely growing discohesive carcinoma, exclusively growing in the alveolar interstitium, thus expanding it, while leaving the original alveolar architecture intact (Figure 2). There was local ulceration of the pleura, while, beyond this ulcer, the tumor formed a thick cake of discohesive tumor cells lining the pleural membrane (Figure 2(c)), with only focal, microscopic invasion into the fatty tissue of the parietal pleura.
The tumor consisted of atypical, moderately polymorphous, and irregularly shaped tumor cells with marked discohesiveness. They featured scant eosinophilic cytoplasm and irregularly contoured and hyperchromatic nuclei, often containing one or more prominent nucleoli (Figure 2(b)). There were many mitoses and apoptoses present, but necrosis was not observed. No squamous or glandular differentiation was observed, and mucin stains (PAS-D and alcian blue) were negative. Within the tumor, there were multiple small blood-filled clefts and blood lakes. Angioinvasion in medium-sized vessels, including an artery, was demonstrated (Figure 2(d)).
Of note, the broadened alveolar septa were lined by markedly atypical epithelial cells, yet less atypical than the interstitial carcinoma (Figures 2(a) and 2(b)). The atypia of the lining cells extended beyond the tumor front, showing a sharp demarcation with normal type I pneumocytes (Figure 2(a)), a feature characteristic to nonmucinous adenocarcinoma in situ with lepidic growth pattern (former bronchioloalveolar carcinoma, BAC) [3].
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="311" length="5"></location><text>tumor</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="340" length="23"></location><text>discohesive tumor cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="273" length="6"></location><text>pleura</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="300" length="5"></location><text>ulcer</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1463" length="26"></location><text>nonmucinous adenocarcinoma</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1401" length="18"></location><text>type I pneumocytes</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1348" length="5"></location><text>tumor</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="375" length="16"></location><text>pleural membrane</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1315" length="12"></location><text>lining cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="454" length="12"></location><text>fatty tissue</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1249" length="22"></location><text>interstitial carcinoma</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1204" length="16"></location><text>epithelial cells</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1157" length="14"></location><text>alveolar septa</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1094" length="6"></location><text>artery</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1072" length="7"></location><text>vessels</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1029" length="5"></location><text>blood</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="79" length="21"></location><text>discohesive carcinoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="198" length="8"></location><text>alveolar</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="129" length="21"></location><text>alveolar interstitium</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="474" length="15"></location><text>parietal pleura</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="495" length="5"></location><text>tumor</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="572" length="11"></location><text>tumor cells</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="633" length="22"></location><text>eosinophilic cytoplasm</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="701" length="6"></location><text>nuclei</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="748" length="8"></location><text>nucleoli</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="853" length="8"></location><text>squamous</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="865" length="9"></location><text>glandular</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="972" length="5"></location><text>tumor</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1534" length="28"></location><text>bronchioloalveolar carcinoma</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1005" length="5"></location><text>blood</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1564" length="3"></location><text>BAC</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T30" role=""></node><node refid="T31" role=""></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation></passage></document><document><id>PMC-3112138-sec-20</id><passage><offset>0</offset><text>Acknowledgements
The authors gratefully acknowledge the support of DRUID study participants, study staff, members of the Indigenous Steering Group, and partner organisations. The DRUID Study was funded by the National Health and Medical Research Council (NHMRC Project Grant #236207), with additional support from the Australian Government Department of Employment and Workplace Relations, the Clive and Vera Ramaciotti Foundation, the Vincent Fairfax Family Foundation, the International Diabetes Institute (AusDiab Partnership), and Bayer HealthCare. The DRUID Study is an in-kind project of the Cooperative Research Centre for Aboriginal Health. LMB had a NHMRC Scholarship 2003-5 and is supported by NHMRC Training Fellowship (#605837), NHMRC #320860 and the Centre of Clinical Research Excellence in Clinical Science in Diabetes, University of Melbourne. JC was supported by a NHMRC Career Development Award (#283310) and a NHMRC Research Fellowship (#545200). AH is supported by NHMRC Fellowship (#520316). Thank you to Dr Jaquelyne Hughes for comments on the manuscript. Funding sources played no role in the study design, in the collection, analysis and interpretation of the data, in the writing of the manuscript, or in the decision to submit the manuscript for publication.
</text></passage></document><document><id>PMID-21582121</id><passage><offset>0</offset><text>3-[(Methyl-carbamo-yl)amino]-1H-isoindolium chloride.
The title compound, C(10)H(12)N(3)O(+).Cl(-), is a derivative of o-phthaldehyde and methyl-thio-urea. The mol-ecules form dimers through intra- and inter-molecular N-H...O hydrogen bonds. The dimers are further linked into chains through one C-H...Cl and two N-H...Cl hydrogen bonds.
</text></passage></document><document><id>PMID-6445577</id><passage><offset>0</offset><text>[Suppurated acute obstructive cholangitis. Anatomoclinical and therapeutic aspects].
A total of 134 cases are discussed, with suppurated acute obstructive angiocholitis, that underwent surgical treatment over a period of 10 years, representing 12,8% of the total number of organic obstructions of the hepato-choledocus. From the standpoint of the etiopathogenic mechanisms the angiocholitis was determined by biliary lithiasis in 59 cases, by sclerosis of the Oddi sphincter in 5 cases, by postoperative cicatriceal stenosis of the main biliary pathway in 2 cases, by hepatic hydatitosis in 16 cases, by Vater ampuloma in 10 cases by cancers of the main biliary pathway in 40 cases and by the congenital cyst of the choledocus in one case. The high frequency was noted, of the severe forms of ictero-uremigenic angiocholitis (representing 68 cases, or 50,7% of the total, with a death rate of 34%). Medico-surgical treatment should be performed as early as possible, and it must be intensive, complex, and adapted to the anatomo-clinical forms. The authors performed evacuation choledocotomy with external draining in 22 cases (3 deaths), and choledoco-duodenal anastomosis in 46 cases (10 deaths), choledoco-jejunostomia in 3 cases, Oddi sphincterotomia in 12 cases (2 deaths) ampulectomia in 5 cases (2 deaths). Peripheral bilio-hepatodigestive anastomoses were performed in 40 cases with 5 deaths.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="460" length="14"></location><text>Oddi sphincter</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="716" length="10"></location><text>choledocus</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="568" length="7"></location><text>hepatic</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="301" length="17"></location><text>hepato-choledocus</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="704" length="4"></location><text>cyst</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="634" length="7"></location><text>cancers</text></annotation></passage></document><document><id>PMID-6216020</id><passage><offset>0</offset><text>Ca++ distribution after Na+ pump inhibition in cultured neonatal rat myocardial cells.
The influence of inhibition of the Na+ pump, with secondary stimulation of Na+-Ca++ exchange, on cellular Ca++ distribution is examined using the on-line scintillation disk technique and cultured neonatal rat myocardial cells. Under control conditions, La+++ displaced 78.1 +/- 1.13% (SEM) of the total cell associated 45Ca. Application of 1 mm ouabain or reduction of [K+]o to 0.5 mM resulted in a net increase of 10.6 +/- 1.3% and 13.8 +/- 2%, respectively, in total cell-associated Ca++. Of this added 45Ca, 75.9 +/- 2.7% and 78.4 +/- 2.1%, respectively remained La+++-displaceable. The 45Ca-binding characteristics of isolated sarcolemma, prepared from the cultured neonatal rat myocardial cells using the gas dissection technique, were examined. When treated with either ouabain or low [K+]o solutions, sarcolemmal 45Ca binding did not change. This result indicates that functional, intact tissue is necessary to observe the Ca++ increase. Treatment of the cells with verapamil before and during ouabain exposure failed to inhibit the ouabain-induced increase in cell-associated 45Ca. The evidence indicates that inhibition of the Na+-pump, and secondary stimulation of Na+-Ca++ exchange, result in a net increase of 11-15% in cell-associated Ca++, 78% of which remains La+++-displaceable and is, therefore, localized to the sarcolemma-glycocalyx complex.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="69" length="16"></location><text>myocardial cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="296" length="16"></location><text>myocardial cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="184" length="8"></location><text>cellular</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="718" length="10"></location><text>sarcolemma</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="770" length="16"></location><text>myocardial cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="390" length="4"></location><text>cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="556" length="4"></location><text>cell</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1049" length="5"></location><text>cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1155" length="4"></location><text>cell</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1417" length="10"></location><text>sarcolemma</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1428" length="10"></location><text>glycocalyx</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="895" length="11"></location><text>sarcolemmal</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="982" length="6"></location><text>tissue</text></annotation></passage></document><document><id>PMID-19922082</id><passage><offset>0</offset><text>Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice.
CONCLUSIONS:
Mouse cochleae are highly resistant to systemically administered cisplatin. However, cochlear lesions can be produced effectively in mice when cisplatin is applied locally through the round window niche or tympanum.
OBJECTIVE:
To explore the optimal approach for creating cisplatin-induced cochlear lesions in mice.
MATERIALS AND METHODS:
Cisplatin was administered to adult C57BL/6J mice via four approaches: (1) transtympanic injection, (2) round window niche injection, (3) intraperitoneal injection (i.p.) at 4 mg/kg/day for 4 consecutive days, and (4) one 15 mg/kg dose i.p. The hearing was monitored using frequency-specific auditory brainstem responses (ABRs) and distortion-product otoacoustic emissions (DPOAEs). Cochlear pathology was observed in cochleograms with Harris' hematoxylin staining.
RESULTS:
Cisplatin applied systemically did not cause any significant ABR threshold elevation across the frequencies tested (2-32 kHz), whereas local application of cisplatin through the round window niche or tympanum resulted in significant ABR threshold elevations from high to medium frequencies. The functional changes were consistent with the cochlear pathology across groups.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="402" length="16"></location><text>cochlear lesions</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="555" length="18"></location><text>round window niche</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="296" length="18"></location><text>round window niche</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1104" length="18"></location><text>round window niche</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="318" length="8"></location><text>tympanum</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1126" length="8"></location><text>tympanum</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1265" length="8"></location><text>cochlear</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="752" length="9"></location><text>brainstem</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="834" length="8"></location><text>Cochlear</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="73" length="16"></location><text>cochlear lesions</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="197" length="16"></location><text>cochlear lesions</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="118" length="8"></location><text>cochleae</text></annotation></passage></document><document><id>PMC-2690976-sec-05</id><passage><offset>0</offset><text>Efficacy of MMF in current immunosuppressive regimens after kidney transplantation
Current established immunosuppressive strategies in kidney transplantation often include an induction agent (monoclonal or polyclonal anti-T-cell antibodies) based on the immunologic risk of the recipient, followed by a maintenance regimen combining a CNI and an anti-proliferative agent, with or without corticosteroids.2-4 As MMF was the first MPA formulation approved in clinical kidney transplantation, more extensive clinical data are available with this drug in comparison to EC-MPS.

</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="466" length="6"></location><text>kidney</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="60" length="6"></location><text>kidney</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="222" length="6"></location><text>T-cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="135" length="6"></location><text>kidney</text></annotation></passage></document><document><id>PMID-9088383</id><passage><offset>0</offset><text>Procedural memory stimulation in Alzheimer's disease: impact of a training programme.
The study evaluates the efficacy of a procedural memory stimulation programme in mild and mild-moderate Alzheimer's disease (AD). Twenty basic and instrumental activities of daily living have been selected, and divided into two groups, comparable for difficulty. Ten normal elderly subjects (age 68.0 +/- 4.8 years; MMSE score: 28.7 +/- 0.9; education: 7.6 +/- 3.5 years) were asked to perform the two groups of daily activities and the time required to perform the tasks of each group was recorded and used as a reference. Ten mild and mild-moderate AD patients (age 77.2 +/- 5.3 years; MMSE score: 19.8 +/- 3.5; education: 7.3 +/- 4.7 years) without major behavioural disturbances constituted the experimental group. Patients were evaluated in all 20 daily activities and the time employed was recorded at baseline and after a 3-week training (1 h/d, 5 d/week) period. Five patients were trained during the 3 weeks on half of the 20 daily activities and the other five patients were trained on the remainder. This procedure was adopted in order to detect separately the improvement in "trained" and "not trained" activities, allowing to control better the effects of the intervention. The assessment of the functional impact of the training was directly measured, through the variation of time employed to perform tasks before and after training. After 3 weeks of training a significant improvement was observed for the trained activities, from 3.6 to 1.9 standard deviations below the performance of the normal elderly controls (P &lt; 0.05). AD patients improved also in not-trained activities from 3.5 to 2.7 standard deviations below the controls' performance (P &lt; 0.05). The rehabilitation of activities of daily living through developing procedural memory strategies may be effective in mild and mild-moderate AD patients.
</text></passage></document><document><id>PMID-4066990</id><passage><offset>0</offset><text>Rapid enzyme analysis of amniotic fluid phospholipids containing choline: a comparison with the lecithin to sphingomyelin ratio in prenatal assessment of fetal lung maturity.
The relation between the choline containing surfactant phospholipids lecithin and sphingomyelin in amniotic fluid and fetal lung maturity is well established. An enzymatic method that had been automated and optimised for use on a centrifugal analyser was used to measure the total choline containing phospholipids in amniotic fluid. The total time taken for this assay was 10 minutes. The results obtained from 100 patient samples, using this procedure, compared favourably with the results obtained by the thin layer chromatography procedure used to determine the lecithin to sphingomyelin ratio (r = 0.93). A clinical study of 60 patients showed that this assay predicted prenatal respiratory distress syndrome as well as the lecithin to sphingomyelin ratios. The advantage of this assay over existing procedures is that it requires minimum preparation of the specimen and no extraction, is quick, and shows a high degree of precision.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1037" length="8"></location><text>specimen</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="858" length="11"></location><text>respiratory</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="154" length="10"></location><text>fetal lung</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="492" length="14"></location><text>amniotic fluid</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="25" length="14"></location><text>amniotic fluid</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="293" length="10"></location><text>fetal lung</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="274" length="14"></location><text>amniotic fluid</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation></passage></document><document><id>PMC-2993542-sec-03</id><passage><offset>0</offset><text>2.1.
Genome sequencing, assembly and validation
DNA shotgun libraries with average insert sizes of 1.6 and 6.5 kb were constructed in pUC118 (TaKaRa), whereas a fosmid library with average insert size of 37 kb was constructed in pCC1FOS (EPICENTRE) as described previously.18,19 A total of 50 400 clones (34 560, 10 752 and 5088 clones from libraries with 1.6, 6.5 and 37 kb inserts, respectively) were subjected to sequencing from both ends of the inserts on either ABI 3730xl DNA Analyzer (Applied Biosystems) or Base Station DNA Fragment Analyzer BST-0100 (MJ Research, Inc.). Sequence reads were trimmed at a threshold quality value of 20 by Phred and assembled by Phrap and CONSED assembly tools.20,21 For alignment and validation of contigs, Optical Mapping (OpGen) was used. Gaps between contigs were closed by sequencing PCR products, which bridge two neighboring contigs. Finally, each base of K. setae NBRC 14216T genome was ensured to be sequenced from multiple clones and from both directions with Phrap quality score &gt;=70 or from one direction with Phrap quality score &gt;=40. Chromosomal terminus was determined after attaching adenine and thymine homopolymers to the naked 3' ends of the chromosome as described previously.5
</text><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1201" length="10"></location><text>chromosome</text></annotation></passage></document><document><id>PMC-2569084-sec-24</id><passage><offset>0</offset><text>Candle wicks
Candles with a lead metal core contribute to lead in the home (Nriagu and Kim 2000; van Alphen 1999). Exposure occurs both from air and from hand-to-mouth activity. However, to date, no children's EBLs traceable to candles have been reported. In 2002, the CPSC banned candlewicks containing &gt; 0.06% lead (CPSC 2003).
</text></passage></document><document><id>PMID-9394578</id><passage><offset>0</offset><text>[Extra-anatomic bypass from the ascending aorta to the supraceliac abdominal aorta--surgical option applied to reoperation for aortic coarctation or interruption].
The optimal approach for reoperation following repair of aortic coarctation (CoA) or interruption (IAA) remains controversial. Four patients underwent extra-anatomic bypass for restenosis after repair of CoA or IAA. The age ranged from 4 to 12 years. The initial repairs for two CoA, one type A-IAA, and one type B-IAA consisted of two grafting, one subclavian arterial turning-down aortoplasty, and one subclavian flap aortoplasty. All of them underwent during infancy. Preoperative right arm systolic pressure ranged from 140 to 190 mmHg ar rest. Through a midline sternotomy and an upper laparotmy incision, an extra-anatomic bypass from the ascending aorta to the supraceliac abdominal aorta was employed using a 12 to 18 mm tube graft. All patients survived surgeries, and their hypertension markedly improved. Our experience confirms safety and effectiveness of this option in selected young patients with re-stenosis of following repair of CoA or IAA.
</text><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="127" length="6"></location><text>aortic</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="648" length="9"></location><text>right arm</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="32" length="15"></location><text>ascending aorta</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="844" length="15"></location><text>abdominal aorta</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="579" length="4"></location><text>flap</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="809" length="15"></location><text>ascending aorta</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="67" length="15"></location><text>abdominal aorta</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="525" length="8"></location><text>arterial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="221" length="6"></location><text>aortic</text></annotation></passage></document><document><id>PMC-2858094-sec-14</id><passage><offset>0</offset><text>Calcium intake and effects on QUS T-score
Figure 5 shows the amounts of dietary calcium intake according to menopausal status. Calcium consumption in most groups, like that in the study population as a whole, was inadequate. Fewer than one third of premenopausal and postmenopausal women received more than 800 mg calcium daily, and fewer than 16% of premenopausal women in the 50-59 age decade (n = 38) consumed more than 800 mg calcium daily.
Figure 5
Daily calcium intake in premenopausal and postmenopausal women. This figure depicts the daily amounts of dietary calcium intake (and percent) according to menopausal status using 800 mg daily as cut off point.
QUS T-score were then calculated according to daily calcium intake in all premenopausal and postmenopausal activity groups using 800 mg daily calcium as cutoff point. As shown in Tables 3 and 4 and Figure 6, premenopausal women who were systematically active and consumed more than 800 mg calcium daily had significantly higher QUS T-scores compared with all other activity groups (p &lt; 0.05). Among systematically active premenopausal women who received more than 800 mg calcium per day, this difference was separately significant verses sedentary (p = 0.028) and moderately active (p = 0.04) women. In contrast, postmenopausal women showed no difference in QUS T-scores regardless of the amount of daily calcium intake.
Figure 6
Synergy between physical activity and dietary calcium intake in women consuming calcium amounts greater than 800 mg/day. This graphic depicts mean QUS T-score values calculated according to daily calcium intake in all premenopausal and postmenopausal activity groups using 800 mg daily as cut off point (for statistical significant values see text).
</text></passage></document><document><id>PMID-21416173</id><passage><offset>0</offset><text>Predictive value of serum carbohydrate antigen 19-9 in malignant intraductal papillary mucinous neoplasms.
BACKGROUND:
The goal of the present study was to evaluate the predictive value of serum carbohydrate antigen 19-9 (CA 19-9) in the diagnosis of malignant intraductal papillary mucinous neoplasms of pancreas (IPMNs).
METHODS:
Eighty-six patients with pathological diagnosis of IPMNs in Zhongshan Hospital between March 1999 and November 2008 were retrospectively reviewed. Data reflecting clinical characteristics, tumor marker level, and prognosis were collected. The potential predictive value of CA 19-9 was analyzed by receiver operating characteristic (ROC) curve.
RESULTS:
Eighty-six consecutive patients with IPMNs all underwent surgical intervention. A high level of CA 19-9 or carcinoembryonic antigen (CEA) was associated with more advanced stage of malignant IPMNs. Carbohydrate antigen 19-9 was significant for judging malignant IPMNs in the binary logistic regression model (p=0.047). The hazard ratio was 1.014, whose 95.0% confidence interval was 0.91-1.028. Receiver operating characteristic analysis showed that the serum CA 19-9 level had good predictive value for malignant or invasive IPMNs, postoperative survival, and disease-specific recurrence. The area under the curve (AUC) was 0.856, 0.893, 0.815, and 0.857 (p&lt;0.05), respectively. According to the follow-up, mean survival time for groups with CA 19-9&gt;63.60 U/ml was dramatically shorter than that for groups with CA 19-9&lt;=63.60 U/ml (57.38+/-2.85 versus 29.24+/-5.82 [months]; p&lt;0.01).
CONCLUSIONS:
Serum CA 19-9 level has good predictive value for malignant or invasive IPMNs. Patients with CA 19-9 &gt; 63.60 U/ml had poor postoperative prognosis in IPMNs. Preoperative abnormal serum CA 19-9 might be predictive for an aggressive surgical intervention in IPMNs.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="20" length="5"></location><text>serum</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="189" length="5"></location><text>serum</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="77" length="28"></location><text>papillary mucinous neoplasms</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="315" length="5"></location><text>IPMNs</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="383" length="5"></location><text>IPMNs</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="261" length="40"></location><text>intraductal papillary mucinous neoplasms</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="305" length="8"></location><text>pancreas</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="947" length="5"></location><text>IPMNs</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1139" length="5"></location><text>serum</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1211" length="5"></location><text>IPMNs</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1584" length="5"></location><text>Serum</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="521" length="5"></location><text>tumor</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1656" length="5"></location><text>IPMNs</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="876" length="5"></location><text>IPMNs</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1734" length="5"></location><text>IPMNs</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1763" length="5"></location><text>serum</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1840" length="5"></location><text>IPMNs</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="722" length="5"></location><text>IPMNs</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T4" role="Arg1"></node><node refid="T5" role="Arg2"></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T4" role=""></node><node refid="T6" role=""></node></relation></passage></document><document><id>PMC-2817706-caption-03</id><passage><offset>0</offset><text>Percentage reported purchasing intentions, comparing ITN-owning to non-owning households
</text></passage></document><document><id>PMID-1934953</id><passage><offset>0</offset><text>The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia.
Nosocomial pneumonia remains a common complication in patients treated with endotracheal intubation and mechanical ventilation and continues to have a significant impact on the mortality rate of these patients. Epidemiologic studies have shown that the risk of pneumonia increases with the duration of intubation but that the period of highest risk is the first 2 weeks of therapy. Gram-negative bacteria account for most nosocomial pneumonias in intubated patients, but Staphylococcus aureus may also play a role in what may be a polymicrobial infection. In the most seriously ill individuals, and in those treated with long-term mechanical ventilation, Pseudomonas aeruginosa is a common pathogen. Endotracheal intubation and mechanical ventilation predispose to pneumonia for a variety of reasons (see Fig. 1). The endotracheal tube can have direct effects on the airway that result in a reduction in local host defenses. Thus, mucosal injury can reduce mucociliary function, while upper airway defenses are bypassed and the effectiveness of cough is reduced. Indirectly, intubation can result in an enhanced capacity of tracheobronchial cells to bind gram-negative bacteria, an effect that favors airway colonization and pneumonia. The injury to the airway can create binding sites for bacteria in the basement membrane of the bronchial tree and the stimulation of the secretion of mucus, which then stagnates and can create potential sites for bacterial adherence. The endotracheal tube also enhances bacterial entry to the lung by serving as a reservoir for bacteria to remain sequestered, safe from host defenses. Respiratory therapy devices can allow bacteria to proliferate and can then introduce them into the patient if not handled properly. Finally, patients who are ill enough to require intubation also have disease-associated impairments in systemic host defense, which add to the impairments caused by the use of an artificial airway. The host defense impairments that occur in mechanically ventilated patients can lead to respiratory tract infection in the form of either febrile tracheobronchitis or pneumonia. The diagnosis of pneumonia in intubated patients is difficult and controversial. It can be made by either clinical criteria or microbiologic criteria, the latter by using a bronchoscopically directed protected specimen brush. Therapy of pneumonia in mechanically ventilated patients is not always successful, and systemic antibiotics may need to be supplemented by topical antimicrobials. No clearly effective prophylactic strategy currently exists, but our understanding of pneumonia pathogenesis has led to some promising directions. As more data are collected, inhaled antibiotics, selective digestive decontamination, and enhancement of host defenses by cytokines and pre-formed antibodies may emerge as useful approaches.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="14" length="8"></location><text>tracheal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1018" length="7"></location><text>mucosal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="954" length="6"></location><text>airway</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1211" length="22"></location><text>tracheobronchial cells</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1288" length="6"></location><text>airway</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1044" length="11"></location><text>mucociliary</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1078" length="6"></location><text>airway</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1473" length="5"></location><text>mucus</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1561" length="17"></location><text>endotracheal tube</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1616" length="4"></location><text>lung</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2030" length="6"></location><text>airway</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1341" length="6"></location><text>airway</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2126" length="17"></location><text>respiratory tract</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1418" length="14"></location><text>bronchial tree</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="905" length="17"></location><text>endotracheal tube</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1393" length="17"></location><text>basement membrane</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T17" role="Arg1"></node><node refid="T9" role="Arg2"></node></relation></passage></document><document><id>PMC-2660356-caption-07</id><passage><offset>0</offset><text>Additional File 2
Full Model Code. Full model code plus instructions for running in Berkeley Madonna(TM).
</text></passage></document><document><id>PMC-1420288-sec-02</id><passage><offset>0</offset><text>Results
The set of E. coli expression vectors, encode for either a hexa-histidine tag or the three most commonly used solubility tags (GST, MBP, NusA) and all with an N-terminal hexa-histidine sequence. The result is two-fold: the His-tag facilitates purification by immobilised metal affinity chromatography, whilst the fusion domains act primarily as solubility aids during expression, in addition to providing an optional purification step. We have also incorporated a TEV recognition sequence following the solubility tag domain, which allows for highly specific cleavage (using TEV protease) of the fusion protein to yield native protein. These vectors are also designed for ligation-independent cloning and they possess a high-level expressing T7 promoter, which is suitable for auto-induction. To validate our vector system, we have cloned four different genes and also one gene into all four vectors and used small-scale expression and purification techniques. We demonstrate that the vectors are capable of high levels of expression and that efficient screening of new proteins can be readily achieved at the laboratory level.
</text></passage></document><document><id>PMID-11716301</id><passage><offset>0</offset><text>Assembly strategies and GTPase regulation of the eukaryotic and Escherichia coil translocons.
The translocation of most proteins across the endoplasmic reticulum or bacterial inner membrane occurs through an aqueous pore that spans the membrane. Substrates that are translocated co-translationally across the membrane are directed to the translocation pore via an interaction between the cytosolic signal recognition particle and its membrane-bound receptor. Together the translocation pore and the receptor are referred to as a translocon. By studying the biogenesis of the translocon a number of alternate targeting and membrane-integration pathways have been discovered that operate independently of the signal recognition particle (SRP) pathway. The novel assembly strategies of the translocon and the ways in which these components interact to ensure the fidelity and unidirectionality of the targeting and translocation process are reviewed here.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="140" length="21"></location><text>endoplasmic reticulum</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="388" length="9"></location><text>cytosolic</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="175" length="14"></location><text>inner membrane</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="434" length="8"></location><text>membrane</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="472" length="18"></location><text>translocation pore</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="236" length="8"></location><text>membrane</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="309" length="8"></location><text>membrane</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="622" length="8"></location><text>membrane</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="529" length="10"></location><text>translocon</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="575" length="10"></location><text>translocon</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="787" length="10"></location><text>translocon</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="338" length="18"></location><text>translocation pore</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="81" length="11"></location><text>translocons</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="208" length="12"></location><text>aqueous pore</text></annotation></passage></document><document><id>PMC-2894766-caption-01</id><passage><offset>0</offset><text>MOR1K expression and binding pattern. (A) The schematic diagram illustrates the exonic composition and relative positions of PCR primers designed to amplify the major MOR1 isoform and the newly identified alternative MOR1K isoform. The relative positions of translation initiation start and stop codons are designated by ATG and TGA, respectively. The predicted protein structure of MOR1 and MOR1K isoforms is schematically presented. Translation of the MOR1K variant results in a 6TM receptor, truncated at the N-terminus. (B) Real-time PCR was performed on total RNA samples from the human brain regions known to express MOR1. Primers specific for exons 1 and 2 were used to measure MOR1 and primers specific for exons 13 and exon 2 were used to measure MOR1K[32]. GAP3DH was used as a control for cDNA loading and PCR efficiency. (C) Confocal images of C-terminally MYC-tagged MOR1 or FLAG-tagged MOR1K overexpressed in HEK293 cells and stained with either Anti-MYC-Tag Antibody (Alexa Fluor 647 Conjugate) or Anti-DYKDDDDK Tag Antibody (Alexa Fluor 555 conjugate). Cells transfected with MOR1 showed membrane expression of receptor, while cell transfected with MOR1K express receptor only intracellular. (D) Confocal images of C-terminally FLAG-tagged MOR1K overexpressed in Be2C cells and stained with either Anti-FLAG M2 Antibody Alexa Fluor Conjugate or fluorescent-labeled naloxone (FNAL). Cells transfected with MOR1K showed intracellular retention of FNAL that co-localized with antibody-labeled receptor. (E) The binding of naloxone to MOR1K was assessed using flow cytometry to measure FNAL retention. Be2C cells transfected with either MOR1 or MOR1K isoforms showed increased retention of FNAL at concentrations of 0.1 and 1 muM. FNAL retention was abolished in the presence of 10 muM unlabelled naloxone (Nal). In panel E, data are presented as mean + SEM. *P &lt; 0.05 different from controls).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1193" length="13"></location><text>intracellular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1279" length="10"></location><text>Be2C cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1104" length="8"></location><text>membrane</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1614" length="10"></location><text>Be2C cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1143" length="4"></location><text>cell</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1398" length="5"></location><text>Cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1434" length="13"></location><text>intracellular</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="592" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1069" length="5"></location><text>Cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="923" length="12"></location><text>HEK293 cells</text></annotation></passage></document><document><id>PMC-1281295-caption-02</id><passage><offset>0</offset><text>Measured analytes in five biologic sample matrices.a
</text></passage></document><document><id>PMID-11712346</id><passage><offset>0</offset><text>[Anesthetic management of a patient with Dyggve-Melchior-Clausen syndrome].
The Dyggve-Melchior-Clausen syndrome (DMCS) is a rare autosomal recessive skeletal dysplasia characterized by short-trunk dwarfism and mental retardation. A 49-year-old male with DMCS underwent resection arthroplasty for contracture of the right hip joint under general anesthesia using thiamylal, nitrous oxide, sevoflurane, and vecuronium. Although he was assumed to have difficult airway due to short neck, macroglossia, and disturbance of neck flexion, tracheal intubation was not difficult. No complications including malignant hyperthermia were observed during the 95 min of the operation.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="316" length="15"></location><text>right hip joint</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="533" length="8"></location><text>tracheal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="480" length="4"></location><text>neck</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="519" length="4"></location><text>neck</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="150" length="8"></location><text>skeletal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="460" length="6"></location><text>airway</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="192" length="5"></location><text>trunk</text></annotation></passage></document><document><id>PMID-15305838</id><passage><offset>0</offset><text>Is there an upper limit of intracranial pressure in patients with severe head injury if cerebral perfusion pressure is maintained?
Authors of recent studies have championed the importance of maintaining cerebral perfusion pressure (CPP) to prevent secondary brain injury following traumatic head injury. Data from these studies have provided little information regarding outcome following severe head injury in patients with an intracranial pressure (ICP) greater than 40 mm Hg, however, in July 1997 the authors instituted a protocol for the management of severe head injury in patients with a Glasgow Coma Scale score lower than 9. The protocol was focused on resuscitation from acidosis, maintenance of a CPP greater than 60 mm Hg through whatever means necessary as well as elevation of the head of the bed, mannitol infusion, and ventriculostomy with cerebrospinal fluid drainage for control of ICP. Since the institution of this protocol, nine patients had a sustained ICP greater than 40 mm Hg for 2 or more hours, and five of these had an ICP greater than 75 mm Hg on insertion of the ICP monitor and later experienced herniation and expired within 24 hours. Because of the severe nature of the injuries demonstrated on computerized tomography scans and their physical examinations, these patients were not aggressively treated under this protocol. The authors vigorously attempted to maintain a CPP greater than 60 mm Hg with intensive fluid resuscitation and the administration of pressor agents in the four remaining patients who had developed an ICP higher than 40 mm Hg after placement of the ICP monitor. Two patients had an episodic ICP greater than 40 mm Hg for more than 36 hours, the third patient had an episodic ICP greater than of 50 mm Hg for more than 36 hours, and the fourth patient had an episodic ICP greater than 50 mm Hg for more than 48 hours. On discharge, all four patients were able to perform normal activities of daily living with minimal assistance and experience ongoing improvement. Data from this preliminary study indicate that intense, aggressive management of CPP can lead to good neurological outcomes despite extremely high ICP. Aggressive CPP therapy should be performed and maintained even though apparently lethal ICP levels may be present. Further study is needed to support these encouraging results.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="291" length="4"></location><text>head</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="396" length="4"></location><text>head</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="203" length="8"></location><text>cerebral</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="856" length="19"></location><text>cerebrospinal fluid</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="258" length="5"></location><text>brain</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1445" length="5"></location><text>fluid</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="2123" length="12"></location><text>neurological</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="428" length="12"></location><text>intracranial</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="564" length="4"></location><text>head</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="27" length="12"></location><text>intracranial</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="88" length="8"></location><text>cerebral</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="73" length="4"></location><text>head</text></annotation></passage></document><document><id>PMC-3249382-caption-01</id><passage><offset>0</offset><text>Predicted methylation level of C. gigas genes categorized by biological processes compared to measured level of DNA methylation. Mean CpG O/E for 10,699 C. gigas genes categorized according to Biological Process Gene Ontology (GO) Slim terms are plotted on the x-axis (modified from Gavery and Roberts, 2010). DNA methylation was empirically measured by performing MBD-seq on the SOLiD 4 platform (Applied Biosystems). Genes identified in the MBD-library were associated with respective GO terms and enrichment analysis was performed based on the entire transcriptome (Fleury et al., 2009) using DAVID (Huang et al., 2009a,b). Results indicate the most underrepresented genes in the library are involved in cell adhesion and genes involved in DNA and protein metabolism were most prevalent in the MBD-library.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="707" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMC-2660343-sec-18</id><passage><offset>0</offset><text>Peptide-BSA conjugates as diagnostic antigens
To analyse the potential of the peptides to behave as antigen mimics, their ability to react with IgM antibodies from individuals infected with EBV was assessed. In our previous study, we demonstrated that the sensitivity of detection was greatly improved when the peptides were coupled to a carrier molecule such as BSA prior to immobilisation onto a solid surface (Casey et al., 2006). This strategy was adopted to test peptides Eb1-4 and H1. A set of 40 clinical samples that were classified as EBV seropositive (n = 16), seronegative (n = 16) or potentially cross-reactive sera (n = 8) were assessed for reactivity with Eb1-4 and H1 peptides individually. The cut-off level was defined as the mean optical density of the seronegative samples plus 3 standard deviations shown as a line on the graphs in Fig. 5. Readings above this level were defined as positive and below this level negative. The same set of samples were analysed on BSA alone and these values were subtracted from the peptide-BSA conjugate readings and the corrected absorbance readings were plotted individually for our new peptides Eb1-4 and H1 in Fig. 5. There was a clear difference in the detection of seropositive antibodies by all the peptides (Fig. 5A-E) compared with the analysis of BSA alone (Fig. 5F), with the majority of absorbance readings above the cut-off level. We compared the ability of our panel of peptide mimotopes to be recognised by antibodies in the same set of seropositive samples in Fig. 6A and the sensitivity of detection is shown in Fig. 6B. We also included F1 and Gp125 mimotopes specific for two mAbs in our previous study (Casey et al., 2006). Of the peptides identified from polyclonal sera Eb1, Gp125 and F1 had the highest sensitivity (94%). Slightly lower sensitivity was observed for Eb2, 3 and 4 (88%) and H1 peptide had the lowest sensitivity (81%) as summarised in Fig. 6B. The sensitivity of F1 and Gp125 was similar to that produced by the mimotopes selected in our previous study, 95% for F1 and 92% for Gp125.
Fig. 5
Evaluation of peptides Eb1-4 and H1 coupled to BSA as EBV diagnostic reagents. Human serum (n = 40) previously analysed using a diagnostic test for VCA IgM was allowed to react with the peptides and the bound IgM antibodies were detected using anti-human IgM HRP. The absorbance readings for 1 (positive), 2 (negative) and putative cross-reactive sera for 3 (Parvo), 4 (HSV), 5 (CMV) and 6 (RF) are plotted for (A) Eb1, (B) Eb2, (C) Eb3, (D) Eb4, (E) H1 and (F) BSA, respectively. The cut-off value is defined as the mean of the negative population +3SD indicated by a solid horizontal line; since there were no false positives, the specificity for each mimotope was 100%.
Fig. 6
Comparison of the reactivities of our panel of mimotopes Eb1-4, H1, F1 and Gp125 conjugated to BSA with EBV IgM-positive sera (n = 16) absorbance values are plotted and the cut-off levels are depicted by a horizontal line in (A). (B) Summary of the false-negative results from the 5/16 serum samples seropositive for IgM EBV and the overall sensitivity for each mimotope for diagnosis of EBV IgM antibodies.
We also considered which seropositive EBV samples contained antibodies that did not recognise the panel of peptides, i.e. false-negative readings, listed in Fig. 6B. The antibodies in serum 1 (s1) were unreactive with all of the peptides identified in this study, s2 was not reactive with Eb3, Eb4 and H1 and s3 was unreactive with H1. Gp125 and F1 that were selected in our previous study were recognised by s1, 2 and 3; however, two different serum samples (s4 and 5) did not recognise F1 or Gp125, respectively. This demonstrates that individual peptides are not recognised by all EBV antibodies and confirms that different peptides are required to represent different epitopes. Therefore, a combination of Eb1 peptide F1 and Gp125 peptides could be recognised by antibodies present in all this set of EBV clinical samples resulting in 100% sensitivity.
For the samples defined as EBV-seronegative, there were no readings above the cut-off level and therefore no false positives, resulting in 100% specificity. In addition, there were no absorbance readings above the cut-off levels for the potentially cross-reactive serum samples, inferring that the peptides identified in this study have high specificity for EBV antibodies.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3354" length="5"></location><text>serum</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3615" length="13"></location><text>serum samples</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2883" length="4"></location><text>sera</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3048" length="13"></location><text>serum samples</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="4291" length="13"></location><text>serum samples</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="623" length="4"></location><text>sera</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3212" length="7"></location><text>samples</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1740" length="4"></location><text>sera</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2429" length="4"></location><text>sera</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2167" length="5"></location><text>serum</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation></passage></document><document><id>PMC-1868914-caption-03</id><passage><offset>0</offset><text>Hypothetical distribution patterns of the meadow brown Maniola jurtina in Europe during the last glacial maximum (dark hatched areas). Postglacial expansions are indicated by solid arrows. The postulated actual hybrid zone is shown by the hatched area. Question marks indicate lack of information concerning ancient distribution patterns in the South and present distribution of hybrid populations in the North. Redrawn from Schmitt et. al. [36]; based on Thomson [37] and Schmitt et al. [36].
</text></passage></document><document><id>PMC-2924302-sec-08</id><passage><offset>0</offset><text>Intervention
Patients' initial introduction to the Wrist Extension Dynasplint (WED) system, [Dynasplint Systems, Inc., Severna Park, MD, USA] included customized fitting (wrist length, width, and girth so that the force and counter force straps could be properly aligned) and training on donning and doffing of the device. (See figure 1.) Verbal and written instructions were provided throughout the duration of treatment for safety, general wear and care, and tension setting goals based on patient tolerance.
Figure 1
Wrist Extension Dynasplint.
Each patient initially wore the WED for 4-6 continuous hours at an initial tension setting of #2 (0.1 foot pounds of torque). This duration was for acclimatization to the system; then patients were instructed to wear the WED system at night while sleeping for 6-8 hours of continuous wear. After each patient was comfortable wearing the unit for one week at tension level #2, they were instructed to increase the tension level to #3 (0.3 ft lbs.) and make continual increases every two weeks. If prolonged soreness followed a session (soreness for more than 15 minutes) the patient was instructed to decrease the tension one half a setting for two days until they were comfortable wearing it for 6-8 hours at the new tension setting. The majority of all patients reached level #5 (0.8 foot pounds of torque) by the end of two months. All range of motion measurements were recorded by the prescribing clinician.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="51" length="5"></location><text>Wrist</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="520" length="5"></location><text>Wrist</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="171" length="5"></location><text>wrist</text></annotation></passage></document><document><id>PMC-3082541-caption-03</id><passage><offset>0</offset><text>Loss of body weight after challenge-infection with WNV.
Mice (n = 8) were vaccinated intranasally with Flu-NA-DIII (*) or Flu-NA-GFP (o) or by the subcutaneous route (^ and ^, respectively). The daily weights of each animal were calculated compared to their respective weight on the day of challenge, and data are shown as the average percentage of initial weight for each group. Error bars represent the standard error for all samples available at that time point. Subsequently, the mice were challenged subcutaneously with 106 TCID50 WNV-NY99 and weighed daily. The mean body weight is expressed as the percentage of the body weight before challenge infection (A). The survival rates of mice after challenge infection with WNV-NY99 are depicted as Kaplan-Meier survival curves (B). The difference in survival rate between Flu-NA-DIII and Flu-NA-GFP vaccinated mice was statistically significant as determined by the logrank test. The symbols for the respective groups are the same as in panel A.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="623" length="4"></location><text>body</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="85" length="12"></location><text>intranasally</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="573" length="4"></location><text>body</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="8" length="4"></location><text>body</text></annotation></passage></document><document><id>PMID-7969665</id><passage><offset>0</offset><text>Appetite regulation by serotoninergic mechanisms and effects of d-fenfluramine.
In this literature review, evidence is presented for the theory that the neurotransmitter, serotonin (5-hydroxytryptamine, 5HT), in medial hypothalamic centres is an important regulator for appetite and for the selection of major food constituents. High local levels of 5HT cause a reduction of appetite and a preference for protein, low levels the opposite. The main antagonistic system is noradrenergic. The drug d-fenfluramine mimics the effects of 5HT by releasing 5HT from serotoninergic nerve endings and inhibiting its neuronal re-uptake. Further experimental data prove that a high-carbohydrate, low-protein diet promotes uptake of serum tryptophan in the brain and its conversion into 5HT. Hence, this serotoninergic system may function as a self-regulatory mechanism. In patients with decreased peripheral insulin sensitivity, the system may be disturbed, causing overconsumption of carbohydrates. This is sometimes compulsive ("carbohydrate craving"). It may be presumed that in the treatment of obesity, in addition to the use of serotoninergic drugs, successes with reducing diets may be enhanced by including periods of high-carbohydrate, low-protein intake. It would be worthwhile to explore whether similar alimentary self-regulatory mechanisms of neurotransmitter function exist in other regulatory systems.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="720" length="5"></location><text>serum</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="744" length="5"></location><text>brain</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="212" length="27"></location><text>medial hypothalamic centres</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="606" length="8"></location><text>neuronal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="573" length="5"></location><text>nerve</text></annotation></passage></document><document><id>PMC-1681490-sec-01</id><passage><offset>0</offset><text>Figures and Tables
Figure 1
Modular crosstalking in synthetic gene networks. A promoter with binding sites for lambda cI dimers (OR1 and OR2) and for the lac repressor (Olac) controls the production of the lac repressor (encoded by lacI) in module 1 and lambda cI (encoded by cI) in module 2. The lac repressor and lambda cI dimers are represented by blue ellipsoids and red circles, respectively. When the two modules are put together, two pairs of lambda cI dimers bound at different operators can loop DNA and octamerize, forming a tetramer of dimers.
</text></passage></document><document><id>PMC-2909993-sec-05</id><passage><offset>0</offset><text>Histological analysis
A cross-section of the distal colon (2 cm) was fixed in 10% paraformaldehyde solution. Afterwards, it was cut into small fragments, dehydrated through an ethanol series (70%-100%), cleared in xylol and embedded in paraffin. The fragments were sliced into 5 mum thick sections and stained with hematoxylin-eosin. Histological evaluation was done by a pathologist who was blinded to the experimental groups, and it was based on the intensity of mononuclear and polymorphonuclear infiltrates in the lamina propria, crypt dilation, cellular destruction and mucosal ulceration. Histopathological changes were graded according to the degree of inflammation using the following scale: absent (0), light (1), moderate (2) and intense (3), and the numbers represented the inflammation score (IS). Results were expressed as mean values of IS +/- standard error of the mean (SEM) for each experimental group.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="575" length="7"></location><text>mucosal</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="534" length="5"></location><text>crypt</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="550" length="8"></location><text>cellular</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="45" length="12"></location><text>distal colon</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="518" length="14"></location><text>lamina propria</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="250" length="9"></location><text>fragments</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMID-17432972</id><passage><offset>0</offset><text>The relationship between brain activity and peak grip force is modulated by corticospinal system integrity after subcortical stroke.
In healthy human subjects, the relative contribution of cortical regions to motor performance varies with the task parameters. Additionally, after stroke, recruitment of cortical areas during a simple motor task varies with corticospinal system integrity. We investigated whether the pattern of motor system recruitment in a task involving increasingly forceful hand grips is influenced by the degree of corticospinal system damage. Nine chronic subcortical stroke patients and nine age-matched controls underwent functional magnetic brain imaging whilst performing repetitive isometric hand grips. Target grip forces were varied between 15% and 45% of individual maximum grip force. Corticospinal system functional integrity was assessed with transcranial magnetic stimulation. Averaged across all forces, there was more task-related activation compared with rest in the secondary motor areas of patients with greater corticospinal system damage, confirming previous reports. However, here we were primarily interested in regional brain activation, which covaried with the amount of force generated, implying a prominent executive role in force production. We found that in control subjects and patients with lesser corticospinal system damage, signal change increased linearly with increasing force output in contralateral primary motor cortex, supplementary motor area and ipsilateral cerebellum. In contrast, in patients with greater corticospinal system damage, force-related signal changes were seen mainly in contralesional dorsolateral premotor cortex, bilateral ventrolateral premotor cortices and contralesional cerebellum, but not ipsilesional primary motor cortex. These findings suggest that the premotor cortices might play a new and functionally relevant role in controlling force production in patients with more severe corticospinal system disruption.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="25" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="303" length="14"></location><text>cortical areas</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="189" length="16"></location><text>cortical regions</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="720" length="4"></location><text>hand</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1165" length="5"></location><text>brain</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="495" length="4"></location><text>hand</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="667" length="5"></location><text>brain</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1571" length="20"></location><text>corticospinal system</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1649" length="43"></location><text>contralesional dorsolateral premotor cortex</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1694" length="41"></location><text>bilateral ventrolateral premotor cortices</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1740" length="25"></location><text>contralesional cerebellum</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1466" length="12"></location><text>motor cortex</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1775" length="33"></location><text>ipsilesional primary motor cortex</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1521" length="10"></location><text>cerebellum</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1842" length="17"></location><text>premotor cortices</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1969" length="20"></location><text>corticospinal system</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="579" length="11"></location><text>subcortical</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="76" length="20"></location><text>corticospinal system</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="113" length="11"></location><text>subcortical</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="357" length="20"></location><text>corticospinal system</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1350" length="20"></location><text>corticospinal system</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="537" length="20"></location><text>corticospinal system</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1052" length="20"></location><text>corticospinal system</text></annotation></passage></document><document><id>PMID-15160301</id><passage><offset>0</offset><text>Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Y-754, a novel benzimidazole compound, was investigated for in vitro and in vivo antibacterial activity. Unlike amoxicillin, clarithromycin, and metronidazole, the compound had no activity against common aerobic and anaerobic bacteria other than Helicobacter pylori. The minimum inhibitory concentration of Y-754 against H. pylori, at 0.025 microg/ml, was nearly equal to that of amoxicillin and clarithromycin. The respective concentrations of Y-754, amoxicillin, clarithromycin, and metronidazole required to inhibit 90% of 39 isolates of H. pylori were 0.05, 0.39, 6.25, and 25 microg/ml, indicating the potent activity of Y-754, including activity against clarithromycin- and metronidazole-resistant strains. The anti-H. pylori activity of Y-754 was potent even at pH 5.5 and was bactericidal at concentrations of 0.1 microg/ml and above. Exposure of H. pylori to Y-754 did not result in the induction of drug-resistant mutation. Oral administration (10 mg/kg twice a day for 7 days) to Mongolian gerbils infected with strain ATCC 43504 demonstrated that Y-754 was effective in H. pylori eradication and that its eradication efficacy increased in line with the progress of damage to the gastric mucosa caused by H. pylori infection. Y-754 was also efficacious in the treatment of infection by the clarithromycin-resistant strain OIT-36. The results obtained lead to the expectation that the new benzimidazole Y-754 will, in the near future, be used for H. pylori eradication therapy in peptic ulcer patients.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1313" length="14"></location><text>gastric mucosa</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1612" length="12"></location><text>peptic ulcer</text></annotation></passage></document><document><id>PMC-2634619-caption-01</id><passage><offset>0</offset><text>Appendix Table
Detection of Nipah virus antibody among bat serum samples collected from 10 provinces in China, 2004-2007*
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="59" length="13"></location><text>serum samples</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMC-3126841-caption-04</id><passage><offset>0</offset><text>Confocal and scanning microscopic images of mammoth's and human hair.
Taphonomic changes, indicated by arrow-heads and straight white arrow in the confocal image. Bacterial-fungal colonies are shown by broken arrows. Red arrow indicates space between cuticle and hair shaft due to shrinkage. Extensive taphonomic changes in YUK are evident. Note the preservation of the cuticle in the human hair in contrast to the craters in the cuticles of the mammoth's hair. Bacterial biofilms are a feature of human hair; mammoth's hair was protected from bacterial invasion in permafrost.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="520" length="4"></location><text>hair</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="263" length="10"></location><text>hair shaft</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="504" length="4"></location><text>hair</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="64" length="4"></location><text>hair</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="456" length="4"></location><text>hair</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="391" length="4"></location><text>hair</text></annotation></passage></document><document><id>PMID-1317293</id><passage><offset>0</offset><text>In situ alkylation of cysteine residues in a hydrophobic membrane protein immobilized on polyvinylidene difluoride membranes by electroblotting prior to microsequence and amino acid analysis.
For identification of cysteine residues on microsequence analysis it is crucial to derivatize the sulfhydryl groups. This reaction requires a desalting step which often represents a major obstacle, especially if the sample consists of limited amounts of a hydrophobic membrane protein. An alkylation procedure is described, allowing efficient derivatization (greater than 90%) of cysteines and cystines even in low microgram quantities, as revealed by test analyses with lysozyme and a hydrophobic membrane protein. The modified protein is recovered in high yields in a form suitable for both microsequence analysis and amino acid analysis. The method involves electrophoretic desalting by miniaturized Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis and in situ alkylation after electro-transfer onto polyvinylidene difluoride membranes. Precautions against NH2-terminal blocking during sample preparations are provided. The general applicability of the method is illustrated by the structural characterization of the low abundance membrane receptor for human urokinase plasminogen activator.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1243" length="8"></location><text>membrane</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="690" length="8"></location><text>membrane</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="57" length="8"></location><text>membrane</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="460" length="8"></location><text>membrane</text></annotation></passage></document><document><id>PMC-1891110-caption-05</id><passage><offset>0</offset><text>Representative PCR/LDR results for HPTs in fimX, BP0059, BP0880, sphB2, ptxA, and bhuR. Raw capillary electrophoresis data for ligation products (green) and molecular weight standards (red) displayed as if an electrophoretic gel image. Assayed locus is indicated at the top of each panel; strain and length of its HPT allele are noted above each lane. Representative LDR results are depicted here; for complete data from all strains see Additional files 8, 9, 10, 11, 12, and 13. BP0880, BP0059, fimX, and sphB2 HPTs were screened by uniplex LDR reactions containing only the discriminating oligonucleotide that targets the Tohama I sequence. The ptxA and bhuR HPTs were screened by multiplex reactions that contain all three discriminating oligonucleotides. Letters in teal indicate molecular weight standards as labeled in the corresponding supplementary figures. Ligation products (arrows) are labeled using the notation described in the legend to Figure 1. The open arrowhead indicates a synthesis artifact in the BP0059 common oligonucleotide preparation.
</text></passage></document><document><id>PMC-2715888-caption-05</id><passage><offset>0</offset><text>Duplicated HGT candidates in K. thermotolerans.
(A) Part of the conserved synteny block surrounding KLTH0C07700g and KLTH0C07722g tandem genes. Same legend as Figure 3A. (B) Part of the conserved synteny block surrounding KLTH0F12276g gene. Same legend as Figure 3A. (C) Sequence alignment of proteins from K. thermotolerans and K. waltii. (D) Phylogenetic tree reconstructed from sequence alignment of 100 sites of K. thermotolerans protein family members, K. waltii gene, bacterial (green) and amoebal (blue) proteins. Bootstrap values are indicated next to the nodes and branch length scale is shown at bottom left.
</text></passage></document><document><id>PMC-2192393-sec-06</id><passage><offset>0</offset><text>Cytology and Histology
For semithin sections, embryoid bodies were washed twice in PBS, fixed in 4% paraformaldehyde at 4degreesC overnight, and after dehydration in ethanol were embedded in JB-4 resin (Polysciences, Inc.). 1-4-mum sections were cut with a glass knife. For cytology, the sections were stained with toluidine blue. In cell mixing experiments, the embryoid bodies were prefixed and stained for beta-galactosidase and the sections were counterstained with neutral red. Teratocarcinomas were fixed in Bouin fixative, embedded in Paraplast, and the sections were stained with hematoxylin and eosin. Microphotography was with a ZEISS Axiomat microscope. Films were scanned and figures were prepared with Photoshop 5.5 software.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="46" length="15"></location><text>embryoid bodies</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="363" length="15"></location><text>embryoid bodies</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="334" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMC-2938375-caption-06</id><passage><offset>0</offset><text>Statistical results showing significant differences between habitats.
</text></passage></document><document><id>PMID-12287551</id><passage><offset>0</offset><text>[A decline in the French demographic situation in the context of a Europe also in demographic decline].
The author analyzes the decline in French fertility which has occurred over the past two years using data from official sources.  Some comparisons are made with fertility trends in other European countries.
</text></passage></document><document><id>PMC-2988921-caption-02</id><passage><offset>0</offset><text>Selective SMA angiography was performed 5 h from onset. Before therapy, the SMA was completely occluded by an embolus at the proximal portion (a), and after the bolus infusion of urokinase (600,000 IU) into the SMA, peripheral blood flow was improved. However, the thrombus decreased in size, but remained (b). Asterisks indicate thrombus.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="265" length="8"></location><text>thrombus</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="330" length="8"></location><text>thrombus</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="110" length="7"></location><text>embolus</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="216" length="16"></location><text>peripheral blood</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="161" length="5"></location><text>bolus</text></annotation></passage></document><document><id>PMC-2913979-sec-10</id><passage><offset>0</offset><text>Authors' contributions
MBH made the pathological diagnosis and was responsible for conception and final approval of the manuscript. MB carried out the literature search and drafted the manuscript. IC carried out the surgical procedure and reviewed the manuscript. RM carried out the surgical procedure, provided clinical details, followed up our patient and obtained her consent to publish this case report. All authors read and approved the final manuscript.
</text></passage></document><document><id>PMC-3032248-caption-05</id><passage><offset>0</offset><text>Tarsoconjunctival flap after division
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="0" length="22"></location><text>Tarsoconjunctival flap</text></annotation></passage></document><document><id>PMC-3134767-sec-08</id><passage><offset>0</offset><text>Calculation of male mating success
In order to compare whether males' access to receptive females followed the predictions of the PoA model, we calculated mating success as follows. For all the mating partners a female had during the receptive period of her conceptive cycle, mating success of each mating partner was calculated as the number of mating series a male was involved in divided by the total number of mating series the female was involved in. Overall mating success of each male was calculated as the sum of all mating successes calculated for this male as described above.
</text></passage></document><document><id>PMC-2250455-caption-01</id><passage><offset>0</offset><text>Mineralization (red) of the aorta is prevented by local (left), but not global (right), Mgp expression.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="28" length="5"></location><text>aorta</text></annotation></passage></document><document><id>PMID-8215620</id><passage><offset>0</offset><text>Methotrexate osteopathy in rheumatic disease.
OBJECTIVE:
To determine whether two adults with stress fractures receiving low weekly doses of methotrexate had methotrexate osteopathy.
CASE REPORTS:
Two adult patients developed features consistent with methotrexate osteopathy while receiving low weekly doses of methotrexate.
METHODS:
Iliac crest biopsy samples were taken and bone histomorphometry carried out.
RESULTS:
Symptoms resolved when the methotrexate was discontinued. Bone histology showed changes consistent with osteoblast inhibition by methotrexate.
CONCLUSIONS:
When given in low doses for prolonged periods, methotrexate may have adverse effects on bone, particularly in post-menopausal women.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="524" length="10"></location><text>osteoblast</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="664" length="4"></location><text>bone</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="334" length="26"></location><text>Iliac crest biopsy samples</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="478" length="4"></location><text>Bone</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="376" length="4"></location><text>bone</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMC-2744784-sec-02</id><passage><offset>0</offset><text>Method

</text></passage></document><document><id>PMID-16101297</id><passage><offset>0</offset><text>A novel conotoxin from Conus delessertii with posttranslationally modified lysine residues.
A major peptide, de13a from the crude venom of Conus delessertii collected in the Yucatan Channel, Mexico, was purified. The peptide had a high content of posttranslationally modified amino acids, including 6-bromotryptophan and a nonstandard amino acid that proved to be 5-hydroxylysine. This is the first report of 5-hydroxylysine residues in conotoxins. The sequence analysis, together with cDNA cloning and a mass determination (monoisotopic mass of 3486.76 Da), established that the mature toxin has the sequence DCOTSCOTTCANGWECCKGYOCVNKACSGCTH, where O is 4-hydroxyproline, W 6-bromotryptophan, and K 5-hydroxylysine, the asterisk represents the amidated C-terminus, and the calculated monoisotopic mass is 3487.09 Da. The eight Cys residues are arranged in a pattern (C-C-C-CC-C-C-C) not described previously in conotoxins. This arrangement, for which we propose the designation of framework #13 or XIII, differs from the ones (C-C-CC-CC-C-C and C-C-C-C-CC-C-C) present in other conotoxins which also contain eight Cys residues. This peptide thus defines a novel class of conotoxins, with a new posttranslational modification not previously found in other Conus peptide families.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="130" length="5"></location><text>venom</text></annotation></passage></document><document><id>PMID-8691230</id><passage><offset>0</offset><text>Referral bias among health workers in studies using hospitalization as a proxy measure of the underlying incidence rate.
Contacts with health services like hospitals or general practitioners are usually the only available proxy measure of incidence of disease in studies based on secondary data and differential referrals or care-seeking behavior often bias such proxy measures. In former analyses based on the Occupational Hospitalization Register in Denmark assisting nurses had high Standardized Hospitalization Ratios for many diseases. It was, however, suspected that it fully or partly was due to a referral bias or self-selection to hospital treatment rather than exposures to occupational hazards. The aim of the present study is to evaluate the referral bias hypothesis by comparing hospitalization and mortality data for health workers for a disease category with a high mortality. Cohorts of all gainfully employed 20- to 59-year-old Danes were formed in order to compare Standardized Mortality Ratios and Standardized Hospitalization Ratios of ischemic heart disease (IHD) in occupational groups. The follow-up period was 10 years. For most of the investigated occupational groups a similar disease pattern was found whether hospitalization or death was used as the outcome measure. In "nurse assistants" a statistically significant higher risk was, however, found using hospitalization due to IHD as the end point rather than mortality. Additional analysis did not support the hypothesis that the finding could be explained by differentiated hospitalization due to social factors. The true incidence rates of the disease need not be equally well described by proxy measures such as hospitalization diagnosis or death diagnosis in all occupational groups. Differential access to medical treatment in some groups may lead to bias when hospital data are used as proxy measures for the underlying incidence rates.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1065" length="5"></location><text>heart</text></annotation></passage></document><document><id>PMID-18330634</id><passage><offset>0</offset><text>Impact of dexamethasone-induced immunosuppression on the duration and level of shedding of Escherichia coli O157:H7 in calves.
The goal of this study was to determine whether immunosuppression plays a role in the level and duration of fecal shedding of Escherichia coli O157. Immunosuppression was induced in calves by administering dexamethasone. Six 1-week-old Holstein bull calves were injected intramuscularly with dexamethasone and orally inoculated with 10(9) CFU of a mixture of three nalidixic-acid resistant strains of E. coli O157:H7. Five 1-week-old Holstein bull calves that were given the same oral inoculation of E. coli O157:H7, but not the dexamethasone injections, served as controls. All calves were examined daily and fecal samples were collected three times a week for detection and enumeration of the nalidixic-acid resistant E. coli O157. Four weeks after the last calf stopped shedding, all calves were necropsied and samples from the gastrointestinal tract were taken for the detection of the nalidixic-acid resistant E. coli O157. Dexamethasone-injected calves shed at higher levels (P = 0.04) on days 4 and 7 postinoculation, but not thereafter. None of the samples collected at necropsy were positive for E. coli O157. Data from this study suggest that there may be a time-dependent relationship between dexamethasone immunosuppression and the fecal concentration of E. coli O157 but that transient immunosuppression does not appear to prolong shedding of E. coli O157.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="958" length="22"></location><text>gastrointestinal tract</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1371" length="5"></location><text>fecal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="235" length="5"></location><text>fecal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="737" length="5"></location><text>fecal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="398" length="15"></location><text>intramuscularly</text></annotation></passage></document><document><id>PMID-1802941</id><passage><offset>0</offset><text>M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
Mycobacterium leprae, in contrast to BCG, failed to trigger any chemiluminescence (CL) response in mononuclear cells from either leprosy patients or healthy subjects, a deficit not reversed by either interferon-gamma or GM-CSF. Chemiluminescence responses induced without mycobacteria or with BCG were found to be lower in leprosy patients than in controls. M. leprae were also less well phagocytosed than BCG. However, there was a significant difference in phagocytosis between healthy and tuberculoid leprosy subjects. Phagocytosis was not altered by the addition of either lymphokine, and no major differences between healthy subjects and patients were observed. Preincubating mononuclear cells with anti-mycobacteria antibodies (lepromatous patients' sera) did not increase the CL response nor the phagocytosis of M. leprae or BCG.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="906" length="4"></location><text>sera</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="57" length="9"></location><text>monocytes</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="831" length="17"></location><text>mononuclear cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="250" length="17"></location><text>mononuclear cells</text></annotation></passage></document><document><id>PMID-1877751</id><passage><offset>0</offset><text>Quantitative retention-biological activity relationship study by micellar liquid chromatography.
In a previous paper, the usefulness of micellar liquid chromatography (MLC) in predicting octanol-water partition coefficients of organic compounds was reported. This paper is the first successful report of a quantitative retention-activity relationship study using the retention factor in MLC for predicting the biological activity of a group of phenolic compounds. Excellent correlation was obtained between the capacity factor in MLC and the bioactivity (measured as log 1/C, where C is the 50% inhibitory growth concentration) of 26 para-substituted phenols. A single MLC retention parameter is capable of describing the bioactivity of phenols, while three conventional molecular descriptors (log P(ow), pKa, and R) are needed to achieve a similar correlation. This indicates that both hydrophobic and electronic interactions are incorporated in a single MLC retention parameter, which is due to the amphiphilic nature of surfactants in the system. In situations like this, QRAR is a suitable alternative to QSAR since measuring MLC retention is much easier than measuring different molecular descriptors needed to build the QSAR model. Addition of 10% 2-propanol to a micellar system (hybrid system) proved to be the best chromatographic system for the best estimation of the phenols bioactivity. Other chromatographic factors such as pH and stationary phase also showed significant effect on the correlation between capacity factor k' and log 1/C.
</text></passage></document><document><id>PMC-2908855-caption-01</id><passage><offset>0</offset><text>The pedigree of a Korean family with macular dystrophy demonstrating the characteristics of an autosomal dominant inheritance trait.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="37" length="7"></location><text>macular</text></annotation></passage></document><document><id>PMC-2474682-caption-05</id><passage><offset>0</offset><text>Summary of studies reporting comorbidities with diabetes.
</text></passage></document><document><id>PMID-17402357</id><passage><offset>0</offset><text>[Anomalous origin of the right coronary artery from the left sinus of Valsalva: case report and literature review].
We describe the case of a patient in whom evaluation of effort angina revealed a tight stenosis of a right coronary artery anomalously arising from the left sinus of Valsalva, which was successfully treated by stent implantation. The abnormal origin of the right coronary artery from the left aortic sinus coursing between the aorta and the pulmonary trunk is a rare congenital anomaly. It may remain asymptomatic, but can also cause major cardiac events, even in the absence of coronary atherosclerosis. We discuss the clinical importance of this anomaly and review the literature concerning current views and therapy.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="409" length="12"></location><text>aortic sinus</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="443" length="5"></location><text>aorta</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="273" length="5"></location><text>sinus</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="595" length="8"></location><text>coronary</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="373" length="21"></location><text>right coronary artery</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="457" length="15"></location><text>pulmonary trunk</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="556" length="7"></location><text>cardiac</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="25" length="21"></location><text>right coronary artery</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="217" length="21"></location><text>right coronary artery</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="61" length="5"></location><text>sinus</text></annotation></passage></document><document><id>PMID-21734284</id><passage><offset>0</offset><text>Oscillatory alpha-band mechanisms and the deployment of spatial attention to anticipated auditory and visual target locations: supramodal or sensory-specific control mechanisms?
Oscillatory alpha-band activity (8-15 Hz) over parieto-occipital cortex in humans plays an important role in suppression of processing for inputs at to-be-ignored regions of space, with increased alpha-band power observed over cortex contralateral to locations expected to contain distractors. It is unclear whether similar processes operate during deployment of spatial attention in other sensory modalities. Evidence from lesion patients suggests that parietal regions house supramodal representations of space. The parietal lobes are prominent generators of alpha oscillations, raising the possibility that alpha is a neural signature of supramodal spatial attention. Furthermore, when spatial attention is deployed within vision, processing of task-irrelevant auditory inputs at attended locations is also enhanced, pointing to automatic links between spatial deployments across senses. Here, we asked whether lateralized alpha-band activity is also evident in a purely auditory spatial-cueing task and whether it had the same underlying generator configuration as in a purely visuospatial task. If common to both sensory systems, this would provide strong support for "supramodal" attention theory. Alternately, alpha-band differences between auditory and visual tasks would support a sensory-specific account. Lateralized shifts in alpha-band activity were indeed observed during a purely auditory spatial task. Crucially, there were clear differences in scalp topographies of this alpha activity depending on the sensory system within which spatial attention was deployed. Findings suggest that parietally generated alpha-band mechanisms are central to attentional deployments across modalities but that they are invoked in a sensory-specific manner. The data support an "interactivity account," whereby a supramodal system interacts with sensory-specific control systems during deployment of spatial attention.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="405" length="6"></location><text>cortex</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1639" length="5"></location><text>scalp</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="799" length="6"></location><text>neural</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="225" length="24"></location><text>parieto-occipital cortex</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="602" length="6"></location><text>lesion</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="696" length="14"></location><text>parietal lobes</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="632" length="16"></location><text>parietal regions</text></annotation></passage></document><document><id>PMC-1097769-caption-08</id><passage><offset>0</offset><text>Effect of Trail on the expression of endogenous M2. (A) Effect of Trail on the level of endogenous M2 protein. The expression level of endogenous M2 protein in HeLa cells was determined using western blot 4 h following Trail (250 mug/ml) treatment. (B) Effect of Trail on the endogenous M2 mRNA. The expression level of endogenous M2 mRNA in HeLa cells was detected using RNase protection assay 4 h following Trail (250 mug/ml) treatment. (C) Effect of Trail on the synthesis of endogenous M2 protein. HeLa cells were first treated with 250 mug/ml Trail followed by pulse labeling of newly synthesized proteins with [35S]methionine. M2 protein was then immunoprecipitated and separated by SDS-PAGE for autoradiography as described in Materials and Methods.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="160" length="10"></location><text>HeLa cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="502" length="10"></location><text>HeLa cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="342" length="10"></location><text>HeLa cells</text></annotation></passage></document><document><id>PMID-8268781</id><passage><offset>0</offset><text>Methodologies for measuring carcinogen adducts in humans.
In summary, although some of the more optimistic aspirations for human biomonitoring studies envisaged a decade ago have not been realized thus far, some considerable advances have been made. The examples cited above indicate that the feasibility of biomonitoring has been clearly established. In addition, they demonstrate the need for preliminary biomarker testing and validation through transitional studies prior to their field application. In the next decade of research into carcinogen adducts in humans, continued improvements in the reproducibility and specificity of assays for DNA adducts will be needed. Perhaps the increasing use of hybrid methodologies to concentrate adducts followed by specific chemical analyses will allow such adducts to be monitored more precisely. Of course, further basic research into the mechanisms of carcinogenesis will allow the measurement of specific novel markers which are more closely tied to the disease endpoint than adducts. The development of new assays for determining metabolic phenotypes and genotypes relevant to carcinogenesis should improve our estimates of susceptibility (46-48). Such new approaches along with the sustained improvement of current assays will allow molecular approaches to continue to enrich cancer epidemiology in the future.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1326" length="6"></location><text>cancer</text></annotation></passage></document><document><id>PMC-2578989-sec-01</id><passage><offset>0</offset><text>Images
Figure 1
Figure 5
Figure 6
</text></passage></document><document><id>PMID-12382229</id><passage><offset>0</offset><text>The Acute Dialysis Quality Initiative--part IV: membranes for CRRT.
The extracorporeal membrane used in a continuous renal replacement therapy (CRRT) for the treatment of a critically ill patient with acute renal failure (ARF) is vitally important for several reasons, including its influence on biocompatibility and filter performance. The clinical relevance of membrane-related biocompatibility markers traditionally used in chronic hemodialysis remains unclear in CRRT. Numerous approaches may be used to assess membrane and filter performance in CRRT, but no specific methodology is accepted widely at present. Although a potential benefit of certain membranes used for CRRT is adsorptive removal of inflammatory mediators, this issue has not been assessed carefully in well-designed clinical trials. These and other issues should be the subject of future clinical research efforts.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="655" length="9"></location><text>membranes</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="515" length="8"></location><text>membrane</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="207" length="5"></location><text>renal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="363" length="8"></location><text>membrane</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="117" length="5"></location><text>renal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="72" length="23"></location><text>extracorporeal membrane</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="48" length="9"></location><text>membranes</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation></passage></document><document><id>PMC-3100842-sec-07</id><passage><offset>0</offset><text>5.
Conclusion
RLs are new actors in animal and plant defense and their low toxicity and biodegradability make them promising molecules to be used against pathogens. In this respect, there are some clues now available for the success of RL applications in greenhouses to fight phytopathogens. A better understanding of RL mode of action, especially their perception and the signaling pathways activated, will be very important to potentiate their beneficial effects in plants. RLs have a dual mode of action: they are antimicrobial and also stimulate plant defense responses. This dual property is probably very important for the efficiency of new biopesticides. In animals, the use of RLs is also at an advanced stage. RLs are successfully used as antimicrobial agents, especially for skin disease treatment. Deep insight into the physiochemical effects of RLs and their biological importance would reveal new dimensions in the fields of research like agriculture and medicine, precisely in plant defense, disease control and pathogenesis. An understanding of bacterial genera producing RLs that are not yet well studied would provide light on these fascinating aspects.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="785" length="4"></location><text>skin</text></annotation></passage></document><document><id>PMC-2579698-caption-02</id><passage><offset>0</offset><text>Characteristics of cases with childhood leukaemia (n=162) and matched controls (n=2125), all registered within 3 months of birth
</text></passage></document><document><id>PMC-1615867-sec-09</id><passage><offset>0</offset><text>Conclusion
The survey indicated that, the study area has plenty of medicinal plants to treat a wide spectrum of human ailments. Earlier studies on traditional medicinal plants also revealed that the economically backward local and tribal people of Tamil Nadu prefer folk medicine due to low cost and sometimes it is a part of their social life and culture [40-45]. It is evident from the interviews conducted in different villages, knowledge of medicinal plants is limited to traditional healers, herbalists and elderly persons who are living in rural areas. This study also points out that certain species of medicinal plants are being exploited by the local residents who are unaware of the importance of medicinal plants in the ecosystem.
This study concluded that even though the accessibility of Western medicine for simple and complicated diseases is available, many people in the studied parts of Kancheepuram district is still continue to depend on medicinal plants, at least for the treatment of some simple diseases such as, cold, cough, fever, headache, poison bites, skin diseases and tooth infections. Well-knowledged healers have good interactions with patients and this would improve the quality of healthcare delivery. The present-day traditional healers are very old. Due to lack of interest among the younger generation as well as their tendency to migrate to cities for lucrative jobs, there is a possibility of losing this wealth of knowledge in the near future. It thus becomes necessary to acquire and preserve this traditional system of medicine by proper documentation and identification of specimens.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1079" length="4"></location><text>skin</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1097" length="5"></location><text>tooth</text></annotation></passage></document><document><id>PMID-10420526</id><passage><offset>0</offset><text>[Histopathologic examination of rectal carcinoma].
In patients with rectal carcinoma, the histopathological evaluation of the surgical specimen provides pivotal prognostic and therapeutic information. Important parameters are tumor site, depth of invasion, histological type and grade, pattern of invasion (diffusely infiltrating versus expanding margin), degree of peritumoral lymphocytic infiltration, and tumor involvement of surgical margins and lymph nodes. Evaluation of the circumferential (deep, lateral) margin is of utmost importance. It should be labeled with ink in the gross specimen and should be examined histologically using several tissue blocks. The number of lymph node metastases and the total number of lymph nodes examined should be reported. A histological evaluation of the distal mesorectum in its entirety is recommended to detect discontinuous distal mesorectal tumor spread. The histopathological findings should be summarized using the TNM-classification.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="32" length="16"></location><text>rectal carcinoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="126" length="17"></location><text>surgical specimen</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="68" length="16"></location><text>rectal carcinoma</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="408" length="5"></location><text>tumor</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="450" length="11"></location><text>lymph nodes</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="226" length="5"></location><text>tumor</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="366" length="23"></location><text>peritumoral lymphocytic</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="678" length="21"></location><text>lymph node metastases</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="724" length="11"></location><text>lymph nodes</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="871" length="23"></location><text>distal mesorectal tumor</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="429" length="16"></location><text>surgical margins</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="588" length="8"></location><text>specimen</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="481" length="38"></location><text>circumferential (deep, lateral) margin</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="649" length="6"></location><text>tissue</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="798" length="17"></location><text>distal mesorectum</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T14" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T13" role=""></node></relation></passage></document><document><id>PMC-2892437-sec-19</id><passage><offset>0</offset><text>Titration of Ab-01 inhibition of ex vivo response to rhIL21
Samples from 4 individual healthy human donors were pre-incubated for 2 hours at the indicated concentration of Ab-01 or the control IgG1TM prior to addition of 10 ng/mL rhIL21 and 2 hr incubation, and the effect on the 6 biomarkers was then assessed (Figures 4 and 5). For the first 2 donors tested, even the lowest concentration of Ab-01 (0.1 mug/mL, 0.66 nM) resulted in complete inhibition of the rhIL21 response, therefore the two subsequent donors were tested at increasing concentrations of Ab-01 starting at 0.003 mug/mL. Ab-01 inhibited the response of all 6 genes in all 4 donors. IC50 values ranged between 0.003 and 0.015 mug/mL Ab-01(Figure 5). Control IgG1TM had no significant effect on rhIL21 response (Figure4B).
Figure 4
Average percent inhibition of the expression level of 6 IL21-responsive genes. Percent inhibition values were calculated based on RQ (relative quantification) values of untreated control and rhIL21-treated samples for each of the 4 donors, and subsequently the mean and standard deviation were determined for each gene shown. A: Percent inhibition in presence of Ab-01. B: Percent inhibition in presence of control IgG1TM. Data for the 0.1 mug/mL , 0.3 mug/mL and 1 mug/mL concentrations were generated using 4 donors. Data for the higher and the lower concentrations were generated using 2 donors.
Figure 5
Inhibition by Ab-01 at the indicated concentration is shown for 6 IL21-responsive genes. IC50 values of inhibition curves shown in Figure 4A were calculated using curve fit (XLfit) program for each of the referred biomarker genes. Values for the 0.1 mug/mL, 0.3 mug/mL and 1 mug/mL concentrations were generated using 4 donors. Data for the higher and the lower concentrations were generated using 2 donors each.
</text></passage></document><document><id>PMID-10841092</id><passage><offset>0</offset><text>Specific subgroup B adenovirus diagnosis by PCR of the fibre gene.
OBJECTIVE:
A highly sensitive and specific PCR assay targeting regions of the fibre gene was developed for the identification of subgroup B adenovirus strains. This is critical, since these adenovirus strains are frequently associated with severe respiratory infections in infants and new-borns.
METHODS:
Clinical samples from nasopharyngeal aspirates were analysed by PCR using several sets of primers corresponding to sequences of the gene coding for the fibre protein.
RESULTS:
The assay allowed the detection and identification of all the genotypes of adenovirus subgroup B, based on the size of the amplified product when analysed on polyacrilamide gel electrophoresis. Specifically, one set of primers was able to amplify DNA of subgroup B but not subgroup C and E viruses.
CONCLUSION:
The detection of adenovirus and the genotyping can be done on a routine basis by a PCR assay using the fibre gene as a target. The assay allows the identification of ADV subgroup B, including genotype 7h, which is the single most important viral pathogen associated with respiratory diseases in infants and young children in the southern part of South America.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="381" length="7"></location><text>samples</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="314" length="11"></location><text>respiratory</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1130" length="11"></location><text>respiratory</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="394" length="24"></location><text>nasopharyngeal aspirates</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T4" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMID-16112981</id><passage><offset>0</offset><text>Management of extremity trauma and related infections occurring in the aquatic environment.
Wounds sustained in oceans, lakes, and streams are exposed to a milieu of bacteria rarely encountered in typical land-based injuries. These include Vibrio species, Aeromonas hydrophila, Pseudomonas and Plesiomonas species, Erysipelothrix rhusiopathiae, Mycobacterium marinum, and other microbes. Failure to recognize and treat these less common pathogens in a timely manner may result in significant morbidity or death. Initial antibiotic therapy should address common gram-positive and gram-negative aquatic bacteria, depending on the environment. Trauma occurring in brackish or salt water should be treated with doxycycline and ceftazidime, or a fluoroquinolone (eg, ciprofloxacin or levofloxacin). Freshwater wounds should be managed with ciprofloxacin, levofloxacin, or a third- or fourth-generation cephalosporin (eg, ceftazidime). Injuries sustained in a marine or freshwater environment may result from bites or venomous stings of aquatic organisms as well as from accidental trauma. Musculoskeletal trauma caused by venomous underwater species (eg, stingrays, stinging fish, sea urchins, and coral) requires immediate neutralization of the heat-labile toxin with immersion in nonscalding water for 30 to 90 minutes. Appropriate management of aquatic wounds requires recognition of the mechanism of injury, neutralization of venom, antibiotic administration, radiographic assessment, surgical debridement with irrigation, wound cultures, and structural repair or amputation as indicated by the severity of the injury.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="805" length="6"></location><text>wounds</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1084" length="22"></location><text>Musculoskeletal trauma</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1351" length="6"></location><text>wounds</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1522" length="5"></location><text>wound</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="92" length="6"></location><text>Wounds</text></annotation></passage></document><document><id>PMC-3113832-caption-05</id><passage><offset>0</offset><text>Concurrent disease in 33 cows with LDA.
</text></passage></document><document><id>PMID-1802899</id><passage><offset>0</offset><text>Melanoma/skin cancer screening clinics: experiences in The Netherlands.
In 1989 and 1990 we conducted two free melanoma/skin screening clinics in Oss and Arnhem in the Netherlands. The study was carried out along the lines of the recent campaigns supported by the American Academy of Dermatology. Of 2564 persons screened, 53 had melanoma or nonmelanoma skin cancer (2.1%). Compliance with follow-up for persons with suspected melanoma/skin cancer was adequate (93 of 103; 90.3%).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="342" length="23"></location><text>nonmelanoma skin cancer</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="427" length="8"></location><text>melanoma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="120" length="4"></location><text>skin</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="330" length="8"></location><text>melanoma</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="436" length="11"></location><text>skin cancer</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="0" length="8"></location><text>Melanoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="111" length="8"></location><text>melanoma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="9" length="11"></location><text>skin cancer</text></annotation></passage></document><document><id>PMID-15316972</id><passage><offset>0</offset><text>Newly recognized syndrome with heminasal aplasia and ocular anomalies or wider spectrum of heminasal aplasia/atypical clefting syndrome?
We report on five unrelated Brazilian patients with heminasal aplasia associated with diverses anomalies, including lateral proboscis, and anomalies of the eye and first branchial arch. We suggest that these patients represent different conditions within the spectrum of the heminasal aplasia malformation. Clinical, genetic, and differential diagnosis are discussed.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="53" length="6"></location><text>ocular</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="307" length="14"></location><text>branchial arch</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="293" length="3"></location><text>eye</text></annotation></passage></document><document><id>PMID-3945631</id><passage><offset>0</offset><text>Immunoglobulins associated with elevated riboflavin binding by plasma from cancer patients.
Plasma from 182 patients with different malignant diseases was tested for riboflavin binding by immunoglobulins, which have been recently identified as major carriers of this micronutrient. A wide range of binding (5.9 to 130 pmole/ml plasma) was observed, and significant elevations were found for patients having breast cancer (21.2 +/- 1.9, P less than 0.05) and melanoma (25.7 +/- 1.9, P less than 0.001) compared to controls (15.5 +/- 1.9). The proteins responsible for a majority of the higher binding were identified as immunoglobulins, based on their elution from gel filtration columns and the removal of 57-88% of the non-albumin binding by treating of plasma with Protein A-agarose. The binding was only weakly related to the total concentration of immunoglobulins (r = 0.11 by linear regression analysis), however, and is apparently due to a subclass that is elevated in some types of cancer. Elevated levels of these immunoglobulins may contribute to the lower urinary levels and clearance of riboflavin in cancer.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="755" length="6"></location><text>plasma</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1066" length="7"></location><text>urinary</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="407" length="13"></location><text>breast cancer</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="458" length="8"></location><text>melanoma</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1112" length="6"></location><text>cancer</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="63" length="6"></location><text>plasma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="92" length="6"></location><text>Plasma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="75" length="6"></location><text>cancer</text></annotation></passage></document><document><id>PMID-16771309</id><passage><offset>0</offset><text>Dendrimer-templated Fe nanoparticles for the growth of single-wall carbon nanotubes by plasma-enhanced CVD.
A fourth-generation (G4) poly(amidoamine) (PAMAM) dendrimer (G4-NH2) has been used as a template to deliver nearly monodispersed catalyst nanoparticles to SiO2/Si, Ti/Si, sapphire, and porous anodic alumina (PAA) substrates. Fe2O3 nanoparticles obtained after calcination of the immobilized Fe3+/G4-NH2 composite served as catalytic "seeds" for the growth of single-wall carbon nanotubes (SWNTs) by microwave plasma-enhanced CVD (PECVD). To surmount the difficulty associated with SWNT growth via PECVD, reaction conditions that promote the stabilization of Fe nanoparticles, resulting in enhanced SWNT selectivity and quality, have been identified. In particular, in situ annealing of Fe catalyst in an N2 atmosphere was found to improve SWNT selectivity and quality. H2 prereduction at 900 degrees C for 5 min was also found to enhance SWNT selectivity and quality for SiO2/Si supported catalyst, albeit of lower quality for sapphire supported catalyst. The application of positive dc bias voltage (+200 V) during SWNT growth was shown to be very effective in removing amorphous carbon impurities while enhancing graphitization, SWNT selectivity, and vertical alignment. The results of this study should promote the use of exposed Fe nanoparticles supported on different substrates for the growth of high-quality SWNTs by PECVD.
</text></passage></document><document><id>PMC-2782986-sec-02</id><passage><offset>0</offset><text>RESEARCH DESIGN AND METHODS
For this study, 20 individuals (mean age 39.5 +/- 11.1 years) with long-standing type 1 diabetes (21.3 +/- 10.7 years) were enrolled in this prospective open-label crossover trial. After achieving optimal blood glucose control, 16 subjects were randomized to exenatide with or without daclizumab. Endogenous insulin production was determined by repeatedly measuring serum C-peptide.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="233" length="5"></location><text>blood</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="394" length="5"></location><text>serum</text></annotation></passage></document><document><id>PMC-2971783-sec-11</id><passage><offset>0</offset><text>Crystal data
C15H12ClN3O2S2 F(000) = 752
Mr = 365.85 Dx = 1.507 Mg m-3
Monoclinic, P21/n Mo Kalpha radiation, lambda = 0.71073 A
Hall symbol: -P 2yn Cell parameters from 25 reflections
a = 10.175 (2) A theta = 9-12degrees
b = 8.4958 (17) A micro = 0.51 mm-1
c = 19.318 (4) A T = 293 K
beta = 105.01 (3)degrees Block, yellow
V = 1613.0 (6) A3 0.25 x 0.15 x 0.15 mm
Z = 4
</text><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="149" length="4"></location><text>Cell</text></annotation></passage></document><document><id>PMC-2673029-caption-03</id><passage><offset>0</offset><text>Secchi depth in the Baltic Proper, June-August, 1957-1998.
Number of data: 3,452.
</text></passage></document><document><id>PMC-3202114-sec-05</id><passage><offset>0</offset><text>3.2. Molecular Mechanisms Mediating the Perinatal Beta-Cell Adaptive Response to Early-Life Stressors
Molecular mechanisms responsible for impaired beta-cell mass formation after IUCR or IUPR have come under investigation.
First, it has been proposed that IUCR can result in a reduction of the embryonic beta-cell progenitor pool leading to inappropriate postnatal beta-cell formation. Stanger et al. [108] demonstrated that selective genetic reduction in the size of PDX-1+ pancreatic progenitors during the fetal period results in impaired beta-cell formation during the postnatal period with consequent development of glucose intolerance during adulthood. Consistent with this, maternal food restriction leads to significant reduction in PDX-1+ and neurogenin-3+ pancreatic precursors during embryonic development in rats, diminished postnatal beta-cell formation, and inability to expand beta-cell mass in response to pregnancy [47, 94]. The UPI model is also characterized by a permanent decrease in islet PDX-1 mRNA expression. This decrease has recently been shown to be due to progressive epigenetic silencing of the Pdx1 gene locus secondary to proximal promoter methylation [69, 109], and it may be responsible for the decreased rate of beta-cell replication and inappropriate postnatal beta-cell mass development [69, 110]. In the same way of thinking, studies have demonstrated that the maintenance of methylated histone H3 Lys4 by Set7/9, a member of the SET methyltransferase family, is crucial to Pdx1 activity in beta-cell lines [111-113]. This led to the hypothesis that Set7/9 may represent a novel chromatin-modifying protein that functions in part through its recruitment to target genes by cell-specific transcription factors such as Pdx1. Since then, a role of histone methyl transferases, particularly set7, has also been demonstrated in the sustained deleterious effects of chronic hyperglycemia on human microvascular endothelial cells [114]. Such an epigenetic change could potentially be involved in the deleterious effect of high glucose upon the fetal pancreas in the IUED models.
Another mechanism proposed to explain reduced beta-cell formation after IUCR is related to prenatal glucocorticoid exposure. Administration of either dexamethasone or carbenoxolone (to inhibit 11 beta-hydroxysteroid dehydrogenase type 2) to normal pregnant rats also causes fetal growth retardation and the adult offspring are hypertensive and hyperglycemic, with hyperactive hypothalamic-pituitary-adrenal axis [115]. Maternal undernutrition significantly increased both fetal and maternal corticosterone concentrations in rats [116]. Subsequently, maternal and/or fetal overexposure to glucocorticoids (via administration of dexamethasone) impairs both fetal and postnatal beta-cell formation in rodents and nonhuman primates [94, 117-119]. Seckl et al. [115] have shown that fetal corticosterone concentrations are inversely correlated with fetal insulin content and postnatal beta-cell formation in rats. Evidence suggests that glucocorticoids can exert a direct effect on the developing fetal pancreas via transcriptional modulation of transcription factors involved in beta-cell formation and differentiation [117]. Glucocorticoid receptors are present in the pancreas during embryonic development of rodents and humans [117], and glucocorticoids can bind to the Pdx1 promoter and thus suppress fetal endocrine cell differentiation [117]. Glucocorticoid treatment has been shown to significantly reduce fetal expression of key endocrine transcription factors such as Pdx1 and Pax6 but simultaneously increase expression of transcription factors that regulate development of the exocrine pancreas [119].
It has also been demonstrated that the UPI or the low-protein IUPR offspring experience increased oxidative stress and impaired mitochondrial function [96, 120]. The mitochondrial dysfunction was not limited to just the beta cell, as mitochondria from both the liver and skeletal muscle exhibit decreased oxidation of pyruvate, subsequently leading to the development of features commonly found in T2D [100, 121]. Also exposure to a Western-style diet before and during pregnancy (an IUEO model) alters the redox state as early as preimplantation development, leading to mild oxidative stress associated with inflammation. The finding that administration of antioxidants to the dam reverses oxidative stress and completely prevents the development of glucose intolerance and increased adiposity in the adult offspring suggests that oxidative stress plays an important role in the development of adiposity in this case [122]. Some studies in the low-protein IUPR model have demonstrated that oxidative stress is not limited to just mitochondrial DNA damage, but also to genomic DNA, impacting cell-cycle regulation and gene expression [123]. While DNA is being targeted throughout by ROS, there are particular regions that are known to be more sensitive to ROS-mediated damage, for example, telomeres. Telomeres comprise GC-rich repeats and are found at the ends of each chromosome. They are known to shorten with each cellular division and, hence, can act as a mitotic clock, registering the number of replicative divisions to have taken place within the cell. Investigations using an IUPR model have indeed reported a decrease in longevity in the offspring [123, 124] accompanied by reduction in mitochondrial antioxidant defences [96, 125] and telomere length in islets [125].
Pancreatic islet development has been shown to be influenced by a number of growth factors including the insulin-like growth factors, IGF-I and IGF-II whose expression in utero is regulated by nutrient and hormone concentrations. IUPR modifies expression of both IGF genes in a variety of fetal tissues. In an IUPR rat model with a decreased beta-cell mass and beta-cell replication and an increased rate of beta-cell apoptosis, gene expression for IGF-II but not IGF-I was found reduced in the fetal pancreas [126]. In a different IUPR model with more severe global food restriction which induced hyperinsulinemia and an increase in beta-cell mass in their fetuses [90], the fetal phenotype was unexpectedly associated with an increase in pancreatic IGF-I expression, islet IGF-1R [91], and IRS-2 [92]. In the fetal GK/Par rat exposed to mild hyperglycemia during gestation (a model of IUED), data from our group suggest that the beta-cell deficit (reduced by more than 50%) starts as early as fetal age E16 and reflects decreased beta-cell proliferation, a limitation of beta-cell neogenesis from precursors, and increased apoptosis of both beta cells and their precursors [86]. Notably, Pdx1 and Neurogenin3 expression were decreased on E18 but normally expressed on E13 [86]. Defective signalling through the Igf2/Igf1-R pathway may represent the primary instrumental anomaly since Igf2 and Igf1-R protein expressions are already decreased within the GK/Par pancreatic rudiment at E13, at a time when beta-cell mass (first wave of beta-cell expansion) is in fact normal [31]. Low levels of pancreatic Igf2 associated with beta-cell mass deficiency are maintained thereafter within the fetal pancreas [87]. Crossbreeding protocols between nondiabetic W and diabetic GK rats showed that, in late gestation (E18), pancreatic Igf2 protein expression was as low in GKmother/GKfather and Wmother/GKfather crosses as in GKmother/GKfather crosses [87]. These findings rather support the hypothesis that the pancreatic Igf2 anomaly in the GK diabetic model is linked to a genetic determinism. This view is also consistent with the results of genetic analyses that linked a locus containing the gene encoding Igf2 to diabetes in the GK rat [127]. The Igf2 gene is subjected to paternal genomic imprinting. However, because the Igf2 expression is similarly affected in fetuses, regardless of whether the father is W or GK [87], we cannot conclude with a simple change of Igf2 gene imprinting in the GK rat.
Finally, our understanding of the underlying mechanisms for reduced BCM in response to inappropriate perinatal nutrition is growing rapidly. However, the relative contribution of the many intrinsic and extrinsic factors which contribute to the adaptive response of the developing endocrine pancreas is still to be established.
</text><annotation id="T75"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="5416" length="13"></location><text>mitochondrial</text></annotation><annotation id="T76"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1005" length="5"></location><text>islet</text></annotation><annotation id="T73"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3885" length="13"></location><text>mitochondrial</text></annotation><annotation id="T74"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="4750" length="13"></location><text>mitochondrial</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="3102" length="14"></location><text>fetal pancreas</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2990" length="9"></location><text>beta-cell</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2888" length="5"></location><text>fetal</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2785" length="9"></location><text>beta-cell</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2765" length="5"></location><text>fetal</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2676" length="5"></location><text>fetal</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2582" length="5"></location><text>fetal</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2509" length="7"></location><text>adrenal</text></annotation><annotation id="T72"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3847" length="13"></location><text>mitochondrial</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2499" length="9"></location><text>pituitary</text></annotation><annotation id="T71"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="6960" length="19"></location><text>pancreatic rudiment</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2486" length="12"></location><text>hypothalamic</text></annotation><annotation id="T70"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="6238" length="10"></location><text>pancreatic</text></annotation><annotation id="T62"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7124" length="9"></location><text>beta-cell</text></annotation><annotation id="T63"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="7187" length="14"></location><text>fetal pancreas</text></annotation><annotation id="T64"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="7313" length="10"></location><text>pancreatic</text></annotation><annotation id="T65"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="7501" length="10"></location><text>pancreatic</text></annotation><annotation id="T66"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="7860" length="7"></location><text>fetuses</text></annotation><annotation id="T67"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="8278" length="18"></location><text>endocrine pancreas</text></annotation><annotation id="T68"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5137" length="8"></location><text>cellular</text></annotation><annotation id="T69"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2954" length="5"></location><text>fetal</text></annotation><annotation id="T38"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="3980" length="5"></location><text>liver</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3953" length="12"></location><text>mitochondria</text></annotation><annotation id="T39"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="3990" length="15"></location><text>skeletal muscle</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="3519" length="5"></location><text>fetal</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3411" length="20"></location><text>fetal endocrine cell</text></annotation><annotation id="T36"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3939" length="9"></location><text>beta cell</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="3694" length="17"></location><text>exocrine pancreas</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3185" length="9"></location><text>beta-cell</text></annotation><annotation id="T61"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="7092" length="10"></location><text>pancreatic</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="3292" length="9"></location><text>embryonic</text></annotation><annotation id="T60"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7033" length="9"></location><text>beta-cell</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="3276" length="8"></location><text>pancreas</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="509" length="5"></location><text>fetal</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="542" length="9"></location><text>beta-cell</text></annotation><annotation id="T49"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6132" length="9"></location><text>beta-cell</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="365" length="9"></location><text>beta-cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="475" length="10"></location><text>pancreatic</text></annotation><annotation id="T48"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="5993" length="14"></location><text>fetal pancreas</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="766" length="10"></location><text>pancreatic</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="795" length="9"></location><text>embryonic</text></annotation><annotation id="T43"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5498" length="16"></location><text>Pancreatic islet</text></annotation><annotation id="T42"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5484" length="6"></location><text>islets</text></annotation><annotation id="T41"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5274" length="4"></location><text>cell</text></annotation><annotation id="T40"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4811" length="4"></location><text>cell</text></annotation><annotation id="T47"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5906" length="9"></location><text>beta-cell</text></annotation><annotation id="T46"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5859" length="9"></location><text>beta-cell</text></annotation><annotation id="T45"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5840" length="9"></location><text>beta-cell</text></annotation><annotation id="T44"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="5787" length="13"></location><text>fetal tissues</text></annotation><annotation id="T50"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="6156" length="7"></location><text>fetuses</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="50" length="9"></location><text>Beta-Cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="294" length="19"></location><text>embryonic beta-cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="148" length="9"></location><text>beta-cell</text></annotation><annotation id="T59"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7003" length="9"></location><text>beta-cell</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="847" length="9"></location><text>beta-cell</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="892" length="9"></location><text>beta-cell</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1247" length="9"></location><text>beta-cell</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1297" length="9"></location><text>beta-cell</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1529" length="15"></location><text>beta-cell lines</text></annotation><annotation id="T52"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6267" length="5"></location><text>islet</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1711" length="4"></location><text>cell</text></annotation><annotation id="T51"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="6174" length="5"></location><text>fetal</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1929" length="31"></location><text>microvascular endothelial cells</text></annotation><annotation id="T54"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6429" length="9"></location><text>beta-cell</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2075" length="14"></location><text>fetal pancreas</text></annotation><annotation id="T53"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="6309" length="5"></location><text>fetal</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2156" length="9"></location><text>beta-cell</text></annotation><annotation id="T56"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6530" length="9"></location><text>beta-cell</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2384" length="5"></location><text>fetal</text></annotation><annotation id="T55"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="6493" length="5"></location><text>fetal</text></annotation><annotation id="T58"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6641" length="10"></location><text>beta cells</text></annotation><annotation id="T57"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6571" length="9"></location><text>beta-cell</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T17" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T33" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T29" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T48" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T44" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T71" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T63" role=""></node></relation></passage></document><document><id>PMC-1168904-sec-12</id><passage><offset>0</offset><text>Discussion
Among adolescent boys in Chapaevsk, Russia, higher serum levels of sum of dioxin-like compounds and sum of dioxin TEQs were positively associated with increased age, consumption of fish, local meats other than chicken, and inversely with weeks of gestation. The age association was found despite a narrow age range of slightly over two years in our study. Although not statistically significant, the distance the boy lived from the Khimprom factory at the time of blood draw was inversely associated with serum levels of sum of dioxin-like compounds and sum of dioxin TEQs. As expected, serum PCBs, specifically PCB 118, were strongly associated with both sum of dioxin-like compounds and sum of dioxin TEQs.
There was no association between the distance of the residence from the Khimprom plant during the pregnancy and subsequent serum dioxin levels. One potential explanation for the lack of association may include misclassification of distance since the mother was asked to recall a time period more than 14 years prior to the study. However, we would expect that the mother would be able to recall residential history at the time of the birth of their son. Mother's self-reported estimates of current residential distance from Khimprom was generally accurate; twenty-one of twenty-nine mothers correctly categorized their current residential distance from the Khimprom plants based on cross-referencing using GIS mapping. Other explanations include that prenatal exposure 14 or more years prior to the current serum sample is not as strong a predictor as are exposures resulting from present residential location. Although there was no association of case status (cryptorchidism or hypospadias) with dioxin levels, we did not have sufficient power to definitively assess this relationship.
Perinatal history (e.g. weeks of breastfeeding) was generally not associated with exposure measures in this population; this may be a function of older age of the children. However, there are limited data on the relationship of perinatal factors with organochlorine exposures in this age group so a null finding is of interest given reports that differences in organochlorine levels among breastfed and non-breastfed are generally no longer discernable by early school age [24,25] and, furthermore, that dietary intake after this age contributes significantly to total dioxin intake [26]. In prior studies, substantial emphasis has been placed on pre- and early postnatal (via breastfeeding) exposures because of particular vulnerability during fetal and early infant development. The exposure risk factors during peri-adolescence, another period of potential developmental vulnerability, has not been studied in-detail, therefore, the identification of exposure risk factors specific to this period will enhance our understanding of this critical period.
Although data on levels of PCDD/PCDFs in children is limited, our results suggest that the mean total TEQs among Chapaevsk adolescents were higher than most values previously reported in non-occupationally exposed populations of comparable or even older ages. Figure 2 shows a comparison of the mean PCDD/PCDFs TEQ levels in Chapaevsk boys with other populations (TEQ from dioxin-like PCBs was not included, since some of these studies did not report them). The mean TEQs of pooled blood samples from 10 year-old German boys in rural and urban settings was 8.2 pg TEQ/g lipid for an urban industrial area, 9.0 pg TEQ/g lipid for an industrial area within a rural setting, and 10.1 pg TEQ/g lipid for a rural area [27]. In comparison, the mean TEQ in the Chapevsk boys was 19.3 pg TEQ/g lipid. With the exception of children described by Wuthe et al. [27], subjects in the other studies in Figure 2 were significantly older than the Chapaevsk boys. Despite age differences, the mean TEQ in Chapaevsk boys was comparable to or even higher than the mean TEQ in older populations from other countries. For example, they were higher than mean TEQs of 18.4 pg TEQ/g lipid in adults (40.6 years old average) from South Germany [27] or 16.4 pg TEQ/g lipid from 20 year old Japanese women [28] or pooled samples from randomly selected males and females 18-69 years of age from the Spanish city of Mataro [29], which were 12.5 and 14.7 pg TEQ/g lipid respectively. The mean levels in adult female (mean age 41 years) non-factory workers in the Russian city of Shelekhovo were also lower at 14.5 pg TEQ/g lipid [30]. Mean TEQs for the general population (mean age 44.2 years) in Germany, collected in 1997-98 [31], and median TEQs for long-term workers of pulp and paper mill and non-workers in the U.S. in 1996 [32] were similar to levels found in the Chapaevsk boys. The mean levels in the study in Germany were 20.71 pg TEQ/g lipid and in the U.S. the median levels were 19.1 pg TEQ/g lipid for community residents and 21.2 pg TEQ/g lipid for low exposure workers.
Figure 2
Mean PCDD/PCDFs TEQ levels in Chapaevsk boys in comparison with other populations.
Although TCDD was largely below the detection limits in this small pilot sample, the two boys with detectable values had high TCDD levels (17.9 and 21.7 pg/g lipid), suggesting that exposure for at least some portion of this population is substantially higher than typical of this age group. In comparison, in a cohort of adult (mean age of 58 years) fishermen from a polluted region of Finland, the mean TCDD concentration was 19 pg/g lipid [33]. In adult (mean age of 53 years) residents from Calcasieu Parish, Louisiana, which is near a chemical industrial complex, the mean TCDD level was 7.6 pg/g lipid [34]. Not only were the dioxin levels in these two children higher than those found in these studies, but the adults in the previous studies were several decades older and therefore would be expected to have higher dioxin body burdens than younger children [35]. Potential explanations for the large number of non-detectable samples for TCDD include the small sample volume and young age of the subjects. In our future studies in this population, we will collect larger volumes of serum for dioxin analysis.
In one of the few studies on dioxin-like compounds in which children were included, Eskenazi and coworkers [36] evaluated the relationship between serum TCDD concentrations and age at exposure of female residents of Seveso, Italy. Residents near the ICMESA chemical plant in Seveso were exposed to some of the highest known residential levels of 2,3,7,8-TCDD as a result of an explosion at the plant. Archived serum collected near the time of the accident was used to measure exposures. Residents closest to the plant had a median 2,3,7,8-TCDD level of 272 ppt (IQR 92 - 883 ppt). Residential proximity to the plant and younger age (up to 13 years old) were the strongest predictors of an individual's serum 2,3,7,8-TCDD level. Other predictors included being outdoors at the time of explosion and consumption of homegrown food. The higher levels found in children were most likely a result of increased exposure as a result of activity patterns and a greater proportionate consumption of food, water and air than adults [37].
Although the exposure scenario (an acute high exposure event) is different than the chronic low/moderate exposure occurring in Chapaevsk, the results from Seveso suggest that children may be at increased risk for high dioxin exposure from environmental contamination. In our study, although distance from the Khimprom plants was a weak predictor of serum dioxin-like compounds, consumption of local foods (specifically meat and fish), as in the Seveso study, was a strong predictor of sum of dioxin-like compounds and dioxin TEQs. This finding is notable given concerns regarding environmental dioxin contamination in the community and suggests that food may be one of the more, if not most, important routes of environmental contaminant exposure for residents in this setting. In other settings, contaminated food generally contributes much more substantially to human organochlorine burden than air or soil (which may be related to residential proximity to pollutant sources) [6]. We will investigate this issue in more detail in our ongoing study.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="62" length="5"></location><text>serum</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="475" length="5"></location><text>blood</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="204" length="5"></location><text>meats</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="843" length="5"></location><text>serum</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1527" length="12"></location><text>serum sample</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="516" length="5"></location><text>serum</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="598" length="5"></location><text>serum</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="6101" length="5"></location><text>serum</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="6275" length="5"></location><text>serum</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="6538" length="5"></location><text>serum</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="6830" length="5"></location><text>serum</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2552" length="5"></location><text>fetal</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="7504" length="5"></location><text>serum</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3345" length="13"></location><text>blood samples</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="4158" length="7"></location><text>samples</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="5945" length="7"></location><text>samples</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="5085" length="6"></location><text>sample</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="5980" length="6"></location><text>sample</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="7574" length="4"></location><text>meat</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="5842" length="4"></location><text>body</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T15" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T17" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T19" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T18" role=""></node></relation></passage></document><document><id>PMID-21596785</id><passage><offset>0</offset><text>mirAct: a web tool for evaluating microRNA activity based on gene expression data.
MicroRNAs (miRNAs) are critical regulators in the complex cellular networks. The mirAct web server (http://sysbio.ustc.edu.cn/software/mirAct) is a tool designed to investigate miRNA activity based on gene-expression data by using the negative regulation relationship between miRNAs and their target genes. mirAct supports multiple-class data and enables clustering analysis based on computationally determined miRNA activity. Here, we describe the framework of mirAct, demonstrate its performance by comparing with other similar programs and exemplify its applications using case studies.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="141" length="8"></location><text>cellular</text></annotation></passage></document><document><id>PMC-2961588-caption-01</id><passage><offset>0</offset><text>The molecular structure of (I), showing displacement ellipsoids at the 30% probability level for non-H atoms.
</text></passage></document><document><id>PMID-19240875</id><passage><offset>0</offset><text>Prolonged control of patterned biofilm formation by bio-inert surface chemistry.
A bio-inert surface chemistry was developed that can confine biofilm formation in designed patterns for at least 26 days.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="31" length="7"></location><text>biofilm</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="142" length="7"></location><text>biofilm</text></annotation></passage></document><document><id>PMC-1698941-caption-09</id><passage><offset>0</offset><text>Comparison of the Predicted Irr Regulon and ICE Motifs with the Published Expression Microarray Data for Iron- and Irr-Affected Genes in Bradyrhizobium japonicum
</text></passage></document><document><id>PMID-18979410</id><passage><offset>0</offset><text>The detection of macrosomia at a teaching hospital.
We sought to determine the detection (clinical or sonographic) rate of macrosomic newborns (at least 4000 g) and the peripartum factors among those who were or were not identified accurately. We retrospectively reviewed all deliveries over 1 year and all maternal and neonatal charts of macrosomic newborns delivered during that year. Odds ratio (ORs) and 95% confidence intervals (CIs) were calculated. Over a 12-month period, the rate of macrosomia was 10% (421/4194) and of those, only 11% (95% CI 8 to 14%) were suspected clinically or sonographically. None of the newborns weighing 4500 g or more were recognized before birth (0/57; 95% CI 0 to 6%). The rate of cesarean delivery was significantly higher among newborns correctly identified as macrosomic (58%) versus those missed (36%; OR 2.76, 95% CI 1.46, 5.16). The incidence of newborns weighing in excess of 4000 g is 10%, and approximately 90% of these macrosomic newborns were unsuspected before birth.
</text></passage></document><document><id>PMID-900085</id><passage><offset>0</offset><text>The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of 16 sibling pairs.
Data on 16 sibling pairs with cystic fibrosis were analyzed to test the hypothesis that early treatment of this condition improves prognosis. Younger siblings' conditions were diagnosed before 1 year of age, usually before the onset of pulmonary disease. Older siblings' conditions were diagnosed after 1 year of age and after the onset of pulmonary disease. Although the sibling pairs received similar treatment, comparison at 7 years of age showed that the younger siblings had significantly better chest roentgenogram scores, total clinical scores, residual lung volumes, and ratios of residual volume to total lung volume. Younger siblings also required fewer hospital admissions to control their lung disease. The results suggest that, in general, early initiation of therapy is beneficial for patients with cystic fibrosis.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="805" length="4"></location><text>lung</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="665" length="4"></location><text>lung</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="718" length="4"></location><text>lung</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="340" length="9"></location><text>pulmonary</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="605" length="5"></location><text>chest</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="444" length="9"></location><text>pulmonary</text></annotation></passage></document><document><id>PMC-3051055-sec-17</id><passage><offset>0</offset><text>Genes related to signal transduction
On day 7, the up-regulated genes related to signal transduction were PDE1A, MYO10, APOB, and so on, and down-regulated genes were CYTL1 and IL6. On day 14, the up-regulated genes were ANGPTL4, EPHA3, RASL10B, etc., and the down-regulated genes were CXCL12, CCL8 and VLDLR. The genes up-regulated on both days were LEP, RAC3, and RASL11B, and those down-regulated both days were MX1 and WISP2. Notably, up- and down-regulated genes PDE1A, APOB, ALCAM, PSCD4, CYTL1, and IL6 were more strongly expressed on day 7 than on day 14, while ANGPTL4, EPHA3, RAB12, CXCL12, CCL8, and VLDLR were more strongly expressed on day 14 than on day 7.
</text></passage></document><document><id>PMC-2677866-sec-12</id><passage><offset>0</offset><text>Nucleotide features of free-standing homing-endonucleases
Gene control elements were identified for several members of each type of intervening homing endonuclease genes described in this study. In 15 out of 16, 5' untranslated regions of the endonucleases we identified RNA hairpin structures upstream of initiation codons (Figures 1 and 4A). This may be a translational regulatory hairpin structure known from various phage genes, including homing endonucleases (22,47-49). The hairpins we found are in fractured gene loci with different protein host types, including gp41, IMPDH, DnaE, NrdJ and NrdA. Ten of these hairpins also include a conserved sequence of Aeh1 phage late promoter element (TATAAATA), which was recently shown to inhibit the translation of a gene-fracturing endonuclease gene, by sequestering its ribosome binding site (22,23). Analysis of the endonuclease 5' untranslated regions revealed two conserved motifs (Figures 4A and Supplementary Figure S4), which usually complement each other on the stem of the conserved hairpin structures. 
Figure 4.
Nucleotide features of endonuclease genes. (A) RNA hairpin structures at the 5' untranslated region of endonuclease ORFs in the gp41-1 (representing the very similar sequences of gp41-1-7), nrdA-5 and DnaE-1 gene loci. Initiator codons are marked by arrows, conserved putative T4 late promoter elements are boxed, and conserved sequence motifs (Supplementary Figure S4) are highlighted in grey. The expected values for motifs 1 and 2 are 1.7-10 and 9.9-3, respectively. RNA structures were calculated using the Vienna package (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi), and sequence motifs were identified using the MEME program. (B) Overlapping#protein coding regions of endonuclease 3' termini and the 5' termini of their downstream genes.
Additionally, 15 loci included an overlapping region of 6-69 bp between the coding regions of the probable endonuclease C-termini and the downstream N-termini of the split-intein part (Figures 1 and 4B). This overlap is present in both types of endonucleases, and is independent on the presence of a split-intein part in the fractured gene, also occurring in the putative sbcD DNA-repair gene that we found, as well as in the Aeh1 fractured nrdA found by Gibb and Edgell (22).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="820" length="8"></location><text>ribosome</text></annotation></passage></document><document><id>PMC-3009312-sec-10</id><passage><offset>0</offset><text>Refinement
The H-atoms were positioned geometrically (O-H = 0.82, C-H = 0.93 A) and were included in the refinement in the riding model approximation, with Uiso(H) = xUeq(C, O), where x = 1.2 for all H-atoms.
</text></passage></document><document><id>PMID-8911863</id><passage><offset>0</offset><text>Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
Previous studies have failed to explain the link between copper accumulation and abnormal caeruloplasmin expression in Wilson's disease. Furthermore, despite the isolation of a candidate gene for Wilson's disease, which predicts a defective copper transport protein, the localization of this putative protein and its relationship to the pathway involved in copper excretion and to caeruloplasmin remain unknown. We now present evidence that caeruloplasmin, the major plasma copper-carrying protein, is present in the liver in Wilson's disease, and thus that reduced circulating levels of the protein result from a post-translational defect in the secretory pathway. We have also identified a novel form of caeruloplasmin, molecular weight 125 kD, which we propose may act as the carrier for excretory copper into bile, since it is normally present in both liver and bile, although largely absent from serum, and undetectable in bile from Wilson's disease patients. The presence of this form of caeruloplasmin in Wilson's disease liver suggests that a related post-translational defect may also be responsible for its absence from bile in Wilson's disease. This study thus provides the first plausible explanation of a link between the defective copper excretion and the reduced plasma caeruloplasmin, which characterize Wilson's disease.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="985" length="5"></location><text>serum</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1012" length="4"></location><text>bile</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="897" length="4"></location><text>bile</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1362" length="6"></location><text>plasma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="950" length="4"></location><text>bile</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1214" length="4"></location><text>bile</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1113" length="5"></location><text>liver</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="551" length="6"></location><text>plasma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="940" length="5"></location><text>liver</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="601" length="5"></location><text>liver</text></annotation></passage></document><document><id>PMC-2960999-sec-02</id><passage><offset>0</offset><text>Experimental

</text></passage></document><document><id>PMID-20379054</id><passage><offset>0</offset><text>Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet.
AIM:
The aim of our work was to determine the influence of intestinal bacteria on the development of atherosclerotic lesions using apolipoprotein E (ApoE)-deficient knockout mice.
METHODS:
The experiments were performed on ApoE-/--deficient mouse strain C57BL/6, bred under germ-free (GF) conditions for two generations or under conventional conditions with defined microflora (CV). The mice were fed a standard low cholesterol diet or cholesterol-rich diet for 3-4 months. We studied the development of advanced lesions in the thoracic and abdominal aorta by histological, morphometric and immunohistological methods.
RESULTS:
Conventionally reared ApoE-/- mice (containing no pathogenic intestinal microbiota) and fed a standard low cholesterol diet in contrast to a high cholesterol diet did not develop atherosclerotic aortic plaques. In contrast, ApoE-/- mice reared under germfree conditions for 2 generations and fed a low cholesterol diet exhibited atherosclerotic plaques in the aorta. Characteristic lipid deposition with foam cells and macrophages was found in their arterial walls.
CONCLUSION:
In contrast to the absence of atherosclerotic plaques in conventionally reared ApoE-deficient mice, germ-free ApoE-/- mice consuming the same low cholesterol standard diet developed atherosclerotic plaques in the aorta. Differences in atherosclerotic plaques between GF and CV ApoE-/- mice are not so apparent when mice are fed a high cholesterol diet. Our findings thus document the protective effect of microbiota (commensal bacteria) on atherosclerosis development.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="648" length="7"></location><text>lesions</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="676" length="15"></location><text>abdominal aorta</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="663" length="8"></location><text>thoracic</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1092" length="23"></location><text>atherosclerotic plaques</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1172" length="5"></location><text>cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="942" length="30"></location><text>atherosclerotic aortic plaques</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1123" length="5"></location><text>aorta</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1271" length="23"></location><text>atherosclerotic plaques</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1423" length="23"></location><text>atherosclerotic plaques</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1454" length="5"></location><text>aorta</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1476" length="23"></location><text>atherosclerotic plaques</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1182" length="11"></location><text>macrophages</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="236" length="23"></location><text>atherosclerotic lesions</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1213" length="14"></location><text>arterial walls</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="194" length="10"></location><text>intestinal</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="824" length="10"></location><text>intestinal</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T2" role="Arg1"></node><node refid="T3" role="Arg2"></node></relation></passage></document><document><id>PMC-3195762-caption-11</id><passage><offset>0</offset><text>Classification result.
</text></passage></document><document><id>PMID-19679742</id><passage><offset>0</offset><text>Aging affects the cardiovascular responses to cold stress in humans.
Cardiovascular-related mortality peaks during cold winter months, particularly in older adults. Acute physiological responses, such as increases in blood pressure, in response to cold exposure may contribute to these associations. To determine whether the blood pressure-raising effect (pressor response) of non-internal body temperature-reducing cold stress is greater with age, we measured physiological responses to 20 min of superficial skin cooling, via water-perfused suit, in 12 younger [25 +/- 1 (SE) yr old] and 12 older (65 +/- 2 yr old) adults. We found that superficial skin cooling elicited an increase in blood pressure from resting levels (pressor response; P &lt; 0.05) in younger and older adults. However, the magnitude of this pressor response (systolic and mean blood pressure) was more than twofold higher in older adults (P &lt; 0.05 vs. younger adults). The magnitude of the pressor response was similar at peripheral (brachial) and central (estimated in the aorta) measurement sites. Regression analysis revealed that aortic pulse wave velocity, a measure of central arterial stiffness obtained before cooling, was the best predictor of the increased pressor response to superficial skin cooling in older adults, explaining approximately 63% of its variability. These results indicate that there is a greater pressor response to non-internal body temperature-reducing cold stress with age in humans that may be mediated by increased levels of central arterial stiffness.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="18" length="14"></location><text>cardiovascular</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="217" length="5"></location><text>blood</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="69" length="14"></location><text>Cardiovascular</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="651" length="4"></location><text>skin</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="688" length="5"></location><text>blood</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="325" length="5"></location><text>blood</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="510" length="4"></location><text>skin</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1105" length="6"></location><text>aortic</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1154" length="8"></location><text>arterial</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1270" length="4"></location><text>skin</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1538" length="8"></location><text>arterial</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1005" length="8"></location><text>brachial</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="848" length="5"></location><text>blood</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1045" length="5"></location><text>aorta</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="390" length="4"></location><text>body</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1429" length="4"></location><text>body</text></annotation></passage></document><document><id>PMC-2648768-caption-01</id><passage><offset>0</offset><text>Power (Y-axis) as a function of main effects (x-axis). For a pure main-effects model (x-axis = a1 &gt; 0; interaction effects a2 = a3 = 0 are all zero), Figure 1 shows that pattern (solid red line) and single-locus (broken blue line) approaches have virtually the same power.
</text></passage></document><document><id>PMID-19278385</id><passage><offset>0</offset><text>Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression.
BACKGROUND:
Perinatal depression is associated with potential negative consequences for the mother and infant, and therefore efforts to improve treatment access and efficacy are warranted. The purpose of this study was to examine pregnant women's preferences and attitudes about treatment for depression, and perceived potential barriers to accessing treatment.
METHODS:
Data were collected by means of a questionnaire from a convenience sample of 509 predominantly well-educated, high-income, married women in the northeastern United States during the last trimester of pregnancy. Participants were queried as to treatment modalities in which they would most likely participate if they wanted help for depression, their attitudes toward psychotherapeutic and pharmacological treatments, and perceived barriers to receiving help.
RESULTS:
Most women (92%) indicated that would likely participate in individual therapy if help was needed. Only 35 percent stated that they would likely take medication if recommended, and 14 percent indicated that they would participate in group therapy. The greatest perceived potential barriers to treatment were lack of time (65%), stigma (43%), and childcare issues (33%). Most women indicated a preference to receive mental health care at the obstetrics clinic, either from their obstetrics practitioner or from a mental health practitioner located at the clinic. Factors associated with acceptability of various depression treatments are presented.
CONCLUSIONS:
Understanding what prevents women from seeking or obtaining help for depression and determining what they prefer in the way of treatment may lead to improved depression treatment rates and hold promise for improving the overall health of childbearing women.
</text></passage></document><document><id>PMC-2847972-sec-01</id><passage><offset>0</offset><text>Background
Over the past decades, extensive comparative mapping research has been performed in the plant family Solanaceae. The recent identification of a large set of single-copy conserved orthologous (COSII) markers has greatly accelerated comparative mapping studies among major solanaceous species including tomato, potato, eggplant, pepper and diploid Nicotiana species (as well as tetraploid tobacco). The large amount of comparative data now available for these species provides the opportunity to describe the overall patterns of chromosomal evolution in this important plant family. The results of this investigation are described herein.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="538" length="11"></location><text>chromosomal</text></annotation></passage></document><document><id>PMC-2837610-sec-05</id><passage><offset>0</offset><text>1. Background
The United Republic of Tanzania, is among the many countries in sub-Saharan Africa facing a human resources crisis in its health sector, with a small and inequitably distributed health workforce [1] that shoulders a disproportionately high burden of disease[2]. Although all poor countries in the world face a severe human resource crisis in their health sectors [3,4], the problem is most acute in Sub-Saharan Africa, in which an estimated workforce of 750 000 health workers in the region serves 682 million people [2]. By comparison, the ratio is 10 to 15 times higher in developed countries. Moreover, this estimated workforce of doctors, nurses and allied health workers in Sub-Saharan Africa constitutes 1.3% of the world's health workforce, while Africa suffers from 25% of the world's burden of disease [2].
A minimum level of a health workforce of 2.5 health workers per 1000 people is required to achieve the Millennium Development Goals [5]. Africa is far from this level with a health workforce density that only averages 0.8 worker per 1000 people, while the world median density of health personnel is 5 per 1000 people [5].
There is a positive correlation between health worker density and various health indices, most notably infant mortality rate, maternal mortality rates, and various disease specific mortality and morbidity rates [6,7]. An increase in the number of health workers per capita is associated with a notable decline in the rates mentioned above. As a consequence, it has been argued that health worker shortages have impeded the implementation of development goals in many poor countries [8].

</text></passage></document><document><id>PMID-8939041</id><passage><offset>0</offset><text>Do we know how much people like one another?
Metaperception is a person's perception about a second person's perception of a third person. The purpose of this article is to examine the accuracy of metaperceptions of liking. A related question concerns whether the heuristics of balance, reciprocity, and agreement are used by perceivers when forming such judgments. The authors present analyses from 5 diverse research studies that used an adaptation of the social relations model for triads (C.F. Bond, E.M. Horn, &amp; D.A. Kenny, in press). The results indicate that people know how much people like one another, even with small amounts of information. Although there is evidence for the use of heuristics, particularly reciprocity and agreement, accuracy is sometimes enhanced by using these heuristics.
</text></passage></document><document><id>PMID-21617625</id><passage><offset>0</offset><text>Non-heart-beating organ donation in Italy.
In 2007 the non-heart-beating organ donation (NHBD) "Programma Alba" (Sunrise Programme) started in Pavia, Italy. The initial plan was to cut down waiting list for kidney transplantation, while its final aim is to shorten organ transplantation waiting lists. When compared to European countries and the USA, the Italian NHBD program has taken longer to get established. Initially Italian physicians were not entirely aware of the NHBD organ viability for transplantation, furthermore ethical issues and the need to regulate medical requirements to Italian law slowed down the NHBD program. In particular, Italian legislation provides for death ascertainment after irreversible cardiac arrest, 20-minute flat electrocardiogram. This no-touch period is longer when compared to worldwide legislation, and organ viability has been a main concern for Italian transplant doctors over the years. However, recent data let up to 40-minute warm ischemia time to preserve organ viability; this has encouraged Pavia's group to establish the NHBD "Programma Alba". It was designed according to Italian legislation from death diagnosis to graft placement, from this perspective must the significant role of the Transplant coordinator be recognized. Since 2007 seven kidneys have been gathered from seven NHBD. Of these, six NHBD kidneys have been transplanted. Currently, four patients are out of dialysis. This report is a detailed description of NHBD "Programma Alba" and its preliminary results.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="4" length="5"></location><text>heart</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="59" length="5"></location><text>heart</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="18" length="5"></location><text>organ</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="265" length="5"></location><text>organ</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="478" length="5"></location><text>organ</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="73" length="5"></location><text>organ</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="207" length="6"></location><text>kidney</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1295" length="7"></location><text>kidneys</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1358" length="7"></location><text>kidneys</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1004" length="5"></location><text>organ</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="845" length="5"></location><text>organ</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="720" length="7"></location><text>cardiac</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1168" length="5"></location><text>graft</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation></passage></document><document><id>PMC-2024775-sec-01</id><passage><offset>0</offset><text>Images
Fig. 1
Fig. 2
Fig. 3
</text></passage></document><document><id>PMC-3277246-caption-01</id><passage><offset>0</offset><text>Relative phage haplotype frequencies in PAO1 samples, (A) planktonic, (B) biofilm 4 days, (C) biofilm 11 days.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="74" length="7"></location><text>biofilm</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="94" length="7"></location><text>biofilm</text></annotation></passage></document><document><id>PMID-911696</id><passage><offset>0</offset><text>Some findings concerning beliefs about alcoholism.
The beliefs that alcoholics hold about alcoholism and themselves, and the beliefs that hospital staff and other personnel hold about alcoholism, were investigated using methods derived from the repertory grid, with anonymous facial photographs as elements. Data are presented as to the degree of association of various characteristics with alcoholism for the various groups. Differences between groups, and overall changes during group psychotherapy for patients were small. The relative contribution of personal and shared aspects of belief was measured. It was found that the agreement between groups was high and closely similar to that predictable from consistencies within groups. It is concluded that there may be a very general stereotype of alcoholism, consistent with a personality disorder concept which is implicitly held even in the face of nominal acceptance of other concepts. The self constructs of alcoholics were found to be complex. In a small follow-up study of patients, there was found to be a relationship of poor outcome with tightness of construing for key constructs after psychotherapy. The implications of the findings are discussed briefly.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="276" length="6"></location><text>facial</text></annotation></passage></document><document><id>PMC-3169771-sec-06</id><passage><offset>0</offset><text>Introduction
Hip fractures in the aged constitute a major health problem with substantial morbidity [1], mortality [2, 3], and, as the ageing population increases, an increasing burden on the health care system [4]. Fracture risk varies markedly between countries [5]. In a study by Kanis et al. [6], comparing 10-year probability of hip fracture, all countries except Norway had lower risk than Sweden. Other countries categorized at very high risk (&gt;75% of the risk of Sweden) were Iceland, Denmark and the US. At the age of 80, the estimated probability of sustaining a hip fracture the next 10 years is 8.6% and 17.7% in Norwegian men and women, respectively [7], and a report from the Norwegian capital Oslo calculated an overall annual fracture rate of 118.0 in women and 44.0 in men per 10,000 [8].
Several recent studies are reporting declining fracture incidence [9-14]. Although the Norwegian hip fracture rates remain the highest reported in the world, data from Oslo in 1996-1997 indicated no increasing incidence rates compared to the 1988-1989 [8].Within Norway, considerable geographic differences have been reported, with substantially lower rates in smaller cities and rural areas compared to Oslo [7, 15]. However, these are reports based on sporadic studies in few regions and in limited time periods [16, 17].
From 1985 to 2003, the Norwegian Institute of Public Health commissioned four Norwegian hospitals, representing 10% of the population, to run a national injury registry [18]. The registry collected a variety of data connected to the actual injury itself and the event leading to the injury. In the city of Harstad in Northern Norway, the registration continued and has been running for more than 23 years. Throughout the years of the National Injury Registry, the injury rates in Harstad closely resembled the rates of the national registry [18]. With reference to the recent reports suggesting stabilizing hip fracture incidence internationally as well as nationally, and regional differences within Norway, we have used the hip fracture data in the Harstad Injury Registry to: 
Describe age- and sex-specific incidence of hip fractures in Harstad, Northern Norway and make comparison with rates from the Norwegian capital Oslo
Describe time trends in hip fracture incidence in Harstad from 1994 to 2008
Describe place of injury and seasonal variations in hip fracture incidence in Harstad
Compare 3-month, 6-month, and 1-year mortality after hip fracture between women and men in Harstad
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2056" length="3"></location><text>hip</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2154" length="3"></location><text>hip</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="903" length="3"></location><text>hip</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2474" length="3"></location><text>hip</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1937" length="3"></location><text>hip</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2283" length="3"></location><text>hip</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2387" length="3"></location><text>hip</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="13" length="3"></location><text>Hip</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="573" length="3"></location><text>hip</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="334" length="3"></location><text>hip</text></annotation></passage></document><document><id>PMC-2993105-caption-03</id><passage><offset>0</offset><text>The thickness of the inner retina was established as the distance between retinal nerve fiber layer and inner nuclear layer and was measured using the 1,000 mum caliper available in the OCT-SLO Spectralis. Ten age-matched normal eyes were used as controls. Observe the decrease in the nasal and temporal inner retinal thickness in the right eye in comparison to the left and normal control eyes.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="341" length="3"></location><text>eye</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="390" length="4"></location><text>eyes</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="229" length="4"></location><text>eyes</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="304" length="13"></location><text>inner retinal</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="285" length="5"></location><text>nasal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="21" length="12"></location><text>inner retina</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="104" length="19"></location><text>inner nuclear layer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="74" length="25"></location><text>retinal nerve fiber layer</text></annotation></passage></document><document><id>PMID-12268797</id><passage><offset>0</offset><text>Male role in fertility decisions in Robertsport, Liberia: an experimental exercise for policy formulation.
There is a tendency to believe that in African societies men are the dominant decision makers in the family.  In Robertsport, Liberia, there are indications that, with respect to fertility regulation, the dominance of the husband in fertility decisions exists, but it is also apparent that many of these decisions are made jointly by both husband and wife.  Education is particularly influential in the joint fertility decision-making process.  The 100 husbands sampled in 1982 desired a large number of children and had experience with infant and child mortality.  If family planning programs should attain their goals, men should be more involved, than at present, in every aspect of the programs.  Equally important is the urgency for studies related to the role of men in fertility regulation, using adequately large samples.
</text></passage></document><document><id>PMC-2039847-sec-08</id><passage><offset>0</offset><text>Miscellaneous Proteins
Apart from the above-described proteins, several other molecules are also associated with the pathological lesions of AD, and some of these can be regarded as amateur chaperones. Acute phase proteins, such as alpha1-antichymotrypsin (ACT), alpha2-macroglobulin (alpha2M), and SAP, are all associated with Abeta deposition [129-132]. ACT is a serine protease inhibitor of the serpin family, and in AD, ACT levels are upregulated, and binding of ACT with Abeta induces Abeta fibrillogenesis [133-135]. Furthermore, when ACT is overexpressed in transgenic mice, an increased plaque load in the brains of these mice and impaired spatial learning is observed [134, 135]. alpha2M also binds Abeta, although in contrast to ACT, this binding prevents Abeta fibril formation and fibril-associated neurotoxicity [136, 137]. alpha2M promotes the protease-mediated degradation of alpha2M/Abeta complexes and contributes to clearance of Abeta from the brain (discussed in paragraph 4) [138, 139]. The glycoprotein SAP belongs to the pentraxin family and is a common component of all known types of amyloid fibrils. SAP is upregulated in AD and protects amyloid fibrils from proteolysis in vitro [140, 141]. SAP not only colocalizes with SPs and interacts with aggregated Abeta; SAP oligomers also bind and activate C1 [142]. Both C1 and SAP may bind to fibrillar Abeta deposits in vivo and induce microglial activation, as cultured human microglial cells show an increase in cytokine production after co-stimulation of Abeta with C1q and SAP [104]. These observations further strengthen the above-noted suggestion that not only Abeta, but also several Abeta-binding proteins, are capable of activating the complement system, and thus, contribute to neuroinflammation in AD. In addition, both alpha2M and ACT, in contrast to SAP, can be regarded as amateur chaperones, as they regulate conformational changes of Abeta.
Tissue-type plasminogen activator (tPA) regulates activation of plasminogen into plasmin and is expressed in various regions of the brain especially in the hippocampus [143]. Several reports suggested an important role for tPA in AD, as the tPA system is involved in Abeta turnover [144, 145]. Fibrillar forms of Abeta stimulate tPA activity in vitro, whereas in AD patients, a reduction of tPA activity is observed in the affected areas [144, 146]. Although tPA has no effect on conformational changes of Abeta, it might play a role in the clearance of Abeta from the brain (paragraph 4].
The actin-regulatory protein gelsolin is found both intracellularly and in plasma [147, 148]. Plasma gelsolin can be considered an amateur chaperone, as it binds Abeta and not only inhibits its Abeta fibrillization but is also capable of degrading preformed Abeta fibrils [149, 150]. Furthermore, gelsolin inhibits Abeta-mediated neurotoxicity [151].
One of the major gangliosides in the brain is GM1. Soluble Abeta binds GM1 and the formed complexes accelerate Abeta fibrillogenesis by acting as a seed for Abeta [152]. In the presence of GM1, Abeta is more neurotoxic than Abeta alone, and cholesterol-rich membranes demonstrate accelerated Abeta binding due to the formation of GM1 clusters [153, 154]. As GM1 is a major component of lipid rafts and recent studies suggest that Abeta accumulation in these lipid rafts is an early event in AD development, GM1 might play an important role in the early steps in AD pathogenesis [155, 156].
In summary, several proteins are associated with Abeta aggregates in the AD brain and contribute to the aggregation of Abeta and should, therefore, be considered as amateur chaperones. In addition, they might play a role in triggering inflammation.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="117" length="20"></location><text>pathological lesions</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="962" length="5"></location><text>brain</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="772" length="6"></location><text>fibril</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1363" length="9"></location><text>fibrillar</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1407" length="10"></location><text>microglial</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1108" length="15"></location><text>amyloid fibrils</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1163" length="15"></location><text>amyloid fibrils</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2084" length="11"></location><text>hippocampus</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2222" length="9"></location><text>Fibrillar</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2497" length="5"></location><text>brain</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2575" length="10"></location><text>cellularly</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1448" length="16"></location><text>microglial cells</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2593" length="6"></location><text>plasma</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2060" length="5"></location><text>brain</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2612" length="6"></location><text>Plasma</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2782" length="7"></location><text>fibrils</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="595" length="6"></location><text>plaque</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3127" length="9"></location><text>membranes</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="614" length="6"></location><text>brains</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2906" length="5"></location><text>brain</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3255" length="11"></location><text>lipid rafts</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3327" length="11"></location><text>lipid rafts</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="3532" length="8"></location><text>AD brain</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T20" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T19" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T21" role=""></node></relation></passage></document><document><id>PMID-9669536</id><passage><offset>0</offset><text>Antisocial patients: a comparison of those with and those without childhood conduct disorder.
The purpose of this study was to compare persons with antisocial personality disorder (ASP) with those who meet the adult criteria for ASP but fail to meet the criteria for childhood conduct disorder. Sociodemographic data, medical history, and psychiatric symptoms exhibited during a recent hospital admission were compared in the two groups by chart review. The two groups were virtually indistinguishable, except that patients without childhood conduct disorder were less likely to smoke or consume alcohol, were less likely to have spent time in a training school/boot camp as a child or adolescent, were less likely to have been admitted for a recent suicide attempt, and were less likely to have conned others. We conclude that persons meeting the adult criteria for ASP but not the childhood conduct disorder criteria essentially suffer the same disorder as those who meet full ASP criteria but are less severely affected.
</text></passage></document><document><id>PMC-3143519-caption-01</id><passage><offset>0</offset><text>Paederus dermatitis involving the neck
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="34" length="4"></location><text>neck</text></annotation></passage></document><document><id>PMID-20345577</id><passage><offset>0</offset><text>Comment on "Why reduced-form regression models of health effects versus exposures should not replace QRA: livestock production and infant mortality as an example," by Louis Anthony (Tony) Cox, Jr., Risk Analysis 2009, Vol. 29, No. 12.
While a recent paper by Cox in this journal uses as its motivating factor the benefits of quantitative risk assessment, its content is entirely devoted to critiquing Sneeringer's article in the American Journal of Agricultural Economics. Cox's two main critiques of Sneeringer are fundamentally flawed and misrepresent the original article. Cox posits that Sneeringer did A and B, and then argues why A and B are incorrect. However, Sneeringer in fact did C and D; thus critiques of A and B are not applicable to Sneeringer's analysis.
</text></passage></document><document><id>PMID-18995207</id><passage><offset>0</offset><text>Atypical mycobacteriosis of the larynx: an unusual clinical presentation secondary to steroids inhalation.
Vocal cords stiffness can be associated with a variety of etiologic agents, but it is rarely seen with atypical mycobacteria, for example, Mycobacterium avium complex. We report a case of a 35-year-old white woman who is and was maintained on inhaled steroids. She presented with hoarseness and low-grade fever, but her medical history was otherwise unremarkable. Laryngoscopy revealed bilateral scarring of the vocal cords. Vocal cord biopsies were performed. Histologic examination revealed unremarkable laryngeal mucosa, except for abundant subepithelial non-necrotizing granulomata. The differential diagnosis included sarcoid, Klebsiella scleroma, and tuberculosis. Special stains reviewed abundant acid-fast bacilli, later confirmed by a DNA assay on induced deep sputum, consistent with M avium complex. Subsequently, steroids were withdrawn, and the patient was treated with a multiple-drug antituberculous regimen and had a full recovery. This unusual clinical presentation of the atypical mycobacteriosis may be encountered by otolaryngologists and pathologists, and it is critical to recognize it in patients immunocompromised because of steroids.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="730" length="7"></location><text>sarcoid</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="739" length="19"></location><text>Klebsiella scleroma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="613" length="16"></location><text>laryngeal mucosa</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="651" length="41"></location><text>subepithelial non-necrotizing granulomata</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="877" length="6"></location><text>sputum</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="32" length="6"></location><text>larynx</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="532" length="10"></location><text>Vocal cord</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="519" length="11"></location><text>vocal cords</text></annotation></passage></document><document><id>PMID-21283795</id><passage><offset>0</offset><text>Dissecting genetic networks underlying complex phenotypes: the theoretical framework.
Great progress has been made in genetic dissection of quantitative trait variation during the past two decades, but many studies still reveal only a small fraction of quantitative trait loci (QTLs), and epistasis remains elusive. We integrate contemporary knowledge of signal transduction pathways with principles of quantitative and population genetics to characterize genetic networks underlying complex traits, using a model founded upon one-way functional dependency of downstream genes on upstream regulators (the principle of hierarchy) and mutual functional dependency among related genes (functional genetic units, FGU). Both simulated and real data suggest that complementary epistasis contributes greatly to quantitative trait variation, and obscures the phenotypic effects of many 'downstream' loci in pathways. The mathematical relationships between the main effects and epistatic effects of genes acting at different levels of signaling pathways were established using the quantitative and population genetic parameters. Both loss of function and "co-adapted" gene complexes formed by multiple alleles with differentiated functions (effects) are predicted to be frequent types of allelic diversity at loci that contribute to the genetic variation of complex traits in populations. Downstream FGUs appear to be more vulnerable to loss of function than their upstream regulators, but this vulnerability is apparently compensated by different FGUs of similar functions. Other predictions from the model may account for puzzling results regarding responses to selection, genotype by environment interaction, and the genetic basis of heterosis.
</text></passage></document><document><id>PMID-6330210</id><passage><offset>0</offset><text>Oesophageal candidiasis and croup in a child with defective neutrophil motility.
Severe oesophageal candidiasis and croup due to involvement of the larynx developed insidiously in a girl aged 20 months. There had been delayed separation of the umbilical cord and repeated infections associated with a defect of neutrophil motility. The significance of the early clinical features was not fully appreciated and the diagnosis considered only when stricture of the oesophagus became evident. She was treated with oral ketoconazole 100 mg daily. After one month's treatment there was striking radiological improvement apart from the persistence of the oesophageal stricture. The croup resolved completely but there was only partial relief of dysphagia because of the residual stricture. We would emphasis that candidiasis should be anticipated and treated vigorously in children with such a defect of neutrophil motility.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="462" length="10"></location><text>oesophagus</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="648" length="11"></location><text>oesophageal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="148" length="6"></location><text>larynx</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="311" length="10"></location><text>neutrophil</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="897" length="10"></location><text>neutrophil</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="0" length="11"></location><text>Oesophageal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="88" length="11"></location><text>oesophageal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="60" length="10"></location><text>neutrophil</text></annotation></passage></document><document><id>PMID-2512762</id><passage><offset>0</offset><text>Gastric microcirculatory change and development of acute gastric mucosal lesions (stress ulcer).
Concerning the pathogenesis of acute gastric mucosal lesions, gastric microcirculatory change has drawn attention as an important factor. In view of this fact, gastric mucosal blood flow and microvascular structure were investigated in normal and in burn stressed rats. Moreover, alterations in acid and pepsin activities in by morphological and biochemical procedures in order to evaluate the relationship between defensive and aggressive factors of the gastric mucosa. Gastric mucosal blood flow decreased significantly in early period after induction of stress (p less than 0.01). The incidence of ulceration showed a correlative relation with the decrease of mucosal blood flow. Reduction of blood flow in burn was due to opening of arteriovenular shunt and it appeared that this was responsible for mucosal ischemia and congestion. Following the decrease of blood flow, acid output was lower in stress than that in control. Finally, the results of these studies demonstrated the importance of defensive factors. The reduction of mucosal blood flow resulted in the sequence of events that led to formation of acute gastric mucosal lesion.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="0" length="7"></location><text>Gastric</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="82" length="12"></location><text>stress ulcer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="57" length="23"></location><text>gastric mucosal lesions</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="257" length="15"></location><text>gastric mucosal</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="273" length="5"></location><text>blood</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="134" length="23"></location><text>gastric mucosal lesions</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="159" length="7"></location><text>gastric</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="568" length="15"></location><text>Gastric mucosal</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="584" length="5"></location><text>blood</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="760" length="7"></location><text>mucosal</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="768" length="5"></location><text>blood</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="288" length="13"></location><text>microvascular</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="793" length="5"></location><text>blood</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="552" length="14"></location><text>gastric mucosa</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="834" length="14"></location><text>arteriovenular</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="901" length="7"></location><text>mucosal</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="960" length="5"></location><text>blood</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1131" length="7"></location><text>mucosal</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1139" length="5"></location><text>blood</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1216" length="22"></location><text>gastric mucosal lesion</text></annotation></passage></document><document><id>PMC-2700800-sec-02</id><passage><offset>0</offset><text>Results
In the established adult rat NSC culture, FGF-2 promotes self-renewal by increasing proliferation and inhibiting spontaneous differentiation of adult NSCs, accompanied with activation of MAPK and PLC pathways. Using a molecular genetic approach, we demonstrate that activation of FGF receptor 1 (FGFR1), largely through two key cytoplasmic amino acid residues that are linked to MAPK and PLC activation, suffices to promote adult NSC self-renewal. The canonical MAPK, Erk1/2 activation, is both required and sufficient for the NSC expansion and anti-differentiation effects of FGF-2. In contrast, PLC activation is integral to the maintenance of adult NSC characteristics, including the full capacity for neuronal and oligodendroglial differentiation.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="660" length="3"></location><text>NSC</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="713" length="8"></location><text>neuronal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="438" length="3"></location><text>NSC</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="535" length="3"></location><text>NSC</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="726" length="16"></location><text>oligodendroglial</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="37" length="3"></location><text>NSC</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="336" length="11"></location><text>cytoplasmic</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="158" length="4"></location><text>NSCs</text></annotation></passage></document><document><id>PMID-19752254</id><passage><offset>0</offset><text>Magnesium for treatment of asthma in children.
QUESTION: Magnesium is considered adjuvant therapy for moderate to severe asthma exacerbations in adults, but can it be used to treat children? ANSWER: Magnesium seems to be beneficial in the treatment of moderate to severe asthma in children. It is a safe drug to administer, but there have been minor side effects reported, such as epigastric or facial warmth, flushing, pain and numbness at the infusion site, dry mouth, malaise, and hypotension. Owing to its bronchodilating and anti-inflammatory effects, magnesium is an encouraging adjuvant therapy for pediatric patients who do not respond to conventional treatment in acute severe exacerbations. Future studies should focus on establishing the optimal dosage for maximal benefits and the best route of administration. Magnesium should also be considered as a prophylactic treatment.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="381" length="10"></location><text>epigastric</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="464" length="5"></location><text>mouth</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="395" length="6"></location><text>facial</text></annotation></passage></document><document><id>PMC-2959025-sec-14</id><passage><offset>0</offset><text>Histology of the lung
The left lung was fixed by gentle infusion of fixative (4% paraformaldehyde) through the tracheal cannula [24]. After excision, the lung was immersed in a fresh fixative for 2 h. The lung lobe was embedded in paraffin and cut into 3 mum transverse sections, followed by immunohistochemical and chemical staining. Photomicrographs were captured using KS400 image analyze platform (Zeiss, Oberkochen, Germany) and analyzed quantitatively.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="154" length="4"></location><text>lung</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="205" length="9"></location><text>lung lobe</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="17" length="4"></location><text>lung</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="111" length="8"></location><text>tracheal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="31" length="4"></location><text>lung</text></annotation></passage></document><document><id>PMID-10597602</id><passage><offset>0</offset><text>Spacing effects on the memory for faces.
25 undergraduate women studied 12 stimulus pictures of female faces successively presented in spaced or massed conditions and made affective judgments for the pictures along a dimension of like to dislike. One week after the exposure (study) period, subjects were given an identification test comprised of photographs of the same female faces with different expressions. Analysis showed that the pictures presented in the spaced condition were more frequently and accurately identified than those presented under the massed condition and that affective judgment was unrelated to conditions of presentation.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="34" length="5"></location><text>faces</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="378" length="5"></location><text>faces</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="103" length="5"></location><text>faces</text></annotation></passage></document><document><id>PMC-3124045-caption-01</id><passage><offset>0</offset><text>Parkin regulates the proteasomal degradation of PARIS and PGC-1alpha-dependent mitochondrial biogenesis. (A) Normal physiological conditions that maintain mitochondrial homeostasis: PINK1 recruits parkin to the mitochondria, where these two proteins interact to eliminate abnormal mitochondria through mitophagy. Alterations in mitochondrial membrane potential (DeltaPsim; a key indicator of mitochondrial physiology and cell viability) initiate the PINK1-parkin cascade of events that lead to mitophagy. Furthermore, parkin ubiquitylates and thereby promotes proteasomal degradation of PARIS. Because PARIS represses the expression of PGC-1alpha, degradation of PARIS by parkin allows PGC-1alpha-dependent gene expression and enables mitochondrial biogenesis. Parkin seems to be an integral regulator of mitochondrial homeostasis, controlling both degradation and biogenesis. (B) Loss of parkin function as a result of familial mutations (in the case of AR-PD) or aging, environmental or cellular stress (in the case of sporadic PD) leads to the accumulation of abnormal mitochondria, owing to faulty mitophagy. In addition, PARIS accumulates and represses PGC-1alpha, preventing mitochondrial biogenesis. Loss of parkin function does not tip the balance between mitochondrial biogenesis and degradation to either side, but leads to a general breakdown of mitochondrial homeostasis that can ultimately lead to PD.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="21" length="11"></location><text>proteasomal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="155" length="13"></location><text>mitochondrial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="79" length="13"></location><text>mitochondrial</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="328" length="22"></location><text>mitochondrial membrane</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="560" length="11"></location><text>proteasomal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="211" length="12"></location><text>mitochondria</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="281" length="12"></location><text>mitochondria</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="989" length="8"></location><text>cellular</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1072" length="12"></location><text>mitochondria</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1181" length="13"></location><text>mitochondrial</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1264" length="13"></location><text>mitochondrial</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="735" length="13"></location><text>mitochondrial</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1357" length="13"></location><text>mitochondrial</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="805" length="13"></location><text>mitochondrial</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="392" length="13"></location><text>mitochondrial</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="421" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMC-3248852-sec-15</id><passage><offset>0</offset><text>Cation binding to yolk platelet phosvitin
In addition to non-heme iron [23], yolk phosvitin also contains Ca2+, Mg2+, Na+ and K+ [11]. Partially relaxed 23Na Fourier transform NMR spectra revealed the existence of at least two major intracellular compartments of NMR-visible Na+ [35]. A large fraction of the Rana oocyte Na+ was NMR-invisible and could be recovered in the yolk platelets [35]. During the first meiotic division there is a net increase in NMR-visible Na+; by completion of the second meiotic division (following fertilization), about 70% of the total Na+ becomes NMR-visible. Thus, phosvitin not only serves as a site for energy storage, but also as a storage site for iron and other ions essential for embryonic development in ponds and streams that contain little dissolved salts and minerals.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="233" length="26"></location><text>intracellular compartments</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="373" length="14"></location><text>yolk platelets</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="719" length="9"></location><text>embryonic</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="18" length="13"></location><text>yolk platelet</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="314" length="6"></location><text>oocyte</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="77" length="4"></location><text>yolk</text></annotation></passage></document><document><id>PMID-15528872</id><passage><offset>0</offset><text>Thiazole orange positive platelets in a dog with Evans' syndrome.
We examined transition for the percentage of reticulated platelets (RP%) and platelet count in a canine case of Evans' syndrome. The result demonstrated that measurement of the RP% can be useful in evaluating platelet production in the bone marrow and response to treatment.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="275" length="8"></location><text>platelet</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="302" length="11"></location><text>bone marrow</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="143" length="8"></location><text>platelet</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="243" length="2"></location><text>RP</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="25" length="9"></location><text>platelets</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="134" length="2"></location><text>RP</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="111" length="21"></location><text>reticulated platelets</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T2" role=""></node><node refid="T3" role=""></node></relation></passage></document><document><id>PMID-12884381</id><passage><offset>0</offset><text>Stereoselective synthesis of 1-aminoalkanephosphonic acids with two chiral centers and their activity towards leucine aminopeptidase.
The stereoselective synthesis of 1-amino-2-alkylalkanephosphonic acids, namely, compounds bearing two chiral centers, was achieved by the condensation of hypophosphorous acid salts of (R)(+) or (S)(-)-N-alpha-methylbenzylamine with the appropriate aldehydes in isopropanol. Simultaneous deprotection and oxidation by the action of bromine water provided equimolar mixtures of the RS:RR and SR:SS diastereomers of desired acids. They appeared to act as moderate inhibitors of kidney leucine aminopeptidase with potency dependent on the absolute configuration of both centers of chirality.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="609" length="6"></location><text>kidney</text></annotation></passage></document><document><id>PMID-16650140</id><passage><offset>0</offset><text>The ictal bradycardia syndrome: localization and lateralization.
PURPOSE:
Previous studies have established the importance of the insular cortex and temporal lobe in cardiovascular autonomic modulation. Some investigators, based on the results of cortical stimulation response, functional imaging, EEG recordings of seizures, and lesional studies, have suggested that cardiac sympathetic and parasympathetic function may be lateralized, with sympathetic representation lateralized to the right insula, and parasympathetic, to the left. These studies have suggested that ictal bradycardia is most commonly a manifestation of activation of the left temporal and insular cortex. However, the evidence for this is inconsistent. We sought to assess critically the predictable value of ictal bradycardia for seizure localization and lateralization.
METHODS:
In this study, we reviewed the localization of seizure activity in 13 consecutive patients with ictal bradycardia diagnosed during prolonged video-EEG monitoring at Mayo Clinic Rochester. The localization of electrographic seizure activity at seizure onset and bradycardia onset was identified in all patients. In addition, we performed a comprehensive review of the ictal bradycardia literature focusing on localization of seizure activity in ictal bradycardia cases.
RESULTS:
All occurrences of ictal bradycardia in the 13 identified patients were associated with temporal lobe-onset seizures. However, no consistent lateralization of seizure activity was found at onset of seizure activity or at onset of bradycardia in this population. Seizure activity was bilateral at bradycardia onset in nine of 13 patients. The results from the literature review also showed that a predominance of patients had bilateral activity at bradycardia onset; however, more of the ictal bradycardia cases from the literature had left hemispheric localization of seizure onset.
CONCLUSIONS:
Ictal bradycardia most often occurs in association with bilateral hemispheric seizure activity and is not a consistent lateralizing sign in localizing seizure onset. Our data do not support the existence of a strictly unilateral parasympathetic cardiomotor representation in the left hemisphere, as has been suggested.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="642" length="13"></location><text>left temporal</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="660" length="14"></location><text>insular cortex</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="488" length="12"></location><text>right insula</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="368" length="7"></location><text>cardiac</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="530" length="4"></location><text>left</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="166" length="14"></location><text>cardiovascular</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1865" length="16"></location><text>left hemispheric</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="130" length="14"></location><text>insular cortex</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="247" length="8"></location><text>cortical</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="149" length="13"></location><text>temporal lobe</text></annotation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T7" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T5" role="Arg1"></node><node refid="T4" role="Arg2"></node></relation></passage></document><document><id>PMID-10823148</id><passage><offset>0</offset><text>Application of microsatellite PCR techniques in the identification of mixed up tissue specimens in surgical pathology.
A fragment of tumour was erroneously mixed up with an endometrial biopsy. Micro-satellite polymerase chain reaction (PCR) clearly demonstrated the extraneous nature of the fragment. Micro-satellite PCR may be useful for the identification of mis-labelled or mismatched tissue fragments in surgical pathology specimens.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="121" length="8"></location><text>fragment</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="291" length="8"></location><text>fragment</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="427" length="9"></location><text>specimens</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="173" length="18"></location><text>endometrial biopsy</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="79" length="16"></location><text>tissue specimens</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="388" length="16"></location><text>tissue fragments</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="133" length="6"></location><text>tumour</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation></passage></document><document><id>PMID-11736312</id><passage><offset>0</offset><text>Renormalization group analysis of autoregressive processes and fractional noise.
A renormalization group analysis is applied to autoregressive processes with an infinite series of coefficients. A simple fixed point is given by a random walk, and a second class is found that is proportional to the high order coefficients of fractional autoregressive integrated moving average (ARIMA) processes. The approach might be useful to detect nonstationarity in autoregressive processes.
</text></passage></document><document><id>PMC-2790131-sec-02</id><passage><offset>0</offset><text>Subjects and Methods
ABPM was conducted for 60 selected patients who had visited Sunlin Hospital between January 2008 and August 2008. Patients were classified into 3 groups; an obese group whose body mass index (BMI) was &gt; the 95th percentile, an overweight group whose BMI was &gt; the 85th percentile but less than the 95th percentile, and a normal group whose BMI was below the 85th percentile. Overall mean BP, day and night BP and BP load were measured by ABPM.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="196" length="4"></location><text>body</text></annotation></passage></document><document><id>PMC-59891-sec-03</id><passage><offset>0</offset><text>Conclusion
Artificial addition of siderophores and HSLs may be a possible method to aid in the identification and isolation of marine bacterial species which are thought to be unknown.
</text></passage></document><document><id>PMID-20116961</id><passage><offset>0</offset><text>A randomized pilot study of the Engaging Moms Program for family drug court.
In response to the need for effective drug court interventions, the effectiveness of the Engaging Moms Program (EMP) versus Intensive Case Management Services (ICMS) on multiple outcomes for mothers enrolled in family drug court was investigated. In this intent-to-treat study, mothers (N = 62) were randomly assigned to either usual drug court care or the Engaging Moms drug court program. Mothers were assessed at intake and 3, 6, 12, and 18 months following intake. Results indicated that at 18 months post drug court enrollment, 77% of mothers assigned to EMP versus 55% of mothers assigned to ICMS had positive child welfare dispositions. There were statistically significant time effects for both intervention groups on multiple outcomes including substance use, mental health, parenting practices, and family functioning. EMP showed equal or better improvement than ICMS on all outcomes. The results suggest that EMP in family drug court is a viable and promising intervention approach to reduce maternal addiction and child maltreatment.
</text></passage></document><document><id>PMID-2211345</id><passage><offset>0</offset><text>Absence of antisperm antibodies in anejaculatory men.
Antisperm antibodies were assessed in the serum samples of 73 men unable to ejaculate naturally and on the sperm cells of 13 of these men. None of the serum samples were found to be positive by sperm agglutination or sperm immobilization methods and antibodies were detected by an immunobead assay on the sperm cells of one of the 13 men examined.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="359" length="11"></location><text>sperm cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="248" length="5"></location><text>sperm</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="271" length="5"></location><text>sperm</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="96" length="13"></location><text>serum samples</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="205" length="13"></location><text>serum samples</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="161" length="11"></location><text>sperm cells</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMC-2171703-sec-06</id><passage><offset>0</offset><text>Immunocytochemistry
C2C12 cells grown in 8-chamber slides (Nunc) were fixed in 4% PFA/PBS for 10 min and permeabilized in 0.1% Triton X-100 for 20 min. In some cases, they were fixed and permeabilized in methanol at -20degreesC for 2 min. The fixed and permeabilized cells were blocked in PBS containing 3% BSA (Jackson ImmunoResearch Laboratories) and incubated overnight at 4degreesC with primary antibodies in blocking solution. Immunoreactivity was detected with either Alexa-conjugated secondary antibody (Molecular Probes) or a combination of biotin-conjugated secondary antibody (Vector Laboratories) and Alexa-conjugated streptavidin (Molecular Probes).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="20" length="11"></location><text>C2C12 cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="267" length="5"></location><text>cells</text></annotation></passage></document><document><id>PMC-2946364-caption-05</id><passage><offset>0</offset><text>Effect of the deletion of IRE1alpha on the liver.
(A) HE-stained sections of the liver tissue (scale bar: 50 mum). (B) Comparison of the serum AST and ALT levels between the IRE1alpha CKO mice and the control mice. Data are expressed as mean +/- S.E.M (n = 5). (C) Quantitative PCR analysis of lipid synthesis genes in the liver of mice fed normal or high-fructose feed. Columns indicate mean and error bars denote S.E.M (n = 3). All the data were obtained from 20 weeks old male mice.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="137" length="5"></location><text>serum</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="323" length="5"></location><text>liver</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="43" length="5"></location><text>liver</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="65" length="8"></location><text>sections</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="81" length="12"></location><text>liver tissue</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T3" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation></passage></document><document><id>PMC-1160588-sec-11</id><passage><offset>0</offset><text>Planning for the Future: Disaster Preparedness and Mitigation
It is often believed that casualties from natural disasters are unavoidable, but this belief is false [8]. There are many measures that can reduce morbidity and mortality following large and potentially catastrophic flooding events [19].
Early warning of impending floods and natural events such as hurricanes allows sufficient time for communities to be evacuated to safe areas. Although Florida experienced one of the worst hurricane seasons on record in 2004, the number of fatalities was lower than expected because of early warning and evacuation. Early warning also provides sufficient time to prepare when evacuation is not possible. Hurricane George in 1998 caused widespread damage and several fatalities in the Dominican Republic, where residents were not warned. In contrast, Cuba and Puerto Rico experienced relatively limited damage and loss of life, because preparations were made in the hours before the storm.
Disaster preparedness can also be developed for communities that are regularly exposed to flooding disasters. Cyclone shelters built by the Red Cross in Orissa, India, saved many thousands of lives in 1999 when two cyclones struck. In the region of the Americas, the Pan American Health Organization has spent many years promoting and integrating disaster preparedness into building health facilities to ensure that medical services needed to treat victims and maintain ongoing care for patients with chronic conditions will not be disrupted by disasters.
A recent global-scale review of health risks from flooding highlights that in flood-prone areas, disaster preparedness within the health system as a whole is particularly important [20]. In addition to infrastructure and early-warning systems, another key element in disaster preparedness is education and raising awareness about disaster risks and response plans. Had there been greater awareness about the risk of tsunamis, perhaps many lives could have been saved in the South Asian disaster in December 2004.
</text></passage></document><document><id>PMC-2793023-sec-09</id><passage><offset>0</offset><text>Follow-up
Patients were followed up at the outpatient clinic at 1, 4, and 7 months after the ablation procedure and every 6 months thereafter. Routine 24 or 48 h Holter monitoring was performed before each appointment, and a 12-lead electrocardiogram was obtained at each visit. Patients were asked to report to the emergency room or our arrhythmia unit for an ECG if any symptom suggestive of recurrence occurred between scheduled visits.
After the ablation procedure, all patients received anti-arrhythmic treatment for at least 1 month to protect against early recurrences and continued oral anticoagulation for a minimum of 2 months to maintain an international normalized ratio between 2.0 and 3.0. Additionally, magnetic resonance angiography was repeated at 3-6 months after the procedure to evaluate the presence of PV stenosis.
Arrhythmia recurrence was defined as a documented AF or atrial flutter episode of &gt;30 s. Arrhythmic episodes within the first 3 months after the CPVA (healing period) were not considered in the evaluation of final success rates because they are often described as transient recurrences related to atrial inflammatory processes following RF lesions.26
The endpoint of the study was freedom from arrhythmia recurrence after a single CPVA procedure, without anti-arrhythmic medication.
A minimum follow-up of 3 months was required.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="893" length="6"></location><text>atrial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1134" length="6"></location><text>atrial</text></annotation></passage></document><document><id>PMC-2889408-caption-02</id><passage><offset>0</offset><text>The eukaryotic parasite Trypanosoma brucei is able to import inositol from the environment or synthesize it de novo. However, according to the current model, inositol imported from the environment is utilized primarily in bulk phosphatidylinositol (red and yellow phospholipid) production via a phosphatidylinositol synthase (PIS) localized to the Golgi complex. Inositol synthesized de novo is primarily used to generate phosphatidylinositol that is used for production of glycosylphosphatidylinositols (GPIs). The de novo-synthesized inositol is believed to be utilized mostly for GPI production because the IMPase that dephosphorylates inositol 3-phosphate to inositol is localized to the ER, where GPI synthesis occurs. Mutants lacking TbINO1 are inviable because of diminished GPI production.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="348" length="13"></location><text>Golgi complex</text></annotation></passage></document><document><id>PMC-2493521-sec-21</id><passage><offset>0</offset><text>Study of freeze-thaw effects and CSF pH on tissue RNA integrity
We have long suspected, on the basis of our tissue banking experience, that most of the molecular degradation that occurs in banked tissue is due to repeated freeze-thaw cycles, which occur due to improper handling during dissection for tissue retrieval or due to freezer malfunctions. Our freezers are currently protected by temperature-sensitive alarms that automatically telephone maintenance and tissue banking personnel when the temperature reaches a certain level. More protection is preferable, with CO2 tanks for backup cooling the optimum (but expensive) approach. We plan to systematically investigate the effects of thawing and refreezing on RNA integrity, by deliberately thawing and freezing small samples of brain tissue over varying time intervals and temperatures.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="786" length="12"></location><text>brain tissue</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="775" length="7"></location><text>samples</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="301" length="6"></location><text>tissue</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="464" length="6"></location><text>tissue</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="43" length="6"></location><text>tissue</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="196" length="6"></location><text>tissue</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="108" length="6"></location><text>tissue</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T6" role="Arg2"></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation></passage></document><document><id>PMC-3103976-caption-01</id><passage><offset>0</offset><text>(a) Sequence alignment of PY-NLSs. The homologous regions of C-NLS of the EWS protein, NLS of Sam68 and FUS/TLS protein and M9 NLS of hnRNP A1 and hnRNP M, classified as PY-NLS are in yellow boxes. Phosphorylated Y656 of the EWS protein and Y440 of Sam68 are indicated (in red). Positions of identical residues in SAM68 and EWS C-NLS are indicated in bold and residues with identical charges are underlined. Known positions of the FUS/TLS mutations in ALS are in bold. (b) Subcellular localization of YFP, the C-terminally tagged EWS-YFP, EWS(Y656A)-YFP, EWS(Y656F)-YFP, and EWS(Y656D)-YFP (in green). Nuclei are shown by DAPI staining (in blue). Bars, 15 mum.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="473" length="11"></location><text>Subcellular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="602" length="6"></location><text>Nuclei</text></annotation></passage></document><document><id>PMID-15202612</id><passage><offset>0</offset><text>Novel insights into the pathogenesis of uric acid nephrolithiasis.
PURPOSE OF REVIEW:
The factors involved in the pathogenesis of uric acid nephrolithiasis are well known. A low urinary pH is the most significant element in the generation of stones, with hyperuricosuria being a less common finding. The underlying mechanism(s) responsible for these disturbances remain poorly characterized. This review summarizes previous knowledge and highlights some recent developments in the pathophysiology of low urine pH and hyperuricosuria.
RECENT FINDINGS:
Epidemiological and metabolic studies have indicated an association between uric acid nephrolithiasis and insulin resistance. Some potential mechanisms include impaired ammoniagenesis caused by resistance to insulin action in the renal proximal tubule, or substrate competition by free fatty acids. The evaluation of a large Sicilian kindred recently revealed a putative genetic locus linked to uric acid stone disease. The identification of novel complementary DNA has provided an interesting insight into the renal handling of uric acid, including one genetic cause of renal uric acid wasting.
SUMMARY:
The recognition of metabolic, molecular, and genetic factors that influence urinary pH, and uric acid metabolism and excretion, will provide novel insights into the pathogenesis of uric acid stones, and open the way for new therapeutic strategies.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="781" length="21"></location><text>renal proximal tubule</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="946" length="15"></location><text>uric acid stone</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1122" length="5"></location><text>renal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1232" length="7"></location><text>urinary</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="242" length="6"></location><text>stones</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1337" length="16"></location><text>uric acid stones</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="178" length="7"></location><text>urinary</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1062" length="5"></location><text>renal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="504" length="5"></location><text>urine</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation></passage></document><document><id>PMC-3234173-sec-08</id><passage><offset>0</offset><text>Assessment instruments
The SCID-I/P was administered by psychiatrists trained and certified in the use of all instruments in this study.
The ICG is a self-report instrument that can be used to identify CG when the total score is &gt; 25, that demonstrated high internal consistency (Cronbach's alpha = 0.94), and convergent and criterion validity [27]. The ICG total score also showed a fairly high association with the Beck Depression Inventory (BDI) [32] total score (r = 0.67, P &lt; 0.001), the Texas Revised Inventory of Grief (TRIG) [33] score (r = 0.87, P &lt; 0.001), and the Grief Measurement Scale (GMS) [34] score (r = 0.70, P &lt; 0.001).
The ASA-27 is a self-report measure developed to rate separation anxiety symptoms in adult life (from 18 years of age). Principal components analysis revealed a coherent construct of adult separation anxiety with high internal consistency (Cronbach's alpha = 0.95) and sound test-retest reliability (r = 0.86; P &lt; 0.001). Further, a receiver operation characteristic (ROC) analysis against the semistructured interview yielded a high area under the curve (AUC) index of 0.9, suggesting that the questionnaire is an adequate alternative measure of adult separation anxiety [29].
The WSAS is a self-report scale of functional impairment that includes five questions rating interference of psychiatric symptoms in work, home management, social or private leisure activities, and ability to form and maintain close relationships with others. Each question is rated on a 0 to 8 scale with 0 indicating no impairment at all and 8 indicating very severe impairment. The Cronbach's alpha measure of internal scale consistency ranged from 0.70 to 0.94, the test-retest correlation was 0.73, and the WSAS interactive voice response administrations gave correlations of 0.81 and 0.86 with clinician interviews [30]. Correlations of WSAS with severity of depression and obsessive-compulsive disorder symptoms were 0.76 and 0.61, respectively, and the scores were sensitive to patient differences in disorder severity and treatment-related change [30].
The MOODS-SR is an instrument developed and validated to assess lifetime mood spectrum symptoms [35], including manic and depressive features, rhythmicity and vegetative functions. The manic and depressive components are subtyped into mood, energy and cognition domains, focusing on manic or depressive symptoms, respectively. The rhythmicity and vegetative functions domain include changes in energy, physical wellbeing, mental and physical efficiency, related to the weather and season, and changes in appetite, sleep and sexual activities. The sum of the scores on the 3 manic domains (mood, energy, cognition) constitutes the 'manic component' (62 items) and that of the 3 depressive domains the 'depressive component' (63 items). The rhythmicity and vegetative functions domain includes 29 items. The instrument can be downloaded from http://www.spectrum-project.org.
</text></passage></document><document><id>PMID-7257720</id><passage><offset>0</offset><text>[Organization of pectoral muscle motor neurons in the rat. Contribution to the study of the axillary arch (Achselbogen)].
In spite of their role of the forelimb activity, the organization of the mammalian pectoral muscles remains unclear. In order to get more information, we have studied, qualitatively and quantitatively, the motor pools of the various pectoral muscles in the rat (musculus pectoralis major, musculus pectoralis minor and musculus panniculus carnosus). The method applied was the retrograde transport of horseradish peroxidase by the peripheral nerves supplying the various muscles. The results provided the precise localization within the ventral horn of the motor neurons from the pectoral muscles which were all in the most ventral part of the gray matter. Three distinct motor pools were observed, which confirms the functional identity of each muscle. The motor neurons of m. panniculus carnosus exhibited some particularities. They were 4 times more numerous than those from m. pectoralis major, they occupied the whole ventral edge of the ventral horn, from its medial part to its lateral tip. The cell size was different from that of the other muscles. These results were discussed, according to the role of this muscle, which links the forelimb to the whole trunk. In mammals, m. panniculus carnosus constitutes, with musculus latissimus dorsi, the axillary arch (Achselbogen). A small area of overlapping between the motor pools of these two muscles was observed. It was suggested that the muscular fibers from the axillary arch were innervated by the same, well-defined spinal area, independent of the muscle from which they originate.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="411" length="25"></location><text>musculus pectoralis minor</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="441" length="28"></location><text>musculus panniculus carnosus</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="355" length="16"></location><text>pectoral muscles</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="384" length="25"></location><text>musculus pectoralis major</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1632" length="6"></location><text>muscle</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1544" length="13"></location><text>axillary arch</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1377" length="13"></location><text>axillary arch</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="553" length="17"></location><text>peripheral nerves</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1346" length="25"></location><text>musculus latissimus dorsi</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="593" length="7"></location><text>muscles</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1519" length="15"></location><text>muscular fibers</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1471" length="7"></location><text>muscles</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1286" length="5"></location><text>trunk</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1264" length="8"></location><text>forelimb</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1240" length="6"></location><text>muscle</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1171" length="7"></location><text>muscles</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="17" length="29"></location><text>pectoral muscle motor neurons</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="205" length="16"></location><text>pectoral muscles</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="152" length="8"></location><text>forelimb</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="659" length="12"></location><text>ventral horn</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="679" length="13"></location><text>motor neurons</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="702" length="16"></location><text>pectoral muscles</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="766" length="11"></location><text>gray matter</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="868" length="6"></location><text>muscle</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="880" length="13"></location><text>motor neurons</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="92" length="13"></location><text>axillary arch</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1045" length="12"></location><text>ventral edge</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1065" length="12"></location><text>ventral horn</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="746" length="12"></location><text>ventral part</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1124" length="4"></location><text>cell</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1600" length="11"></location><text>spinal area</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T30" role="Arg1"></node><node refid="T13" role="Arg2"></node></relation></passage></document><document><id>PMID-14729736</id><passage><offset>0</offset><text>Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.
OBJECTIVES:
After infection of non-phagocytic cells, some Staphylococcus aureus strains are able to survive and kill their host cells. The purpose of this study was to determine the action of various antibiotics on the survival of host cells and/or intracellular S. aureus.
METHODS:
Murine keratinocyte (PAM212) and fibroblast (mKSA) cell lines were infected with cytotoxic S. aureus and cultured in the presence of various antibiotics at graded concentrations. The viability of host cells was measured 24 h after infection. To determine the bacterial viability within host cells, cellular lysates were prepared and colony forming units were quantified using a spiral plater. Host cells infected with fluorescein isothiocyanate (FITC)-labelled S. aureus were analysed by flow cytometry and microscopy to determine the subcellular localization S. aureus.
RESULTS:
Oxacillin, vancomycin, gentamicin, ciprofloxacin and trimethoprim/sulfamethoxazole did not rescue host cells from cell death induced by intracellular S. aureus. In contrast, linezolid, rifampicin, azithromycin, clindamycin, erythromycin and quinupristin/dalfopristin suppressed the cytotoxic action of S. aureus. After withdrawal of antibiotics, intracellular S. aureus regained cytotoxic activity and killed their host cells. Only rifampicin was able to eliminate intracellular S. aureus completely within 72 h. In contrast, clindamycin, azithromycin and linezolid induced a state of intracellular persistence of viable S. aureus.
CONCLUSIONS:
Antibiotics commonly used for the management of S. aureus infections appear to create a niche for invasive intracellular S. aureus, which may play an important role for persistence and recurrence of infection. Because of its unique ability to eliminate intracellular S. aureus, rifampicin appears to be valuable for the treatment of invasive S. aureus infections.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="69" length="20"></location><text>non-phagocytic cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="219" length="5"></location><text>cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="122" length="20"></location><text>non-phagocytic cells</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="395" length="6"></location><text>PAM212</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="407" length="10"></location><text>fibroblast</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="327" length="5"></location><text>cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="381" length="12"></location><text>keratinocyte</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="665" length="5"></location><text>cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="772" length="5"></location><text>cells</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1057" length="5"></location><text>cells</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1068" length="4"></location><text>cell</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="419" length="16"></location><text>mKSA) cell lines</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1374" length="5"></location><text>cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="575" length="5"></location><text>cells</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="340" length="13"></location><text>intracellular</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="672" length="16"></location><text>cellular lysates</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1852" length="13"></location><text>intracellular</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="909" length="11"></location><text>subcellular</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1706" length="13"></location><text>intracellular</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1090" length="13"></location><text>intracellular</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1539" length="13"></location><text>intracellular</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1300" length="13"></location><text>intracellular</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1419" length="13"></location><text>intracellular</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T8" role="Arg2"></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation></passage></document><document><id>PMID-15913739</id><passage><offset>0</offset><text>Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells.
OBJECTIVES:
The Bcl-2 protein is an important regulator of the apoptotic cascade and promotes cell survival. Bcl-2 can also delay entry into the cell cycle from quiescence. In the present study, we used two isogenic human ovarian carcinoma cell lines, which expressed differential levels of Bcl-2 proteins, to demonstrate that Bcl-2 may regulate the growth rates of adenocarcinoma cells.
METHODS:
The growth rates of two isogenic ovarian cancer cell lines were determined by XTT assays and flow cytometry combined with PI staining. Bcl-2-overexpressing SKOV3 cells were modified to express a doxycycline-inducible anti-Bcl-2 single-chain antibody and the effects of Bcl-2 protein inhibition on cell proliferation and apoptosis were assessed.
RESULTS:
We demonstrate that Bcl-2 promotes the accumulation of proliferating carcinoma cells in S phase. The Bcl-2-overexpressing SKOV3 cell line proliferates markedly faster and shows delayed progression to G2M phase compared to its low Bcl-2-expressing counterpart SKOV3.ip1 cell line. Single-chain antibody-mediated inhibition of Bcl-2 in SKOV3 cells was associated with increased growth rates and more rapid cell cycle progression. Treatment with cisplatin resulted in more cells accumulating in S phase in Bcl-2-overexpressing SKOV3 cells, while the inhibition of Bcl-2 abolished delayed entry into G2M phase without affecting cisplatin-induced apoptosis.
CONCLUSIONS:
Our results suggest that, in ovarian cancer cells, Bcl-2 delays cell cycle progression by promoting accumulation of cells in S phase without affecting the rate of apoptosis. Thus, in addition to its known role at the G0/G1 checkpoint, we demonstrate for the first time that Bcl-2 also regulates the S phase.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="16" length="4"></location><text>cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="130" length="23"></location><text>ovarian carcinoma cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="64" length="5"></location><text>cells</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="377" length="28"></location><text>ovarian carcinoma cell lines</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="521" length="20"></location><text>adenocarcinoma cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="249" length="4"></location><text>cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="300" length="4"></location><text>cell</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="849" length="4"></location><text>cell</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="975" length="15"></location><text>carcinoma cells</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1007" length="36"></location><text>Bcl-2-overexpressing SKOV3 cell line</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1136" length="48"></location><text>Bcl-2-expressing counterpart SKOV3.ip1 cell line</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="585" length="25"></location><text>ovarian cancer cell lines</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1240" length="11"></location><text>SKOV3 cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="687" length="32"></location><text>Bcl-2-overexpressing SKOV3 cells</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1310" length="4"></location><text>cell</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1409" length="32"></location><text>Bcl-2-overexpressing SKOV3 cells</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1601" length="20"></location><text>ovarian cancer cells</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1636" length="4"></location><text>cell</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1376" length="5"></location><text>cells</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1688" length="5"></location><text>cells</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T14" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation><relation id="A11"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T17" role=""></node></relation><relation id="A10"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation><relation id="A9"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T13" role=""></node></relation></passage></document><document><id>PMC-3140111-sec-24</id><passage><offset>0</offset><text>Tail flick test
CSLE did not show any difference compared with control, at all the tested doses [Figure 4]. Morphine showed a significant increase of latency time at 45, 60 and 75 min.
Figure 4
Effect of CSLE (100, 200 and 500 mg/kg) and morphine on the latency response of mice in the tail flick test. Values are presented as the mean +/- SEM (n = 5) *P &lt; 0.05, significant increase from control
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="286" length="4"></location><text>tail</text></annotation></passage></document><document><id>PMID-6776697</id><passage><offset>0</offset><text>[In vitro studies of the thyroid gland regulation principles and their evaluation].
The free fractions of the thyroid hormone further the metabolism of the body cells and regulate the synthesis of the thyroid hormone. Once the level of FT3 and FT4 decreases. With the help of a liberation of the hormone stimulating the thyroid gland from the anterior lobe of the pituitary gland the lack of thyroid hormone is corrected. The synthesis and secretion of the thyroid gland stimulating hormone is induced by the thyreotropin releasing hormone which is given by the hypothalamus. Moreover, the organism is able as needed to carry out the monodiodation of LT4 to biologically active LT3 or biologically inactive so-called revers T3 (RT3). The estimation of thyroid gland stimulating hormone before and 30 minutes after intravenous application of thyreotropin releasing hormone has its main importance for the early recognition of a disturbance of the regulating circle hypophysis-thyroid gland, above all in the diagnosis of clinically not yet manifest clinical pictures, such as the latent hypothyreosis and the latent hyperthyreosis, respectively (Basedow hyperthyreosis and thyroidal autonomy). According to the questioning the estimations of the levels of the thyroid hormones and of the thyroid gland stimulating hormone should be used stepwise.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="343" length="13"></location><text>anterior lobe</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="364" length="15"></location><text>pituitary gland</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="562" length="12"></location><text>hypothalamus</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="320" length="13"></location><text>thyroid gland</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="752" length="13"></location><text>thyroid gland</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="814" length="11"></location><text>intravenous</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="975" length="13"></location><text>thyroid gland</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="457" length="13"></location><text>thyroid gland</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1287" length="13"></location><text>thyroid gland</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="25" length="13"></location><text>thyroid gland</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="156" length="10"></location><text>body cells</text></annotation></passage></document><document><id>PMID-1078780</id><passage><offset>0</offset><text>Abdominal approach for the ligation of bleeding oesophageal varices.
The conventional surgical treatment of bleeding oesophageal varices in the emergency situation is based upon the Boerema-Crile operation of transthoracic oesophagotomy and ligation of the varices. This and the other methods of treatment of this condition in current practice are discussed. Two cases are reported in which a transabdominal oesophagogastrotomy was used to approach the site of bleeding. This operation is described and the theoretical and practical advantages it appears to offer over the standard approach are considered.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="393" length="14"></location><text>transabdominal</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="209" length="13"></location><text>transthoracic</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="257" length="7"></location><text>varices</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="0" length="9"></location><text>Abdominal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="117" length="19"></location><text>oesophageal varices</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="48" length="19"></location><text>oesophageal varices</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation></passage></document><document><id>PMC-2644583-sec-04</id><passage><offset>0</offset><text>Variables
Our study used the following 9 HRQOL questions from the 2004 Rhode Island BRFSS: 1) self-rated general health status; and self-reported number of healthy and unhealthy days in the previous 30 days for 2) physical health, 3) mental health, 4) physical or mental health-related activity limitation, 5) pain-related activity limitation, 6) sad, blue, or depressed, 7) worried, tense, or anxious, 8) lack of rest or sleep, and 9) lack of energy (1,2,15). We created 9 dichotomous indicator variables. The responses to the self-rated general health status question were dichotomized into "poor" (poor or fair) health or "good" (good, very good, or excellent) health. The indicators measured in days were dichotomized at a cutoff value of 14 or more days of poor health in the previous month compared to less than 14 days (3). We selected the 14-day minimum period because most of the publications we reviewed that use the BRFSS HRQOL indicators (outcomes) use the cutoff of 14 or more days compared to 13 or fewer days (3-5,7-11,16,17). Adopting this precedent ensured comparability. In addition, clinicians and clinical researchers often use this period as a marker for clinical depression and anxiety disorders, and long symptomatic durations are associated with high levels of activity limitation (2,18). Detailed definitions of the 9 indicators are available in our previous article (1) or are accessible through the Centers for Disease Control and Prevention's HRQOL Web site (2).
We chose 12 predictors for the analysis: 5 standard demographic measures (age, sex, race/Hispanic ethnicity, annual income, and employment status); 4 health conditions (asthma, diabetes, obesity, and physical disability); and 3 health risk behaviors (smoking, chronic alcohol use, and no leisure-time physical activity). These predictors paralleled the results of other studies that have examined relationships between a specific HRQOL indicator and various predictors (17,19), or that have examined multiple HRQOL indicators in relation to demographics (4,20), health risks (5,10,21), or specific health conditions (6-9,12,22). We dichotomized some predictors for the analysis (ie, sex, current smoking, alcohol use, physical activity, asthma, diabetes, obesity, and disability), whereas other predictors had multiple categories (ie, age, race/Hispanic ethnicity, income, and employment status). The definitions of the 12 predictors are available in our previous article (1). Reference groups chosen for the IRT model were those having the lowest risk for poor or fair general health and usually the lowest risk for the other HRQOL variables as well.
</text></passage></document><document><id>PMC-1072800-sec-07</id><passage><offset>0</offset><text>Immunostaining and confocal analysis
DNA labelling and staining with 5-bromo-2'-deoxyuridine (BrdU labelling and detection kit I; Boehringer Mannheim, Germany) was performed according to the manufacturer's instructions. The nucleoli were detected with an anti-nucleolin antibody (clone 3G4B2; Upstate biotechnology, Lake Placid, NY) on cells fixed in 2% formalin for 10 min followed by permeabilization with ice-cold methanol for 30 min. The secondary antibody used for both BrdU and nucleoli staining was a rhodamine (tetra-methyl)-conjugated goat anti-mouse antibody (T-2762) from Molecular Probe (Eugene, OR). The cells were examined in a Zeiss LSM 510 laser scanning microscope equipped with a Plan-Apochromate 63x/1.4 oil immersion objective. We used the 488 nm laser line for excitation of EGFP (detected at 505 nm &lt; lambdaEGFP &lt; 530 nm) and the 543 nm laser line for rhodamine (tetra-methyl) (detected at lambdaRhodamine &gt; 560 nm). ECFP fusion protein was excited with a 458 nm laser line (detected at 480 nm &lt; lambdaECFP &lt; 520 nm), EYFP fusion protein was excited with a 514 nm laser line (lambdaEGFP &gt; 560 nm) and HcRed fusion protein was excited with a 543 nm laser line and detected at &gt;585 or 650 nm. The images were from 1 mum thick slices of the cells. The images were exported into Adobe Photoshop (Adobe Systems Inc., San Jose, CA).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="484" length="8"></location><text>nucleoli</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1246" length="6"></location><text>slices</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1260" length="5"></location><text>cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="224" length="8"></location><text>nucleoli</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="617" length="5"></location><text>cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="336" length="5"></location><text>cells</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T4" role="Arg2"></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation></passage></document><document><id>PMC-1112599-caption-08</id><passage><offset>0</offset><text>The most highly represented gene ontology themes in the neurosphere vs. differentiated cells comparison (F-G).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="56" length="11"></location><text>neurosphere</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="72" length="20"></location><text>differentiated cells</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T1" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation></passage></document><document><id>PMID-424394</id><passage><offset>0</offset><text>[Histophysiology and histopathology of the adrenals in experimental hypokinesia].
In experiments on male rats in the course of 3-month hypokinesia phasic changes were observed in the relative adrenal gland weight, in the volume of the cell nuclei of the glomerular, fasicular zones and the medulla, in the activity of the succinic dehydrogenase, alkaline and acid phosphatases, in the RNA and catecholamine content. These changes are associated with variations in the secretion and biosynthesis of the hormones of the cortical and the medullary layer of the adrenal glands during the hypokinetic stress development.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="518" length="8"></location><text>cortical</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="535" length="15"></location><text>medullary layer</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="192" length="13"></location><text>adrenal gland</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="290" length="7"></location><text>medulla</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="558" length="14"></location><text>adrenal glands</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="266" length="15"></location><text>fasicular zones</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="43" length="8"></location><text>adrenals</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="254" length="10"></location><text>glomerular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="235" length="11"></location><text>cell nuclei</text></annotation><relation id="R6"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T2" role="Arg1"></node><node refid="T9" role="Arg2"></node></relation><relation id="R4"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T2" role="Arg1"></node><node refid="T3" role="Arg2"></node></relation><relation id="R5"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T2" role="Arg1"></node><node refid="T5" role="Arg2"></node></relation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T8" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T8" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T7" role="Arg2"></node></relation></passage></document><document><id>PMID-17241819</id><passage><offset>0</offset><text>Segmental atrial contraction in patients restored to sinus rhythm after cardioversion for chronic atrial fibrillation: a colour Doppler tissue imaging study.
AIMS:
There is little known about segmental atrial function in patients with atrial arrhythmias. We evaluated segmental atrial contractility using colour Doppler tissue imaging (CDTI) in patients with chronic atrial fibrillation (CAF) who were successfully restored and maintained in sinus rhythm (SR).
METHODS AND RESULTS:
We compared the segmental atrial contractility in 39 CAF patients who were successfully cardioverted and maintained in SR for 6 months. Follow up echocardiograms were performed at baseline, 1 week, 1 month and 6 months and compared to a normal age matched cohort (n = 34). Using CDTI, mean peak velocities of atrial contraction were measured from annular, mid and superior segments of lateral and septal walls of the left atrium and right atrium in the apical four-chamber view. Segmental velocities from the posterior and anterior walls of the left atrium were measured from the apical two-chamber view. Segmental left atrial velocities improved over time in the CAF group, with the majority of the recovery occurring in the first month, but failed to normalise even at 6 months. In comparison, the right atrial velocities in the AF group had normalised at 1 month.
CONCLUSION:
Patients with CAF have persistent segmental left atrial dysfunction even 6 months after restoration and maintenance of SR, though right atrial velocities appear to normalise. This differential recovery indicates that left atrial function remains subnormal in patients with CAF despite maintenance of SR, suggesting underlying atrial myopathy or fibrosis as a consequence of CAF.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="10" length="6"></location><text>atrial</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="98" length="6"></location><text>atrial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="53" length="5"></location><text>sinus</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="235" length="6"></location><text>atrial</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="278" length="6"></location><text>atrial</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="136" length="6"></location><text>tissue</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="202" length="6"></location><text>atrial</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="508" length="6"></location><text>atrial</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="791" length="6"></location><text>atrial</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="867" length="7"></location><text>lateral</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="879" length="12"></location><text>septal walls</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="367" length="6"></location><text>atrial</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="899" length="11"></location><text>left atrium</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="320" length="6"></location><text>tissue</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="915" length="12"></location><text>right atrium</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1097" length="11"></location><text>left atrial</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1027" length="11"></location><text>left atrium</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1282" length="12"></location><text>right atrial</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="442" length="5"></location><text>sinus</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1405" length="11"></location><text>left atrial</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1687" length="6"></location><text>atrial</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1491" length="12"></location><text>right atrial</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1578" length="11"></location><text>left atrial</text></annotation><relation id="R4"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T12" role="Arg1"></node><node refid="T14" role="Arg2"></node></relation><relation id="R5"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T12" role="Arg1"></node><node refid="T15" role="Arg2"></node></relation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T13" role="Arg1"></node><node refid="T14" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T13" role="Arg1"></node><node refid="T15" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T12" role="Arg1"></node><node refid="T13" role="Arg2"></node></relation></passage></document><document><id>PMID-20433031</id><passage><offset>0</offset><text>Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model.
Recent estimates show that the transmission rate of human immunodeficiency virus (HIV) in the U.S. has substantially decreased. This raises the question, is elimination of HIV infection in the nation feasible in the foreseeable future? We demonstrate that if the HIV transmission rate were reduced by 50%, then the reproductive rate of HIV infection would drop below unity and lead to eventual elimination of infection. In recent congressional testimony, the director of the Centers for Disease Control and Prevention and others asserted that the HIV transmission rate can be halved by 2020, if not earlier, provided sufficient investment is made toward achieving this goal. We assert that if adequate investment is made and the transmission rate is in fact lowered by 50%, then the HIV reproductive rate would fall below unity, setting the stage for eventual elimination of HIV infection in the U.S.
</text></passage></document><document><id>PMID-2902221</id><passage><offset>0</offset><text>Time course of transmitter action at the sympathetic neuroeffector junction in rodent vascular and non-vascular smooth muscle.
1. Transmitter release from sympathetic postganglionic nerve terminals innervating the guinea-pig and mouse vas deferens and the rat tail artery has been studied in vitro by focal extracellular recording with particular emphasis on the time course of transmitter action underlying the intracellular potential changes. 2. In the absence of stimulation, spontaneous excitatory junction currents (SEJCs) were recorded with amplitudes up to 500 microV and durations between 40 and 100 ms. SEJCs were unaffected by the competitive alpha-adrenoceptor antagonist prazosin but blocked by alpha, beta-methylene ATP which desensitizes P2-purinoceptors. 3. During trains of supramaximal stimuli at 0.1-4 Hz stimulus locked excitatory junction currents (EJCs) were evoked intermittently from the population of varicosities located under the suction electrode. 4. SEJCs were similar in amplitude and time course to EJCs evoked by low-frequency stimulation in the same attachment in all three tissues. 5. SEJCs recorded using either a conventional AC amplifier or a patch clamp amplifier had the same time course. 6. These studies show that the time course of the current underlying the excitatory junction potential is brief and essentially the same in three different tissues. The prolonged time course of the excitatory junction potential in different tissues can be accounted for by the passive membrane properties.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="86" length="8"></location><text>vascular</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="155" length="32"></location><text>sympathetic postganglionic nerve</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="99" length="26"></location><text>non-vascular smooth muscle</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1106" length="7"></location><text>tissues</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="491" length="19"></location><text>excitatory junction</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="260" length="11"></location><text>tail artery</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="235" length="12"></location><text>vas deferens</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1383" length="7"></location><text>tissues</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1425" length="19"></location><text>excitatory junction</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="41" length="34"></location><text>sympathetic neuroeffector junction</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="839" length="19"></location><text>excitatory junction</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="307" length="13"></location><text>extracellular</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="412" length="13"></location><text>intracellular</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1300" length="19"></location><text>excitatory junction</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1468" length="7"></location><text>tissues</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1512" length="8"></location><text>membrane</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T1" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation></passage></document><document><id>PMID-4031558</id><passage><offset>0</offset><text>Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.
Six women developed chronic long-term arthropathy after postpartum immunization against rubella. All individuals developed acute polyarticular arthritis within 12 days to three weeks postimmunization and have had continuing chronic or recurrent arthralgia or arthritis for two to seven years after vaccination. Acute neurological manifestations, consisting of carpal tunnel syndrome or multiple paresthesiae, developed postvaccination in three women. Two have developed continuing active or chronic recurrent episodes of blurred vision, paresthesiae, and painful limb syndromes together with recurrent joint symptoms. Chronic rubella viremia has been detected in peripheral blood mononuclear cell (MNC) populations in five of the six women up to six years after vaccination. In addition rubella virus was isolated from breast milk MNCs in one individual at nine months postvaccination and from peripheral blood MNCs in two of four breast-fed infants studied at 12-18 months of age. Immune responses to rubella virus studied at sequential intervals after vaccination correlated with development of rheumatologic and neurological manifestations.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1069" length="6"></location><text>breast</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="957" length="16"></location><text>breast milk MNCs</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1253" length="12"></location><text>neurological</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1032" length="21"></location><text>peripheral blood MNCs</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="86" length="12"></location><text>neurological</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="455" length="12"></location><text>neurological</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="701" length="4"></location><text>limb</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="836" length="3"></location><text>MNC</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="801" length="33"></location><text>peripheral blood mononuclear cell</text></annotation></passage></document><document><id>PMC-2792620-sec-33</id><passage><offset>0</offset><text>Surgery
Trabeculectomy should be considered in all patients, when the 'target IOP' is not achieved with glaucoma medications and if the expected rate of visual loss could affect the patient during their lifetime. In this procedure, an opening is made in the trabecular meshwork, so that aqueous humor can drain into the sclera.
Many patients can discontinue glaucoma medications after surgery. Approximately one-third of the trabeculectomy patients develop cataract within five years. If trabeculectomy fails, another type of surgery places a drainage tube (Molteno tube) in the eye, between the cornea and iris, which exits at the junction of the cornea and sclera. Cyclodestructive procedures, which lower IOP by destroying the ciliary body, are typically reserved for eyes, which are refractory to all other forms of therapy. These procedures include cyclocryotherapy, cylcodiathermy and laser cyclophotocoagulation.[91-93]
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="648" length="6"></location><text>cornea</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="659" length="6"></location><text>sclera</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="596" length="6"></location><text>cornea</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="258" length="10"></location><text>trabecular</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="607" length="4"></location><text>iris</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="730" length="12"></location><text>ciliary body</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="771" length="4"></location><text>eyes</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="295" length="5"></location><text>humor</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="579" length="3"></location><text>eye</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="320" length="6"></location><text>sclera</text></annotation></passage></document><document><id>PMC-3096661-sec-08</id><passage><offset>0</offset><text>Results

</text></passage></document><document><id>PMC-3125269-sec-23</id><passage><offset>0</offset><text>Acknowledgments and Funding
The authors thank CRB GADIE (Diane Esquerre) for BAC clones handling and Brian Smith, Renee Fincham and Kristy Shewbridge for microsatellites genotyping. We are grateful to Yann Guiguen for help and precious contribution to fund raising for this study. This work was made possible by financial support of Genoscope. We acknowledge Rene Guyomard for his initial contribution in BAC library procurement. The microsatellites genotyping was supported by NRI Grant No. 2007-35616-17875 from the USDA National Institute of Food and Agriculture.
</text></passage></document><document><id>PMC-1697817-sec-02</id><passage><offset>0</offset><text>2- Theory
Scanning holography is a two-pupil interaction method [8] by which incoherent imaging with complex point-spread-functions (PSF) is possible. The method has recently been applied to the recording of high resolution holographic images of incoherent objects and fluorescent biological specimens [6,7]. A single-sideband in-line Fresnel hologram is obtained by a 2D raster scan of the object with the superposed 3D diffraction distributions of two pupils, as sketched in fig. 1. The two pupil distributions P~1(rho--&gt;) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa@3295@ and P~2(rho--&gt;) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa@3297@ from the same source (for example, but not necessarily, a laser) are combined by a beam splitter in the pupil plane of the objective where they interfere, forming a Fresnel pattern with a depth-dependent Fresnel number. To obtain the conventional point-spread function of wide field imaging, P1 is chosen as a point source, and P2 as a spherical wave with appropriate curvature. The 3D specimen is placed in the focal region of the objective, and scattered lights (transmitted, reflected, and fluorescent) are collected by non-imaging detectors. The hologram data can be obtained by heterodyne detection with one of the pupils shifted in frequency (as done in this work), or by a homodyne method requiring the capture of at least three frames with different relative phases between the two pupils [9]. The amplitude distribution of the illuminating beam, in a transverse plane at an axial distance z from the focal plane of the objective, is the Fourier transform of the combined pupil distributions [10]. Namely:
Figure 1
Experimental set up of a scanning holographic microscope. Sketch of the experimental setup. M's are mirrors, BS's are beam splitters, EO is an electro-optic phase modulator. Lens L1 (achromat doublet 16 cm focal length) produces the desired Fresnel pattern in the focal plane of L2 (achromat doublet 16 cm focal length). L2 and the objective form a 4-f system projecting a reduced image of the Fresnel pattern onto the specimen. L3 (achromat doublet 12 cm focal length) projects the images of the pupils on the pinhole detector. (Not shown are the beam expanders used to illuminate the pupils).
S(r--&gt;,z)=F-1{[P~1(rho--&gt;;z)+P~2(rho--&gt;;z)exp (-iOmegat]}, (1a) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGtbWucqGGOaakcuWGYbGCgaWcaiabcYcaSiabdQha6jabcMcaPiabg2da9iabdAeagnaaCaaaleqabaGaeyOeI0IaeGymaedaaOWaaiWabeaadaWadaqaaiqbdcfaqzaaiaWaaSbaaSqaaiabigdaXaqabaGccqGGOaakiiGacuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiabgUcaRiqbdcfaqzaaiaWaaSbaaSqaaiabikdaYaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiGbcwgaLjabcIha4jabcchaWjabcIcaOiabgkHiTiabdMgaPjabfM6axjabdsha0bGaay5waiaaw2faaaGaay5Eaiaaw2haaiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaIXaqmcqqGHbqyaiaawIcacaGLPaaaaaa@5D95@
where
P~1,2(rho--&gt;;z)=P~1,2(rho--&gt;)exp (ipilambdazrho2) (1b) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmcqGGSaalcqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcqGH9aqpcuWGqbaugaacamaaBaaaleaacqaIXaqmcqGGSaalcqaIYaGmaeqaaOGaeiikaGIaf8xWdiNbaSaacqGGPaqkcyGGLbqzcqGG4baEcqGGWbaCcqGGOaakcqWGPbqAcqWFapaCcqWF7oaBcqWG6bGEcqWFbpGCdaahaaWcbeqaaiabikdaYaaakiabcMcaPiaaxMaacaWLjaWaaeWaaeaacqaIXaqmcqqGIbGyaiaawIcacaGLPaaaaaa@53A8@
are the generalized defocused pupils [11]. F-1 stands for inverse Fourier transform, and Omega is the frequency shift of one of the pupils. The transverse spatial frequency vector rho--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacuWFbpGCgaWcaaaa@2E85@ = r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@P/lambdaf0 is proportional to the real space coordinate r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@P in the pupil plane [10]. lambda is the wavelength of the illumination, and f0 is the focal length of the objective. The two pupils used to obtain an in-line Fresnel hologram are, respectively, a spherical wave filling the pupil of the objective, and a point at the center of that pupil:
P~1(rho--&gt;) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa@3295@ = exp(ipilambdaz0rho2)circ(rho/rhoMAX)
P~2(rho--&gt;)=delta(rho--&gt;). (2) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpcqWF0oazcqGGOaakcuWFbpGCgaWcaiabcMcaPiabc6caUiaaxMaacaWLjaWaaeWaaeaacqaIYaGmaiaawIcacaGLPaaaaaa@3D5F@
circ(x) is a disc function of unit radius. rhoMAX = sinalpha/lambda is the cutoff frequency of the objective, where sinalpha = NA is its numerical aperture. The Fresnel pattern projected on the object is the interference of the Fourier transforms of the two pupils, namely a spherical wave and a plane wave in the paraxial approximation. The Fresnel number of this pattern is determined by the free parameter z0, which is the distance from the objective's focal plane to the point where the spherical wave comes to a focus.
There are two possible modes of operation, depending on the detector geometry [5]. With a spatially integrating detector, the resulting data is a convolution of the object's intensity distribution with the desired complex PSF (namely, a spherical wave with a radius of curvature z0 + z, and a radius a = z0sinalpha, in this case). This detection mode leads to a hologram from which the three-dimensional distribution of scattering intensity, absorption, and fluorescence intensity can be reconstructed. With a point detector at the center of a conjugate pupil plane, the resulting data is a convolution of the object's complex amplitude distribution with the same complex PSF. The reconstruction of this hologram gives the three-dimensional distribution of the specimen's complex amplitude transmittance. In particular, assuming that multiple scattering can be ignored, the phase of the reconstruction is a quantitative measure of the integrated optical path length through the specimen. These two modes of operation are similar to the usual coherent/incoherent imaging modes of a conventional system, which are obtained by using, respectively, a point source, or a large spatially incoherent source. In scanning holography, the detector size plays a similar role to that of the source size in conventional imaging.
For simplicity, let's assume an object with an amplitude transmittance T(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z). Note that for an incoherent or fluorescent object, the phase of the transmitted field is a random variable, and only the intensity I(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z) = |T(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z)|2 is measurable. For a quasi transparent object, the phase is equal to the integrated optical thickness of the object: Phi(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@) = (2pi/lambda)integraldzn(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z), where n(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z) is the 3D distribution of refractive index. The amplitude distribution after the object is written as
A(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, t) = integraldzS(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z)T[r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@-r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@S(t), z], (3)
where r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@S(t) is the instantaneous position of the 2D raster scan.
The incoherent imaging mode is obtained with a spatially integrating detector, leading to a temporal signal proportional to the integrated intensity, integrald2r|A(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, t)|2, which is stored in the computer. The data corresponding to each hologram line is cut from the signal, and band pass filtered to extract the term oscillating at Omega. The lines are then rearranged in a 2D format. The resulting hologram amplitude is found to be
HI(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@) = integraldzI(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z) (+) [p1(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z)p*2(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z)], (4)
where (+) symbolizes a convolution integral, I(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z) = |T(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z)|2, and p1,2(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z) are the inverse Fourier transforms of the defocused pupil distributions (eq.1b). The superscript * stands for complex conjugate. The hologram is thus the convolution of the object intensity with a spherical wave, i.e. an in-line single-sideband Gabor hologram. In Fourier space, the hologram can be written as
H~I(rho--&gt;)=integraldzI~(rho--&gt;;z)[P~1(rho--&gt;;z)(*)P~2(rho--&gt;;z)], (5) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGjbqsaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdMeajzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkdaWadaqaaiqbdcfaqzaaiaWaaSbaaSqaaiabigdaXaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiabgEPielqbdcfaqzaaiaWaaSbaaSqaaiabikdaYaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPaGaay5waiaaw2faaiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaI1aqnaiaawIcacaGLPaaaaaa@58FF@
where (+) symbolizes a correlation integral. With the pupils of eq.2, we find, in the paraxial approximation,
H~I(rho--&gt;)=integraldzI~(rho--&gt;;z)exp [ipilambda(z0+z)rho2]circ(rho/rhoMAX), (6) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGjbqsaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdMeajzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcyGGLbqzcqGG4baEcqGGWbaCdaWadaqaaiabdMgaPjab=b8aWjab=T7aSjabcIcaOiabdQha6naaBaaaleaacqaIWaamaeqaaOGaey4kaSIaemOEaONaeiykaKIae8xWdi3aaWbaaSqabeaacqaIYaGmaaaakiaawUfacaGLDbaacqWGJbWycqWGPbqAcqWGYbGCcqWGJbWycqGGOaakcqWFbpGCcqGGVaWlcqWFbpGCdaWgaaWcbaGaemyta0KaemyqaeKaemiwaGfabeaakiabcMcaPiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaI2aGnaiaawIcacaGLPaaaaaa@67E3@
which is the Fourier transform of the Fresnel hologram of the object's intensity distribution.
The coherent imaging mode is obtained by using a pinhole or a point detector at the center of a conjugate plane of the pupil of the objective. This leads to the hologram amplitude
HC(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@) = integraldz[T(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z) (+) p1(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z)][T(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z) (+) p2(r--&gt; MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa@2E2B@, z)]*. (7)
Where again, (+) symbolizes a convolution product, and the superscript * stands for complex conjugate. In Fourier space,
H~C(rho--&gt;)=integraldzT~(rho--&gt;;z)P~1(rho--&gt;;z)(*)T~(rho--&gt;;z)P~2(rho--&gt;;z). (8) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGdbWqaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdsfauzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcqGHxkcXcuWGubavgaacaiabcIcaOiqb=f8aYzaalaGaei4oaSJaemOEaONaeiykaKIafmiuaaLbaGaadaWgaaWcbaGaeGOmaidabeaakiabcIcaOiqb=f8aYzaalaGaei4oaSJaemOEaONaeiykaKIaeiOla4IaaCzcaiaaxMaadaqadaqaaiabiIda4aGaayjkaiaawMcaaaaa@5E5B@
With the pupils of eq.2, we find
H~C(rho--&gt;)=integraldzT~*(0;z)T~(rho--&gt;;z)exp [ipilambda(z0+z)rho2]circ(rho/rhoMAX). (9) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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f8aYjabc+caViab=f8aYnaaBaaaleaacqWGnbqtcqWGbbqqcqWGybawaeqaaOGaeiykaKIaeiOla4IaaCzcaiaaxMaadaqadaqaaiabiMda5aGaayjkaiaawMcaaaaa@6F41@
Aside from an inconsequential complex constant (the first term under the integral), eq.9 is the Fourier transform of the Fresnel hologram of the object's complex amplitude distribution. Thus, the reconstruction of the hologram recorded in the coherent mode carries a quantitative measure of the object's phase distribution.
</text></passage></document><document><id>PMID-6132379</id><passage><offset>0</offset><text>Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity.
Antisera raised against synthetic dynorphin or [Leu5]enkephalin demonstrate immunostaining in hippocampal mossy fibers and in dentate granule cells. However, dynorphin immunoreactivity (ir) appears to be denser in immunocytochemical preparations and is quantitatively greater by radioimmunoassay than enkephalin-ir. Immunostaining with dynorphin antisera is eliminated by adsorption with 1-100 microM dynorphin-17 whereas immunostaining with enkephalin antisera is eliminated by adsorption with 1-100 microM [Leu5]enkephalin, dynorphin-17, dynorphin-(1-13), or alpha-neo-endorphin. Intrahippocampal colchicine injections, which selectively destroy dentate granule cells, significantly decrease the dynorphin-ir and enkephalin-ir levels in rat hippocampus. Intraventricularly administered kainic acid, which selectively destroys CA3-4 pyramidal cells, results in an increase of enkephalin immunostaining in mossy fibers and a significant increase in enkephalin-ir by radioimmunoassay in whole hippocampus. The enkephalin-ir cells and fibers in entorhinal/perirhinal cortex, which innervate rat hippocampus and dentate gyrus, do not contain dynorphin-ir.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="30" length="24"></location><text>hippocampal mossy fibers</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="248" length="24"></location><text>hippocampal mossy fibers</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="158" length="4"></location><text>sera</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="897" length="11"></location><text>hippocampus</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="910" length="18"></location><text>Intraventricularly</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="280" length="21"></location><text>dentate granule cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="736" length="16"></location><text>Intrahippocampal</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1163" length="19"></location><text>enkephalin-ir cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1187" length="6"></location><text>fibers</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1197" length="10"></location><text>entorhinal</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1208" length="17"></location><text>perirhinal cortex</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="982" length="21"></location><text>CA3-4 pyramidal cells</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1247" length="11"></location><text>hippocampus</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1146" length="11"></location><text>hippocampus</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1263" length="13"></location><text>dentate gyrus</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1060" length="12"></location><text>mossy fibers</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T12" role="Arg1"></node><node refid="T13" role="Arg2"></node></relation></passage></document><document><id>PMID-2003384</id><passage><offset>0</offset><text>Costs of hip fracture. Rehabilitation of 180 patients in primary health care.
Costs related to functional status were calculated for 180 consecutive hip fracture patients (mean age 78 years) who were admitted from their own home and rehabilitated in primary health care. Within 4 months after the fracture, 75 percent of the patients had been discharged to their own home, 9 percent were dead, and the short-term medical treatment costs per patient were SEK 43,000, whereas the total costs including communal help and costs for living accommodations after discharge were twice as high. The total costs per patient for long-term medical treatment (from 4 months up to 3 years after fracture) were 7 percent of the short-term medical treatment costs. Patients with a cervical fracture discharged to their own home and with good functional status consumed only one fifth of the resources that patients with a trochanteric fracture discharged to institutional care and who had reduced functional status consumed. A substantial part of the costs can be saved by improved organization of rehabilitation after discharge from the hospital. A further cost reduction would require a combination of technologic, social, and organizational changes aimed at early discharge and continued follow-up in primary health care.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="149" length="3"></location><text>hip</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="765" length="8"></location><text>cervical</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="9" length="3"></location><text>hip</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="906" length="12"></location><text>trochanteric</text></annotation></passage></document><document><id>PMID-2331105</id><passage><offset>0</offset><text>The enlarging clinical spectrum of Lyme disease: Lyme cerebral vasculitis, a new disease entity.
The case of a patient with cerebral vasculitis with a right thalamic infarct associated with cerebral spinal fluid Lyme disease is presented. This entity has not been described in the United States, and only one similar case in the world literature could be found. The patient presented with a progressive headache and subsequent development of grand mal seizure activity. Lyme disease has been associated with cranial nerve palsies, peripheral and cranial radiculopathies, aseptic meningitis, encephalitic symptoms, chorea, and demyelinating polyneuropathy presenting like Guillain-Barre syndrome. These syndromes can occur separately or in combination. Stroke and strokelike syndromes have been attributed to Lyme disease. The literature concerning the neurologic manifestations of Lyme disease is reviewed.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="151" length="14"></location><text>right thalamic</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="852" length="10"></location><text>neurologic</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="508" length="13"></location><text>cranial nerve</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="546" length="7"></location><text>cranial</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="54" length="8"></location><text>cerebral</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="190" length="21"></location><text>cerebral spinal fluid</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="124" length="8"></location><text>cerebral</text></annotation></passage></document><document><id>PMID-7684185</id><passage><offset>0</offset><text>Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Distinguishing primary hepatocellular carcinoma (HCC) from metastatic carcinomas to the liver is often difficult, if not impossible, particularly in needle biopsy and fine-needle aspiration specimens. In an attempt to identify a specific immunohistochemical profile that would distinguish HCC from metastatic carcinomas, we studied 56 HCCs, 8 cholangiocarcinomas, and 24 metastatic adenocarcinomas with monoclonal antibodies to alpha-fetoprotein (AFP), keratin (AE1, AE3, and CAM5.2), Leu-M1, human milk fat globule (HMFG-2), tumor-associated glycoprotein-72(B72.3), epithelial specific membrane antigen (Ber-EP4), and BCA-225 (CU-18). Both monoclonal and polyclonal (mCEA and pCEA) antibodies to carcinoembryonic antigen also were used. Metastatic adenocarcinomas were often positive for CU-18(71%), Leu-M1 (75%), B72.3 (50%), HMFG-2 (67%), Ber-EP4(83%) and mCEA(71%). Using these antibodies, the frequency of positivity for HCC was 9%, 16%, 11%, 20%, 36%, and 11%, respectively. CU-18 was the only monoclonal antibody in which there was a significant difference in positive rates between HCC and metastatic adenocarcinomas. Most HCCs (71%) revealed a bile canalicular staining pattern with pCEA. Because this staining pattern was absent in metastatic carcinomas, pCEA appears to be useful in confirming a diagnosis of HCC. AE1, AE3 and CAM5.2 antibodies were not useful in distinguishing HCC from metastatic carcinomas. Each cholangiocarcinoma shared a staining profile similar to that of metastatic carcinomas.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="148" length="21"></location><text>metastatic carcinomas</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="177" length="5"></location><text>liver</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="104" length="32"></location><text>primary hepatocellular carcinoma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="138" length="3"></location><text>HCC</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1580" length="21"></location><text>metastatic carcinomas</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1516" length="18"></location><text>cholangiocarcinoma</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1488" length="21"></location><text>metastatic carcinomas</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="238" length="13"></location><text>needle biopsy</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="256" length="32"></location><text>fine-needle aspiration specimens</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1479" length="3"></location><text>HCC</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1331" length="21"></location><text>metastatic carcinomas</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1242" length="16"></location><text>bile canalicular</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1220" length="4"></location><text>HCCs</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1187" length="26"></location><text>metastatic adenocarcinomas</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1179" length="3"></location><text>HCC</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1015" length="3"></location><text>HCC</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="41" length="7"></location><text>primary</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="82" length="5"></location><text>liver</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="53" length="21"></location><text>metastatic carcinomas</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="378" length="3"></location><text>HCC</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="387" length="21"></location><text>metastatic carcinomas</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="432" length="19"></location><text>cholangiocarcinomas</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="460" length="26"></location><text>metastatic adenocarcinomas</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="615" length="5"></location><text>tumor</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="656" length="10"></location><text>epithelial</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="676" length="8"></location><text>membrane</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="827" length="26"></location><text>Metastatic adenocarcinomas</text></annotation><relation id="R4"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T8" role="Arg1"></node><node refid="T9" role="Arg2"></node></relation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T2" role="Arg1"></node><node refid="T3" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T7" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T1" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T4" role=""></node><node refid="T5" role=""></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation></passage></document><document><id>PMID-20562040</id><passage><offset>0</offset><text>A generative model for image segmentation based on label fusion.
We propose a nonparametric, probabilistic model for the automatic segmentation of medical images, given a training set of images and corresponding label maps. The resulting inference algorithms rely on pairwise registrations between the test image and individual training images. The training labels are then transferred to the test image and fused to compute the final segmentation of the test subject. Such label fusion methods have been shown to yield accurate segmentation, since the use of multiple registrations captures greater inter-subject anatomical variability and improves robustness against occasional registration failures. To the best of our knowledge, this manuscript presents the first comprehensive probabilistic framework that rigorously motivates label fusion as a segmentation approach. The proposed framework allows us to compare different label fusion algorithms theoretically and practically. In particular, recent label fusion or multiatlas segmentation algorithms are interpreted as special cases of our framework. We conduct two sets of experiments to validate the proposed methods. In the first set of experiments, we use 39 brain MRI scans-with manually segmented white matter, cerebral cortex, ventricles and subcortical structures-to compare different label fusion algorithms and the widely-used FreeSurfer whole-brain segmentation tool. Our results indicate that the proposed framework yields more accurate segmentation than FreeSurfer and previous label fusion algorithms. In a second experiment, we use brain MRI scans of 282 subjects to demonstrate that the proposed segmentation tool is sufficiently sensitive to robustly detect hippocampal volume changes in a study of aging and Alzheimer's Disease.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1409" length="5"></location><text>brain</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1602" length="5"></location><text>brain</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1289" length="10"></location><text>ventricles</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1304" length="22"></location><text>subcortical structures</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1730" length="11"></location><text>hippocampal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1218" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1272" length="15"></location><text>cerebral cortex</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1258" length="12"></location><text>white matter</text></annotation></passage></document><document><id>PMID-15542670</id><passage><offset>0</offset><text>Human cytomegalovirus 5-kilobase immediate-early RNA is a stable intron.
Immediate-early viral gene products of human cytomegalovirus (HCMV) are derived from several genomic loci and largely serve to establish a cellular environment conducive to viral replication. We have further examined an unusual immediate-early transcript known as the 5-kb RNA, concluding that it is a stable intron encoded by HCMV. The 5-kb RNA is highly AT rich in sequence and lacks open reading frames likely to be translated into protein. We confirmed the absence of polyadenylation of the transcript and showed that it is primarily nuclear localized during viral infection. We mapped the 5' end of the 5-kb RNA to a consensus splice donor site and localized the 3' end in the vicinity of a splice acceptor site. In transfection studies, we showed that the 5-kb RNA can be spliced from a heterologous primary transcript. Using bacterial artificial chromosome technology, we constructed a viral recombinant containing a mutation in the 5' splice donor site that defines the 5' end of the RNA and found that this mutation eliminates expression of the 5-kb RNA during viral infection. This mutant grows in human fibroblasts without complementation. Taken together, these data support the conclusion that the 5-kb RNA is a stable intron expressed by HCMV.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="212" length="8"></location><text>cellular</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="611" length="7"></location><text>nuclear</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1187" length="11"></location><text>fibroblasts</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="926" length="10"></location><text>chromosome</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMID-12338811</id><passage><offset>0</offset><text>The patterns of internal migration in Maharashtra:  an analysis of 1971 census data.
Patterns of internal migration in the state of Maharashtra, India, for the period 1961-1971 are analyzed using 1971 census data.  The nature, volume, and direction of migration are examined.  Migrants are characterized according to factors including age, sex, marital status, occupation, and areas of origin and destination.
</text></passage></document><document><id>PMC-2879834-sec-01</id><passage><offset>0</offset><text>Summary
Kindt et al.1 published a report entitled "Intestinal immune activation in presumed post-infectious functional syspepsia" in the August issue of Neurogastroenterology and Motility in 2009. By comparing the signs of inflammation and the degree of hyperplasia of the enterochromaffin cells (EC) in duodenal biopsies obtained from patients with presumed post-infectious functional dyspepsia (PI-FD) and unspecified-onset functional dyspepsia (U-FD), they showed that PI-FD is associated with persistence of focal T-cell aggregates, decrease in CD4+ cells and increased macrophage counts surrounding the crypts, without any significant differences in the numbers of EC or chromogranin A (CA)-positive cells (mast cells). This finding may indicate impaired ability of the immune system in these cases to terminate the inflammatory response after an acute insult.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="574" length="10"></location><text>macrophage</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="608" length="6"></location><text>crypts</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="518" length="6"></location><text>T-cell</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="712" length="10"></location><text>mast cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="549" length="10"></location><text>CD4+ cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="775" length="13"></location><text>immune system</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="670" length="2"></location><text>EC</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="676" length="34"></location><text>chromogranin A (CA)-positive cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="51" length="10"></location><text>Intestinal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="297" length="2"></location><text>EC</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="273" length="22"></location><text>enterochromaffin cells</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T2" role=""></node><node refid="T3" role=""></node></relation></passage></document><document><id>PMC-3173373-caption-02</id><passage><offset>0</offset><text>Parameters derived from normalized averaged data across participants
</text></passage></document><document><id>PMID-15202937</id><passage><offset>0</offset><text>Effects of buffer properties on cyclodextrin glucanotransferase reactions and cyclodextrin production from raw sago (Cycas revoluta) starch.
Results from the present study have shown that the ionic species of buffers, pH values and reaction temperature can affect the enzyme unit activities and product specificity of Toruzyme (Novo Nordisk A/S Bagsvaerd, Denmark) CGTase (cyclodextrin glucanotransferase). Applying a similar reaction environment (acetate buffer, pH 6.0; temperature, 60 degrees C), the CGTase was found to be capable of producing pre dominantly beta-cyclodextrin from either raw or gelatinized sago (Cycas revoluta) starch. Changing the buffer from acetate to phosphate reduced the yield of beta-cyclodextrin from 2.48 to 1.42 mg/ml and also affected the product specificity, where production of both alpha- and beta-cyclodextrins were more pronounced. The decrease in the production of cyclodextrins in phosphate buffer was significant at both pH 6.0 and 7.0. However, changing the buffer to Tris/HCl (pH 7.0) showed a significant increase in beta-cyclodextrin production. Increasing the ionic strength of sodium acetate and Tris/HCl buffers at pH 6.0 and 7.0 to equivalent ionic strength of phosphate buffers showed no significant effects on cyclodextrin production. Higher yield of cyclodextrins at pH 7.0 when Tris/HCl was used might be due to the binding of chloride ions at the calcium-binding sites of the CGTase, resulting in the shift of the optimum pH close to physiological environment, leading to an increase in the activities and specificity.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="133" length="6"></location><text>starch</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="634" length="6"></location><text>starch</text></annotation></passage></document><document><id>PMC-1852096-sec-05</id><passage><offset>0</offset><text>Case Presentation
The patient is an 80 year old male with diabetes mellitus and hypertension, who at age 74 (March 2001) had received a living non-related donor kidney transplant. At that time he was discharged with a double immunosuppressive therapy consisting of prednisone 20 mg/day and mophetil mycophenolate 1.5 gr/day. No calcineurin inhibitor was administered. His prednisone dose was further decreased to 5 mg/day and mophetil mycophenolate doses sustained. In November 2001 he developed cutaneous purple elevated lesions in his lower limbs that were diagnosed as KS by skin biopsy. He received 19 administrations of vincristine (1 mg) and bleomycin (15 mg) weekly that resulted in flattening and fading of the lesions. Treatment was discontinued for two months, and KS recurred, with pain and edema in both legs.
On July 2002, with an almost 100% involvement of his lower limbs skin with KS but no visceral involvement he received 50 mg of liposomal-adriamycin. In addition, he was then prescribed valganciclovir 450 mg BID (corrected for creatinine clearance) [7] and three additional administrations of liposomal-adriamycin, up to December 2002. He showed 40% response again with early relapse. On January 2003 the patient developed disseminated herpes zoster, which was treated with IV acyclovir.
In May 2003 KS progression was observed and received radiotherapy with no benefit Figure 1. In August 2003 he started oral etoposide at 50 mg QD for two weeks followed by two weeks off until May 2004 achieving a very slow 50% response. Tolerance was good and serum creatinine remain stable at around 1,4 mg/dl. Mophetil mycophenolate dose was reduced to 1 g/day and prednisone to 2.5 mg/day.
Figure 1
Kaposi's sarcoma progressions after chemotherapy withdrawal, both lower limbs were completely covered with Kaposi's Sarcoma (June 2003).
On May 2004 the patient requested a second opinion and was prescribed Imatinib 200 mg qd for two weeks followed by 400 mg qd. After four weeks of Imatinib, his health deteriorated rapidly, he developed anasarca, worsening of KS, his serum creatinine increased from 1.4 mg/dl to 2.3 mg/dl and he developed grade 4 granulocytopenia (Figure 2). The patient was hospitalized with fever and was started on IV antibiotics and daily G-CSF for four days after which his WBC count normalized. Two weeks later the creatinine level returned to 1.5 mg/dl. On February 2005 he was started on 30 mg of paclitaxel IV every three weeks. After three courses with no clinical benefit he developed a skin rash that prompted discontinuation.
Figure 2
Patient developed anasarca with rapid progression of Kaposi's Sarcoma after four weeks of taking Imatinib (June 2004).
On April 2005, he was started on Sirolimus 2 mg a day, and after 8 weeks escalated to 4 mg a day. Three weeks later mophetil mycophenolate and prednisone were discontinued. Sustained and significant KS regression was evident after 16 weeks, but he developed a basal cell carcinoma and pneumonia that required hospital admission; Sirolimus dose was lowered to 2 mg a day. Thereafter his clinical course has been satisfactory with continuous and progressive regression of KS lesions (Figure 3). His serum creatinine has remained under 1.6 mg/dl and he has not developed new infectious episodes.
Figure 3
Extensive regression of Kaposi Sarcoma after immune-suppression was changed to Sirolimus, (14 months later), he only has hyperpigmented areas at knee levels, skin looks thin and delicate and easily bruised (July 2006).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="802" length="5"></location><text>edema</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="816" length="4"></location><text>legs</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="578" length="4"></location><text>skin</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="719" length="7"></location><text>lesions</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="572" length="2"></location><text>KS</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2596" length="8"></location><text>anasarca</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="875" length="16"></location><text>lower limbs skin</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1568" length="5"></location><text>serum</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="775" length="2"></location><text>KS</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="3457" length="4"></location><text>skin</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="3444" length="4"></location><text>knee</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="3323" length="14"></location><text>Kaposi Sarcoma</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="3194" length="5"></location><text>serum</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="3167" length="10"></location><text>KS lesions</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2957" length="20"></location><text>basal cell carcinoma</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="161" length="6"></location><text>kidney</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="537" length="11"></location><text>lower limbs</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="522" length="7"></location><text>lesions</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="897" length="2"></location><text>KS</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2309" length="3"></location><text>WBC</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2528" length="4"></location><text>skin</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1710" length="16"></location><text>Kaposi's sarcoma</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1776" length="11"></location><text>lower limbs</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1817" length="16"></location><text>Kaposi's Sarcoma</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2049" length="8"></location><text>anasarca</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2080" length="5"></location><text>serum</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2631" length="16"></location><text>Kaposi's Sarcoma</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1321" length="2"></location><text>KS</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2896" length="2"></location><text>KS</text></annotation></passage></document><document><id>PMC-2840784-sec-02</id><passage><offset>0</offset><text>CASE:
Here for the first time a case of CDLS from Iran, a 15-week-old male infant who was refereed as a case of multiple congenital anomalies. Clinical investigation showed that the child was a case of CDLS.
</text></passage></document><document><id>PMID-7806663</id><passage><offset>0</offset><text>Image-directed and color Doppler studies of gallbladder tumors.
Thirteen cases of primary adenocarcinoma of the gallbladder (GB), 1 of malignant fibrous histocytoma, 3 of metastatic adenocarcinoma, 5 of adenoma, 5 of polypus, 2 of xanthogranuloma, 6 of chronic cholecystitis, 4 of acute cholecystitis, and 8 of subacute cholecystitis were studied by image-directed and color Doppler ultrasonography (CDUS). All of the 14 cases of primary GB cancer (10 masses, 4 thickening wall) were found to have a high velocity arterial blood flow signal in the wall of the GB. In contrast, the 3 cases of metastatic cancer of the GB had no blood flow signal in the wall of the GB. For the 30 cases of benign lesions of the GB, only in 12 cases was a low velocity blood flow signal found. Nine of 10 cases of primary GB malignancy were found to have high velocity arterial blood flow signals in the tumor masses. No blood flow signal was observed in the masses of 13 cases (3 of metastatic adenocarcinoma, 5 of adenoma, 5 of polypus). An abnormal high velocity arterial blood flow signal observed within masses in the GB or in the GB wall is a significant feature of primary GB cancer and thus helps to differentiate primary GB cancer from metastatic and benign lesions of the GB.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="171" length="25"></location><text>metastatic adenocarcinoma</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="203" length="7"></location><text>adenoma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="125" length="2"></location><text>GB</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="135" length="29"></location><text>malignant fibrous histocytoma</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1011" length="7"></location><text>polypus</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="997" length="7"></location><text>adenoma</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="965" length="25"></location><text>metastatic adenocarcinoma</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="217" length="7"></location><text>polypus</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="902" length="5"></location><text>blood</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="231" length="15"></location><text>xanthogranuloma</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="885" length="5"></location><text>tumor</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="850" length="14"></location><text>arterial blood</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="803" length="13"></location><text>GB malignancy</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="750" length="5"></location><text>blood</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="710" length="2"></location><text>GB</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="688" length="14"></location><text>benign lesions</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="44" length="18"></location><text>gallbladder tumors</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="112" length="11"></location><text>gallbladder</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="90" length="14"></location><text>adenocarcinoma</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="438" length="9"></location><text>GB cancer</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="473" length="4"></location><text>wall</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1263" length="2"></location><text>GB</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="514" length="14"></location><text>arterial blood</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="548" length="4"></location><text>wall</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="560" length="2"></location><text>GB</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1211" length="9"></location><text>GB cancer</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="592" length="17"></location><text>metastatic cancer</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1161" length="9"></location><text>GB cancer</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="617" length="2"></location><text>GB</text></annotation><annotation id="T36"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1241" length="14"></location><text>benign lesions</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="627" length="5"></location><text>blood</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1226" length="10"></location><text>metastatic</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="652" length="4"></location><text>wall</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1047" length="14"></location><text>arterial blood</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="664" length="2"></location><text>GB</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1117" length="7"></location><text>GB wall</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1104" length="2"></location><text>GB</text></annotation><relation id="R6"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T35" role="Arg1"></node><node refid="T36" role="Arg2"></node></relation><relation id="R7"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T36" role="Arg1"></node><node refid="T37" role="Arg2"></node></relation><relation id="R4"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T18" role="Arg1"></node><node refid="T19" role="Arg2"></node></relation><relation id="R5"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T20" role="Arg1"></node><node refid="T21" role="Arg2"></node></relation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T13" role="Arg1"></node><node refid="T14" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T15" role="Arg1"></node><node refid="T16" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T2" role="Arg1"></node><node refid="T3" role="Arg2"></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T3" role=""></node><node refid="T4" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation></passage></document><document><id>PMC-3172042-caption-03</id><passage><offset>0</offset><text>(a) The Tn6087 target site within S. oralis F.MI.5. (b) The left end and (c) right end of Tn6087 are shown in bold. (d) The joint of the circular intermediate of Tn6087 is shown. The transposon's coupling sequences are shown in bold italics. As can be seen in (d), the coupling sequence at the joint of the circular form is a heteroduplex.
</text></passage></document><document><id>PMC-2845033-sec-09</id><passage><offset>0</offset><text>Applying A1C cut offs to the AusDiab population (4.6% undiagnosed diabetes)
Applying the same cut offs, a total 75.9% of the AusDiab population had diabetes ruled in or ruled out (Fig. 1B), while the remaining 24.1% had impaired A1C. From those with impaired A1C, 69.3% had abnormal glucose status. For diabetes, A1C at 5.5% provided moderate sensitivity (83.5%) but high NPV (99.0%), since diabetes prevalence was lower in the AusDiab than in the MP population. A1C at 7.0% gave 100% specificity and 100% PPV. By dropping the cut off to 6.5%, specificity remained 99.9%, with PPV near 100%.
</text></passage></document><document><id>PMID-8010976</id><passage><offset>0</offset><text>Inhibition of calmodulin-dependent myosin light-chain kinase by growth-hormone-releasing factor and vasoactive intestinal peptide.
In view of the ability of calmodulin to bind vasoactive intestinal peptide (VIP) and growth-hormone-releasing factor (GRF) with high affinity [Stallwood, Brugger, Baggenstoss, Stemmer, Shiraga, Landers and Paul (1992) J. Biol. Chem. 267, 19617-19621], the effects of these neuropeptides on a model calmodulin-dependent enzyme, myosin light-chain kinase (MLCK), were studied. Both peptides were potent inhibitors of MLCK activity. The inhibition of enzyme activity by VIP and GRF was progressively overcome with increasing calmodulin concentrations, with no inhibition observed at a saturating calmodulin concentration. Nanomolar concentrations of MLCK blocked the formation of calmodulin-[125I-Tyr10]VIP complexes. These data provide support for a functional role of VIP and GRF binding by calmodulin.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="111" length="10"></location><text>intestinal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="187" length="10"></location><text>intestinal</text></annotation></passage></document><document><id>PMC-2528170-sec-05</id><passage><offset>0</offset><text>Printing solution
Several transfection reagents were tested (data not shown), and we found that the X-tremeGENE siRNA transfection reagent (Roche) gave good transfection efficiencies both for plasmids and siRNAs, and chose to use this reagent for all transfected cell microarray experiments in the present study. For printing the arrays, one major challenge is to find a good balance between high transfection efficiency and spatially confined spots to avoid cross-contamination between the spots. In order to optimize the reverse transfection protocol for HEK 293ind-ICER IIgamma cells (see below) and X-tremeGENE transfection reagent, we investigated the effect of varying the concentrations of gelatine and sucrose in the printing solution. These reagents have been reported to influence both the transfection efficiency and spot integrity (6,27). Sucrose was observed to be specifically beneficial for obtaining high transfection efficiency when storing the arrays for several weeks before use (data not shown). Figure 1A and B show representative images of the observed effects of varying the concentrations of gelatine and sucrose. We observed that the transfection efficiency increased with increasing gelatine concentration (tested in the range 0.01-0.40%). However, an increased disturbance of the spatial definition of the spots was observed with increasing concentrations of gelatine or sucrose (tested in the range 0-100 mM). A combined effect of the concentrations of gelatine and sucrose was also observed, as low concentrations of gelatine allowed us to use higher concentrations of sucrose than with higher concentrations of gelatine before cells spread outside the spots. Based on several optimizing experiments, we found that 3 microl X-tremeGENE solution per microgram nucleic acid, 25 mM sucrose and 0.1% gelatine in the final printing solution reproducibly gave spatial restricted transfection with high transfection efficiency printing the arrays with both a pipette tip and a hand-held arrayer (see below). 
Figure 1.
Effects of sucrose and gelatine concentrations on spot integrity and transfection efficiency. (A) Array printed with pDsRed (50 ng/microl) in a printing solution with different gelatine and sucrose concentrations. Scanning image of the whole array and magnifications of specific spots. (B) Array printed with pEGFP (50 ng/microl) in a printing solution with 25 mM sucrose and four different concentrations of gelatine. Top: Box plot of the fluorescence intensities in each spot (n = 32-34). Bottom: Scanning image showing squares of seven times five spots for the four gelatine concentrations. From left to right: 0.01, 0.05, 0.1 and 0.2% gelatine. The DNA-lipid-gelatine-sucrose solutions were printed manually with a 10 microl pipette tip (A) or by MicroCasterTM manual arrayer system (B).
In a 1.5 ml microcentrifuge tube, plasmid (1 microg/microl) and siRNA were mixed with growth medium without fetal calf serum (FCS), 0.5 microl 1.5 M sucrose and 3 microl X-tremeGENE per microgram nucleic acid to a final volume of 22.5 microl. After 15-20 min of incubation, 7.5 microl 0.4% gelatine (Type B, G9391, Sigma) was added to give 30 microl printing solution. The gelatine solution was prepared as described by Ziauddin and Sabatini (1). To achieve sufficient level of expression from the transfected plasmids, 25-50 ng/microl pEGFP-N1 or pDsRed-express-N1 and 50-75 ng/microl of CRE or NFkappaB reporter plasmids was used. For siRNA studies, 2-30 ng/microl siRNA in the final printing solution was used.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2952" length="5"></location><text>serum</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="3447" length="8"></location><text>plasmids</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1657" length="5"></location><text>cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="192" length="8"></location><text>plasmids</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="2941" length="5"></location><text>fetal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="557" length="29"></location><text>HEK 293ind-ICER IIgamma cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="263" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMC-1182367-sec-19</id><passage><offset>0</offset><text>Figures and Tables
Figure 1
Allergen and particle dose-response experiments in BALB/cA and NIH mice Levels of serum OVA-specific IgE (A, D), IgG1 (B, E) and IgG2a (C, F) on day 26 after injection into one hind footpad of 100 (open columns), 50 (gray) or 10 (black) mug OVA combined with 100, 40, 10 or 0 mug PSP, or buffer (HBSS (hatched)), in BALB/cA (A, B, C) and NIH (D, E, F) mice. On day 21 the mice were boostered with the same OVA dose in the footpad. The PSP-control ("PSP ctr") group was given 100 mug PSP on day 0, followed by HBSS injection on day 21 (diamonds). Values (arbitrary units, AU) for individual mice (circles) and median values (columns) for groups of eight mice are shown. Dotted lines indicate the lower or higher detection limits for the ELISA assays. Note different scales for the two strains of mice.
Figure 2
The adjuvant effect of PSP on OVA-specific IgE and IgG2a responses in different strains of mice Levels of serum OVA-specific IgE (A) and IgG2a (B) on day 26 after injection into one hind footpad of HBSS (open columns), 10 mug OVA (gray), 40 mug PSP (hatched) or 10 mug OVA + 40 mug PSP (black) in different mouse strains. On day 21 all mice were boostered with 10 mug OVA in the footpad. Vertical straight lines indicate separate experiments. Values (arbitrary units, AU) for individual mice (circles) and median values (columns) for groups of mice are shown. Dotted lines indicate the lower detection limits for the ELISA assays. Brackets indicate statistically significant differences between groups (p &lt; 0.05). All experiments were performed twice with similar results, with eight mice per group.
Figure 3
The primary cellular response in the draining lymph node The primary cellular response in the draining PLN was determined five days after a single injection of HBSS (open columns), 10 mug OVA (gray), 40 mug PSP (hatched) or 10 mug OVA + 40 mug PSP (black) into both hind footpads of BALB/cA, NIH and C3H/HeN mice. The total lymph node cell numbers (A) and IL-4 (B), IFN-gamma (C) and IL-10 (D) secreted from the PLN cells after ex vivo stimulation with Con A were determined. Values for individual samples (circles) and group median values (columns) are shown. Dotted lines indicate the lower detection limits for the cytokine ELISA assays, and brackets indicate statistically significant differences between groups (p &lt; 0.05).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="110" length="5"></location><text>serum</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="450" length="7"></location><text>footpad</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="205" length="12"></location><text>hind footpad</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1217" length="7"></location><text>footpad</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1659" length="8"></location><text>cellular</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="944" length="5"></location><text>serum</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1020" length="12"></location><text>hind footpad</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1750" length="3"></location><text>PLN</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1971" length="15"></location><text>lymph node cell</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2059" length="9"></location><text>PLN cells</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2145" length="7"></location><text>samples</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1693" length="10"></location><text>lymph node</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1716" length="8"></location><text>cellular</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T13" role=""></node></relation></passage></document><document><id>PMID-16850045</id><passage><offset>0</offset><text>Fluoroscopically guided cervical prolotherapy for instability with blinded pre and post radiographic reading.
BACKGROUND:
Several authors have postulated that cervical instability is a major cause of traumatic spinal pain.
OBJECTIVE:
The purpose of this prospective case series study (n = 6) was to determine if proliferant injections have an effect on cervical translation as measured by a blinded reader.
DESIGN:
This study was a prospective case series. Study participants were selected from patients seen for the primary complaint of Motor Vehicle Collision related neck pain in a private sub-specialty pain clinic.
METHODS:
Flexion and extension views were obtained by standard radiographs taken with a C-Arm fluoroscope under Valium sedation. Patients with more than 2.7 mm of absolute cervical translation and at least 50% reduction of cervical and referred pain with a two day rigid cervical immobilization test were admitted into the study. Participants underwent 3 prolotherapy injections at all sites that demonstrated translation. The difference in means between pre-test and post-test measurements (flexion translation, extension translation, and pain VAS scores) were assessed by a Wilcoxon signed ranks test (alpha = 0.05).
RESULTS:
The mean post-test VAS score (M= 3.83, SD=2.3, t=2.889) was significantly less (p=0.04) than the mean pre-test VAS score (M=5.75, SD=1.94). The correlation between difference in mean extension at C2-3 and C5-6 and difference in mean extension was significant (rho=0.89, p=0.02 and rho=0.85, p=0.03 respectively). Difference in mean flexion at C3-4 and C4-5 was significantly correlated with difference in mean flexion (rho=0.88, p=0.02 and rho=0.941, p &lt;0.01 respectively).
CONCLUSIONS:
The results of this study demonstrate statistically significant correlations between proliferant injections, a reduction of both cervical flexion and extension translation, as well as a reduction in pain VAS score. Since patients with traumatic cervical instability have few viable treatment options other than surgical fusion, cervical proliferant injections under C-Arm fluoroscope may be a viable treatment option.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="792" length="8"></location><text>cervical</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="843" length="8"></location><text>cervical</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="353" length="8"></location><text>cervical</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1980" length="8"></location><text>cervical</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="570" length="4"></location><text>neck</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="2063" length="8"></location><text>cervical</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="891" length="8"></location><text>cervical</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1864" length="8"></location><text>cervical</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="24" length="8"></location><text>cervical</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="210" length="6"></location><text>spinal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="159" length="8"></location><text>cervical</text></annotation></passage></document><document><id>PMC-3144695-caption-01</id><passage><offset>0</offset><text>Genes associated with nonsegmental vitiligo.
</text></passage></document><document><id>PMID-16089987</id><passage><offset>0</offset><text>Experimental investigation of equibiaxial extension and breakup of drops in a molten two-phase polymer blend.
We experimentally investigate the breakup of an equibiaxially elongated polystyrene (PS) drop in a poly(methyl methacrylate) (PMMA) matrix during relaxation after melt elongation. In equibiaxial elongation, the initially spherical PS drop is deformed into an ellipsoidal disclike shape for our test parameters. Using a hotstage in combination with a light microscope, we observe the evolution of the drop shape during relaxation. In the initial stage of relaxation, fingers and holes are formed. The holes are located preferentially near the rim of the drop. The number and the size of the holes increase with time such that the elongated PS drop attains a complex shape during relaxation. The fingers form bulbous ends which separate from the fingers. We discuss the dynamics of this breakup process by taking into account the interfacial energy between PS and PMMA. Our analysis shows that a very large number of small PS droplets can be generated by the sequential breakup of the elongated PS drop.
</text></passage></document><document><id>PMC-194858-caption-04</id><passage><offset>0</offset><text>Extrapyramidal symptoms based on Extrapyramidal Symptoms Rating Scale
</text></passage></document><document><id>PMID-12476350</id><passage><offset>0</offset><text>CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.
Chemokines and their receptors are constitutively present in the central nervous system (CNS), expressed in neurons and glial cells. Much evidence suggests that, beyond their involvement in neuroinflammation, these proteins play a role in neurodevelopment and neurophysiological signaling. The goal of this review is to summarize recent information concerning expression, signaling, and function of CXC chemokine receptor in the CNS, with the main focus on the developmental and neuromodulatory actions of chemokines in the cerebellum.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="227" length="11"></location><text>glial cells</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="631" length="10"></location><text>cerebellum</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="196" length="3"></location><text>CNS</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="215" length="7"></location><text>neurons</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="536" length="3"></location><text>CNS</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="31" length="22"></location><text>central nervous system</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="172" length="22"></location><text>central nervous system</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="63" length="10"></location><text>cerebellar</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T3" role=""></node><node refid="T4" role=""></node></relation></passage></document><document><id>PMID-17151534</id><passage><offset>0</offset><text>[Treatment of squamous intraepithelial lesion of type CIN2 et CIN3 with laser CO2 vaporization: retrospective study of 52 cases].
OBJECTIVES:
This study was carried out over an 8-year period in order to evaluate the long-term effectiveness of laser CO2 vaporization in the treatment of squamous intraepithelial lesion of type CIN2 and CIN3.
MATERIALS AND METHODS:
A retrospective study of 52 cases of cervical lesions of type CIN2 and CIN3 treated in first intention by laser CO2 vaporization was carried out at the hospital Jeanne-de-Flandre in CHRU of Lille from 1996 to 2003. This treatment was performed on only high-grade exo-cervical lesions, of small size (&lt;2cm2), after a complete colposcopic examination.
RESULTS:
Fifty-two patients were treated by first-intention laser vaporization only. Mean age was 29.4 years and 51.9% were nulliparous. At the first cyto-colposcopic control, there were 17 persistent lesions (32.7%). Among the 35 patients without persistent lesion, 29 achieved cure (absence of recurrence), 4 presented a recurrence and 2 were lost to follow-up.
CONCLUSION:
The current data of the literature concerning the treatment by laser CO2 vaporization authorize application of this method for certain high-grade exocervical lesions after a complete colposcopic examination. This type of treatment remains less aggressive than a surgical treatment. The high rate of residual lesions in particular in the event of CIN3 can be due to an incomplete destruction of the lesion. Patients should thus be advised that monitoring is an integral part of the treatment. Laser vaporization could be limited to CIN1 and CIN2 lesions.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="915" length="7"></location><text>lesions</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="973" length="6"></location><text>lesion</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1488" length="6"></location><text>lesion</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="627" length="20"></location><text>exo-cervical lesions</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1635" length="7"></location><text>lesions</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1236" length="19"></location><text>exocervical lesions</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1398" length="7"></location><text>lesions</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="14" length="31"></location><text>squamous intraepithelial lesion</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="401" length="16"></location><text>cervical lesions</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="286" length="31"></location><text>squamous intraepithelial lesion</text></annotation></passage></document><document><id>PMC-2972690-sec-19</id><passage><offset>0</offset><text>Discussion
Our results indicate beneficial effects of motivational incentives on cognitive performance and alleviating effects on cognitive decline. These beneficial effects were evident in healthy young and older adults and in patients with Parkinson's disease. Young adults showed improved antisaccade preparation when a reward was at stake; older adults and PD patients could utilize reward prospect to improve their impaired antisaccade preparation. Elderly participants and PD patients were not only better prepared by means of commonly used preparatory aids (i.e., more preparation time and advance information on the upcoming response) but also by means of motivational incentives. These beneficial effects of motivational incentives on cognitive action preparation in healthy and pathological aging further support views that question the notion of monotonic deterioration of cognitive function with age (Allen et al., 2001). They indicate that age-related declines can be modulated by emotion-cognition interactions.
In line with the predominant view that cognitive control deteriorates in aging and Parkinson's disease, and in line with previous findings on age-related changes in antisaccade control specifically (Eenshuistra et al., 2004; Chan et al., 2005; Amador et al., 2006; Abel and Douglas, 2007), the current results showed decline in antisaccade preparation in PD patients with severe motor symptoms as compared to healthy seniors. Mild-symptom patients and healthy elderly did not differ in antisaccade preparation. Healthy seniors showed declining antisaccade preparation as compared to young adults. Decline was evident on several oculomotor parameters and most pronounced on antisaccade onset latencies. In line with the notion that in general, elderly tend to prefer accuracy over speed, elderly showed no decreased antisaccade accuracy as compared to young adults. As compared to the young group, elderly and PD patients exhibited slightly, but not significantly more premature eye movements. Premature eye movements, however significantly increased in elderly and PD patients but only slightly in the young, when more specific information on the upcoming movement was available in advance. Presumably, this increase in premature eye movements reflects difficulties with the inhibition of externally guided movement and/or the suppression of strongly activated prepotent action plans. On the one hand, the choice for medicated PD patients represents a limitation of the current study as we cannot exclude differential effects of medication on behavior. On the other hand, PD patients generally take medication in their daily routine, such that the results can be generalized to clinical practice. Exploratory analysis within the PD patient group revealed that patients with more severe motoric symptoms (as indexed by their motoric subscore on the UPDRS) displayed more signs of antisaccade decline, such as longer antisaccade latencies and lower accuracy compared to mildly affected patients, who initiated saccades equally fast as healthy adults. This suggests that dopaminergic medication was not sufficient to raise the patient's antisaccadic preparation up to the level of the healthy older adults.
One intriguing observation was that despite the different extents of observed antisaccade performance decline in elderly and PD patients, reward prospect led to beneficial effects on antisaccade latency and accuracy in young, elderly, and PD patients alike. Young, elderly and PD patients benefited from reward prospect to the same extent, confirming that the expectancy of reward is a powerful mediator of cognitive control, even if cognitive control suffers from decline. The expectation of rewarding incentives thus seems to support older adults' and PD patients' ability to anticipate, prepare and initiate goal-directed behavior.
These findings imply that despite a general decline in the action preparation system as indexed by increased antisaccade latency, action preparation processes remain susceptible to the prospect of future reward. It could thus be argued that the neural representations of upcoming rewards influence neural systems concerned with action preparation and oculomotor control. Although the current behavioral results cannot exclude or confirm neural links between reward anticipation and action preparation systems in the brain, they suggest intact cross-talk among subcortical circuits that allow goal-directed action to be modified by motivational factors. The motivational neural reward anticipation signal presumably activates the reward network including the amygdala, orbitofrontal cortex, the more ventral and dorsal striatum (nucleus accumbens, putamen, and caudate), leading to an release of caudate/SNr inhibition on the executive oculomotor structure superior colliculus. This transiently decreased inhibitory force on superior colliculus may improve goal-directed oculomotor control. Thus reward anticipation might compensate for the age- and disease-related dopaminergic loss in the SNc projections to the caudate/SNr and may thus play a compensatory role in "boosting" the efficiency of interactions between motivational and impaired cognitive control processes.
However the reward-related modulation of the oculomotor control system may not only apply to the basal ganglia part of the oculomotor network. Although speculative, it could extend to the cortical eyefields (frontal, supplementary, and parietal eyefields) and to parts of the visual cortex. Human research shows that more preparatory activation in the frontal eyefields leads to a faster antisaccade latency (Connolly et al., 2002, 2005). The compensatory effect on the antisaccade latency, therefore, could theoretically stem from a propagation of reward anticipation signal in the caudate to the frontal eyefields. Complex structural connections enable the striatum to exert a controlling influence over the cerebral cortex via a series of reentrant corticobasal ganglia circuits. Thus reward anticipation may increase the level of preparation in the intact cortical eyefields and thereby compensate for age- and disease-related subcortical decrements in the oculomotor network.
Taken together, it seems plausible that motivational reward processes in the caudate enhance preparatory activation in subcortical as well as in cortical nodes of the oculomotor network. Several neurotransmission mechanisms may underlie the remedial effect of positive incentives on declining antisaccadic control. Given the convergence of dopamine and glutamate inputs at the spiny projection neurons in the striatum (Burns et al., 1994), an interaction between dopamine and glutamate might underlie striatal processes of reward anticipation and action preparation. However, it cannot be fully excluded that alterations in other neurotransmitter systems may also have an effect on declining oculomotor control and on remediating incentive effects. Non-dopaminergic changes such as noradrenergic, serotonergic, and cholinergic deafferentation of the cortex also occur in PD and can inflict cognitive deficits (Agid et al., 1987). Evidence from non-human primates suggests that basal ganglia dopamine acts to speed motor responding in response to rewarding cues (Niv, 2007; Niv et al., 2007). Among at least five types of DA receptors, mainly D1 and D2 receptors are expressed in caudate projection neurons (Nakamura and Hikosaka, 2006). Tendencies to speed responses to obtain large rewards have been found to be dependent on striatal D1 receptors (Dalley et al., 2005; Berridge, 2007). In contrast to this D1 modulated speeding in reward-motor tasks, evidence from saccade tasks in non-human primates suggests D2 receptor modulation of reward dependent improvements of performance (Nakamura and Hikosaka, 2006). Injections of a D1 antagonist and a D2 antagonist into the region of the caudate where saccade-related neurons are clustered while the monkey performed a reward-biased saccade task showed that D1 antagonists attenuate the reward modulation of saccade behavior whereas D2 antagonists into the same region enhanced the reward-dependent changes.
Future studies of Parkinson patients on versus off medication, could provide some information on the role of dopaminergic mechanisms in the remedial effects on antisaccadic performance. A recent study of reward learning in Parkinson patients on/off dopaminergic medication showed that patients adapted their behavior to maximize expected reward value dependent on their medication status (Moustafa et al., 2008). Whilst off dopaminergic medication, patients slowed their responses to avoid low expected values, but succeeded less well in speeding responses when a reward was at stake. The opposite pattern emerged when the same patients were on medication; patients showed better response speeding, and worse response slowing, to maximize expected value.
The current behavioral findings are in line with neuroimaging research showing intact neural representations of future reward in the aging striatum (Samanez-Larkin et al., 2007). The observation however that older adults and PD patients can use this intact neural representation of reward anticipation (a positive motivational incentive) to optimize their preparatory processes, cannot necessarily be generalized to cognitive contexts with negative motivational incentives. Samanez-Larkin et al.(2010) recently showed that older adults were not able to optimally use their intact neural reward anticipation system in risky financial decision making. Elderly made more suboptimal choices when they were to choose risky assets. The authors deemed it likely that these decrements in value-based decision making are explained by the fact that value-based decision making requires the weighting of behavioral alternatives, that may lead to either gain or loss. During anticipation of rewards older adults show similar neural responses as young adults but they show reduced neural activation during the anticipation of losses (Samanez-Larkin et al., 2007). The latter, together with the observation that older adults tend to shift their attention away from negative stimuli and attend to positive information instead (Mather and Carstensen, 2003, 2005), may have led to the underestimation of loss and therefore to more risky and suboptimal decisions.
In this respect, one limitation of the current task is that it built solely on reward prospect and not on the prospect of loss, such that the question of how the anticipation of loss influences action preparation was not tested. The impact of negative incentives might be an intriguing question for future research, as due to the decreased activation of the neural loss anticipation system (Samanez-Larkin et al., 2007) together with the observed differential attentional bias for negative and positive information (Mather and Carstensen, 2003), it seems likely that negative motivational incentives, i.e., the prospect of loss, might have a different impact on action preparation in older adults than in the young. Future approaches to the effect of loss anticipation on declining antisaccade control may ideally contain a sequence of experiments, starting with a separate (punishment only) approach before moving to combined reward-punishment designs. This might be necessary as previous evidence (from healthy young adults) suggests that the reward effect on oculomotor control disappears in the presence of punishment trials. The authors deemed it likely that the participants increased caution to all incentive (reward and punishment) trials (Blaukopf and DiGirolamo, 2006).
As of yet, age-related changes in neural reward anticipation have mainly been studied in isolation. Recently however, the interaction of neural reward processing with other cognitive functions and their underlying neural systems, such as the action control system, has gained increasing interest (Haber and Knutson, 2010). Initial evidence suggests coordinated activity between distant brain regions responsible for reward processing (Cohen et al., 2009). The current results encourage further neural network investigations on the role of coordinated brain network activity in motivated behavior. Behavioral benefits from motivation might be associated with changes in functional brain connectivity on a larger scale, e.g., between frontostriatal reward and action preparation structures.
Another important factor that emerges from the present and previous results, is the importance of the training of the motivational aspects of the instructions that need to be kept in working memory when performing a cognitive task. Samanez-Larkin et al. (2007) found intact neural reward anticipation processes specifically in the absence of learning (after the learning process of reward cue-reward associations was completed). Therefore it might be important for researchers doing experiments with motivation based instructions to keep in mind that, compared to young adults, elderly and PD patients are generally hampered on stimulus-response learning (Shohamy et al., 2004; Marschner et al., 2005). Reward instruction cues, as they were used in the current study require participants to form reward cue-reward associations. Impairments in the learning of associations between the cue signaling reward and the actual reward might conceal intact reward anticipation processes. When the formation of associations is weakened, it could appear as a failure to capitalize on the neural reward anticipation system, whereas it represents an indirect effect of non-available reward associations in working memory when preparing the response. Hence, one might circumvent the effect of potential learning impairments on reward anticipation processes by the training of abstract reward cues (as in the current and in Samanez-Larkin's study) or by using explicit and concrete rewards. Once the learning of reward cues is accomplished the intact reward anticipation processes might become evident.
In sum, the results confirmed that the preparation of goal-directed actions declined in PD patients compared to healthy seniors, and in healthy seniors compared to young adults. Due perhaps to deterioration in dopaminergic striatal circuitry, antisaccade performance is subject to decline in healthy seniors, and even more in individuals with Parkinson's disease. The prospect of future reward however provided a motivational incentive for optimizing oculomotor preparation in all groups alike. These results suggest that reward-processing networks and oculomotor-control networks in the brain are connected in such a way (presumably with the dorsal striatum as a common nexus) that reward anticipation can facilitate oculomotor control and alleviate the deficiencies experienced by healthy seniors and PD patients. Future investigations should examine whether the observed effects are specific for the current task or generalize to other tasks that show age- and PD-related cognitive decrements (e.g., in task switching) and have been related to dopaminergic denervation in the caudate (e.g., impaired verbal episodic memory, attention, and response inhibition; Rinne et al., 2000; Bruck et al., 2005). Future studies on network processes may help to localize the neural link between reward prospect and action preparation that enables alleviating effects of motivational incentives on cognitive decline.
</text><annotation id="T75"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="15296" length="6"></location><text>neural</text></annotation><annotation id="T76"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5819" length="7"></location><text>caudate</text></annotation><annotation id="T73"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="14749" length="10"></location><text>oculomotor</text></annotation><annotation id="T74"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="15110" length="7"></location><text>caudate</text></annotation><annotation id="T79"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6718" length="8"></location><text>striatal</text></annotation><annotation id="T77"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="7903" length="7"></location><text>caudate</text></annotation><annotation id="T78"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="14482" length="10"></location><text>oculomotor</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5472" length="18"></location><text>parietal eyefields</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5453" length="13"></location><text>supplementary</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5444" length="7"></location><text>frontal</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5424" length="18"></location><text>cortical eyefields</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5359" length="18"></location><text>oculomotor network</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5333" length="13"></location><text>basal ganglia</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5281" length="25"></location><text>oculomotor control system</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4935" length="10"></location><text>oculomotor</text></annotation><annotation id="T72"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="14674" length="15"></location><text>dorsal striatum</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4889" length="19"></location><text>superior colliculus</text></annotation><annotation id="T71"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="14619" length="5"></location><text>brain</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4800" length="40"></location><text>oculomotor structure superior colliculus</text></annotation><annotation id="T70"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="14584" length="27"></location><text>oculomotor-control networks</text></annotation><annotation id="T62"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="11896" length="21"></location><text>action control system</text></annotation><annotation id="T63"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="12040" length="5"></location><text>brain</text></annotation><annotation id="T64"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="12148" length="14"></location><text>neural network</text></annotation><annotation id="T65"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="12205" length="5"></location><text>brain</text></annotation><annotation id="T66"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="12334" length="5"></location><text>brain</text></annotation><annotation id="T67"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="12386" length="14"></location><text>frontostriatal</text></annotation><annotation id="T68"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="12717" length="6"></location><text>neural</text></annotation><annotation id="T69"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="13520" length="6"></location><text>neural</text></annotation><annotation id="T38"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6197" length="18"></location><text>oculomotor network</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6167" length="11"></location><text>subcortical</text></annotation><annotation id="T39"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6294" length="7"></location><text>caudate</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5946" length="15"></location><text>cerebral cortex</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5895" length="8"></location><text>striatum</text></annotation><annotation id="T36"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6096" length="18"></location><text>cortical eyefields</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5978" length="30"></location><text>reentrant corticobasal ganglia</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5512" length="13"></location><text>visual cortex</text></annotation><annotation id="T61"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="11868" length="14"></location><text>neural systems</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5834" length="17"></location><text>frontal eyefields</text></annotation><annotation id="T60"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="11791" length="6"></location><text>neural</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="5588" length="17"></location><text>frontal eyefields</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4110" length="6"></location><text>neural</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2256" length="3"></location><text>eye</text></annotation><annotation id="T49"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7396" length="26"></location><text>caudate projection neurons</text></annotation><annotation id="T48"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="7225" length="11"></location><text>speed motor</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="4163" length="14"></location><text>neural systems</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4216" length="10"></location><text>oculomotor</text></annotation><annotation id="T43"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6594" length="24"></location><text>spiny projection neurons</text></annotation><annotation id="T42"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6384" length="18"></location><text>oculomotor network</text></annotation><annotation id="T41"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6362" length="14"></location><text>cortical nodes</text></annotation><annotation id="T40"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6336" length="11"></location><text>subcortical</text></annotation><annotation id="T47"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="7194" length="13"></location><text>basal ganglia</text></annotation><annotation id="T46"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="7067" length="6"></location><text>cortex</text></annotation><annotation id="T45"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6909" length="10"></location><text>oculomotor</text></annotation><annotation id="T44"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="6626" length="8"></location><text>striatum</text></annotation><annotation id="T50"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7933" length="7"></location><text>neurons</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1654" length="10"></location><text>oculomotor</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2029" length="3"></location><text>eye</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2004" length="3"></location><text>eye</text></annotation><annotation id="T59"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="11688" length="6"></location><text>neural</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4302" length="6"></location><text>neural</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="4381" length="5"></location><text>brain</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4425" length="11"></location><text>subcortical</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4535" length="6"></location><text>neural</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4633" length="20"></location><text>orbitofrontal cortex</text></annotation><annotation id="T81"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="14254" length="8"></location><text>striatal</text></annotation><annotation id="T52"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="9067" length="8"></location><text>striatum</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4664" length="7"></location><text>ventral</text></annotation><annotation id="T80"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="7543" length="8"></location><text>striatal</text></annotation><annotation id="T51"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="9014" length="6"></location><text>neural</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4676" length="15"></location><text>dorsal striatum</text></annotation><annotation id="T54"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="9508" length="6"></location><text>neural</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4693" length="17"></location><text>nucleus accumbens</text></annotation><annotation id="T53"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="9185" length="6"></location><text>neural</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4712" length="7"></location><text>putamen</text></annotation><annotation id="T56"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="9996" length="6"></location><text>neural</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4725" length="7"></location><text>caudate</text></annotation><annotation id="T55"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="9941" length="6"></location><text>neural</text></annotation><annotation id="T58"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="11436" length="10"></location><text>oculomotor</text></annotation><annotation id="T57"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="10732" length="6"></location><text>neural</text></annotation><relation id="R4"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T70" role="Arg1"></node><node refid="T71" role="Arg2"></node></relation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T28" role="Arg1"></node><node refid="T29" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T27" role="Arg1"></node><node refid="T29" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T15" role="Arg1"></node><node refid="T16" role="Arg2"></node></relation></passage></document><document><id>PMID-19232911</id><passage><offset>0</offset><text>An introduction to evidence-based practice for hand surgeons and therapists.
Evidence-based practice is a methodical approach to clinical practice where experience, best research evidence, and patient goals and values are integrated to make optimal decisions when making a diagnosis, selecting a diagnostic test, picking an intervention or determining prognosis. There are five steps in this process. Hand surgeons and therapists can use the evidence-based process to attain optimal management of individual patients, manage their overall practice, guide the ongoing professional development, and deal with funding and policy makers.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="47" length="4"></location><text>hand</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="401" length="4"></location><text>Hand</text></annotation></passage></document><document><id>PMC-2133064-sec-12</id><passage><offset>0</offset><text>Results
The observation that AP-3 is found in both cytosolic and membrane subcellular fractions, and that membrane-associated AP-3 can be extracted with salts (Dell'Angelica et al., 1997a) is consistent with its role as a membrane coat that can be recruited from a cytosolic pool. In addition, the punctate staining of AP-3 by immunofluorescence microscopy, its redistribution to the cytosol by BFA, and the reversibility of the BFA effect (Dell'Angelica et al., 1997a; Simpson et al., 1997) also indicate that AP-3 can cycle between the cytosol and membranes. The sensitivity of AP-3 to BFA in cells suggests that its membrane association may be regulated by ARF1, since BFA inhibits ARF1 guanine nucleotide exchange, and has been shown to prevent ARF1 membrane binding in vitro (Donaldson et al., 1992; Helms and Rothman, 1992; Randazzo et al., 1993).

</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="384" length="7"></location><text>cytosol</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="538" length="7"></location><text>cytosol</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="222" length="8"></location><text>membrane</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="619" length="8"></location><text>membrane</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="265" length="14"></location><text>cytosolic pool</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="754" length="8"></location><text>membrane</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="550" length="9"></location><text>membranes</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="595" length="5"></location><text>cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="51" length="9"></location><text>cytosolic</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="106" length="8"></location><text>membrane</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="65" length="30"></location><text>membrane subcellular fractions</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T1" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMID-10080451</id><passage><offset>0</offset><text>Ventricular fibrillation due to long QT syndrome probably caused by clindamycin.
Prolongation of QT time interval may be provoked by a limited number of drugs, especially macrolide antibiotics. We describe a case of QT time interval prolongation induced by clindamycin with subsequent repeated ventricular fibrillation and resuscitation; there is no previous report in the literature of QT time prolongation caused by lincosamides.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="0" length="11"></location><text>Ventricular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="294" length="11"></location><text>ventricular</text></annotation></passage></document><document><id>PMC-2721591-sec-02</id><passage><offset>0</offset><text>COMMENTS
Recurrent anterior vaginal wall prolapse can develop in more than 20% of patients undergoing traditional anterior colporrhaphy. In light of this high recurrence rate many surgeons have been incorporating synthetic or allograft mesh to augment the repair.
In this study there are some shortcomings, including retrospective design, short follow-up for a study spanning almost six years and a lack of validated questionnaires. Authors report a negative experience with porcine dermis, both in terms of success and extrusion rate. However, others have reported better outcome[1] which may be due to different follow-up times and outcome measures. Apart from this, biological grafts are also associated with allergic reactions and disease transmission. There is paucity of data regarding prospective randomized trials on the use of these biomaterials prior to their widespread human need which might help in reducing such type of experiences. Unless such data are available surgeons should give serious thought prior to embarking on the use of such biological materials.[2]
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="19" length="21"></location><text>anterior vaginal wall</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="483" length="6"></location><text>dermis</text></annotation></passage></document><document><id>PMC-2892686-caption-01</id><passage><offset>0</offset><text>Large nodular hepatic flexure lesions as seen on Colonoscopy.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="6" length="31"></location><text>nodular hepatic flexure lesions</text></annotation></passage></document><document><id>PMID-21423801</id><passage><offset>0</offset><text>Saliva proteins of vector Culicoides modify structure and infectivity of bluetongue virus particles.
Bluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV) are related orbiviruses, transmitted between their ruminant hosts primarily by certain haematophagous midge vectors (Culicoides spp.). The larger of the BTV outer-capsid proteins, 'VP2', can be cleaved by proteases (including trypsin or chymotrypsin), forming infectious subviral particles (ISVP) which have enhanced infectivity for adult Culicoides, or KC cells (a cell-line derived from C. sonorensis). We demonstrate that VP2 present on purified virus particles from 3 different BTV strains can also be cleaved by treatment with saliva from adult Culicoides. The saliva proteins from C. sonorensis (a competent BTV vector), cleaved BTV-VP2 more efficiently than those from C. nubeculosus (a less competent/non-vector species). Electrophoresis and mass spectrometry identified a trypsin-like protease in C. sonorensis saliva, which was significantly reduced or absent from C. nubeculosus saliva. Incubating purified BTV-1 with C. sonorensis saliva proteins also increased their infectivity for KC cells ~10 fold, while infectivity for BHK cells was reduced by 2-6 fold. Treatment of an 'eastern' strain of EHDV-2 with saliva proteins of either C. sonorensis or C. nubeculosus cleaved VP2, but a 'western' strain of EHDV-2 remained unmodified. These results indicate that temperature, strain of virus and protein composition of Culicoides saliva (particularly its protease content which is dependent upon vector species), can all play a significant role in the efficiency of VP2 cleavage, influencing virus infectivity. Saliva of several other arthropod species has previously been shown to increase transmission, infectivity and virulence of certain arboviruses, by modulating and/or suppressing the mammalian immune response. The findings presented here, however, demonstrate a novel mechanism by which proteases in Culicoides saliva can also directly modify the orbivirus particle structure, leading to increased infectivity specifically for Culicoides cells and, in turn, efficiency of transmission to the insect vector.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1209" length="9"></location><text>BHK cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2129" length="5"></location><text>cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="526" length="8"></location><text>KC cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1168" length="8"></location><text>KC cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="538" length="9"></location><text>cell-line</text></annotation></passage></document><document><id>PMC-529442-sec-05</id><passage><offset>0</offset><text>Results

</text></passage></document><document><id>PMC-1285065-sec-02</id><passage><offset>0</offset><text>Results

</text></passage></document><document><id>PMID-3455408</id><passage><offset>0</offset><text>Sensitivity analysis of the influence of source-term and environmental parameters on the radiological risk of coal-fired plants.
A sensitivity analysis was undertaken to determine the influence of different source-term and environmental parameters on the radiological risks from a coal-fired plant (CFP). It was found that the release rate of radionuclides and the effective release height most significantly influence radiological risk. Site characteristics, such as rain scavenging coefficients and food acquirement habits, have a lesser influence, and some parameters, such as time delay before ingestion of contaminated food, have practically no influence on the radiological impact of a CFP. The contribution to radiation risks of different exposure modes (i.e. inhalation, ingestion and contact with ground surface) were also analyzed, as well as of specific radionuclides and human body organs. Results of the sensitivity analysis were interpreted in terms of the characteristics of the fuel, facilities and site of a CFP. It is concluded that by proper choice of coal, furnace, ash filtration and stack height, as well as by proper siting, the radiological impact of a CFP can be drastically reduced.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="889" length="11"></location><text>body organs</text></annotation></passage></document><document><id>PMC-3178617-sec-35</id><passage><offset>0</offset><text>Breeding of p53 mice with BCCIP conditional knockdown mice
The heterozygous p53 knockout mice [36] were crossed with LoxPshBCCIP+/+-4 mouse and EIIaCre+/+ mouse respectively to generate p53+/-;LoxPshBCCIP+/-, and p53+/-;EIIaCre+/- mice. The PCR primers used to genotype p53 are: p53ex6F: 5'-GTATCCCGAGTATCTGGAAGACAG-3', p53neoF: 5'-GCCTTCTATCGCCTTCTTGACG-3', p53ex7RN: 5'-AAGGATAGGTCGGCGGTTCATGC-3'. The same PCR primer pairs as described earlier in this report were used for BCCIPshRNA and EIIaCre genotyping. The p53+/-;LoxPshBCCIP+/+ mice were obtained by crossing p53+/-;LoxPshBCCIP+/- females with p53+/-;LoxPshBCCIP+/- males. The p53+/-;LoxPshBCCIP+/+ or p53+/-;LoxPshBCCIP+/- mice were crossed with p53+/-;EIIaCre+/- mice respectively.
</text></passage></document><document><id>PMID-6728933</id><passage><offset>0</offset><text>Hippocampal afterdischarge interferes with storage of spatial information in a working memory test.
In an attempt to impair spatial working memory by reversible functional blockade rather than by irreversible lesion of the hippocampus, eight male hooded rats were trained to asymptotic performance of 1.2 to 1.4 errors per trial in the spatial 12-choice apparatus ( Bure s et al. 1982), formally similar to the radial maze. The rats were implanted with hippocampal stimulating and recording electrodes, which were used for eliciting and monitoring hippocampal afterdischarge (HAD) lasting for at least 20 s. In Experiment 1, HAD elicited 1 or 10 min before testing increased the incidence of errors to 2.75 or 2.50 per trial, respectively, but the performance still remained above chance level (4.18). In Experiment 2, interruption of the trial by 1, 10, 20 and 30 min intervals inserted between choices 6 and 7 increased the incidence of errors in choices 7 to 12 to 1.0, 1.5, 2.1 and 2.5, respectively. HAD elicited immediately after choice 6 increased error incidence in the subsequent 6 choices performed after 1-min or 10-min intervals to 3.1 or 2.75, respectively, i.e. to the chance level of 3 errors in 6 choices. It is concluded that HAD elicits transient shortening of the memory span for newly acquired spatial information (anterograde effect) and erases the current spatial working memory record (retrograde effect).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="209" length="6"></location><text>lesion</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="548" length="11"></location><text>hippocampal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="0" length="11"></location><text>Hippocampal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="453" length="11"></location><text>hippocampal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="223" length="11"></location><text>hippocampus</text></annotation></passage></document><document><id>PMID-21915357</id><passage><offset>0</offset><text>Burns from hot wheat bags: a public safety issue.
Introduction: Wheat bags are therapeutic devices that are heated in microwaves and commonly used to provide relief from muscle and joint pain. The Royal Adelaide Hospital Burns Unit has observed a number of patients with significant burn injuries resulting from their use. Despite their dangers, the products come with limited safety information. Methods: Data were collected from the Burns Unit database for all patients admitted with burns due to hot wheat bags from 2004 to 2009. This was analyzed to determine the severity of the burn injury and identify any predisposing factors. An experimental study was performed to measure the temperature of wheat bags when heated to determine their potential for causing thermal injury. Results: 11 patients were admitted with burns due to hot wheat bags. The median age was 52 years and the mean total body surface area was 1.1%. All burns were either deep dermal (45.5%) or full thickness (54.5%). Ten patients required operative management. Predisposing factors (eg, neuropathy) to thermal injury were identified in 7 patients. The experimental study showed that hot wheat bags reached temperatures of 57.3degreesC (135.1degreesF) when heated according to instructions, 63.3degreesC (145.9degreesF) in a 1000 W microwave and 69.6degreesC (157.3degreesF) on reheating. Conclusions: Hot wheat bags cause serious burn injury. When heated improperly, they can reach temperatures high enough to cause epidermal necrosis in a short period of time. Patients with impaired temperature sensation are particularly at risk. There should be greater public awareness of the dangers of wheat bag use and more specific safety warnings on the products.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1493" length="9"></location><text>epidermal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="897" length="17"></location><text>body surface area</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="170" length="6"></location><text>muscle</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="952" length="6"></location><text>dermal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="181" length="5"></location><text>joint</text></annotation></passage></document><document><id>PMC-1592238-sec-23</id><passage><offset>0</offset><text>Supporting Information
Table S1
Supplementary Information on Genes in the Three Gene Sets
(219 KB PDF)
Click here for additional data file.
Table S2
UFW Primers for Gene Set I
(36 KB PDF)
Click here for additional data file.
Table S3
UFW Primers for Gene Set II
(44 KB PDF)
Click here for additional data file.
Table S4
UFW Primers for Gene Set III
(31 KB PDF)
Click here for additional data file.
Table S5
Transposable Element-Specific Primers for Additional Screens
(80 KB PDF)
Click here for additional data file.
Table S6
Primers for Intergenic Regions
(58 KB PDF)
Click here for additional data file.
Table S7
P Element-Specific Primers for Orientation and Length Determination
(299 KB PDF)
Click here for additional data file.
</text></passage></document><document><id>PMID-950045</id><passage><offset>0</offset><text>Conservative treatment of endometriosis: the effects of limited surgery and hormonal pseudopregnancy.
This study compares the effects of limited surgery or hormonal pseudopregnancy, or a combination of these two, upon fertility and the need for subsequent surgery with respect to the extent of the disease at the time of initial diagnosis in patients with endometriosis externa. Of the 61 patients who desired to enhance or preserve reproductive capacity, 20 patients became pregnant, for a pregnancy rate of 33%. The pregnancy rate in all categories, that is, those patients treated with pseudopregnancy, conservative surgery, and combined pseudopregnancy and surgery, was found to be in direct relationship to the initial extent of disease. In such patients, conservative surgery alone seemed to give the best results in the achievement of pregnancy. There seemed to be little difference between pseudopregnancy alone and conservative surgery in regard to the need for subsequent surgery after initial therapy, although there seemed to be a significantly greater chance for the need for subsequent surgery in patients receiving a combination of the two forms of therapy. The need for subsequent surgery after initial therapy in 80 patients increased in direct relationship to the initial extent of disease present, despite the form of therapy used. Fifty-nine other patients with endometriosis, who did not desire to preserve fertility and presented for relief of other symptoms, underwent initial "radical" therapy. Forty-six patients underwent complete operation, including removal of uterus, tubes and ovaries, and none required subsequent reoperation. Of the 13 remaining patients, who underwent incomplete surgical removal, leaving one or both ovaries in situ, 11 required subsequent reoperation for recurrent pelvic endometriosis.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1751" length="7"></location><text>ovaries</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1589" length="6"></location><text>uterus</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1607" length="7"></location><text>ovaries</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1597" length="5"></location><text>tubes</text></annotation></passage></document><document><id>PMID-2704697</id><passage><offset>0</offset><text>Early post-mortem metabolism and muscle shortening in the Pectoralis major muscle of broiler chickens.
Three experiments were conducted to examine the effects of sodium pentobarbital (SP), iodoacetate (IO), tubocurarine (TC), and surgical denervation (DN) on early rigor development in broiler breast muscle. In Experiment 1, birds were either anesthetized or not with SP before receiving an injection of IO or TC or maintained as noninjected controls. Experiment 2 was identical except that a treatment of denervation of the breast muscle was added. Experiment 3 was conducted to contrast birds at 1 day (DN1) and 3 days (DN3) denervation prior to slaughter to nonoperated controls. Measurements of muscle lactate, ATP, R value (ratio of inosine to adenine nucleotides), pH, sarcomere lengths, and shear were used to evaluate treatment effects. Results for Experiment 1 showed no significant differences among treatment and control groups for ATP and lactate contents, R values, or sarcomere lengths; however, significantly lower pH and higher shear values were observed for control birds. In Experiment 2, no significant differences were observed among the treatment groups for ATP, R values, or sarcomere lengths. However, lactate and shear values were significantly lower, and pH higher, for the DN and SP treated birds. Experiment 3 resulted in lower lactate and higher pH values for the DN3 treatment in comparison with both DN1 and control groups. Results of these studies indicate that the use of SP and DN can be used to alter the early profiles of rigor development.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="776" length="9"></location><text>sarcomere</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="983" length="9"></location><text>sarcomere</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="526" length="13"></location><text>breast muscle</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="700" length="6"></location><text>muscle</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1198" length="9"></location><text>sarcomere</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="33" length="6"></location><text>muscle</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="294" length="13"></location><text>breast muscle</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="75" length="6"></location><text>muscle</text></annotation></passage></document><document><id>PMID-20460116</id><passage><offset>0</offset><text>Pain assessment by continuous EEG: association between subjective perception of tonic pain and peak frequency of alpha oscillations during stimulation and at rest.
Recordings of neurophysiological brain responses to noxious stimuli have been traditionally based on short stimuli, in the order of milliseconds, which induce distinct event-related potentials (ERPs). However, using such stimuli in the experimental setting is disadvantageous as they are too brief to faithfully simulate clinical pain. We aimed at utilizing continuous EEG to investigate the properties of peak alpha frequency (PAF) as an objective cortical measure associated with subjective perception of tonic pain. Five minute long continuous EEG was recorded in 18 healthy volunteers under: (i) resting-state; (ii) innocuous temperature; and (iii) psychophysically-anchored noxious temperature. Numerical pain scores (NPSs) collected during the application of tonic noxious stimuli were tested for correlation with peak frequencies of alpha power-curves derived from central, temporal and frontal electrodes. NPSs and PAFs remained stable throughout the recording conditions (RM-ANOVAs; Ps&gt;0.51). In the noxious condition, PAFs obtained at the bilateral temporal scalp were correlated with NPSs (Ps&lt;0.001). Moreover, resting-state PAFs recorded at the bilateral temporal scalp were correlated with NPSs reported during the noxious condition (Ps&lt;0.01). These psychophysical-neurophysiological relations attest to the properties of PAF as a novel cortical objective measure of subjective perception of tonic pain. Moreover, resting-state PAFs might hold inherent pain modulation attributes, possibly enabling the prediction of individual responsiveness to prolonged pain. The relevance of PAF to the neural processing of tonic pain may indicate its potential to advance pain research as well as clinical pain characterization.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1331" length="14"></location><text>temporal scalp</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1767" length="6"></location><text>neural</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1223" length="14"></location><text>temporal scalp</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="197" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1514" length="8"></location><text>cortical</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="613" length="8"></location><text>cortical</text></annotation></passage></document><document><id>PMC-3122670-sec-13</id><passage><offset>0</offset><text>Subject disposition.
Data from 110 enrolled subjects were eligible for analysis. The demographics of the study subjects, by site, are recorded in Table 1. The population studied was predominantly not HIV infected (92%), and by the study entry criteria, their probability of infection was considered to be low. The risk categories assigned at the time of study entry were combined into groups for analysis, based on the predisposition for PCP. The analysis groups were as follows: (i) HIV/AIDS, (ii) lung transplant (one subject with a dual organ transplant [lung/kidney] was included in this category), (iii) all other organ transplants and allogeneic hematopoietic stem cell transplants (HSCT), (iv) leukemia, other hematological disorders, and autologous HSCT, (v) other solid tumors, and (vi) other nonmalignant conditions.
Table 1.
Subject enrollment, disposition, and demographics by sitea
Characteristic Valueb
Site 1 Site 2 Site 3 Site 4
Enrollment
Unique subjects 18 29 22 62
Subjects entering into primary analysisc 18 22 22 48
Subjects with repeat visits 0 0 0 16
No. of samples assayed 18 22 22 70
Gender
Male 7 10 13 29
Female 11 12 9 19
Race
Caucasian 12 4 0 48
Black 6 13 0 0
Other (nonwhite) 0 5 0 0
No data 0 0 22 0
Mean (range) age (yr) 57 (26-78) 54 (21-75) 52 (26-74) 56 (23-73)
Pretest probability of PCP
Moderate 0 3 4 0
Low 18 19 18 48
Sample type
BAL 18 20 20 43
Sputum 0 1 1 0
Other LRT 0 1 1 5
At-risk group
HIV/AIDS 0 3 6 0
Lung transplant 8 0 1 31
Other transplants 1 7 3 0
Leukemia 1 1 7 0
Other solid tumors 2 1 1 7
Other nonmalignant conditions 6 10 4 10
a
The testing and enrollment sites for the study were Duke University School of Medicine, Durham, NC; Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY; Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; and Medizinische Universitat and Landeskrankenhaus Natters, Innsbruck, Austria.
b
Except where otherwise indicated, values are numbers of patients.
c
Subjects were excluded from analysis if they withdrew consent or if there was inadequate sample left for PCR testing.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="641" length="34"></location><text>allogeneic hematopoietic stem cell</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="773" length="12"></location><text>solid tumors</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="563" length="6"></location><text>kidney</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1524" length="12"></location><text>solid tumors</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="619" length="5"></location><text>organ</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1386" length="6"></location><text>Sputum</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1450" length="4"></location><text>Lung</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="499" length="4"></location><text>lung</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="558" length="4"></location><text>lung</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="540" length="5"></location><text>organ</text></annotation></passage></document><document><id>PMID-10295626</id><passage><offset>0</offset><text>Decontamination of medical equipment--manufacturer's problems.
1. Small items sent via the post present a much greater hidden hazard and a higher potential for catching people unawares. 2. Large items accompanied by a Decontamination Certificate need to be treated with caution because only those surfaces which are accessible will have been cleaned; as soon as engineers start dismantling equipment, areas which are still soiled become exposed. 3. Total co-operation between hospital staff and service engineers is necessary to resolve these problems-neither can work safely without the assistance of the other. 4. Many products in use in hospitals may be up to 20 years old and clearly were not designed to facilitate decontamination and therefore present far greater risk to all concerned. 5. For the future there a clearly a responsibility with manufacturers to give more thought to the design of their equipment so that decontamination can be achieved more effectively.
</text></passage></document><document><id>PMID-19788957</id><passage><offset>0</offset><text>Range of motion limitation after rotator cuff repair.
HYPOTHESIS:
This study was conducted to identify preoperative factors correlating with limited motion after rotator cuff repair (RCR) and to evaluate the affect of loss of motion on outcome. We hypothesized that patients with preoperative ROM loss, diabetes, and workman's compensation claims would exhibit postoperative ROM loss at 3 months.
MATERIAL AND METHODS:
Preoperative and postoperative evaluations, including outcomes assessment and physical examination parameters, were reviewed for 345 patients who underwent RCR. Correlations between demographic, physical examination, and surgical variables and postoperative limitation of motion and need for capsular release were determined.
RESULTS:
At 3-month follow-up, mean active forward elevation (AFE), active external rotation (AER), and passive internal rotation (PIR) were 90%, 78%, and 80% of the contralateral side. Limitation of preoperative motion correlated with limitation of postoperative AFE, AER, and PIR (P &lt; .001). Forty-seven patients considered clinically stiff were followed at 1 year postoperatively. Three patients required arthroscopic capsular release for persistent range of motion loss.
CONCLUSION:
Early postoperative limitation of motion after RCR is associated with restricted preoperative motion. Other factors, including diabetes mellitus and worker's compensation claim, are also associated with range of motion loss. Most shoulders with early motion loss recover motion and rarely require capsular release.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="33" length="12"></location><text>rotator cuff</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1462" length="9"></location><text>shoulders</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="162" length="12"></location><text>rotator cuff</text></annotation></passage></document><document><id>PMID-18709350</id><passage><offset>0</offset><text>[TESE and mTESE. Therapeutic options in male infertility due to testicular azoospermia].
Modern techniques of testicular sperm extraction (TESE) make it possible for an infertile man to father a child. The operations are standardized to a large extent and the underlying morphological alterations of spermatogenesis also appear to be sufficiently known. Current research is focused on prognostic factors for the testicular material that determine the sperm retrieval rate and success rates after in vitro fertilization/intracytoplasmic sperm injection (IVF-ICSI).TESE and microTESE are accepted standard operations for testicular sperm retrieval for IVF/ICSI. Predictions for effective sperm recovery are addressed.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="619" length="16"></location><text>testicular sperm</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="686" length="5"></location><text>sperm</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="451" length="5"></location><text>sperm</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="536" length="5"></location><text>sperm</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="110" length="16"></location><text>testicular sperm</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="64" length="10"></location><text>testicular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="412" length="10"></location><text>testicular</text></annotation></passage></document><document><id>PMC-2858170-sec-04</id><passage><offset>0</offset><text>CONCLUSIONS
The lack of association between depression and glycemic control is not due to the use of a binary measure of depression. Findings further clarify the significant association between distress and A1C.
</text></passage></document><document><id>PMC-1075924-caption-01</id><passage><offset>0</offset><text>(a) Schematic drawing of the magnetic tweezers. A DNA molecule is attached at one end to the bottom of the flow cell and at the other end to a magnetic bead. This molecule can be pulled and twisted using small magnets placed above the flow cell. The position of the magnetic bead is measured using an inverted microscope placed beneath the flow cell. The bead position and thus the end-to-end distance of the DNA molecule is determined using video microscopy and image analysis. (b) Extension of a DNA molecule versus the number of turns applied by the magnets for various stretching forces. At low force, contraction of the molecule is symmetrical under positive and negative applied turns. At higher force, the molecule's extension initially remains constant for positive applied turns. The induced torque increases linearly with the number of applied turns, as depicted in the top graph until a buckling transition allows the system to saturate its torsional constraint through the formation of plectonemes.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="998" length="11"></location><text>plectonemes</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="112" length="4"></location><text>cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="345" length="4"></location><text>cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="240" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMC-1592597-caption-02</id><passage><offset>0</offset><text>Correlation between sperm morphology and seminal plasma NO (a) and TBARS (b) levels in both groups.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="20" length="5"></location><text>sperm</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="41" length="14"></location><text>seminal plasma</text></annotation></passage></document><document><id>PMC-2992534-sec-07</id><passage><offset>0</offset><text>Results and Discussion
Figure 4 shows the frequency response of the device before and after plating cells. In the frequency range measured (4-600 Hz), only two clear peaks can be seen in the bare device. After cells had adhered to the surface, there is a shift in both the resonant frequency and the height of these peaks. Table 1 shows the results for this trial and a second trial where the experiment was repeated to confirm the initial results. At a plating density of 1300 cells/mm2, there were approximately 140 cells on the portion of the cantilever free to vibrate (dimensions shown in Figure 1).
Table 1
Cantilever response data from two trials
Experiment #1 Experiment #2
Freq. 1 (kHz) Amp. 1 (deg) Freq. 2 (kHz) Amp. 2 (deg) Freq. 1 (kHz) Amp. 1 (deg) Freq. 2 (kHz) Amp. 2 (deg)
Initial 313.0 .086 375.5 .055 313.9 .091 376.5 .071
With cells 307.5 .031 371.0 .018 308 .052 370.5 .043
Change 5.5 .055 4.5 .037 5.9 .039 6.0 .028
Figure 4
Phase angle vs. frequency. (left) Phase angle of impedance with linear regression line. (right) To provide an easier comparison, phase angles have been levelled with respect to the linear regression line that passes through each set of data. The addition of cells causes the peaks to shift to lower frequencies and decrease in amplitude.
The two peaks shown were the only detectable resonances despite the relatively wide frequency range measured. The electrical detection of resonances is critically compromised by the strong damping imposed by the cell media, making these measurements more challenging than those carried out in air or in a vacuum where resonance peaks show much larger amplitude [18].
In the desired in vivo application for this work, as a sensor for stent healing, it can be expected that in the course of normal healing the stent will be fully populated with a significantly thicker layer of endothelial cells. In the case of restenosis, this lining would be even thicker. This may hamper any movement of the cantilever and cause the peaks to eventually become undetectable. Frequent measurements of the resonant frequencies will differentiate this end state with the possibility of device failure. The noninvasive nature of these measurements that can be transmitted wirelessly to an external device make this an attractive and low risk option for monitoring healing.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1497" length="4"></location><text>cell</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1861" length="17"></location><text>endothelial cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="518" length="5"></location><text>cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1205" length="5"></location><text>cells</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="847" length="5"></location><text>cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="100" length="5"></location><text>cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="478" length="5"></location><text>cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="210" length="5"></location><text>cells</text></annotation></passage></document><document><id>PMID-9744629</id><passage><offset>0</offset><text>Brainstem auditory-evoked potential evaluation in children with meningitis.
Brainstem auditory-evoked potential (BAEP) was performed on 101 children with meningitis to assess the incidence of hearing impairment. Fifty-two (51.5%) children had bacterial meningitis, six (5.9%) had viral meningitis, and 43 (42.6%) had aseptic meningitis. Fifty-one (50.5%) patients were assessed before discharge and 50 (49.5%) 9 days to 17 months later (mean = 4 months). BAEP impairment was found in 28 (27.7%) of 101 patients; 24 had sensorineural and four had conductive type of hearing loss, and 17 (60.7%) had unilateral and 11 (39.3%) had bilateral impairment. Hearing threshold was elevated in 22 (21.8%) patients, and the other six had increased latency and interpeak latencies with normal threshold. Frequency of BAEP impairment or hearing loss associated with bacterial meningitis was 34.6% and 30.8%, respectively; frequency associated with aseptic meningitis was 20.9% and 13.9%, respectively. One child with viral meningitis (coxsackie virus) had mild BAEP impairment. Most of the BAEP impairment in the bacterial meningitis group was associated with H. influenzae. Prospective BAEP study was performed in 20 patients randomly at 0.3 to 18 months to assess hearing status after antibiotic treatment, 10 with normal and 10 with abnormal BAEP. All the initially normal BAEP patients remained normal. Of the 10 patients with abnormal BAEP results initially, four returned to normal, two improved, three remained unchanged, and one deteriorated. The incidence of hearing loss after bacterial and aseptic meningitis is high. BAEP is useful to screen for possible hearing loss in children with meningitis, and follow-up BAEP is necessary for those patients with initially abnormal BAEP.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="0" length="9"></location><text>Brainstem</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="76" length="9"></location><text>Brainstem</text></annotation></passage></document><document><id>PMC-2983913-sec-03</id><passage><offset>0</offset><text>Crystal data
C24H21ClN4O2S
M r = 464.96
Triclinic, 
a = 8.6798 (18) A
b = 11.078 (2) A
c = 11.372 (2) A
alpha = 78.984 (7)degrees
beta = 81.867 (10)degrees
gamma = 81.718 (11)degrees
V = 1054.8 (4) A3
Z = 2
Cu Kalpha radiation
mu = 2.78 mm-1
T = 113 K
0.28 x 0.24 x 0.20 mm
</text></passage></document><document><id>PMID-18455498</id><passage><offset>0</offset><text>Analysis of processivity of mungbean dideoxynucleotide-sensitive DNA polymerase and detection of the activity and expression of the enzyme in the meristematic and meiotic tissues and following DNA damaging agent.
Analysis of the processivity of mungbean ddNTP-sensitive DNA polymerase showed the incorporation of approximately 35-40 nucleotides per binding event in the replication assays involving M13 ss DNA template with 5'-labeled 17-mer primer. Optimal processivity was obtained with 100-150 mM KCl and 6-8 mM Mg2+ at pH 7.5. The enzyme showed preference for Mg2+ over Mn2+ as the metal activator for processivity. 2', 3' dideoxythymidine 5' triphosphate (ddTTP) and rat DNA pol beta antibody strongly influenced distributive synthesis. Considerable enhancement in processivity was noticed at 1mM ATP and 2-4 mM spermidine while higher concentrations of spermidine caused distributive synthesis. The enzyme was found to be active in both meristematic and meiotic tissues and distinctly induced by EMS treatment. DNA-binding assays revealed distinct binding ability of the enzyme to template/primer and damaged DNA substrate. Together these observations illustrate the probable involvement of the enzyme in replication and repair machinery in higher plants.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="943" length="12"></location><text>meristematic</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="146" length="12"></location><text>meristematic</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="960" length="15"></location><text>meiotic tissues</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="163" length="15"></location><text>meiotic tissues</text></annotation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T4" role="Arg1"></node><node refid="T3" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T1" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation></passage></document><document><id>PMID-16773443</id><passage><offset>0</offset><text>Fluoro-Jade B staining following zymosan microinjection into the spinal cord white matter.
1. The fluorescein derivate Fluoro-Jade B (FJB), which primarily labels dead or dying neurons, was used to study the acute focal inflammation in the spinal cord white matter. Inflammation was induced by microinjection of the yeast particulate zymosan to evaluate the biological effects of intraspinal macrophages activation without the confounding effects of physical trauma. 2. A single bolus of zymosan (Sigma, 75 nL) was stereotaxically injected at the thoracic level into the lateral white matter of rat spinal cord. A standard Fluoro-Jade B staining protocol was applied to spinal cord sections at 6, 12, 24 h and 2, 4 days postinjection. Neutral Red, NADPH-diaphorase, Iba1-IR, and DAPI staining protocols accomplished examination of the cells participating in the acute inflammatory response. 3. Zymosan caused formation of clearly delineated inflammation lesions localized in the lateral white matter of the spinal cord. Fluoro-Jade B stained cells in the area of inflammation were not observed at 12 h postinjection while mild FJB staining appeared at 24 h and intense staining was observed at 2 and 4 days postinjection. 4. This study shows that the acute response to zymosan-induced inflammation in the rat spinal cord white matter causes a gradual appearance of phagocytic microglia/macrophages and delayed FJB staining of the inflammatory cells. 5. FJB, a reliable marker of dying neurons, is a more universal agent than formerly believed. One possible explanation for the gradual appearance of FJB-stained cells in the area of inflammation is that specific time is required for sufficient levels of proteins and/or myelin debris of axonal origin to appear in the cytoplasm of phagocytic microglia/macrophages.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="65" length="24"></location><text>spinal cord white matter</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="240" length="24"></location><text>spinal cord white matter</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="177" length="7"></location><text>neurons</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="670" length="11"></location><text>spinal cord</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="835" length="5"></location><text>cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="571" length="20"></location><text>lateral white matter</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="599" length="11"></location><text>spinal cord</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1042" length="5"></location><text>cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1309" length="24"></location><text>spinal cord white matter</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1365" length="20"></location><text>phagocytic microglia</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1386" length="11"></location><text>macrophages</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1007" length="11"></location><text>spinal cord</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1430" length="18"></location><text>inflammatory cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="979" length="20"></location><text>lateral white matter</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="547" length="8"></location><text>thoracic</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1485" length="7"></location><text>neurons</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="380" length="23"></location><text>intraspinal macrophages</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1611" length="5"></location><text>cells</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="941" length="20"></location><text>inflammation lesions</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1802" length="11"></location><text>macrophages</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1063" length="12"></location><text>inflammation</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1781" length="20"></location><text>phagocytic microglia</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1632" length="12"></location><text>inflammation</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1768" length="9"></location><text>cytoplasm</text></annotation><relation id="R6"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T20" role="Arg1"></node><node refid="T22" role="Arg2"></node></relation><relation id="R4"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T16" role="Arg1"></node><node refid="T19" role="Arg2"></node></relation><relation id="R5"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T20" role="Arg1"></node><node refid="T21" role="Arg2"></node></relation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T9" role="Arg1"></node><node refid="T8" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T10" role="Arg1"></node><node refid="T18" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T4" role="Arg1"></node><node refid="T5" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T10" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T16" role=""></node></relation></passage></document><document><id>PMC-2374702-caption-19</id><passage><offset>0</offset><text>Click here for file
</text></passage></document><document><id>PMC-534790-sec-23</id><passage><offset>0</offset><text>Authors' contributions
FR initiated and designed the research, collected and analyzed the data and wrote the paper. FO was the main supervisor, helped in analysis, and revised and edited the drafts. MN was co- supervisor and revised the drafts.
</text></passage></document><document><id>PMC-2193592-sec-11</id><passage><offset>0</offset><text>Stimulation/Inhibition of iDC Functions by Activated NK Cells.
Two previous studies have shown that both resting and activated NK cells partially kill autologous DCs, as measured by 3-4-h chromium release assays using high NK/DC ratios (11, 12). However, in our long-term cultures (24-48 h) the NK cells stimulated the iDCs rather than lysing them. Based on these conflicting results, we examined in more detail the apparent stimulation of iDCs after contact with NK cells. We reasoned that activated NK cells would be more useful for these experiments because (i) an encounter in vivo between NK cells that normally traffic in the blood (4) and iDCs which reside in the tissues (1, 3), should only occur when both cells are activated; (ii) activated NK cells mediate more potent lysis of iDCs (11-13), thereby allowing for a more rigorous examination of a potential cytotoxic effect; and (iii) the number of NK cells obtained after short-term in vitro culture would be far greater providing more cells for analysis (9).
The DC maturation induced by resting NK cells we observed was dependent on endogenous TNF-alpha production. Furthermore, TNF-alpha and other proinflammatory cytokines are important amplifiers of immune responses (14). Therefore, we used TNF-alpha production as a readout for DC stimulation in our culture system. Culturing activated NK cells with DCs at low NK/DC ratios (1:5) led to increases in TNF-alpha production, which were augmented dramatically by the addition of suboptimal doses (10 ng/ml) of LPS (Fig. 2 A). The increased TNF-alpha production was dependent on cell-to-cell contact because when the two cell types were separated in trans-wells, no stimulation was observed (Fig. 2 B). In separate experiments we observed this NK-stimulatory effect on TNF-alpha production at NK/DC ratios as low as 1:20 and 1:40 (data not shown). Raising the NK/DC ratio to 5:1 changes the interaction from one of potent DC stimulation to that of complete inhibition in the presence or absence of LPS (Fig. 2 C). An identical pattern is seen for IL-12 p40 production (Fig. 2 D). No IL-10 production in the cultures was detected under any of the conditions tested (data not shown). The massive production of TNF-alpha in the cultures at the lowest ratios was mediated primarily by DCs in the culture due to the low number of NK cells (2 x 104 cells per well) used in these experiments. In addition, efforts to stimulate NK cells directly with optimal doses of anti-CD16, rIL-2, rIL-12, and PMA/ionomycin alone or in combination induced only moderate (&lt;500 pg/ml) TNF-alpha production by the NK cells alone which were present at 2 x 105 cells per well (data not shown).
Figure 2.
Activated/cultured NK cell-mediated amplification/inhibition of DC cytokine production. Results are presented on log scales. Cultured iDCs were incubated alone or with cultured/purified NK cells for 24 h (A and B) or 48 h (C-E) in the presence or absence of the indicated concentrations of LPS. After culture the supernatants were removed and analyzed by ELISA for TNF-alpha or IL-12 p40. (A) TNF-alpha production was measured in the supernatants from cultures of: DCs alone (gray bars); NK+DC (1:5) (black bars). LPS concentrations used were: 0, 10, and 1,000 ng/ml (DCs alone only). (B) Contact-dependent stimulation of iDC TNF-alpha production by NK cells was tested under the following conditions: DCs alone (gray bars); NK+DC (1:5) (black bars); NK/DC (1:5) trans-wells (striped bars). LPS concentrations used were: 10 ng/ml (donor 1) and 20 ng/ml (donor 2). (C and D) Effect of increasing the NK/DC ratio (DCs alone; NK:DC-1:5; 1:1; 5:1) on (C) TNF-alpha and (D) IL-12 p40 production. LPS concentrations used were: 0 ng/ml (*); 20 ng/ml (*); 50 ng/ml (^); and 1,000 ng/ml-LPS (*) (DCs alone only). (E) The effect of neutralizing IFN-gamma production was tested under the following conditions: DCs alone (gray bars); NK+DC (1:5) (black bars); NK+DC (1:5) and 10 mug/ml of blocking anti-IFN-gamma mAb (stippled bars). LPS concentrations used were: 0 ng/ml (NO LPS) and 20 ng/ml (LPS 20).
Blocking reagents for CD80, CD86, CD154, CD95, CD11a, CD50, or IL-12, had no effect on the NK cell-induced TNF-alpha or IL-12 p40 production, whereas a neutralizing antibody for IFN-gamma while not affecting TNF-alpha production partially blocked (&lt;20%) IL-12 p40 production induced by the NK cells (Fig. 2 E). This partial inhibition is consistent with numerous previous reports demonstrating a central role for an IL-12/IFN-gamma positive feedback loop active between NK cells and IL-12-producing cells (15-17). Clearly, however, this well-described cytokine cross-talk mechanism is secondary to the contact-dependent activation of DCs by NK cells described here. Taken together these results indicate that novel mechanisms control cognate interactions between NK cells and DCs and that NK-DC contact has the potential to serve as an important control switch for both amplifying and attenuating innate immune responses in vivo.
We next tested directly whether NK cell killing was active in our system using both short-term (4-h) chromium release assays (data not shown) and a flow cytometric assay which allowed us to follow the survival of the autologous iDCs in the presence of NK cells over longer periods (Fig. 3). The results demonstrate that NK cells kill autologous iDCs (Fig. 3 A) at all NK/DC ratios tested after 4 h and the level of killing is similar to the lysis of K562 cells over the same time (Fig. 3 B). After 24 h, however, the presence of NK cells led to completely divergent effects on the DCs. At the 5:1 (NK/DC) ratio, NK cell-mediated destruction of the iDCs was the dominant feature, whereas at the low ratio (1:5) the same NK cells promoted iDCs survival compared with iDCs alone over the same period (Fig. 3 A). The equal ratio of NK/DC (1:1) fell between these two extremes. The NK cell-mediated lysis of the K562 targets increased at all ratios tested after the 24-h incubation. These striking differences between death and survival of DCs upon encountering NK cells correlate precisely with our previous results on TNF-alpha and IL-12 p40 production where increasing numbers of NK cells in the culture shifts the NK effect from potent stimulation to complete inhibition (Fig. 2).
Figure 3.
Activated/cultured NK cell-mediated death/survival of DCs and NK-DC conjugate formation. NK cell mediated killing/survival of CFDA.SE-loaded iDCs (A) and K562 cells (B) was measured by flow cytometry over 4 h (*) or 24 h (*) at the indicated NK/DC ratios as described in Materials and Methods. Results are presented as percentage of specific lysis +/- SEM (n = 3 independent experiments). NK-DC (C-E) or NK-K562 (F-H) conjugate formation was measured by flow cytometry, at the following ratios (NK/DC or NK/K562): 1:5 (C and F); 1:1 (D and G); and 5:1 (E and H). Snarf-1 (FL3)-labeled iDCs or K562 cells were incubated (30 min) with CFDA.SE (FL1)-labeled NK cells at the different ratios. The percentage of conjugates formed (top right quadrant) was calculated by determining the percentage of FL3+ (Snarf-1) events which were also positive for FL1 (CFDA.SE). The results are representative of four experiments performed with activated NK cells. Resting NK cells also readily formed conjugates with autologous iDCs (data not shown).
NK cells can both efficiently kill and potently stimulate DCs in our model system and each of these opposing effects appear dependent on cell-to-cell contact. To quantify these apparent cognate interactions we measured the formation of NK-DC conjugates and compared them to conjugates formed by NK cells and tumor targets. Our analysis revealed that NK cells bound DC (Fig. 3 C-E) with an efficiency almost equal to that of NK cell binding to the classical NK-target, K562 (Fig. 3 F-H). Binding was detectable even at the lowest NK/DC ratio tested (1:5) indicating that NK-DC conjugates are formed in our other experiments measuring cytokine production and cell killing.
Our initial experiments using resting NK cells (Fig. 1) demonstrated a contact-dependent NK effect driving iDCs to mature. Therefore, we tested what effects activated NK cells mediated on DC maturation (Fig. 4). Similar to our previous results with activated NK cells (Figs. 2 and 3), addition of NK cells to the culture leads to opposing effects on the iDC population depending on the NK/DC ratio. Compared with the untreated DCs (Fig. 4 A-C), low NK/DC ratios (1:5 or 1:1) consistently augmented expression of the maturation markers: CD86 (Fig. 4 D-I), CD83, and HLA-DR (data not shown). At a 5:1 ratio (NK/DC) most of the DCs are nonviable (Fig. 4 J-L). Addition of suboptimal doses of LPS (Fig. 4 C, F, I, and L) augmented the NK-induced maturation at NK/DC ratios of 1:5 and 1:1, but had no effect at the 5:1 ratio. Again, DC maturation was dependent on NK cell contact and endogenously produced TNF-alpha, because it did not occur when the two cell types were separated in trans-wells or upon the addition of a neutralizing antibody for TNF-alpha (Fig. 5). Moreover, addition of blocking reagents for CD80, CD86, CD154, CD95, CD11a, CD50, IL-12, IFN-gamma, IFN-alpha, or IFN-beta had no effect on the NK-induced maturation (data not shown).
Figure 4.
Activated/cultured NK cell-mediated maturation/death of DCs. Cultured iDCs were incubated for 48 h, alone (A-C), or with NK cells at the following ratios (NK/DC), 1:5 (D-F), 1:1 (G-I), and 5:1 (J-L). Forward versus side scatter plots (A, D, G, and J) show the gating on the DC subset and demonstrate its disappearance at the 5:1 (NK/DC) ratio (J). Propidium iodide staining of the NK/DC (5:1) cultures confirmed the almost complete absence of viable DCs (data not shown). Staining for CD86 expression was performed as described in Fig. 1 and the histograms are shown for DCs cultured in the presence (C, F, I, and L) or absence (B, E, H, and K) of 1 ng/ml of LPS. Results are representative of six experiments performed.
Figure 5.
Activated/cultured NK cell-induced DC maturation is dependent on cell-to-cell contact and endogenous TNF-alpha production. Cultured iDCs were incubated alone (A, D, and G); with activated NK cells at an NK/DC ratio of 1:5 (B, E, and H); with activated NK cells (NK/DC; 1:5) separated in trans-wells (C and F); or with activated NK cells and 10 mug/ml of a neutralizing antibody for TNF-alpha (I). LPS concentrations used were: 0 ng/ml (A-C); 10 ng/ml (D-F) and 50 ng/ml (G-I). CD86 staining of the DC subset was performed as in Figs. 1 and 4. Results are representative of four experiments performed.
</text><annotation id="T114"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6799" length="2"></location><text>NK</text></annotation><annotation id="T115"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6802" length="2"></location><text>DC</text></annotation><annotation id="T116"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6808" length="2"></location><text>NK</text></annotation><annotation id="T117"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6811" length="4"></location><text>K562</text></annotation><annotation id="T118"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6889" length="4"></location><text>iDCs</text></annotation><annotation id="T119"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6897" length="10"></location><text>K562 cells</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1634" length="4"></location><text>cell</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1600" length="4"></location><text>cell</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1592" length="4"></location><text>cell</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1382" length="2"></location><text>DC</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1379" length="2"></location><text>NK</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1368" length="3"></location><text>DCs</text></annotation><annotation id="T120"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6959" length="8"></location><text>NK cells</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1354" length="8"></location><text>NK cells</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1296" length="2"></location><text>DC</text></annotation><annotation id="T122"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7258" length="8"></location><text>NK cells</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1058" length="8"></location><text>NK cells</text></annotation><annotation id="T121"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7240" length="8"></location><text>NK cells</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1025" length="2"></location><text>DC</text></annotation><annotation id="T124"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7337" length="8"></location><text>NK cells</text></annotation><annotation id="T123"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7314" length="4"></location><text>iDCs</text></annotation><annotation id="T127"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7482" length="4"></location><text>cell</text></annotation><annotation id="T128"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7573" length="2"></location><text>NK</text></annotation><annotation id="T125"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7395" length="3"></location><text>DCs</text></annotation><annotation id="T126"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7474" length="4"></location><text>cell</text></annotation><annotation id="T129"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7576" length="2"></location><text>DC</text></annotation><annotation id="T38"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2433" length="8"></location><text>NK cells</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2338" length="8"></location><text>NK cells</text></annotation><annotation id="T39"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2604" length="8"></location><text>NK cells</text></annotation><annotation id="T131"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7702" length="2"></location><text>DC</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1876" length="2"></location><text>DC</text></annotation><annotation id="T130"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7687" length="8"></location><text>NK cells</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1873" length="2"></location><text>NK</text></annotation><annotation id="T36"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2294" length="3"></location><text>DCs</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1935" length="2"></location><text>DC</text></annotation><annotation id="T135"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7866" length="2"></location><text>NK</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1757" length="2"></location><text>NK</text></annotation><annotation id="T134"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7805" length="4"></location><text>K562</text></annotation><annotation id="T133"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7794" length="2"></location><text>NK</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1809" length="2"></location><text>DC</text></annotation><annotation id="T132"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7761" length="7"></location><text>NK cell</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1806" length="2"></location><text>NK</text></annotation><annotation id="T191"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2356" length="5"></location><text>cells</text></annotation><annotation id="T190"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="7645" length="5"></location><text>tumor</text></annotation><annotation id="T193"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7994" length="4"></location><text>cell</text></annotation><annotation id="T192"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2649" length="5"></location><text>cells</text></annotation><annotation id="T49"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3342" length="8"></location><text>NK cells</text></annotation><annotation id="T48"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3314" length="3"></location><text>iDC</text></annotation><annotation id="T100"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6227" length="2"></location><text>NK</text></annotation><annotation id="T43"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2878" length="8"></location><text>NK cells</text></annotation><annotation id="T42"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2826" length="4"></location><text>iDCs</text></annotation><annotation id="T102"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6358" length="3"></location><text>DCs</text></annotation><annotation id="T41"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2756" length="2"></location><text>DC</text></annotation><annotation id="T101"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6323" length="7"></location><text>NK cell</text></annotation><annotation id="T40"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2711" length="7"></location><text>NK cell</text></annotation><annotation id="T47"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3260" length="3"></location><text>DCs</text></annotation><annotation id="T46"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3183" length="2"></location><text>DC</text></annotation><annotation id="T45"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3180" length="2"></location><text>NK</text></annotation><annotation id="T44"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3157" length="3"></location><text>DCs</text></annotation><annotation id="T109"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6549" length="2"></location><text>DC</text></annotation><annotation id="T107"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6458" length="10"></location><text>K562 cells</text></annotation><annotation id="T108"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6546" length="2"></location><text>NK</text></annotation><annotation id="T182"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10202" length="2"></location><text>DC</text></annotation><annotation id="T105"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6393" length="7"></location><text>NK cell</text></annotation><annotation id="T181"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10199" length="2"></location><text>NK</text></annotation><annotation id="T106"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6445" length="4"></location><text>iDCs</text></annotation><annotation id="T180"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10184" length="8"></location><text>NK cells</text></annotation><annotation id="T103"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6366" length="2"></location><text>NK</text></annotation><annotation id="T104"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6369" length="2"></location><text>DC</text></annotation><annotation id="T50"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3394" length="3"></location><text>DCs</text></annotation><annotation id="T186"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10324" length="8"></location><text>NK cells</text></annotation><annotation id="T185"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10261" length="2"></location><text>DC</text></annotation><annotation id="T184"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10258" length="2"></location><text>NK</text></annotation><annotation id="T183"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10248" length="8"></location><text>NK cells</text></annotation><annotation id="T189"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7632" length="8"></location><text>NK cells</text></annotation><annotation id="T188"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="671" length="7"></location><text>tissues</text></annotation><annotation id="T187"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10494" length="2"></location><text>DC</text></annotation><annotation id="T59"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3618" length="2"></location><text>DC</text></annotation><annotation id="T113"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6711" length="4"></location><text>K562</text></annotation><annotation id="T52"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3420" length="2"></location><text>DC</text></annotation><annotation id="T112"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6708" length="2"></location><text>NK</text></annotation><annotation id="T51"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3417" length="2"></location><text>NK</text></annotation><annotation id="T111"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6696" length="2"></location><text>DC</text></annotation><annotation id="T54"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3446" length="2"></location><text>DC</text></annotation><annotation id="T110"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6693" length="2"></location><text>NK</text></annotation><annotation id="T53"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3443" length="2"></location><text>NK</text></annotation><annotation id="T56"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3594" length="2"></location><text>DC</text></annotation><annotation id="T55"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3591" length="2"></location><text>NK</text></annotation><annotation id="T58"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3615" length="2"></location><text>NK</text></annotation><annotation id="T57"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3604" length="3"></location><text>DCs</text></annotation><annotation id="T75"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4876" length="2"></location><text>DC</text></annotation><annotation id="T76"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5046" length="7"></location><text>NK cell</text></annotation><annotation id="T73"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4860" length="3"></location><text>DCs</text></annotation><annotation id="T74"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4873" length="2"></location><text>NK</text></annotation><annotation id="T79"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5334" length="8"></location><text>NK cells</text></annotation><annotation id="T77"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5242" length="4"></location><text>iDCs</text></annotation><annotation id="T78"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5266" length="8"></location><text>NK cells</text></annotation><annotation id="T159"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8867" length="7"></location><text>NK cell</text></annotation><annotation id="T158"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8836" length="2"></location><text>DC</text></annotation><annotation id="T161"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9215" length="2"></location><text>NK</text></annotation><annotation id="T162"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9284" length="7"></location><text>NK cell</text></annotation><annotation id="T163"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9321" length="3"></location><text>DCs</text></annotation><annotation id="T164"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9335" length="4"></location><text>iDCs</text></annotation><annotation id="T165"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9386" length="8"></location><text>NK cells</text></annotation><annotation id="T166"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9420" length="2"></location><text>NK</text></annotation><annotation id="T167"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9423" length="2"></location><text>DC</text></annotation><annotation id="T168"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9539" length="2"></location><text>DC</text></annotation><annotation id="T72"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4847" length="8"></location><text>NK cells</text></annotation><annotation id="T71"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4725" length="8"></location><text>NK cells</text></annotation><annotation id="T70"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4718" length="3"></location><text>DCs</text></annotation><annotation id="T160"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8958" length="4"></location><text>cell</text></annotation><annotation id="T62"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3914" length="2"></location><text>NK</text></annotation><annotation id="T63"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3917" length="2"></location><text>DC</text></annotation><annotation id="T64"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3940" length="2"></location><text>NK</text></annotation><annotation id="T65"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3943" length="2"></location><text>DC</text></annotation><annotation id="T66"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4175" length="7"></location><text>NK cell</text></annotation><annotation id="T67"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4374" length="8"></location><text>NK cells</text></annotation><annotation id="T68"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4554" length="8"></location><text>NK cells</text></annotation><annotation id="T69"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="4567" length="21"></location><text>IL-12-producing cells</text></annotation><annotation id="T169"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9595" length="2"></location><text>NK</text></annotation><annotation id="T174"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9836" length="3"></location><text>DCs</text></annotation><annotation id="T175"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10015" length="7"></location><text>NK cell</text></annotation><annotation id="T172"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9649" length="2"></location><text>DC</text></annotation><annotation id="T173"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9715" length="3"></location><text>DCs</text></annotation><annotation id="T178"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10069" length="4"></location><text>cell</text></annotation><annotation id="T179"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10128" length="4"></location><text>iDCs</text></annotation><annotation id="T176"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10031" length="2"></location><text>DC</text></annotation><annotation id="T177"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="10061" length="4"></location><text>cell</text></annotation><annotation id="T170"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9598" length="2"></location><text>DC</text></annotation><annotation id="T171"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="9646" length="2"></location><text>NK</text></annotation><annotation id="T61"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3891" length="3"></location><text>DCs</text></annotation><annotation id="T60"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="3779" length="3"></location><text>DCs</text></annotation><annotation id="T99"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6192" length="8"></location><text>NK cells</text></annotation><annotation id="T97"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6049" length="3"></location><text>DCs</text></annotation><annotation id="T98"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="6071" length="8"></location><text>NK cells</text></annotation><annotation id="T95"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5891" length="7"></location><text>NK cell</text></annotation><annotation id="T96"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5921" length="4"></location><text>K562</text></annotation><annotation id="T137"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7907" length="2"></location><text>NK</text></annotation><annotation id="T136"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7869" length="2"></location><text>DC</text></annotation><annotation id="T139"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8046" length="8"></location><text>NK cells</text></annotation><annotation id="T138"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="7910" length="2"></location><text>DC</text></annotation><annotation id="T143"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8196" length="2"></location><text>DC</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="295" length="8"></location><text>NK cells</text></annotation><annotation id="T144"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8267" length="8"></location><text>NK cells</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="26" length="3"></location><text>iDC</text></annotation><annotation id="T145"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8305" length="8"></location><text>NK cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="162" length="3"></location><text>DCs</text></annotation><annotation id="T146"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8362" length="3"></location><text>iDC</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="226" length="2"></location><text>DC</text></annotation><annotation id="T140"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8097" length="2"></location><text>NK</text></annotation><annotation id="T141"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8115" length="4"></location><text>iDCs</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="319" length="4"></location><text>iDCs</text></annotation><annotation id="T142"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8175" length="8"></location><text>NK cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="440" length="4"></location><text>iDCs</text></annotation><annotation id="T94"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5845" length="2"></location><text>DC</text></annotation><annotation id="T93"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5842" length="2"></location><text>NK</text></annotation><annotation id="T92"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5779" length="4"></location><text>iDCs</text></annotation><annotation id="T91"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5751" length="4"></location><text>iDCs</text></annotation><annotation id="T90"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5733" length="8"></location><text>NK cells</text></annotation><annotation id="T88"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5626" length="7"></location><text>NK cell</text></annotation><annotation id="T89"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5662" length="4"></location><text>iDCs</text></annotation><annotation id="T84"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5543" length="8"></location><text>NK cells</text></annotation><annotation id="T85"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5595" length="3"></location><text>DCs</text></annotation><annotation id="T86"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5612" length="2"></location><text>NK</text></annotation><annotation id="T87"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5615" length="2"></location><text>DC</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="53" length="8"></location><text>NK Cells</text></annotation><annotation id="T149"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8435" length="3"></location><text>DCs</text></annotation><annotation id="T148"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8397" length="2"></location><text>DC</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="223" length="2"></location><text>NK</text></annotation><annotation id="T147"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8394" length="2"></location><text>NK</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="127" length="8"></location><text>NK cells</text></annotation><annotation id="T156"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8764" length="2"></location><text>NK</text></annotation><annotation id="T157"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8767" length="2"></location><text>DC</text></annotation><annotation id="T154"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8633" length="3"></location><text>DCs</text></annotation><annotation id="T155"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8739" length="2"></location><text>NK</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="464" length="8"></location><text>NK cells</text></annotation><annotation id="T152"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8614" length="2"></location><text>NK</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="501" length="8"></location><text>NK cells</text></annotation><annotation id="T153"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8617" length="2"></location><text>DC</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="594" length="8"></location><text>NK cells</text></annotation><annotation id="T150"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8457" length="2"></location><text>NK</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="646" length="4"></location><text>iDCs</text></annotation><annotation id="T151"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="8460" length="2"></location><text>DC</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="632" length="5"></location><text>blood</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="789" length="4"></location><text>iDCs</text></annotation><annotation id="T81"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5382" length="2"></location><text>NK</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="715" length="5"></location><text>cells</text></annotation><annotation id="T80"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5359" length="4"></location><text>iDCs</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="751" length="8"></location><text>NK cells</text></annotation><annotation id="T83"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5464" length="10"></location><text>K562 cells</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="909" length="8"></location><text>NK cells</text></annotation><annotation id="T82"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="5385" length="2"></location><text>DC</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="997" length="5"></location><text>cells</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T113" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T107" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T134" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T119" role=""></node></relation></passage></document><document><id>PMC-2211454-sec-18</id><passage><offset>0</offset><text>Acknowledgements
We would like to thank our colleague Dr. Nikolaos Papathanasiou for his assistance in performing the statistical analysis.
</text></passage></document><document><id>PMC-2724388-sec-01</id><passage><offset>0</offset><text>Background
Opioid analgesics are generally used to combat the pain associated with cancerous conditions. These agents not only inhibit respiratory function and cause constipation, but also induce other significant side effects such as addiction and tolerance, all of which further contribute to a reduced quality of life for cancer patients. Thus, in the present study, the effects of electro-acupuncture treatment (EA) on mechanical allodynia were examined in a cancer pain mouse model.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="135" length="11"></location><text>respiratory</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="83" length="9"></location><text>cancerous</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="463" length="6"></location><text>cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="325" length="6"></location><text>cancer</text></annotation></passage></document><document><id>PMC-1188249-sec-02</id><passage><offset>0</offset><text>Figures and Tables
Stages in the life cycle of Plasmodium falciparum
(Illustration: Coatney GR, Collins WE, Warren M, Contacos PG (1971)
The primate malarias. (Bethesda): U.S. Department of Health, Education and Welfare.)
</text></passage></document><document><id>PMC-3212806-sec-17</id><passage><offset>0</offset><text>Authors' contributions
EEKN was responsible for data collection, statistical analysis and drafting the manuscript. SAGN and YW involved in data collection and helped with the data analysis. AS helped in data analysis. EST and JL directed the study and helped in revising the manuscript. RMVD helped in data analysis, interpretation of the results and led writing of the manuscript. All authors read and approved the final manuscript.
</text></passage></document><document><id>PMC-2638008-sec-12</id><passage><offset>0</offset><text>Whole-Body gamma-Irradiation
To evaluate differential sensitivity to irradiation, mice were exposed to gamma-irradiation (4-10 Gy, single dose) and closely monitored throughout the experimentation period. Animals were killed at the first appearance of signs of poor health. Recipients of bone marrow transplants were pre-irradiated with a total dose of 10.2 Gy (two doses of 5.1 Gy, 3 h apart). For in vivo DNA damage experiments, mice were irradiated with a single dose of 5Gy and killed after 1, 3 or 6 hours. All irradiations were carried out in a Cesium Mark1 irradiator (Shepherd Associates).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="288" length="11"></location><text>bone marrow</text></annotation></passage></document><document><id>PMC-2739198-caption-20</id><passage><offset>0</offset><text>Click here for file
</text></passage></document><document><id>PMC-2736529-sec-09</id><passage><offset>0</offset><text>Assessment of various forms of bevavioural addictions
A first approach for the comprehensive and standardized assessment of different forms of behavioural addictions (e.g., pathological gambling, workaholism, compulsive buying) is the German self-assessment questionnaire "Fragebogen zur Differenzierten Anamnese exzessiver Verhaltensweisen" (FDAV, Questionnaire on Differentiated Assessment of Excessive Behaviours) [96]. The FDAV is based on the criteria of substance-related addictions, pathological gambling and impulse control disorders of the ICD-10 [3] and the DSM-IV-TR [2].
The FDAV is a modified version of the "Fragebogen zur Differenzierten Drogenanamnese" (FDDA; Questionnaire on Differentiated Assessment of Addiction, QDAA) [97]. Its seven modules obtain "sociodemographic information" (e.g., age, profession, marital status), "history of excessive behaviour" (e.g., diagnostic criteria for addictions and impulse control disorder, individual patterns of behaviour, craving symptoms), "critical life events" (stress caused by traumatic events), "legal situation", "medical history", "physical and psychological complaints", and "emotional state" (triggering psychological conditions, or consequences of the addictive behaviour, respectively). Every module can be administered separately according to the suspected behavioural addiction, thereby making the FDAV an economical tool in assessing behavioural addictions. The FDAV is suitable for diagnostics, evaluation of therapy and follow-up in clinical practice and research. Currently, the FDAV is being validated in clinical and non-clinical samples.
</text></passage></document><document><id>PMID-6326669</id><passage><offset>0</offset><text>Preliminary evidence for a pyridine nucleotide cycle in Bordetella pertussis.
Preliminary evidence that Bordetella pertussis has a functional pyridine nucleotide cycle was the observation that [14C]-nicotinic acid was rapidly metabolized during its uptake by the bacteria to pyridine nucleotides and nicotinamide. Nicotinamide deamidase activity, necessary for the completion of the cycle by conversion of nicotinamide to nicotinic acid, was found in a soluble extract (20 000 X g supernatant) of B. pertussis cell lysates.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="510" length="12"></location><text>cell lysates</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMID-14714614</id><passage><offset>0</offset><text>Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer.
Bcl-2 and TGF-beta receptors type II (RII) in colon carcinomas were studied in a series of 113 patients, to determine their prognostic significance and to correlate their expression with other prognostic indicators. Bcl-2 expression in the tumor cells showed a reverse relation with tumor size (P = 0.018), histological grade (P = 0.04), and stage (P = 0.013). Univariate survival analysis using the log rank test showed that the survival of patients with bcl-2-positive tumors was significantly better than the survival of patients with bcl-2-negative tumors (P = 0.02). However, when entered into a multivariate analysis model, it was not found to be of independent prognostic significance. TGF-beta RII expression was correlated with stage (P = 0.03), while no statistically significant correlation was found between TGF-beta RII expression and histological grade or survival. In conclusion, these results provide additional evidence for the role of bcl-2 and TGF-beta RII in carcinogenesis of the colon, while they do not support the use of these factors as prognostic markers in patients with colon cancer.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="635" length="21"></location><text>bcl-2-negative tumors</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1098" length="5"></location><text>colon</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="380" length="5"></location><text>tumor</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="553" length="21"></location><text>bcl-2-positive tumors</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1195" length="12"></location><text>colon cancer</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="83" length="12"></location><text>colon cancer</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="337" length="11"></location><text>tumor cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="143" length="16"></location><text>colon carcinomas</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation></passage></document><document><id>PMID-9671543</id><passage><offset>0</offset><text>Acylase I-catalyzed deacetylation of N-acetyl-L-cysteine and S-alkyl-N-acetyl-L-cysteines.
The aminoacylase that catalyzes the hydrolysis of N-acetyl-L-cysteine (NAC) was identified as acylase I after purification by column chromatography and electrophoretic analysis. Rat kidney cytosol was fractionated by ammonium sulfate precipitation, and the proteins were separated by ion-exchange column chromatography, gel-filtration column chromatography, and hydrophobic interaction column chromatography. Acylase activity with NAC and N-acetyl-L-methionine (NAM), a known substrate for acylase I, as substrates coeluted during all chromatographic steps. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that the protein was purified to near homogeneity and had a subunit Mr of 43 000, which is identical with the Mr of acylase I from porcine kidney and bovine liver. n-Butylmalonic acid was a slow-binding inhibitor of acylase I and inhibited the deacetylation of NAC with a Ki of 192 +/- 27 microM. These results show that acylase I catalyzes the deacetylation of NAC. The acylase I-catalyzed deacetylation of a range of S-alkyl-N-acetyl-L-cysteines, their carbon and oxygen analogues, and the selenium analogue of NAM was also studied with porcine kidney acylase I. The specific activity of the acylase I-catalyzed deacetylation of these substrates was related to their calculated molar volumes and log P values. The S-alkyl-N-acetyl-L-cysteines with short (C0-C3) and unbranched S-alkyl substituents were good acylase I substrates, whereas the S-alkyl-N-acetyl-L-cysteines with long (&gt;C3) and branched S-alkyl substituents were poLr acylase I substrates. The carbon and oxygen analogues of S-methyl-N-acetyl-L-cysteine and the carbon analogue of S-ethyl-N-acetyl-L-cysteine were poor acylase I substrates, whereas the selenium analogue of NAM was a good acylase I substrate.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1261" length="6"></location><text>kidney</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="273" length="14"></location><text>kidney cytosol</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="871" length="5"></location><text>liver</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="853" length="6"></location><text>kidney</text></annotation></passage></document><document><id>PMC-2217075-caption-07</id><passage><offset>0</offset><text>Anion to cation selectivity ratio determined from the relative rates of reaction of MTSES- and MTSET+ with the water exposed residues in the M6 segment. The anion selectivity ratio is calculated as described in Table II, column 5. Note the marked increase in anion selectivity at the residues T351C and Q353C. A ratio of 1 indicates no selectivity between anions and cations. The larger the ratio the greater the anion selectivity.
</text></passage></document><document><id>PMID-2607031</id><passage><offset>0</offset><text>Screening method for insecticidal activity using first instars of black blow fly (Diptera: Calliphoridae).
A bioassay method suitable for rapid mass screening of fermentation and synthetic organic compounds for insecticidal activity is described. The test, which uses first instars of susceptible black blow fly, Phormia regina (Meigen), in a bovine serum medium, detects insecticidal activity with reproducible results. It is capable of selecting the most active compound in structure-activity relationships by minimum effective dose concentration studies. The bioassay system is easy to operate and requires only a minute quantity of chemical compound.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="350" length="5"></location><text>serum</text></annotation></passage></document><document><id>PMC-2959883-sec-06</id><passage><offset>0</offset><text>Data collection: CrystalClear (Rigaku/MSC, 2005 &gt;); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 &gt;); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 &gt;); molecular graphics: ORTEPII (Johnson, 1976 &gt;); software used to prepare material for publication: SHELXL97.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="52" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMID-14663884</id><passage><offset>0</offset><text>[Laboratory diagnostics of Crimean hemorrhagic fever by polymerase chain reaction].
Our group developed, within the present case study, two techniques' variations, i.e. a single-step RT-PCR and nested RT-PCR assays, for the purpose of detecting the Crimean-Congo hemorrhagic fever RNA virus in human samples. The above assays as well as those previously recommended by the Ministry of Health of the Russian Federation were simultaneously used in 14 clinical samples obtained from patients with Crimean hemorrhagic fever. After assessing the detection accuracy, it was found that the developed-by-us test system displayed the same or even better diagnostic values versus the previously recommended nested RT-PCR and a 1000-fold advantage over the previously recommended single-step RT-PCA. The single-step RT-PCR assay variation is always more preferable in sense of technical and economic motivations. Finally, the test system developed by us has every reason to become the method of choice in routine PCR diagnosis of Crimean hemorrhagic fever after all official trials and approvals are duly complied with.
</text></passage></document><document><id>PMID-15224342</id><passage><offset>0</offset><text>Rational synthesis of multicyclic bis[2]catenanes.
Bis-loop tetraurea calix[4]arene 6 has been prepared by acylation of the wide-rim calix[4]arene tetraamine 1 with the activated bis(urethane) 8 under dilution conditions. Similarly the bis(Boc-protected) tetraamine 2 is converted into the mono-loop derivative 3 which after deprotection and acylation gives the bisalkenyl derivative 5. In apolar solvents this tetraurea calix[4]arene 5 forms regioselectively a single hydrogen-bonded homodimer, from which the bis[2]catenane 10a is formed in 49% by a metathesis reaction followed by hydrogenation. Bis-loop derivative 6 forms no homodimers for steric reasons, but a stoichiometric mixture with the open-chain tetraalkenyl derivative 7a contains exclusively the heterodimer. Metathesis and subsequent hydrogenation now yields 65 % of the pure bis[2]catenane 10a which could not be isolated from the complex reaction mixture obtained from the homodimer 7a.7a. The chirality of 10a (D(2) symmetry) has been verified by optical resolution using HPLC on a chiral stationary phase.
</text></passage></document><document><id>PMC-3199853-sec-07</id><passage><offset>0</offset><text>Patients and Study Design
A prospective evaluation of the different CMR parameters for predicting LV segmental and global functional recovery was performed in 46 patients (63 +/- 10 years old, 3 with previous CABG, 35 with three-vessel disease, 3 with one-vessel disease) with LV systolic dysfunction (LVEF 35 +/- 8%) before they underwent surgical (n = 34) or percutaneous (n = 12) revascularisation. Sixty patients without contraindications for CMR were screened for the following inclusion criteria: (1) CAD (&gt; 70% stenosis in one or more major epicardial vessels), scheduled for a revascularisation procedure; (2) LVEF &lt;= 45%; (3) at least two adjacent segments with wall motion abnormalities at rest; and (4) no infarction or revascularisation within the last two months. Patients were included in the study only after a successful and complete coronary revascularisation. Of the 14 patients who did not complete the study, 3 decided not to undergo the repeated CMR scan or were lost during follow-up; 7 had significant periprocedural injury (new LGE zones on repeated CMR scans and clinically proven periprocedural myocardial infarction (MI) or MI between both scans); 3 had pacemakers or defibrillators implanted in the period between the MR scans; and 1 was excluded because of dilated cardiomyopathy with secondary CAD. None of the patients were excluded from the study for technical reasons or image quality.
The mean interval between CMR and revascularisation was 12 +/- 13 days, and none of the patients presented clinical evidence of infarction during this period. The mean interval between MI and the first CMR was 3.6 years. In 46 patients, the extent of regional contractility and LGE were determined repeatedly by CMR 28 +/- 4 weeks (6 months) after revascularisation.
The study was approved by the Lithuanian Bioethics Committee (Nr. 17), and informed written consent was obtained from each patient prior to inclusion in the study.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="671" length="4"></location><text>wall</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="98" length="2"></location><text>LV</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1052" length="3"></location><text>LGE</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1697" length="3"></location><text>LGE</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="277" length="2"></location><text>LV</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="548" length="18"></location><text>epicardial vessels</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1121" length="10"></location><text>myocardial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="850" length="8"></location><text>coronary</text></annotation></passage></document><document><id>PMID-9931156</id><passage><offset>0</offset><text>Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats.
Both dopamine D1-like (D1A and D1B) and D2-like (D2, D3, and D4) receptor subfamilies are present in the kidney. Blockade of the intrarenal D1-like receptor family is associated with natriuresis and diuresis. Because the D1A and D1B receptor subtypes are not distinguishable by currently available dopaminergic agents, their functional role remains undefined. In the present study, the effect of selective inhibition of the renal D1A receptor with phosphorothioated antisense oligodeoxynucleotide (AS-ODN) was investigated in conscious uninephrectomized rats. After renal interstitial administration of Texas red-labeled D1A receptor AS-ODN, intense fluorescent signal was localized in the renal tubular epithelium and vasculature. In rats on normal salt intake, AS-ODN injected interstitially into the kidney reduced daily urinary sodium excretion (1.4+/-0.04 versus 0.8+/-0.2 mEq/d, n=5, P&lt;0.05) and urine output (16.9+/-3.8 versus 12.5+/-3.6 mL/d, n=5, P&lt;0.05). In rats on high sodium intake, continuous renal interstitial administration of D1A receptor AS-ODN transiently decreased daily urinary sodium excretion (5.4+/-0.5 versus 4.2+/-0.3 mEq/d, n=7, P&lt;0.01) and urine output (27.6+/-4.5 versus 18.1+/-1.8 mL/d, n=7, P&lt;0.01). Neither vehicle nor sense oligodeoxynucleotide had significant effects. Systolic blood pressure remained unchanged. The renal D1A receptor protein was significantly decreased by 35% and 46% at the end of the study in AS-ODN-treated rats on normal and high salt intake, respectively, whereas the D1B receptor and beta-actin were not affected. These results provide the first direct evidence that the renal D1A receptor subtype plays an important role in the control of sodium excretion.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="28" length="5"></location><text>renal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="673" length="18"></location><text>renal interstitial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="212" length="6"></location><text>kidney</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="826" length="11"></location><text>vasculature</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="910" length="6"></location><text>kidney</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="531" length="5"></location><text>renal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="797" length="24"></location><text>renal tubular epithelium</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1114" length="18"></location><text>renal interstitial</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1199" length="7"></location><text>urinary</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1276" length="5"></location><text>urine</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1420" length="5"></location><text>blood</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="931" length="7"></location><text>urinary</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1459" length="5"></location><text>renal</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1009" length="5"></location><text>urine</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1738" length="5"></location><text>renal</text></annotation></passage></document><document><id>PMC-2467402-sec-01</id><passage><offset>0</offset><text>Background
Previous publications indicate that acupuncture is efficient for the treatment of pelvic girdle pain, PGP, in pregnant women. However, the use of acupuncture for PGP is rare due to insufficient documentation of adverse effects of this treatment in this specific condition. The aim of the present work was to assess adverse effects of acupuncture on the pregnancy, mother, delivery and the fetus/neonate in comparison with women that received stabilising exercises as adjunct to standard treatment or standard treatment alone.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="93" length="13"></location><text>pelvic girdle</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="400" length="5"></location><text>fetus</text></annotation></passage></document><document><id>PMID-6524192</id><passage><offset>0</offset><text>[Reactive states among psychopathic personalities of different clinical groups].
On the basis of a clinical follow-up of 71 psychopaths with manifestations of reactive psychosis, the authors established the clinico-typological characteristics of both groups of pathology and the system of correlations between them. They also described the structure of the psychopathic and psychogenic syndromes, the type of psychopathic personality reaction and the form of psychogenic responses and proved statistically their close interrelationship. Data were obtained on some general regularities of interrelations of reactive psychoses with a psychopathic background which are important for the prognosis, prophylaxis and therapy of reactive states.
</text></passage></document><document><id>PMC-2727621-caption-02</id><passage><offset>0</offset><text>Model of how estrogen induces DNA damage. Estrogen enters the cell and is bound by the ER. The dimeric ER-estrogen complex enters the nucleus and induces AID expression. This leads to an increase in mutations and translocations, and potentially cancer
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="62" length="4"></location><text>cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="245" length="6"></location><text>cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="134" length="7"></location><text>nucleus</text></annotation></passage></document><document><id>PMID-19595081</id><passage><offset>0</offset><text>[Quantitative analysis of regional cerebral blood flow in elderly with white matter lesions].
OBJECTIVE:
To observe whether the severity of white matter lesions (WML) is related to ischemia in elderly.
METHODS:
WML were divided into 2 categories (centrum semiovale and periventricular regions) and four grades (grade 0, grade 1, grade 2 and grade 3) according to the severity of WML showing on the FLAIR sequence of MRI using modified Fazekas scale. The values of regional cerebral blood flow (rCBF) within WML and other brain regions were measured using Xenon contrast CT.
RESULTS:
Mean rCBF (ml x 100 g(-1) x min(-1)) within lesions around periventricular areas, in right and left centrum semiovale were 20.8 +/- 2.8, 22.3 +/- 1.9 and 22.2 +/- 2.1 in grade 0; 20.3 +/- 2.5, 21.3 +/- 1.0 and 21.0 +/- 1.8 in grade1; 16.3 +/- 2.0, 15.6 +/- 1.7 and 15.9 +/- 0.9 in grade 2; 14.1 +/- 2.6, 14.5 +/- 2.2 and 14.2 +/- 1.9 in grade 3 respectively. The severity of WML is associated significantly with reduction of rCBF within lesions both in centrum semiovale and periventricular regions (all P &lt; 0.05). There was no significant difference in rCBF values between grade 0 and 1, but significant differences existed between grade 0 and grades 2 and 3, between grade 1 and grades 2 and 3 (all P &lt; 0.05). Statistical significance also existed between the severity of white matter lesions and rCBF in bilateral temporal lobes and lentiform nucleases (P &lt; 0.05).
CONCLUSIONS:
The severity of WML both in centrum semiovale and periventricular regions is associated significantly with reduction of rCBF within lesions.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="269" length="23"></location><text>periventricular regions</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="379" length="3"></location><text>WML</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="211" length="3"></location><text>WML</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="247" length="17"></location><text>centrum semiovale</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="482" length="5"></location><text>blood</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1400" length="14"></location><text>temporal lobes</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="507" length="3"></location><text>WML</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="473" length="8"></location><text>cerebral</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="35" length="8"></location><text>cerebral</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="71" length="20"></location><text>white matter lesions</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1596" length="7"></location><text>lesions</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1514" length="23"></location><text>periventricular regions</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1492" length="17"></location><text>centrum semiovale</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="44" length="5"></location><text>blood</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="162" length="3"></location><text>WML</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="140" length="20"></location><text>white matter lesions</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="521" length="5"></location><text>brain</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="627" length="7"></location><text>lesions</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="642" length="21"></location><text>periventricular areas</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="683" length="17"></location><text>centrum semiovale</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="958" length="3"></location><text>WML</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1020" length="7"></location><text>lesions</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1036" length="17"></location><text>centrum semiovale</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1058" length="23"></location><text>periventricular regions</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1357" length="20"></location><text>white matter lesions</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1480" length="3"></location><text>WML</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T2" role=""></node><node refid="T3" role=""></node></relation></passage></document><document><id>PMID-15012488</id><passage><offset>0</offset><text>Covariance structure analysis: statistical practice, theory, and directions.
Although covariance structure analysis is used increasingly to analyze nonexperimental data, important statistical requirements for its proper use are frequently ignored. Valid conclusions about the adequacy of a model as an acceptable representation of data, which are based on goodness-of-fit test statistics and standard errors of parameter estimates, rely on the model estimation procedure being appropriate for the data. Using analogies to linear regression and anova, this review examines conditions under which conclusions drawn from various estimation methods will be correct and the consequences of ignoring these conditions. A distinction is made between estimation methods that are either correctly or incorrectly specified for the distribution of data being analyzed, and it is shown that valid conclusions are possible even under misspecification. A brief example illustrates the ideas. Internet access is given to a computer code for several methods that are not available in programs such as EQS or LISREL.
</text></passage></document><document><id>PMC-3220010-sec-02</id><passage><offset>0</offset><text>Abbreviations
ARDS: acute respiratory distress syndrome; CMV: conventional mechanical ventilation; HFOV: high-frequency oscillation ventilation; LPS: lipopolysaccharide; PEEP: positive end-expiratory pressure; VILI: ventilator-induced lung injury.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="26" length="11"></location><text>respiratory</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="235" length="4"></location><text>lung</text></annotation></passage></document><document><id>PMC-1475211-sec-01</id><passage><offset>0</offset><text>Images
FIGURE 2. A
FIGURE 2. B
FIGURE 3.
</text></passage></document><document><id>PMID-16623714</id><passage><offset>0</offset><text>A potential role for the Src-like adapter protein SLAP-2 in signaling by the colony stimulating factor-1 receptor.
The development of macrophages from myeloid progenitor cells is primarily controlled by the growth factor colony stimulating factor-1 (CSF-1) and its cognate receptor, a transmembrane tyrosine kinase encoded by the c-Fms proto-oncogene. The CSF-1 receptor exerts its biological effects on cells via a range of signaling proteins including Erk1/2 and Akt. Here we have investigated the potential involvement of the Src-like adapter protein (SLAP-2) in signaling by the CSF-1 receptor in mouse bone marrow-derived macrophages. RT-PCR analysis revealed constitutive expression of the SLAP-2 gene in bone marrow macrophages. Surprisingly, co-immunoprecipitation and GST binding experiments demonstrated that the CSF-1 receptor could bind to SLAP-2 in a ligand-independent manner. Furthermore, the binding of SLAP-2 to the CSF-1 receptor involved multiple domains of SLAP-2. SLAP-2 also bound c-Cbl, with the interaction being mediated, at least in part, by the unique C-terminal domain of SLAP-2. Overexpression of SLAP-2 in bone marrow macrophages partially suppressed the CSF-1-induced tyrosine phosphorylation and/or expression level of a approximately 80 kDa protein without affecting CSF-1-induced global tyrosine phosphorylation, or activation of Akt or Erk1/2. Significantly, CSF-1 stimulation induced serine phosphorylation of SLAP-2. Pharmacologic inhibition of specific protein kinases revealed that CSF-1-induced phosphorylation of SLAP-2 was dependent on JNK activity. Taken together, our results suggest that SLAP-2 could potentially be involved in signaling by the CSF-1 receptor.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="627" length="11"></location><text>macrophages</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="711" length="23"></location><text>bone marrow macrophages</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="404" length="5"></location><text>cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="607" length="11"></location><text>bone marrow</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1136" length="23"></location><text>bone marrow macrophages</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="134" length="11"></location><text>macrophages</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="285" length="13"></location><text>transmembrane</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="151" length="24"></location><text>myeloid progenitor cells</text></annotation></passage></document><document><id>PMID-19919099</id><passage><offset>0</offset><text>Neural network analysis of spectroscopic data of lycopene and beta-carotene content in food samples compared to HPLC-UV-vis.
In this study a neural network (NN) model was designed to predict lycopene and beta-carotene concentrations in food samples, combined with a simple and fast technique, such as UV-vis spectroscopy. The measurement of the absorbance at 446 and 502 nm of different beta-carotene and lycopene standard mixtures was used to optimize a neural network based on a multilayer perceptron (MLP) (learning and verification process). Then, for validation purposes, the optimized NN has been applied to determine the concentration of both compounds in food samples (fresh tomato, tomato concentrate, tomato sauce, ketchup, tomato juice, watermelon, medlar, green pepper, and carrots), comparing the NN results with the known values of these compounds obtained by analytical techniques (UV-vis and HPLC). It was concluded that when the MLP-NN is used within the range studied, the optimized NN is able to estimate the beta-carotene and lycopene concentrations in food samples with an adequate accuracy, solving the UV-vis interference of beta-carotene and lycopene.
</text><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="698" length="11"></location><text>concentrate</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="741" length="5"></location><text>juice</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation></passage></document><document><id>PMC-2759629-sec-03</id><passage><offset>0</offset><text>Results:
All fractures united. Individual movement of dorsiflexion, palmar flexion, supination, pronation and radial-ulnar deviation were all significantly better in the dorsiflexed-immobilized group as compared with the palmar flexed immobilized group. Grip strength recovery with subjective assessment was better in the dorsiflexed group (77%) as compared to the palmar flexed group (23%). Radiological parameters were markedly better in the dorsiflexed group. Ninety-one per cent of patients in the dorsiflexed group had excellent to good results as compared to 66% in the palmar flexed group.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="365" length="6"></location><text>palmar</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="117" length="5"></location><text>ulnar</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="221" length="6"></location><text>palmar</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="576" length="6"></location><text>palmar</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="110" length="6"></location><text>radial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="68" length="6"></location><text>palmar</text></annotation></passage></document><document><id>PMID-8389297</id><passage><offset>0</offset><text>Lactotransferrin binding to its platelet receptor inhibits platelet aggregation.
A fluorescent lactotransferrin probe was prepared by coupling 5-(([2-(carbhydrazino)methyl]-thio)acetyl)amino fluorescein to aldehyde groups that were produced by a mild periodic-acid oxidation of the glycan moieties of lactotransferrin. In this manner, the receptor-binding site of the lactotransferrin remains active in contrast to the binding site of the lactotransferrin derivatized with fluorescein isothiocyanate. The fluorescent probe allowed us to characterize, by flow cytometry, the binding of lactotransferrin to non-activated human platelets. The putative lactotransferrin platelet receptor was purified and its immunological and physico-chemical properties were found to be very similar to those of the receptor previously isolated from activated human lymphocytes. Lactotransferrin inhibits ADP-induced platelet aggregation at concentrations down to 5 nM, which can be reached in the plasma after leukocyte degranulation. Inhibition of platelet aggregation was also observed with the N-terminal fragment of lactotransferrin (residues 3-281; 50% inhibition = 2 microM) and with CFQWQRNMRKVRGPPVSC synthetic octodecapeptide (residues 20-37; 50% inhibition = 20 microM) corresponding to one of the two external loops (residues 28-34 and 39-42) where we recently located the receptor-binding site. The activity (50% inhibition = 500 microM) of the tetrapeptide KRDS (residues 39-42), which has already been described, was at least 25-times and 16000-times lower than the activity of the octodecapeptide and of the lactotransferrin molecules, respectively. Finally, the inhibition was demonstrated to be mediated by a mechanism which requires the binding of lactotransferrin to its putative receptor and not to platelet glycoprotein IIb-IIIa.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="898" length="8"></location><text>platelet</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="979" length="6"></location><text>plasma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="666" length="8"></location><text>platelet</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1801" length="8"></location><text>platelet</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="847" length="11"></location><text>lymphocytes</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="992" length="9"></location><text>leukocyte</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1031" length="8"></location><text>platelet</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="32" length="8"></location><text>platelet</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="625" length="9"></location><text>platelets</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="59" length="8"></location><text>platelet</text></annotation></passage></document><document><id>PMC-3032734-sec-23</id><passage><offset>0</offset><text>Statistical analysis
All statistical analyses were performed using SPSS13.0 software. The differences between groups were compared using Student's t-test, and data were expressed as mean +/- SD. Statistical difference was accepted at P&lt;0.05.
</text></passage></document><document><id>PMC-2958498-caption-01</id><passage><offset>0</offset><text>The right eye of a 50-year-old patient with severe hypertension at the first visit. (a) Fundus photograph shows serous retinal detachment. The optic disc is pale at the temporal side. (b) Optical coherence tomography (OCT) shows retinal detachment involving the fovea and cystic change of inner retina. (c) Early phase images of fluorescein angiography (FA) (left) and indocyanine green angiography (IA) (right). (d) Late phase images of FA (left) and IA (right). FA shows window defect associated with macular cystic change. Note that no active leakage is observed in the area with serous retinal detachment or cystoid edema. IA shows decreased perfusion of the choroid at the macula and window defect with the damaged RPE. Hypofluorescence (arrow) along the retinal artery are observed. These are unique findings.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="590" length="7"></location><text>retinal</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="612" length="13"></location><text>cystoid edema</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="289" length="12"></location><text>inner retina</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="503" length="7"></location><text>macular</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="678" length="6"></location><text>macula</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="760" length="14"></location><text>retinal artery</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="10" length="3"></location><text>eye</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="229" length="7"></location><text>retinal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="119" length="7"></location><text>retinal</text></annotation></passage></document><document><id>PMID-10354550</id><passage><offset>0</offset><text>Novel mechanism for the impairment of cell proliferation in HIV-1 infection.
The synthesis of ribonucleotides is essential to cell proliferation. Defects in the relevant metabolic pathways have been demonstrated in stimulated T cells from AIDS patients and are associated with lymphocyte necrotic death. Here, Margarita Bofill and colleagues discuss the possibility that an impaired ribonucleotide metabolism might be common to all rapidly dividing cells and thus contribute to other recognized symptoms of HIV-1 infection.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="277" length="10"></location><text>lymphocyte</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="449" length="5"></location><text>cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="38" length="4"></location><text>cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="226" length="7"></location><text>T cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="126" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMID-15673543</id><passage><offset>0</offset><text>Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era.
AIMS:
To test the prognostic value of ventricular late potentials (LPs) in a large cohort of post-infarction patients in the modern reperfusion era.
METHODS AND RESULTS:
1800 consecutive survivors of acute myocardial infarction in sinus rhythm and under 76 years of age were enrolled. Many (99%) of the patients received reperfusion/revascularization therapy (91% percutaneous coronary intervention) and up-to-date pharmacological treatment (99% aspirin, 93% beta-blockers, 90% ACE-inhibitors, and 85% statins). LPs were calculated in 968 patients and found to be present in 90 (9.3%). The primary endpoint was the composite of cardiac death and serious arrhythmic events. The secondary endpoint was the composite of sudden cardiac death and serious arrhythmic events. During follow-up (median 34 months), 26 patients reached the primary endpoint. The presence of LPs was not significantly associated with the primary endpoint in univariable or multivariable analysis. In contrast, low (&lt; or = 30%) left ventricular ejection fraction (hazard ratio 9.6, 95% confidence interval 4.1-22.4), heart rate turbulence category 2 (7.5, 2.4-23.9) and category 1 (5.3, 1.9-14.9) were significant predictors in both univariable and multivariable analysis.
CONCLUSION:
Ventricular LPs are of limited use for risk stratification in unselected post-infarction patients in the modern reperfusion era.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1107" length="16"></location><text>left ventricular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1196" length="5"></location><text>heart</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="736" length="7"></location><text>cardiac</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="339" length="5"></location><text>sinus</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="832" length="7"></location><text>cardiac</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1364" length="11"></location><text>Ventricular</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="485" length="8"></location><text>coronary</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="28" length="11"></location><text>ventricular</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="314" length="10"></location><text>myocardial</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="146" length="11"></location><text>ventricular</text></annotation></passage></document><document><id>PMC-2882287-sec-12</id><passage><offset>0</offset><text>Temporary migration module
A temporary migration census module was conducted in 2002 and 2007. People who were identified as temporary migrants were entered into the module, and a household respondent answered questions about the migration. Key areas included the duration of migration, destination, reasons for migration, return pattern, communication pattern, remittances, linked moves and child care arrangements.
</text></passage></document><document><id>PMC-2375120-caption-08</id><passage><offset>0</offset><text>Haplotype block structure from one replicate generated by the block method (ALS).
</text></passage></document><document><id>PMID-16252749</id><passage><offset>0</offset><text>Sensitivity variation in two-center holographic recording.
An experimental study of variation of sensitivity with recording and sensitizing intensities in two-center recording is presented. The experimental results are in good agreement with the theoretical predictions. It is shown experimentally, for what is to our knowledge the first time, that the sensitivity is a function of the ratio of recording to sensitizing intensities and not the absolute intensities. Also, the ratio of recording to sensitizing intensities should be small to obtain high sensitivity values. We also report the highest sensitivity (S=0.15 cm/J) that has been achieved to date for a LiNbO3:Fe:Mn crystal.
</text></passage></document><document><id>PMID-7511490</id><passage><offset>0</offset><text>Additional tests of interest to the dermatologist.
The carcinoid syndrome and its clinical manifestations have been discussed. The standard laboratory test for making that diagnosis is urinary 5-HIAA levels but newer, more sensitive tests may also be available.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="185" length="7"></location><text>urinary</text></annotation></passage></document><document><id>PMID-1517352</id><passage><offset>0</offset><text>Active respiratory syncytial virus purified by ion-exchange chromatography: characterization of binding and elution requirements.
Two viruses, respiratory syncytial virus (RSV) and vesicular stomatitis virus (VSV) were used to evaluate viral purification by an affinity resin column (Matrex Cellufine Sulfate (MCS); Amicon Division, WR Grace &amp; Co.). Viable RSV was purified significantly from crude cell lysate by a single pass through a column containing the anionic MCS resin. Most cell protein and albumin eluted from the MCS resin with phosphate buffered saline (PBS) but RSV eluted at high ionic strength, i.e., greater than or equal to 0.6 M NaCl. Further purification was possible by sucrose step gradient centrifugation. The RSV prepared by column purification or by column plus sucrose gradient separation was both intact and infective. RSV and pure samples of VSV were used to optimize ionic strength and salts for elution from the MCS column: 0.8 M NaCl removed most of the viral protein. The capacity of the MCS gel for RSV or VSV was found to be about 0.6-0.8 mg viral protein per ml of hydrated resin. Detergent-solubilized viral membrane proteins bound to the MCS resin in 0.145 M NaCl and eluted with higher salt concentrations. Thus, this resin also may be a useful aid for relatively gentle purification of these proteins.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1144" length="8"></location><text>membrane</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="399" length="11"></location><text>cell lysate</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="484" length="4"></location><text>cell</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation></passage></document><document><id>PMID-17476983</id><passage><offset>0</offset><text>[Synthetic fragments of the NS1 protein of the tick-borne encephalitis virus exhibiting a protective effect].
Potentially immunoactive regions of the NS1 nonstructural protein of the tick-borne encephalitis virus that can stimulate the antibody formation in vivo and protect animals from this disease were chosen on the basis of theoretical calculations. Eleven 16- to 27-aa peptides containing the chosen regions were synthesized. The ability of the free peptides (without any high-molecular-mass carrier) to stimulate the production of antipeptide antibodies in mice of three lines and ensure the formation of protective immunity was studied. Most of these peptides were shown to exhibit the immunogenic activity in a free state. Five fragments that can protect mice from the infection by a lethal dose of tick-borne encephalitis virus were found.
</text></passage></document><document><id>PMC-3238981-sec-11</id><passage><offset>0</offset><text>Figures
Fig. 1.
A view of (I) with displacement ellipsoids drawn at the 30% probability level.
Fig. 2.
Stereoview of the sheet formed by C--H...pi interactions. Hydrogen atoms not involved in the motifs are not included.
</text></passage></document><document><id>PMID-2596160</id><passage><offset>0</offset><text>Endoscopic injection therapy for acute upper GI bleeding.
In summary, we have found this technique to be useful in patients in whom coagulation therapy is not possible or effective. It must still be considered a technique which is undergoing evaluation. Prospective randomized trials comparing this therapy with other currently available therapies such a electrocoagulation, laser and conservative management must be completed to firmly define its place in treatment strategy for acute upper GI bleeding.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="39" length="8"></location><text>upper GI</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="486" length="8"></location><text>upper GI</text></annotation></passage></document><document><id>PMC-1971061-sec-09</id><passage><offset>0</offset><text>Etiology
Anorectal malformations (ARM) represent a spectrum of abnormalities ranging from mild anal anomalies to complex cloacal malformations. The etiology of such malformations remains unclear and is likely multifactorial. There are however reasons to believe there is a genetic componenet. As early as the 1950s, it was recognized that there was an increased risk for a sibling of a patient with ARM to be born with a malformation, as much as 1 in 100, compared with the incidence of about 1 in 5000 in the general population. Since that time there have been reports of families with 2 or more affected members and associations of ARMs with multisystem syndromes. In particular, mutations in specific genes encoding transcription factors have been described in patients having Townes-Broks syndrome, Currarino's syndrome, and Pallister-Hall syndrome, each of which have autosomal dominant modes of inheritance. In addition, it has been found that there is not only an increased incidence of ARM in patient with trisomy 21 (Down's syndrome), but that 95% of patients with trisomy 21 and ARM have imperforate anus without fistula, compared with only 5% of all patients with ARM. Based on this evidence, it is likely that the mutation of a variety of different genes can result in ARM, or that the etiology of ARM is multigenic [13].
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1123" length="7"></location><text>fistula</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="9" length="9"></location><text>Anorectal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1110" length="4"></location><text>anus</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="95" length="4"></location><text>anal</text></annotation></passage></document><document><id>PMC-3012732-sec-15</id><passage><offset>0</offset><text>Reagents and antibodies
Maxisorp strips (NunC, Roskilde, Denmark), GST-PNMA2 recombinant protein (Abnova, Taipei, Taiwan); 3,3',5,5-tetramethylbenzidine (TMB) + substrate (Dako, Glostrup, Denmark), Peroxidase with dakocytomation peroxidase block (Dako), Dakocytomation envision(R) system labeled polymer-HRP anti-rabbit kit and 3-3'-diaminobenzidine (Dako), Mayer's hematoxylin (Histolab Product AB, Gothenburg, Sweden), Graded alcohol (Kemetyl, Vestby, Norway), Xylen (Solveco, Rosersberg, Sweden), Pertex(R) (Histolab, Gothenburg, Sweden), Tris-Glycine blotting buffer (Amresco, Solon, OH), Western blotting (WB) reagent and Lumi-Light WB substrate (Roche, Basel, Switzerland), EasyTag Methionine-L-35S, NEG709A005MC (PerkinElmer, Waltham, MA), Full-length cDNA clone for human PNMA2, ID6580976 (BioScience Geneservice, Cambridge, UK), TnT(R) SP6 Quick Coupled Transcription/Translation System (Promega, Madison, WI), Protein G-Sepharose beads (GE Healthcare, Little Chalfont, Buckinghamshire, UK), Peroxidase (HRP)-conjugated rabbit anti human IgG (anti-IgG) (Dako), rabbit polyclonal antibody anti-PNMA2 (Atlas Antibodies, Stockholm, Sweden), monoclonal mouse anti-GST, sc-138, polyclonal goat anti-human Ma2, sc-68099, HRP-donkey anti-goat, sc-2020, (Santa Cruz Biotechnology, Santa Cruz, CA), HRP-goat anti-rabbit, P0448, (Dako) and Ravo PNS-Blot, (Ravo Diagnostika GmbH, Freiburg, Germany).
</text></passage></document><document><id>PMC-1968612-sec-01</id><passage><offset>0</offset><text>Images
Figure 5
</text></passage></document><document><id>PMID-11271930</id><passage><offset>0</offset><text>Tonometry in normal and scarred corneas, and in postkeratoplasty eyes: a comparative study of the Goldmann, the ProTon and the Schiotz tonometers.
PURPOSE:
Clinical comparison of intraocular pressure (IOP) measured with the Goldmann applanation tonometer (GAT), the ProTon tonometer (PT), and the Schiotz tonometer (ST), in normal eyes, eyes with scarred corneas and postkeratoplasty eyes.
MATERIAL AND METHODS:
The IOP readings with GAT, PT, and ST were compared in 125 eyes with normal corneas (Group A), 17 eyes with scarred corneas (Group B), and in 21 postkeratoplasty eyes (Group C). The data were statistically analysed at 95% confidence interval; linear regression analysis and paired t-test were done.
RESULTS:
The mean differences and their standard deviation [SD] between GAT and PT readings, and GAT and ST readings respectively were: [1] in Group A: -0.23 [SD 2.75] mmHg and +0.24 [SD 3.18] mmHg respectively; [2] in Group B: -1.8 [SD 12.67] mmHg and -4.5 [SD 9.95 mmHg; and [3] in Group C: +0.24 [SD 8.72] mmHg and -0.12 [SD 8.7] mmHg. They were not statistically significant. In Group A the 95% confidence interval between GAT and PT readings was -5.27 mmHg to 5.73 mmHg, and between GAT and ST readings, -6.12 mmHg to 6.59 mmHg. Ninety six [77%] eyes with the PT and 84 [69%] eyes with ST measurements were within 3 mmHg of GAT pressure. The correlation coefficients [r] for PT and ST were 0.93 [P = 0.0000] and 0.88 [P = 0.0000] respectively. In Group B 95% confidence interval between GAT and PT readings was -27.17 mmHg to 23.51 mmHg, and between GAT and ST measurement, -24.37 mmHg to 15.44 mmHg. The correlation coefficients [r] for the PT and ST were 0.112 [P = 0.660] and 0.630 [P = 0.006] respectively. In group C, the 95% confidence interval between GAT and PT measurements was -17.20 mmHg to 17.67 mmHg, and between GAT and ST measurements, -17.51 mmHg to 17.27 mmHg. The correlation coefficients [r] for the PT and the ST were 0.780 [P = 0.0000] and 0.740 [P = 0.0001] respectively.
CONCLUSIONS:
In clinical practice PT appears to have a higher level of accuracy than ST in normal corneas. In scarred corneas and post-penetrating keratoplasty eyes, because of high SD for mean differences and wide confidence interval of 95%, both PT and ST are inaccurate in measuring IOP as compared to GAT in such eyes.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="32" length="7"></location><text>corneas</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="331" length="4"></location><text>eyes</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="65" length="4"></location><text>eyes</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="384" length="4"></location><text>eyes</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="471" length="4"></location><text>eyes</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="337" length="4"></location><text>eyes</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="355" length="7"></location><text>corneas</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="528" length="7"></location><text>corneas</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="574" length="4"></location><text>eyes</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1262" length="4"></location><text>eyes</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1292" length="4"></location><text>eyes</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="488" length="7"></location><text>corneas</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2108" length="7"></location><text>corneas</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="510" length="4"></location><text>eyes</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2128" length="7"></location><text>corneas</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2170" length="4"></location><text>eyes</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2327" length="4"></location><text>eyes</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="179" length="11"></location><text>intraocular</text></annotation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T10" role="Arg1"></node><node refid="T9" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T8" role="Arg1"></node><node refid="T7" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T5" role="Arg1"></node><node refid="T4" role="Arg2"></node></relation></passage></document><document><id>PMC-1896192-sec-09</id><passage><offset>0</offset><text>Supporting Information
Alternate Language Article S1
Translation of the manuscript into French by EL
(201 KB DOC).
Click here for additional data file.
</text></passage></document><document><id>PMID-2539554</id><passage><offset>0</offset><text>Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
125I-Bolton Hunter-cholecystokinin octapeptide (BH-CCK8) and (-)-[3H]L-364718 membrane binding assays were used to identify and characterize cholecystokinin (CCK) receptors in CHP212 human neuroblastoma cells. The ligand binding properties of CCK receptors in these cells are similar to those found in pancreas (CCK-A sites) and differ from the predominant type of CCK binding site found in brain (CCK-B sites). The specific binding of 125I-BH-CCK8 but not (-)-[3H]L-364718 was reduced by the metabolically stable GTP analog guanosine 5'-(beta-delta-imido)trisphosphate. A substantial difference in the Bmax for the radiolabeled agonist (125I-BH-CCK8) and antagonist [(-)-[3H]L-364718] was noted. These observations are consistent with CCK receptors existing in guanine nucleotide-binding protein-coupled and -uncoupled states. Similar to its action in pancreatic acinar cells, CCK8(S) stimulated the accumulation of [3H]inositol phosphates in cells prelabeled with [3H]myo-inositol (EC50 = 3.2 +/- 0.4 nM; maximum response = 4.5 +/- 0.4 x basal). The intrinsic activity of CCK analogues in stimulating phosphoinositide hydrolysis was substantially less than their reported intrinsic activity in stimulating phosphoinositide hydrolysis in pancreatic acinar cells. The CHP212 neuroblastoma cell may serve as a useful model for the recently reported CCK-A binding site found in the central nervous system.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="453" length="8"></location><text>pancreas</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="542" length="5"></location><text>brain</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="340" length="19"></location><text>neuroblastoma cells</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1390" length="23"></location><text>pancreatic acinar cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="417" length="5"></location><text>cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1419" length="25"></location><text>CHP212 neuroblastoma cell</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1531" length="22"></location><text>central nervous system</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1004" length="23"></location><text>pancreatic acinar cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1095" length="5"></location><text>cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="36" length="26"></location><text>CHP212 neuroblastoma cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="327" length="6"></location><text>CHP212</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="229" length="8"></location><text>membrane</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T11" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation></passage></document><document><id>PMID-73315</id><passage><offset>0</offset><text>An unusual case of benign mucous membrane pemphigoid.
This case of benign mucous membrane pemphigoid (BMMP) is unusual in that blistering, scarring lesions were confined to the skin for 15 years before mucous membranes were involved. The onset of this disorder at the age of 38 is also unusual. Detailed immunological investigation was performed on this patient but the results in no way clarify the present confusion regarding the immunopathological processes in BMMP related to those operative in bullous pemphigoid.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="177" length="4"></location><text>skin</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="202" length="16"></location><text>mucous membranes</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="26" length="15"></location><text>mucous membrane</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="148" length="7"></location><text>lesions</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="74" length="15"></location><text>mucous membrane</text></annotation></passage></document><document><id>PMID-16165242</id><passage><offset>0</offset><text>Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug.
Pressure sensitive adhesive (PSA) matrices containing amorphous ketotifen were prepared and evaluated for enhanced skin permeability of the drug. A solvent casting method using silicone-typed PSA was employed, and n-hexane, an original solvent for the PSA and one more solvent, dichloromethane, tetrahydrofuran, acetone, ethyl acetate or toluene, were used for complete dissolution of ketotifen and high dispersion in an amorphous state of the drug. Presence of the amorphous form was judged based on the in vitro drug release rate from the matrix. As a result, dichloromethane and tetrahudrofuran were selected as appropriate dilution solvents. In vitro permeation experiments through excised hairless mouse skin revealed that the steady-state flux from the amorphous ketotifen-dispersed matrices was about five times greater than that of the crystalline ketotifen-dispersed matrices, and that the enhancement ratio was in good agreement with the solubility ratio of the amorphous to crystalline form of the drug. Comparison of the skin permeation profiles of amorphous ketotifen-dispersed matrices between two different drug contents suggested that the steady-state flux was not influenced by the drug content. In addition, at both drug contents, the period of the steady-state permeation coincided with the time until the amorphous drug was depleted from the matrix. These results suggest that the increase in skin permeation of ketotifen from PSA matrix was due to the supersaturation generated by amorphous form, and that the amorphous form was stable during the application period.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1137" length="4"></location><text>skin</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1517" length="4"></location><text>skin</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="15" length="4"></location><text>skin</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="813" length="4"></location><text>skin</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="219" length="4"></location><text>skin</text></annotation></passage></document><document><id>PMID-16969171</id><passage><offset>0</offset><text>Medical adherence and childhood chronic illness: family daily management skills and emotional climate as emerging contributors.
PURPOSE OF REVIEW:
To describe recent research that examines family factors that promote or derail adherence to medical regimens for children with chronic health conditions, primarily asthma, diabetes, and cystic fibrosis. From the past 2 years, eight correlational studies were identified which specifically examined the links between family management strategies, family climate and medical adherence.
RECENT FINDINGS:
Findings from the studies suggest that team-based management strategies and cohesive family climate promote adherence to medical treatments over time. Family interactions that are characterized by conflict and disengagement tend to disrupt adherence and inevitably cause a decline in child health. Moreover, these findings seem to be moderated by child age in that poorer adherence often occurs when a child reaches adolescence and is searching for greater autonomy.
SUMMARY:
Future research should consider the challenges in measuring medical adherence in the family context as well as incorporating more naturalistic studies of family interactions. Randomized controlled trials using family-based interventions may consider focusing on medical adherence as an important mediator between family process and child health outcomes.
</text></passage></document><document><id>PMC-1044634-sec-01</id><passage><offset>0</offset><text>Images
Figure 1
Figure 2
Figure 3
Figure 4
</text></passage></document><document><id>PMID-18393343</id><passage><offset>0</offset><text>A practical interface for microfluidics and nanoelectrospray mass spectrometry.
We report a new method for fabricating nanospray ionization tips for MS, formed from glass substrates and the inert polymer, parylene-C. Using a single photolithography step, the emitters are formed contiguously with microchannels, such that no dead volumes are observed. In addition, because the devices are very thin (approximately 0.3 mm) and the tips are formed at rectangular corners, the Taylor cone volumes are small, which makes the method attractive for future integration with microfluidic separations. Device performance was demonstrated by evaluating diverse analytes, ranging from synthetic polymers, to peptides, to nucleic acids. For all analytes, performance was similar to that of conventional emitters (pulled-glass capillaries and the Agilent HPLC Chip) with the advantage of rapid, batch fabrication of identical devices.
</text></passage></document><document><id>PMID-2777242</id><passage><offset>0</offset><text>Anaplastic and sarcomatoid carcinoma of the small intestine: a clinicopathologic study.
Carcinomas involving the jejunum and ileum are rare tumors. During a review of small intestinal neoplasms, six primary carcinomas of jejunum or ileum with an anaplastic and sarcomatoid histology were identified. At presentation, three of the patients had symptoms related to metastatic disease and three had symptoms referable to the local tumor. The tumors were large (greater than 4.5 cm in diameter), usually endophytic masses composed of large cells with eosinophilic cytoplasm, anaplastic nuclei, and prominent nucleoli. In many areas, the cells had a spindled configuration. Mucin positivity was identified in all six cases. Electron microscopic findings in two cases were indicative of epithelial differentiation. The tumors behaved aggressively; all five patients for whom there was clinical follow-up died of metastases within 40 months. The six anaplastic and sarcomatoid carcinomas were compared with 29 typical adenocarcinomas arising in the jejunum or ileum. Only two of the latter group had symptoms referable to distant metastases at presentation. These tumors also tended to be smaller at presentation (11 tumors were less than 4 cm in greatest dimension). Of 25 patients with typical adenocarcinomas who had acceptable follow-up, 18 (72%) died of disease and five (20%) were alive with no evidence of disease after 5 years. We conclude that anaplastic and sarcomatoid carcinoma is a rare variant of small intestinal carcinoma with an aggressive clinical course.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="140" length="6"></location><text>tumors</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="167" length="26"></location><text>small intestinal neoplasms</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="113" length="7"></location><text>jejunum</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="125" length="5"></location><text>ileum</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1289" length="15"></location><text>adenocarcinomas</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1210" length="6"></location><text>tumors</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1157" length="6"></location><text>tumors</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="207" length="10"></location><text>carcinomas</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1123" length="10"></location><text>metastases</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="221" length="7"></location><text>jejunum</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1053" length="5"></location><text>ileum</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1042" length="7"></location><text>jejunum</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1011" length="15"></location><text>adenocarcinomas</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="943" length="37"></location><text>anaplastic and sarcomatoid carcinomas</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="906" length="10"></location><text>metastases</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="813" length="6"></location><text>tumors</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="0" length="36"></location><text>Anaplastic and sarcomatoid carcinoma</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="88" length="10"></location><text>Carcinomas</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="44" length="15"></location><text>small intestine</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="232" length="5"></location><text>ileum</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="261" length="11"></location><text>sarcomatoid</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="428" length="5"></location><text>tumor</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="439" length="6"></location><text>tumors</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="536" length="5"></location><text>cells</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="547" length="22"></location><text>eosinophilic cytoplasm</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="582" length="6"></location><text>nuclei</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="604" length="8"></location><text>nucleoli</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="633" length="5"></location><text>cells</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1446" length="36"></location><text>anaplastic and sarcomatoid carcinoma</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="781" length="10"></location><text>epithelial</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1504" length="26"></location><text>small intestinal carcinoma</text></annotation></passage></document><document><id>PMC-3047434-sec-08</id><passage><offset>0</offset><text>DNA isolation
All solutions used for DNA isolation are purged with nitrogen (immediately prior to use) and supplemented with 50 muM phenyl-tert-butyl nitrone to minimise oxidative damage to DNA[31].
Qiagen DNAeasy Kit (#69506)
includes: Proteinase K, AW1, AW2, AE and Spin-columns
Dithiothreitol (DTT; Sigma)
Ethanol (Ajax Finechem #214-2.5L)
Nitrogen (for purging of buffers)
</text></passage></document><document><id>PMC-2771789-caption-06</id><passage><offset>0</offset><text>Percutaneous coronary intervention for the very late stent thrombosis in right coronary artery. A: a balloon angioplasty was performed to treat total occlusion of the stented right coronary artery. B: final coronary angiogram showed good distal flow without residual stenosis.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="13" length="8"></location><text>coronary</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="73" length="21"></location><text>right coronary artery</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="207" length="8"></location><text>coronary</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="175" length="21"></location><text>right coronary artery</text></annotation></passage></document><document><id>PMID-9754701</id><passage><offset>0</offset><text>Hemispheric control of motor function: a whole brain echo planar fMRI study.
The aim of this study was to explore whether recruitment of the ipsilateral motor cortex during non-dominant motor movement reflects left hemispheric control of motor function or simply the greater complexity or unfamiliarity of the motor task. BOLD fMRI was performed in normal right-handers during two motor tasks: (1) sequential finger movements (SM task) with the right or left hand; and (2) random finger movements (RM task) with the right hand. In all subjects, activation was predominantly in the contralateral motor areas (primary sensorimotor, lateral premotor, parietal and supplementary motor regions) and ipsilateral cerebellum. While the ipsilateral motor areas were also activated, single subject analysis revealed these areas to be more extensive and to be seen in more subjects during the non-dominant hand SM task and dominant hand RM task than during the more familiar dominant hand SM task. Similarly, group analysis also revealed ipsilateral activation in the primary sensorimotor and lateral premotor areas, but only during the non-dominant SM task and the dominant hand RM task. Non-dominant hand movements, perhaps because they are less 'automatic', appear to require more cortical activity similar to complex tasks with the dominant hand, and result in greater recruitment of ipsilateral cortical motor areas and striatum. The study also illustrates how potentially meaningful subtleties seen on individual maps may be obscured with group averaging approaches.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="47" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="409" length="6"></location><text>finger</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="141" length="24"></location><text>ipsilateral motor cortex</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="522" length="4"></location><text>hand</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="694" length="22"></location><text>ipsilateral cerebellum</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="459" length="4"></location><text>hand</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="480" length="6"></location><text>finger</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1377" length="32"></location><text>ipsilateral cortical motor areas</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1414" length="8"></location><text>striatum</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="210" length="16"></location><text>left hemispheric</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="973" length="4"></location><text>hand</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="728" length="23"></location><text>ipsilateral motor areas</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1191" length="4"></location><text>hand</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1082" length="22"></location><text>lateral premotor areas</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1334" length="4"></location><text>hand</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1164" length="4"></location><text>hand</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="895" length="4"></location><text>hand</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="921" length="4"></location><text>hand</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1273" length="8"></location><text>cortical</text></annotation></passage></document><document><id>PMC-2984323-caption-02</id><passage><offset>0</offset><text>Characteristics of fistula lesions
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="19" length="15"></location><text>fistula lesions</text></annotation></passage></document><document><id>PMID-15882577</id><passage><offset>0</offset><text>Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture.
Cranial suture development involves a complex interaction of genes and tissues derived from neural crest cells (NCC) and paraxial mesoderm. In mice, the posterior frontal (PF) suture closes during the first month of life while other sutures remain patent throughout the life of the animal. Given the unique NCC origin of PF suture complex (analogous to metopic suture in humans), we performed quantitative real-time PCR and immunohistochemistry to study the expression pattern of the NCC determinant gene Sox9 and select markers of extracellular matrix. Our results indicated a unique up-regulated expression of Sox9, a regulator of chondrogenesis, during initiation of PF suture closure, along with the expression of specific cartilage markers (Type II Collagen and Type X Collagen), as well as cartilage tissue formation in the PF suture. This process was followed by expression of bone markers (Type I Collagen and Osteocalcin), suggesting endochondral ossification. Moreover, we studied the effect of haploinsufficiency of the NCC determinant gene Sox9 in the NCC derived PF suture complex. A decrease in dosage of Sox9 by haploinsufficiency in NCC-derived tissues resulted in delayed PF suture closure. These results demonstrate a unique development of the PF suture complex and the role of Sox9 as an important contributor to timely and proper closure of the PF suture through endochondral ossification.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="179" length="7"></location><text>tissues</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="261" length="29"></location><text>posterior frontal (PF) suture</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="220" length="3"></location><text>NCC</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="229" length="17"></location><text>paraxial mesoderm</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="341" length="7"></location><text>sutures</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="5" length="12"></location><text>neural crest</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="415" length="3"></location><text>NCC</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1473" length="9"></location><text>PF suture</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1370" length="9"></location><text>PF suture</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1297" length="9"></location><text>PF suture</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1257" length="19"></location><text>NCC-derived tissues</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="992" length="4"></location><text>bone</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1184" length="9"></location><text>PF suture</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="74" length="32"></location><text>posterior frontal cranial suture</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="200" length="18"></location><text>neural crest cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="108" length="14"></location><text>Cranial suture</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="429" length="9"></location><text>PF suture</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="461" length="14"></location><text>metopic suture</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="592" length="3"></location><text>NCC</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="640" length="20"></location><text>extracellular matrix</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="778" length="9"></location><text>PF suture</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="835" length="9"></location><text>cartilage</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="904" length="16"></location><text>cartilage tissue</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="938" length="9"></location><text>PF suture</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1139" length="3"></location><text>NCC</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1172" length="3"></location><text>NCC</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T3" role=""></node><node refid="T4" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T26" role=""></node></relation></passage></document><document><id>PMID-12813373</id><passage><offset>0</offset><text>The septic abscess wall: a cytokine-generating organ associated with portal venous cytokinemia, hepatic outflow fibrosis, sinusoidal congestion, inflammatory cell sequestration, hepatocellular lipid deposition, and focal cell death.
An acute septic inflammatory response with access to the portal circulation was created in a rat model using an intra-abdominal abscess composed of a sterile agar pellet, or one contaminated with 102 Escherichia coli (E. coli) and 109 Bacteriodes fragilis (B. fragilis). After 3 days postimplantation, a well-formed intra-abdominal abscess occurred whose wall showed IL-6 DNA by PCR and IL-6 mRNA by in situ hybridization. Portal venous blood draining into the liver from the intra-abdominal abscess had increased levels of TNF-alpha, IL-1beta, and IL-6 in both sterile and septic groups compared with a control normal animal group. Increased levels of these cytokines were also found in suprahepatic inferior vena caval blood, but were correlated with the higher portal vein levels, suggesting a gradient from abscess wall to portal vein into the systemic circulation via the liver. Liver histology demonstrated sinusoidal congestion centering on the central vein, growing worse with progression from normal in control, to sterile, to septic. Similarly, the degree of intrahepatic myeloperoxidase-positive inflammatory cell infiltration and hepatocellular lipid deposition and apoptosis also increased from control, to sterile, to septic. Gene expression by in situ hybridization demonstrated a significant increase in IL-6 and fibrinogen mRNAs in cells surrounding the central vein in sterile and septic animals, being greatest in animals with sepsis, associated with an increased deposition of collagen in the central vein area, most prominent in the septic liver. The pericentral vein cells with IL-6 and fibrinogen mRNA increases paralleled the increases in cells containing IL-6 and fibrinogen mRNAs in the abscess walls of sterile and septic animals, respectively. The data suggest that an intra-abdominal abscess, especially when contaminated with gram-negative bacteria, induces mRNA-generated cytokine responses in the abscess wall that are related to increased portal venous levels of the inflammatory cytokines TNF-alpha, IL-1beta, and IL-6 perfusing the liver. These, in turn, induce localized production of IL-6 and fibrinogen mRNAs in cells at the central vein area with resultant outflow fibrosis and increased inflammatory cell sequestration within the liver lobular sinuses. This is associated with a generalized inflammatory response and intrahepatic portal sinusoid congestion. There is also increased hepatocellular lipid deposition and apoptosis. Thus, the cytokine production of the abscess wall itself appears to be a major mediator of the septic hepatic response.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="178" length="14"></location><text>hepatocellular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="221" length="4"></location><text>cell</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="122" length="10"></location><text>sinusoidal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="145" length="17"></location><text>inflammatory cell</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="4" length="19"></location><text>septic abscess wall</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1946" length="13"></location><text>abscess walls</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1896" length="5"></location><text>cells</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="351" length="17"></location><text>abdominal abscess</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1805" length="22"></location><text>pericentral vein cells</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="555" length="17"></location><text>abdominal abscess</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1787" length="12"></location><text>septic liver</text></annotation><annotation id="T42"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="588" length="4"></location><text>wall</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1746" length="12"></location><text>central vein</text></annotation><annotation id="T41"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2655" length="14"></location><text>hepatocellular</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1604" length="12"></location><text>central vein</text></annotation><annotation id="T40"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2797" length="14"></location><text>septic hepatic</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1582" length="5"></location><text>cells</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1375" length="14"></location><text>hepatocellular</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1340" length="17"></location><text>inflammatory cell</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="47" length="5"></location><text>organ</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="96" length="7"></location><text>hepatic</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="69" length="13"></location><text>portal venous</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="656" length="19"></location><text>Portal venous blood</text></annotation><annotation id="T38"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2739" length="12"></location><text>abscess wall</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="694" length="5"></location><text>liver</text></annotation><annotation id="T37"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2460" length="17"></location><text>inflammatory cell</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="715" length="17"></location><text>abdominal abscess</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="921" length="38"></location><text>suprahepatic inferior vena caval blood</text></annotation><annotation id="T39"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2503" length="21"></location><text>liver lobular sinuses</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="997" length="11"></location><text>portal vein</text></annotation><annotation id="T34"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="2300" length="5"></location><text>liver</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1060" length="11"></location><text>portal vein</text></annotation><annotation id="T33"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2205" length="13"></location><text>portal venous</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1110" length="5"></location><text>liver</text></annotation><annotation id="T36"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2396" length="12"></location><text>central vein</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1117" length="5"></location><text>Liver</text></annotation><annotation id="T35"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2383" length="5"></location><text>cells</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1146" length="10"></location><text>sinusoidal</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1044" length="12"></location><text>abscess wall</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1185" length="12"></location><text>central vein</text></annotation><annotation id="T32"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2162" length="12"></location><text>abscess wall</text></annotation><annotation id="T31"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2036" length="17"></location><text>abdominal abscess</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T42" role="Arg1"></node><node refid="T9" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T28" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T25" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T30" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T29" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T37" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T32" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T20" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T38" role=""></node></relation><relation id="A11"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T42" role=""></node></relation><relation id="A10"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A9"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T40" role=""></node></relation></passage></document><document><id>PMC-3159351-sec-02</id><passage><offset>0</offset><text>Materials and Methods:
A total of 75 brain abscess pus specimens were collected during neurosurgery, either by burr hole or by craniotomy. These specimens were further subjected to Gram stain, Ziehl-Neelsen (ZN) stain, and conventional microbiological culture. Only those cases which showed presence of AFB on ZN stain along with the growth of Mycobacterium tuberculosis were considered as TBAs. Such TBA cases were further presented along with their In vitro Proton Magnetic Resonance (MR) Spectroscopic findings.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="37" length="27"></location><text>brain abscess pus specimens</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="145" length="9"></location><text>specimens</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation></passage></document><document><id>PMID-16955335</id><passage><offset>0</offset><text>Structure of the genetic code suggested by the hydropathy correlation between anticodons and amino acid residues.
The correlation between hydropathies of anticodons and amino acids, detected by other authors utilizing scales of amino acid molecules in solution, was improved with the utilization of scales of amino acid residues in proteins. Three partitions were discerned in the correlation plot with the principal dinucleotides of anticodons (pDiN, excluding the wobble position). (a) The set of outliers of the correlation: Gly-CC, Pro-GG, Ser-GA and Ser-CU. The amino acids are consistently small, hydro-apathetic, stabilizers of protein N-ends, preferred in aperiodic protein conformations and belong to synthetases class II. The pDiN sequences are representative of the homogeneous sector (triplets NRR and NYY), distinguished from the mixed sector (triplets NRY and NYR), that depict a 70% correspondence to the synthetases class II and I, respectively. The triplet pairs proposed to be responsible for the coherence in the set of outliers are of the palindromic kind, where the lateral bases are the same, CCC: GGG and AGA: UCU. This suggests that UCU previously belonged to Ser, adding to other indications that the attribution of Arg to YCU was due to an expansion of the Arg-tRNA synthetase specificity. The other attributions produced two correlation sets. (b) One corresponds to the remaining pDiN of the homogeneous sector, containing both synthetase classes; its regression line overlapped the one formed by the remaining attributions to class II. (c) The other contains the pDiN of the mixed sector and produced steeper slopes, especially with the class I attributions. It is suggested that the correlation was established when the amino acid composition of the protein synthetases became progressively enriched and that the set of outliers were the earliest to have been fixed.
</text></passage></document><document><id>PMID-15033343</id><passage><offset>0</offset><text>Deletion of guanine nucleotide binding protein alpha z subunit in mice induces a gene dose dependent tolerance to morphine.
The mechanism underlying the development of tolerance to morphine is still incompletely understood. Morphine binds to opioid receptors, which in turn activates downstream second messenger cascades through heterotrimeric guanine nucleotide binding proteins (G proteins). In this paper, we show that G(z), a member of the inhibitory G protein family, plays an important role in mediating the analgesic and lethality effects of morphine after tolerance development. We blocked signaling through the G(z) second messenger cascade by genetic ablation of the alpha subunit of the G protein in mice. The Galpha(z) knockout mouse develops significantly increased tolerance to morphine, which depends on Galpha(z) gene dosage. Further experiments demonstrate that the enhanced morphine tolerance is not caused by pharmacokinetic and behavioural learning mechanisms. The results suggest that G(z) signaling pathways are involved in transducing the analgesic and lethality effects of morphine following chronic morphine treatment.
</text></passage></document><document><id>PMC-3266646-sec-09</id><passage><offset>0</offset><text>Origins of Acquired Antibiotic Resistance Mechanisms
Recently, D'Costa et al. (2011) have reported a metagenomic analysis of the Beringian permafrost, which is 30,000 years old. They showed molecular evidences of the ancient origins of antibiotic resistances, detecting beta-lactamases genes, vanX-like, component of the vancomycin resistance operon, and tetM, coding for a protein protecting the ribosomal target from tetracycline. Sequence analysis revealed that the beta-lactamases genes recovered from the permafrost demonstrated an amino-acid homology (53-84%) to known beta-lactamases from beta-lactams producing Streptomyces. The tetM sequences revealed a high similarity to the genes coding for the ribosomal protection protein of actinomycetes. The vanX sequence showed a similarity to the vanX gene recovered in pathogenic vancomycin resistant enterococci (VRE) and to the vanX gene from Amycolatopsis orientalis. This environmental species, belonging to the actinobacteria phylum, is a natural producer of vancomycin, and very likely the progenitor of the van genes operons, responsible for resistance to vancomycin. The integration of the van operons on transposons and on conjugative plasmids has enhanced their spread (Courvalin, 2006). Reports of VRE in freshwater have been provided by several authors (Talebi et al., 2008; Lata et al., 2009; Luczkiewicz et al., 2010). Interestingly, Schwartz et al. (2003) detected vanA genes in the biofilm of drinking water supplies, in the absence of enterococci, demonstrating the lateral transfer of this gene. Notably, the progenitors of these resistance genes are soil bacteria thus most likely, a shuttle has been responsible for the introduction of these genes into the commensal bacterial community and afterward into the pathogenic species.

</text><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1451" length="7"></location><text>biofilm</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="397" length="9"></location><text>ribosomal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1185" length="20"></location><text>conjugative plasmids</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="707" length="9"></location><text>ribosomal</text></annotation></passage></document><document><id>PMID-3540090</id><passage><offset>0</offset><text>Antishock trousers: a collective review.
Antishock trousers have become an integral part of emergency medical care for many traumatic and life-threatening emergencies. This article represents a summary of the current state of knowledge concerning the use of this device. A brief history of the development of antishock garments is discussed. This is followed by a discussion of human clinical studies and results of clinical research on hemodynamics, respiration, use in head injury, and effects on vascular hemostasis. Indications, contraindications, complications, and recommended procedure for use are discussed. Based on randomized prospective studies, antishock garments have not, as yet, been shown to improve patient morbidity or mortality. Proper use of antishock garments requires an understanding of both their function and their limitations.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="471" length="4"></location><text>head</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="499" length="8"></location><text>vascular</text></annotation></passage></document><document><id>PMC-2823704-sec-12</id><passage><offset>0</offset><text>School environment
At the majority of the schools a soft drink vending machine (91%, n = 446) and/or a vending machine containing sweets and candy bars (81%, n = 413) is present (Table 2). At 78% (n = 393) of the schools there is a supermarket, gas station or a fast food restaurant in the neighbourhood (within 1 km of the school). At 68% (n = 345) of the schools there are facilities at or around the school property where the students can be physically active, for example a soccer field or a basketball field.
Table 2
The school environment
Total School level
Vocational education schools Mixed schools Higher education schools Vocational education schools versus higher education schools# Mixed schools versus higher education schools#
n = 515 n = 216 n = 232 n = 67
% (n) % (n) % (n) % (n) OR (95%CI) OR (95%CI)
Soft drink vending machine present at school 91.4 (466) 90.2 (194) 91.3 (209) 95.5 (63) 1.0 (0.9;1.1) 1.0 (0.9;1.0)
Percentage of soft drink vending machines present at school that contain light soft drinks 79.8 (372) 75.4 (147) 82.2 (171) 85.7 (54) 0.9 (0.8;1.0) 1.0 (0.9;1.1)
Soft drink vending machines contain more unhealthy drinks than healthy drinks 57.9 (268) 61.9 (120) 58.5 (121) 43.6 (27) 1.4 (1.0;1.9) 1.4 (1.0;1.9)*
Vending machine present at school that contains sweets/candy bars 80.7 (413) 75.6 (161) 84.9 (197) 82.1 (55) 1.1 (0.9;1.2) 1.1 (1.0;1.2)
Sweets/candy bars vending machines contain more unhealthy than healthy foods 63.7 (260) 70.6 (113) 64.4 (125) 40.7 (22) 1.7 (1.2;2.4)* 1.6 (1.1;2.3)*
There is a supermarket, gas station, or fast food restaurant in the neighbourhood of the school 78.3 (393) 76.7 (161) 79.7 (181) 78.5 (51) 1.1 (0.9;1.2) 1.1 (0.9;1.2)
The students are allowed to leave the school property during school hours 57.4 (295) 42.6 (92) 65.8 (152) 76.1 (51) 0.6 (0.5;0.8)* 0.9 (0.8;1.0)
There are facilities at and around the school property where the students can be physically active 68.1 (345) 63.1 (135) 70.3 (161) 76.6 (49) 0.8 (0.7;1.0) 0.9 (0.8;1.1)
# Associations are adjusted for school size
* p &lt; 0.05
The vocational education schools did not differ from the higher education schools with regard to the presence of vending machines and a canteen, but the vending machines and the canteen contained a less favourable selection of foods and drinks. The vocational education schools indicated more often that the vending machines and the canteen contained more unhealthy foods and drinks than healthy foods and drinks. Vocational education schools had fewer facilities at and around the school property to be physical than the higher education schools. Most associations were attenuated after adjustment for school size. For example, the association between school level and content of the soft drink vending machines was OR = 1.42, 95%CI: 1.05-1.93 in the crude analysis and OR = 1.35, 95%CI: 0.99-1.85 in the adjusted analysis.
</text></passage></document><document><id>PMID-3134031</id><passage><offset>0</offset><text>Differential secretion of proteins and glycoproteins by livers of immature and adult rats. Effect of antimicrotubule drugs.
This study was initiated to re-examine reported differences in the action of antimicrotubule agents on plasma protein secretion from livers of immature versus adult rats. The aim was (1) to determine the composition and to monitor the secretion of various plasma proteins and glycoproteins from liver slices labeled in vitro with specific amino acids and sugar residues, and (2) to correlate observed differences in secretion of these proteins with structural changes in the hepatocytes of the different aged animals. For the most part, slices of liver from fetal (term), neonatal (4- to 5 days old), and adult rats (70 days old) were incubated with radioactive amino acids or various tritiated sugars specific for N-linked core oligosaccharide and/or N-linked terminal oligosaccharide chains. Our findings indicate that liver slices of fetal and neonatal rats are efficient in synthesizing plasma proteins including fully glycosylated glycoproteins. The secretion of glycosylated and nonglycosylated proteins believed to be processed through Golgi complexes was inhibited to the same extent (approximately 70-80%) by antimicrotubule agents, regardless of the age of the host animal. However, other proteins and glycoproteins secreted by livers of immature rats were found to be relatively insensitive (i.e. inhibited to only 30-40%) to the action of various antimicrotubule drugs. The glycoproteins were found to lack N-linked terminal sugars (although the glycoproteins did contain N-linked core sugars), and it is likely that the drug-insensitive proteins bypassed critical glycosylating sites in the Golgi compartment prior to release. Overall, these findings support earlier data showing that antimicrotubule drugs have a special impact on Golgi-associated events in liver cells. To what extent these findings are related to the action of microtubules remains to be seen.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="56" length="6"></location><text>livers</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="205" length="11"></location><text>microtubule</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="105" length="11"></location><text>microtubule</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="380" length="6"></location><text>plasma</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="419" length="12"></location><text>liver slices</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="227" length="6"></location><text>plasma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="257" length="6"></location><text>livers</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="661" length="6"></location><text>slices</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="682" length="5"></location><text>fetal</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="945" length="12"></location><text>liver slices</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Developing_anatomical_structure</infon><location offset="961" length="5"></location><text>fetal</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="599" length="11"></location><text>hepatocytes</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1015" length="6"></location><text>plasma</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="671" length="5"></location><text>liver</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1167" length="15"></location><text>Golgi complexes</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1246" length="11"></location><text>microtubule</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1968" length="12"></location><text>microtubules</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1362" length="6"></location><text>livers</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1896" length="11"></location><text>liver cells</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1487" length="11"></location><text>microtubule</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1869" length="5"></location><text>Golgi</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1728" length="17"></location><text>Golgi compartment</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1826" length="11"></location><text>microtubule</text></annotation><relation id="R2"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T9" role="Arg1"></node><node refid="T11" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T12" role="Arg1"></node><node refid="T13" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T10" role="Arg1"></node><node refid="T9" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T10" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation></passage></document><document><id>PMID-1316705</id><passage><offset>0</offset><text>Neutrophil function in chronic neutrophilic leukemia: defective respiratory burst in response to phorbol esters.
Functional analyses were performed on neutrophils isolated from 6 patients from two institutions who displayed features of chronic neutrophilic leukemia (CNL). These neutrophils demonstrated a consistent deficiency (44 +/- 8% of control values) in superoxide anion (O2-) production in response to the phorbol ester, phorbol myristate acetate (PMA). O2- production in response to chemotactic peptides was near normal (82.3 +/- 10.7% of control values). Bacterial killing was normal in the two patients studied, and chemotaxis was diminished in response to zymosan-activated plasma and to high concentrations of chemotactic peptides in the patients studied. Cytosolic C kinase activity was decreased in one of the two patients studied. These results suggest that a deficient O2- release in response to PMA is a hallmark of neutrophils in CNL and may provide a diagnostic indicator of this condition.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="279" length="11"></location><text>neutrophils</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="686" length="6"></location><text>plasma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="151" length="11"></location><text>neutrophils</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="244" length="12"></location><text>neutrophilic</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="934" length="11"></location><text>neutrophils</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="0" length="10"></location><text>Neutrophil</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="64" length="11"></location><text>respiratory</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="31" length="12"></location><text>neutrophilic</text></annotation></passage></document><document><id>PMC-3168409-sec-03</id><passage><offset>0</offset><text>Results
primary pancreatic sarcomas are extremely rare. Pancreatic sarcomas are more aggressive than other pancreatic neoplasms.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="16" length="19"></location><text>pancreatic sarcomas</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="107" length="20"></location><text>pancreatic neoplasms</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="56" length="19"></location><text>Pancreatic sarcomas</text></annotation></passage></document><document><id>PMID-7725754</id><passage><offset>0</offset><text>Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data.
Comparing patients with primary hyperparathyroidism (PHP) to a normocalcemic control population, those with PHP have a higher incidence of cardiovascular disease and cardiac abnormalities. This study aimed at correlating cardiac findings (valvular and myocardial calcification, myocardial hypertrophy) with clinical data (age, sex, clinical manifestation, nephrolithiasis, nephrocalcinosis, hypertension, skeletal abnormalities, hypercalcemic syndrome) and biochemical data (serum calcium, serum phosphate, serum iPTH level, serum creatinine). A group of 132 consecutive patients with surgically verified PHP (94 women, 38 men; ages 15-86, mean age 57 +/- 16 years) were included in this study. Blood chemistry, clinical presentation, radiography, and echocardiography were carried out in all patients for univariate and multivariate analyses of all parameters. There was no statistical correlation between clinical symptoms, biochemical data, and cardiac calcific alterations. Typical skeletal manifestations (osteolysis/subperiostal resorption) and valvular calcifications were significantly correlated to left ventricular hypertrophy (p = 0.005). Cardiac abnormalities such as calcific myocardial deposits or mitral and aortic valvular calcifications do not correlate with laboratory findings and clinical presentation at the time of diagnosis. There was no biochemical or clinical variable that could predict the frequency or severity of valvular sclerosis or calcific deposits in the myocardium. However, PHP-related skeletal abnormalities and valvular calcification were predicting factors for left ventricular hypertrophy, a reversible cardiac manifestation of PHP. Myocardial hypertrophy is more often found with classic symptomatic PHP with osseous abnormalities.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="349" length="8"></location><text>valvular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="362" length="10"></location><text>myocardial</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="276" length="7"></location><text>cardiac</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="331" length="7"></location><text>cardiac</text></annotation><annotation id="T29"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1783" length="10"></location><text>Myocardial</text></annotation><annotation id="T28"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1753" length="7"></location><text>cardiac</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1710" length="16"></location><text>left ventricular</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="388" length="10"></location><text>myocardial</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1659" length="8"></location><text>valvular</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="515" length="8"></location><text>skeletal</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1632" length="8"></location><text>skeletal</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1599" length="10"></location><text>myocardium</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1552" length="8"></location><text>valvular</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1333" length="15"></location><text>aortic valvular</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1322" length="6"></location><text>mitral</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1299" length="10"></location><text>myocardial</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="36" length="5"></location><text>heart</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="249" length="14"></location><text>cardiovascular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="43" length="7"></location><text>cardiac</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="585" length="5"></location><text>serum</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="600" length="5"></location><text>serum</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="617" length="5"></location><text>serum</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="635" length="5"></location><text>serum</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="805" length="5"></location><text>Blood</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1058" length="7"></location><text>cardiac</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="1096" length="8"></location><text>skeletal</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1161" length="8"></location><text>valvular</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1218" length="16"></location><text>left ventricular</text></annotation><annotation id="T30"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1860" length="7"></location><text>osseous</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1260" length="7"></location><text>Cardiac</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T21" role="Arg1"></node><node refid="T22" role="Arg2"></node></relation></passage></document><document><id>PMID-7828172</id><passage><offset>0</offset><text>Differential effects of carbachol on calcium entry and release in CHO cells expressing the m3 muscarinic receptor.
Calcium signalling was examined in CHO-k1 cells that stably express the m3 subtype of the muscarinic receptor. The calcium indicator Fura-2 was retained in these cells only in the presence of probenecid (1 mM), suggesting that Fura-2 efflux was mediated by an organic anion transporter. The addition of carbachol (CCh) to Fura-2 loaded cells in suspension caused a rapid transient increase in intracellular calcium [Ca]i followed by a smaller sustained plateau phase. The transient rise in [Ca]i was dose-dependent with a threshold response of 89 +/- 18 nM above baseline with 10 nM CCh and a maximum stimulation of 734 +/- 46 nM with 10 microM CCh. This phase was accompanied by a similar dose-dependent stimulation of total inositol phosphate production and was assumed to be generated by release from intracellular stores of the endoplasmic reticulum (ER). The sustained increase in [Ca]i was generated by entry from the extracellular bath since it was blocked by pretreatment with La3+ (1 microM) and was absent when bath calcium was chelated with EGTA. This phase was not dependent on CCh dose, and a stimulation of [Ca]i of approximately 90 nM above baseline was observed with CCh concentrations between 50 nM and 10 microM. With this dose range, the rate of Mn2+ quenching of Fura-2 at the Ca-insensitive excitation wavelength of 360 nm was likewise maximally stimulated. At lower CCh concentrations (10-50 nM), it was clear that the activation of Ca entry could not be dissociated from a threshold release of Ca from intracellular stores. The phorbol ester PMA, which uncouples the muscarinic receptor from phospholipase C, reduced the transient rise in [Ca]i by approximately 50% with little or no effect on Ca entry at higher CCh levels (&gt; or = 1 microM). At lower CCh concentrations (&lt; or = 100 nM) however, pretreatment with PMA completely blocked all Ca mobilization and supports the contention that Ca entry is coupled to Ca release from stores or to store depletion. The emptying of inositol trisphosphate-sensitive stores with thapsigargin (10 nM) stimulated Ca entry and also the rate of Mn2+ quenching. Store depletion by incubation in Ca-free media likewise stimulated Mn2+ uptake without a rise in [Ca]i. Our data are therefore consistent with a 'capacitative' coupling model, whereby the activation of the plasma membrane receptor leads to an InsP3-induced change in the degree of filling of the ER Ca pool.(ABSTRACT TRUNCATED AT 400 WORDS)
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="919" length="13"></location><text>intracellular</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="947" length="21"></location><text>endoplasmic reticulum</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="451" length="5"></location><text>cells</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="508" length="13"></location><text>intracellular</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2442" length="15"></location><text>plasma membrane</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1640" length="13"></location><text>intracellular</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2532" length="2"></location><text>ER</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="970" length="2"></location><text>ER</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1039" length="13"></location><text>extracellular</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="66" length="9"></location><text>CHO cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="277" length="5"></location><text>cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="150" length="12"></location><text>CHO-k1 cells</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T7" role=""></node><node refid="T8" role=""></node></relation></passage></document><document><id>PMID-7714663</id><passage><offset>0</offset><text>Colorimetrical rate assay for urinary dipeptidyl peptidase IV (DPPIV) activity using a new substrate.
We synthesized a new substrate glycyl-L-proline 3,5-dibromo-4-hydroxyanilide (Gly-Pro-DBAP), for dipeptidyl peptidase IV (DPPIV). Its hydrolysis by DPPIV resulted in the formation of a chromophore, 2,6-dibromophenol-indo-p-xylenol, and its maximal absorption wavelength (600 nm) was longer than that of p-nitroaniline (415 nm) released from conventional substrate, glycyl-L-proline p-nitroanilide (Gly-Pro-pNA). We also established the rate assay for urinary DPPIV activity using Gly-Pro-DBAP. The optimum pH was between 8.5 and 9.0. The apparent Km was 1.1 mmol/1. The detectable range was 2.5-350 U/l. No changes in blank values occurred throughout the enzyme reaction in the optimum pH. Its value was also much lower than Gly-Pro-pNA. CVs for within-run and between-run were 1.1% (n = 10) and 3.0% (n = 10), respectively. Among tested peptidases, only DPPIV could hydrolyze Gly-Pro-DBAP. Among the protease inhibitors, only two, diprotin-A and phenylmethylsulfonyl fluoride (PMSA), could inhibit DPPIV activity. The present method did not interfere with urinary ingredients such as hemoglobin. The correlation between the present (y) and conventional (x) methods is presented by the equation y = 1.121x + 0.096 (r = 0.993). Thus the present method provides practical advantages over the conventional method for routine laboratory use.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="30" length="7"></location><text>urinary</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1159" length="7"></location><text>urinary</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="553" length="7"></location><text>urinary</text></annotation></passage></document><document><id>PMID-12957491</id><passage><offset>0</offset><text>Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
There is controversy over potential effects of dopaminergic replacement therapies on the partially lesioned nigrostriatal dopaminergic projection. We evaluated indirect (levodopa, L-DOPA) versus direct (pramipexole, PRA) dopaminergic treatment effects on nigrostriatal lesion severity as measured with vesicular monoamine transporter type-2 (VMAT2) binding. Prior studies have shown that striatal VMAT2 density provides an objective estimate of dopaminergic neuronal integrity, without confounding effects of compensatory regulation. Partial unilateral median forebrain bundle lesions were made by injection of 6-hydroxydopamine in adult male Sprague-Dawley rats. Lesion severity was estimated using rotational behavior after injections of apomorphine and amphetamine. Rats were ranked and matched in pairs by rotation and assigned to receive either PRA (1 mg/kg/day) or L-DOPA/benserazide (100/25 mg/kg/day) ip via osmotic pump. After 4 weeks of drug treatment, in vitro autoradiography was performed with [(3)H]methoxytetrabenazine to measure striatal VMAT2 binding density. Lesion-to-intact VMAT2 density correlated with rotation in both treatment groups. There was no treatment effect on VMAT2 expression in the partially lesioned striatum and thus no differential effect of indirect versus direct dopamimetic treatment on nigrostriatal integrity.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="663" length="42"></location><text>unilateral median forebrain bundle lesions</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="785" length="6"></location><text>Lesion</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="376" length="20"></location><text>nigrostriatal lesion</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1448" length="13"></location><text>nigrostriatal</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="579" length="8"></location><text>neuronal</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="509" length="8"></location><text>striatal</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1166" length="8"></location><text>striatal</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1198" length="6"></location><text>Lesion</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1347" length="17"></location><text>lesioned striatum</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="21" length="13"></location><text>nigrostriatal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="220" length="22"></location><text>lesioned nigrostriatal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="74" length="7"></location><text>lesions</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation></passage></document><document><id>PMID-7566744</id><passage><offset>0</offset><text>The LHRH pulse generator: a mediobasal hypothalamic location.
The location and mechanism of LHRH pulse generator are discussed based on our series of experiments. Suckling stimulus is a novel stimulus that inhibits LH pulses without any cooperation from ovarian steroids, unlike other stimuli such as stress, photoperiod etc. It is directly involved in suppressing the activity of the LHRH pulse generator. The information from teats suckled by pups or babies is conveyed dorsally to the mediobasal hypothalamus (MBH), where the LHRH pulse generator may be located. Experiments using various types of deafferentation and fetal brain tissue transplantation confirmed that the LHRH pulse generator is located in the MBH and suggested that LHRH pulse generator consists of nonLHRH neurons. Endogenous excitatory amino acid is one of the possible neurotransmitters that regulate LHRH release at the nerve terminal in ME.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="488" length="23"></location><text>mediobasal hypothalamus</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="895" length="14"></location><text>nerve terminal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="254" length="7"></location><text>ovarian</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="28" length="23"></location><text>mediobasal hypothalamic</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="621" length="18"></location><text>fetal brain tissue</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Developing</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMC-1557851-sec-01</id><passage><offset>0</offset><text>Background
Hallucinations may occur in any sensory modalities. Formed musical hallucinations (i.e. Perception of either vocal or instrumental melodies) reported in English literature to date have typically been associated with marked hearing loss, advanced age, female sex (71%), lack of response to treatment and associated psychopathology [1] but has been concluded that hearing loss is neither a necessary nor sufficient condition for the occurrence of musical hallucinations [1]. Tumor like Astrocytoma, Temporal lobe epilepsy, raised intra cranial tension, drug induced (tricyclics, Propronolol etc ;), meningitis and psychotic illness were shown to cause palinacousis and musical hallucinations [2,3].
Musical hallucinations are pseudo hallucinations that originate in memory representations and they may undergo a transition to true hallucination. In musical hallucination spatial projection is less definite. Sometimes they are perceived like the tinnitus in patient's own head. The quality is usually very intense and distinct often very loud. They vary from elementary sounds to instrumental music, vocal music, bird songs, bells, pieces of melodies or sentences, religious music etc:- We report an unusual presentation of an elderly lady who had experienced musical hallucinations whilst being treated with Electro Convulsive Therapy. Though this has never been reported earlier, there seemed to have a good association between the initiation of Electro convulsive therapy and musical hallucination in our patient.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="545" length="7"></location><text>cranial</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="981" length="4"></location><text>head</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="484" length="5"></location><text>Tumor</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="508" length="13"></location><text>Temporal lobe</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="495" length="11"></location><text>Astrocytoma</text></annotation></passage></document><document><id>PMID-1085358</id><passage><offset>0</offset><text>Stimulation of the sodium pump by azide and high internal sodium: changes in the number of pumping sites and turnover rate.
1. The effects of 5 mM azide on [3H]ouabain uptake and 22Na efflux were determined. Both glycoside uptake and 22Na efflux were enhanced by azide. 2. Azide stimulated the Na pump in muscles whose pumping sites had been inhibited by ouabain and then transferred to a glycoside-free solution. This stimulation was observed before detecting any recovery of the initial pumping activity. 3. When both the resting and the azide-stimulated 22Na efflux had been blocked by ouabain, an additional exposure to azide, in a ouabain-free solution, had no further effects on 22Na efflux. 4. It is concluded that the increase in Na pumping caused by azide is due in part to an increase in the number of pumping sites. 5. [3H]ouabain binding was measured in muscles with different intracellular alkali cation concentrations. Variations in [Na]i from 15 up to 50 mM did not significantly affect the amount of glycoside bound. A substantial increase in binding occurred when [Na]i reached 70 mM. 6. It is proposed that the increase in Na extrusion that occurs during the recovery of Na loaded muscles mostly results from an increased turnover rate of the pump rather than from an increase in number of pumping sites.
</text><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="866" length="7"></location><text>muscles</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="305" length="7"></location><text>muscles</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="889" length="13"></location><text>intracellular</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1199" length="7"></location><text>muscles</text></annotation></passage></document><document><id>PMID-133805</id><passage><offset>0</offset><text>The effect of p-chlorophenylalanine on the pethidine- or methadone-induced decrease in locomotor activity of rats.
Either pethidine HCl (50 mg/kg s.c.) or methadone HCl (8 mg/kg s.c.) produced a prominent decrease in locomotor activity of rats. Pretreatment of rats with p-chlorophenylalanine (p-CPA, 320 mg/kg i.p.) 48 h before the narcotic injection significantly antagonized the activity-decreasing effects of narcotics. When rats pretreated with p-CPA were given 5-hydroxytryptophan (75 mg/kg s.c.) 30 min before narcotic administration, the activity-decreasing response to narcotics was restored. Thus, a decrease in locomotor activity induced in rats by either pethidine or methadone is probably mediated by serotonergic mechanisms.
</text></passage></document><document><id>PMC-2920104-caption-01</id><passage><offset>0</offset><text>Pteris vittata
</text></passage></document><document><id>PMC-3052613-caption-01</id><passage><offset>0</offset><text>Modified radiology-guided percutaneous gastrostomy technique.
A. 21G fine needle punctured localized collection of air, which was visible in collapsed stomach under fluoroscopy-guided gastrostomy. Needle tip is then gradually withdrawn while injecting small amounts of water-soluble contrast medium. Location of stomach is confirmed by visualization of opacified gastric rugae. B. Stomach was inflated with approximately 600-800 mL of room air through 21G fine needle. C. 100-cm stainless steel guide wire is inserted through needle, and gastro-percutaneous tract is gradually dilated. D. Insertion of 14-Fr pigtail gastrostomy catheter and injection of small amount of water-soluble contrast medium via pigtail catheter confirmed that gastrostomy catheter is correctly placed within stomach.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="784" length="7"></location><text>stomach</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="381" length="7"></location><text>Stomach</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="538" length="6"></location><text>gastro</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="151" length="7"></location><text>stomach</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="363" length="7"></location><text>gastric</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="312" length="7"></location><text>stomach</text></annotation></passage></document><document><id>PMC-2861602-sec-09</id><passage><offset>0</offset><text>Discussion
This is the first study to employ such a large number of replicated samples in order to assess the bacterial communities of healthy and diseased corals, and the first culture-independent assessment of bacterial communities on Acroporid WS corals on the GBR. Despite the potential of not capturing rare or very low abundance bacterial ribotypes, the DGGE analysis used in this study indicated similar results of captured bacterial ribotypes and tentative bacterial species replacement in unhealthy corals to that of less replicated studies using other non-culture based techniques (e.g. [3], [54], [69]; Figure 4). The results from this research reinforce, with statistically relevant data, that corals harbour bacterial communities different to the water column [7], [9], [42], corroborate findings that corals associate only with certain specific bacterial groups, and that these coral-associated bacterial communities are 'host' species-specific [2]. The data presented here highlight a cluster of bacterial ribotypes frequently associated with corals, and the distribution of these bacterial ribotypes on healthy and diseased corals, which allows for further targeted research into a tentative link between these common coral associates and coral health. This study indicates that coral bacterial community assessments require a number of replicates per coral species and site to accurately describe the diversity present across the population and in order to draw inferences on health-related changes in the community composition. In addition, the comparisons of healthy and diseased Acropora hyacinthus samples showed that bacterial communities can change dramatically in diseased individuals. The DGGE profiles observed for corals displaying signs of White Syndrome comprised a range of bacterial ribotypes not generally found on healthy corals, including close relatives of bacteria previously found on Black Band Diseased corals. However the community profiles across the samples taken from diseased coral colonies were inconsistent and not indicative of a single bacterial causative agent.

</text></passage></document><document><id>PMC-3231843-sec-03</id><passage><offset>0</offset><text>
TxA2, generated from arachidonic acid by cyclooxygenase 1 (COX-1) and Tx synthase, further amplifies platelet activation. COX-1 converts arachidonic acid into prostaglandin endoperoxides PGG2 and PGH2, the latter being, in turn, transformed by Tx synthase into TxA2, a potent amplifier of platelet aggregation with vasoconstrictive properties. At the site of the atheroma rupture, platelet-released TxA2 leads to downstream micro-vessel contraction and thrombus propagation (7).
In addition to its role in coagulation, thrombin at extremely low concentrations is one of the major platelet activators (8). Human platelets express two cell surface G-protein-coupled protease-activated receptors (PARs) for thrombin: PAR-1 and PAR-4. By binding the hirudin-like extracellular amino terminal domain (the so-called thrombin receptor), thrombin activates platelets and smooth muscle cells, thus promoting platelet pro-coagulant activity, shape change, secretion and release of agonists (ADP and TxA2), expression of P-selectin, activation of the alphaIIbbeta3 integrin receptor, and aggregation. Thrombin also binds to GpIbalpha on the surface of platelets, thought to act as a co-factor that localizes the enzyme on the platelet surface and accelerates the hydrolysis of PAR-1 (9). PAR-1 and P2Y12 cross-react in platelet activation, and Galphaq and Galphai-coupled receptors are involved in this process. Thrombin-dependent platelet aggregation is mediated in part by secreted ADP, acting on the Galphai-linked ADP receptor. By blocking Galphaq via PAR-1 and Gbetai via P2Y12, combined inhibition of thrombin and P2Y12 receptors leads to a synergistic inhibitory effect on thrombin-induced platelet aggregation (10).
5-HT is a vasoconstrictor agent that binds to 5HT-2A receptors and amplifies the platelet response by stimulating shape change and enhancing platelet recruitment at sites of injury (3). It may also play a pro-coagulant role by promoting the retention of fibrinogen and thrombospondin on the platelet surface. Intraplatelet 5-HT stores are implicated in shear-induced platelet aggregation and thrombus propagation (3).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="102" length="8"></location><text>platelet</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="364" length="8"></location><text>atheroma</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="290" length="8"></location><text>platelet</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="454" length="8"></location><text>thrombus</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="581" length="8"></location><text>platelet</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="382" length="8"></location><text>platelet</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="760" length="13"></location><text>extracellular</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="425" length="12"></location><text>micro-vessel</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="850" length="9"></location><text>platelets</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="864" length="19"></location><text>smooth muscle cells</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="612" length="9"></location><text>platelets</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="900" length="8"></location><text>platelet</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1142" length="9"></location><text>platelets</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="634" length="12"></location><text>cell surface</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1216" length="16"></location><text>platelet surface</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2106" length="8"></location><text>thrombus</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1309" length="8"></location><text>platelet</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2081" length="8"></location><text>platelet</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1421" length="8"></location><text>platelet</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2023" length="13"></location><text>Intraplatelet</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1687" length="8"></location><text>platelet</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="2005" length="16"></location><text>platelet surface</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1795" length="8"></location><text>platelet</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1855" length="8"></location><text>platelet</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T24" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation></passage></document><document><id>PMID-2729721</id><passage><offset>0</offset><text>Effects of hypertension and sympathetic denervation on cerebral blood flow in newborn pigs.
To investigate the potential role of sympathetic nerves in preventing pronounced increases in cerebral blood flow, we evaluated the effects of abrupt hypertension on the cerebral circulation of newborn pigs with intact cerebral sympathetic innervation and after cerebral sympathetic denervation. Epinephrine infusion was used to induce abrupt increases in mean (+/- SEM) arterial pressure (innervated pigs, 62 +/- 3 mm of Hg to 115 +/- 3 mm of Hg; denervated pigs, 71 +/- 4 mm of Hg to 132 +/- 4 mm of Hg) that remained increased for the 3 minutes of the study. Abrupt hypertension increased blood flow to all brain regions. In denervated pigs, the increased flow to the cerebrum was prolonged, compared with that in pigs with intact sympathetic innervation. Differences between pigs of the innervated and denervated groups were not apparent, with respect to blood flow to any other region (caudate region, brain stem, cerebellum). In newborn pigs, sympathetic nerves may attenuate hypertension-induced increases in blood flow to the cerebrum, but do not appear to affect flow to the rest of the brain.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="55" length="8"></location><text>cerebral</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="186" length="8"></location><text>cerebral</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="64" length="5"></location><text>blood</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="311" length="8"></location><text>cerebral</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="354" length="8"></location><text>cerebral</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="195" length="5"></location><text>blood</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="262" length="8"></location><text>cerebral</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="763" length="8"></location><text>cerebrum</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="999" length="10"></location><text>brain stem</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1011" length="10"></location><text>cerebellum</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1053" length="6"></location><text>nerves</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="684" length="5"></location><text>blood</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1108" length="5"></location><text>blood</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="702" length="5"></location><text>brain</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1126" length="8"></location><text>cerebrum</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1188" length="5"></location><text>brain</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="141" length="6"></location><text>nerves</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="951" length="5"></location><text>blood</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="463" length="8"></location><text>arterial</text></annotation></passage></document><document><id>PMC-3042182-caption-05</id><passage><offset>0</offset><text>Observed type I error for datasets simulated under the null hypothesis
</text></passage></document><document><id>PMID-2093149</id><passage><offset>0</offset><text>The proenkephalin-A-derivative Met-enkephalin-Arg-Gly-Leu is not present in the feline species.
No opioid octapeptide Met-enkephalin-Arg-Gly-Leu was detected either in the brain or in the adrenal gland of the cat using a specific radioimmunoassay. Whereas it was possible to determine the Met-enkephalin and Leu-enkephalin contents. The Met-enkephalin versus Leu-enkephalin concentration ratio was around five in each area of the brain assayed. The presence of authentic Met-enkephalin and Leu-enkephalin was confirmed by high performance liquid chromatography analysis. All in all, these data seem to indicate that the cat proenkephalin is partly different from that previously analysed in mammalian species including humans, rats and cows.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="172" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="430" length="5"></location><text>brain</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="188" length="13"></location><text>adrenal gland</text></annotation></passage></document><document><id>PMID-14565598</id><passage><offset>0</offset><text>Induction of apoptosis in skeletal tissues: phosphate-mediated chick chondrocyte apoptosis is calcium dependent.
In an earlier study, we have shown that Pi induced apoptosis of terminally differentiated hypertrophic chondrocytes. To ascertain whether Ca2+ modulates Pi-induced cell death, we asked the following two questions: First, can we prevent Pi-induced apoptosis by removing Ca2+ from the culture medium; alternatively, can we potentiate cell death by increasing the Ca2+ concentration? Second, can we inhibit chondrocyte apoptosis by blocking Pi transport? We also explored the mechanism of apoptosis by evaluating mitochondrial activity and reactive oxygen species (ROS) generation in cells treated with the ion pair. We noted that EDTA and EGTA blocked Pi-induced apoptosis in a dose-dependent manner. While high levels of Ca2+ alone had little effect on chondrocyte viability, the cation enhanced Pi-dependent cell death and greatly increased Pi uptake. When Pi transport was blocked, there was complete inhibition of cell killing. The process of cell death was characterized by mitochondrial hyperpolarization; two hours following apoptogen treatment, there was a significant decrease in the mitochondrial membrane potential. Coincident with the changes in mitochondrial function, there was an increase in intracellular Ca2+ that was maintained throughout the experimental period. A raised Ca2+ signal was observed in blebs at the cell membrane. Finally, we noted that, 75 minutes after treatment with the ion pair, there was a six-fold elevation in ROS levels. This increase declined to baseline values after three hours. Based on these observations, we suggest that, at the cartilage mineralization front, an elevation in local environmental Ca2+ and Pi concentrations modulates oxidative metabolism, and triggers apoptosis of terminally differentiated chondrocytes.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="26" length="16"></location><text>skeletal tissues</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="216" length="12"></location><text>chondrocytes</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="69" length="11"></location><text>chondrocyte</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="517" length="11"></location><text>chondrocyte</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="623" length="13"></location><text>mitochondrial</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="277" length="4"></location><text>cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="445" length="4"></location><text>cell</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="921" length="4"></location><text>cell</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1029" length="4"></location><text>cell</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1058" length="4"></location><text>cell</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1090" length="13"></location><text>mitochondrial</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="694" length="5"></location><text>cells</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1204" length="22"></location><text>mitochondrial membrane</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="865" length="11"></location><text>chondrocyte</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1269" length="13"></location><text>mitochondrial</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1443" length="13"></location><text>cell membrane</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1867" length="12"></location><text>chondrocytes</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="1318" length="13"></location><text>intracellular</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1688" length="9"></location><text>cartilage</text></annotation></passage></document><document><id>PMC-2672944-sec-14</id><passage><offset>0</offset><text>Disk preparation phase
o Adoption of a two-stage sampling scheme.
o Careful planning and choice of representative sampling groups and sites according to the adopted network sampling technique, and determining certain criteria such as control sites where major sampling groups exist (i.e. surface water points, valleys, and wells), impact sites where contamination is expected, such as polygons, and outlets (e.g. treated water discharges site) to maximise understanding the quality of urban water sources, and with the least risk of missing the correct representative sampling groups and sites.
o Attention paid to ensure inclusion in the sampling frame of all groups and locations (sites, roads, venues, and so on) via screening, browsing, and delineation from a satellite digital map of the Khamis Mushait Governorate zone, because local pre-knowledge was preferred with regard to accessibility, safety, and permission.
o Approximation of the number of the target study population in each group and sampling location.
o Determination of the proportional allocation of samples between different groups and locations.
o Training of interviewers\sample collectors to follow and to use the sampling strategy and procedures.
o Implementation of ways to boost participation rates in the screening and core interviews and sample collection.
o Planning of logistic needs of timing, gathering, handling samples, and laboratory.
o Producing sampling cards to be completed to record observations at scene (sample ID and data/information: date, time, temperature, group, locality, problems in the area, sketch map).
o Selection of an appropriate major sampling method [52] (i.e. simple random sample; network sampling).
o Planning of pilot visits to samples of each group in the field to review strategy.
</text></passage></document><document><id>PMID-9770688</id><passage><offset>0</offset><text>[The assessment of flow velocity in carotid and intracranial arteries in three different age groups].
In this report we assess the systolic maximal flow velocity in carotid and intracranial arteries in 191 subjects with no history of cerebral vascular disease in 3 age groups: 20-40 years (1 group), 41-60 years (2 group), and above 60 years (3 group). The subjects were assessed using Sonomed Transcranial Doppler Spectrograph according to generally accepted principles. The purpose of the study was to establish the mean value of maximal flow velocity in each particular artery in three age groups, and to observe the changes in this parameter with age. The results were analyzed using statistical methods and a significant decrease in blood flow, Vmax, was found in all investigated arteries. A mean decrease of 8.02% in flow velocity Vmax was found, when comparing groups 2 and 1, and difference 15.99% comparing 3 and 1.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="36" length="7"></location><text>carotid</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="165" length="7"></location><text>carotid</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="738" length="5"></location><text>blood</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="786" length="8"></location><text>arteries</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="573" length="6"></location><text>artery</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="48" length="21"></location><text>intracranial arteries</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="234" length="17"></location><text>cerebral vascular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="177" length="21"></location><text>intracranial arteries</text></annotation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T1" role="Arg2"></node></relation></passage></document><document><id>PMID-17523137</id><passage><offset>0</offset><text>Characterization of transferrin glycoforms in human serum by CE-UV and CE-ESI-MS.
Human transferrin (Tf) is a model glycoprotein for congenital disorders of glycosylation (CDG) diagnosis. In the last few years, new CE-UV methods for intact Tf glycoforms analysis have been developed using nonvolatile BGEs and organic modifiers. However, the use of these BGEs does not allow the coupling of these procedures with electrospray MS (ESI-MS). In this study, a new CE-UV separation method of Tf glycoforms is developed, using a double-layer stable coating and a volatile BGE based on ammonium acetate. The separation method is optimized using standard Tf and their potential is demonstrated applying the method to the analysis of sera Tf from healthy individuals and CDG patients. The CE-UV separation method has been coupled to ESI-MS detection. Main parameters such as sheath liquid composition are optimized in order to obtain a good sensitivity. The CE-ESI-MS method has also been used in serum samples obtaining the separation of the different proteins present in serum and partial separation of Tf glycoforms. Different mass spectra and deconvoluted molecular masses were obtained for each sialoform, allowing unequivocal glycoform identification.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="52" length="5"></location><text>serum</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="725" length="4"></location><text>sera</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1064" length="5"></location><text>serum</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="988" length="13"></location><text>serum samples</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document><document><id>PMC-2947726-sec-04</id><passage><offset>0</offset><text>Conclusion:
This study demonstrates that surgery plus chemotherapy and radiation therapy is helpful for treating patients with pelvic Ewing's sarcoma, particularly in achieving local control.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="127" length="22"></location><text>pelvic Ewing's sarcoma</text></annotation></passage></document><document><id>PMID-8455978</id><passage><offset>0</offset><text>[Prehospital service in Denmark].
In Denmark, emergency ambulances are dispatched by 41 centres manned either by trained firemen (in Copenhagen) or policemen (outside Copenhagen). In 1990, emergency ambulance calls totalled 284,000. Utilisation of emergency ambulance services increases with urbanisation. A doctor-manned ambulance is in operation in Copenhagen, and in some other large towns anaesthesiology and intensive care teams can be dispatched from hospital to give on-the-spot care. In less populated areas, some general practitioners give advanced life-support. Although many areas are serviced by ambulances equipped with defibrillators, the majority of patients receive only basic life-support from ambulance personnel. New initiatives resulting from a recent report by a commission appointed by central authorities, and focused on prehospital treatment, are expected to improve the service by raising the level of training given to ambulance personnel.
</text></passage></document><document><id>PMC-2704942-sec-22</id><passage><offset>0</offset><text>Stochastic models
Stochasticity inevitably emerges when molecular components are present at low cellular concentrations (McAdams &amp; Arkin, 1997; Kierzek et al., 2001). This physical phenomenon generates noise in synthetic and natural circuits (Paulsson, 2004; Mettetal et al., 2006), and its consequences over the phenotype are starting to be explored (Suel et al., 2006). For example, noise constitutes the driving force behind differentiation in isogenetic colonies (Colman-Lerner et al., 2005). Biological and theoretical studies have aided to delineate the regulatory mechanism by which the cell handles noise efficiently and effectively to carry out its biological functions (Gardner &amp; Collins, 2000; Orrell &amp; Bolouri, 2004; Raser &amp; O'Shea, 2005). From a theoretical point of view, stochastic models are the most challenging but also the most realistic ones: there is a precise counting of how, through individual chemical reactions, the populations of every chemical species change. The milestone to simulate stochastic processes is the Gillespie algorithm (Gillespie, 1992). Because of their analytical and computational complexity, the present models do not surpass a handful of chemical species. Two immediate problems must be solved to model systems with several dozens of genetic components: the systematic determination of kinetic constants and the efficient computation of thousands of chemical stochastic equations (Kuwahara et al., 2006; Sanchez &amp; Kondev, 2008).
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="96" length="8"></location><text>cellular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="594" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMID-12479523</id><passage><offset>0</offset><text>Combined tracheal and esophageal stenting for palliation of tracheoesophageal symptoms from mediastinal lymphoma.
Mediastinal lymphoma as a cause of tracheobronchial obstruction is uncommon, and a malignant tracheoesophageal fistula in the setting of mediastinal lymphoma is rare. Malignant tracheoesophageal fistulas are associated with pronounced morbidity and mortality. We describe a patient with mediastinal lymphomatous infiltration resulting in tracheal obstruction, esophageal obstruction, and tracheoesophageal fistula that were successfully palliated with combined airway and esophageal stent placement.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="9" length="8"></location><text>tracheal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="60" length="17"></location><text>tracheoesophageal</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="22" length="10"></location><text>esophageal</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="149" length="16"></location><text>tracheobronchial</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="207" length="25"></location><text>tracheoesophageal fistula</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="92" length="20"></location><text>mediastinal lymphoma</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="114" length="20"></location><text>Mediastinal lymphoma</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="401" length="24"></location><text>mediastinal lymphomatous</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="452" length="8"></location><text>tracheal</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="474" length="10"></location><text>esophageal</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="502" length="25"></location><text>tracheoesophageal fistula</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="251" length="20"></location><text>mediastinal lymphoma</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="575" length="6"></location><text>airway</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="291" length="26"></location><text>tracheoesophageal fistulas</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="586" length="10"></location><text>esophageal</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T13" role=""></node></relation></passage></document><document><id>PMID-9633825</id><passage><offset>0</offset><text>Multiple phosphotyrosine phosphatase mRNAs are expressed in the human lung fibroblast cell line WI-38.
Protein tyrosine phosphatases are important components of signal transduction pathways. The authors have used reverse transcription/polymerase chain reactions to accomplish a comprehensive examination of the RNA expression for 58 distinct mammalian protein tyrosine and dual specificity phosphatase (PTPase) and PTPase-like genes in the normal human diploid fibroblast cell line WI-38. Thirty-seven of these PTPase genes express easily measurable RNA, and four simultaneously express the RNA for two or more isoforms. Messages for an additional eight PTPase genes are detectable at low levels. Only 14 known PTPase genes do not express measurable RNA under our conditions. For purposes of comparison, the authors also assessed the PTPases expressed in the WI-38 cell line using highly degenerate primers to conserved motifs found in the classical tyrosine-specific PTPases. Only eight of the 22 classic tyrosine-specific PTPases detected using the specific primers were detected using these degenerate primers. Our panel of specific PTPase primers should be very useful for semiquantitatively assessing the repertoire of PTPases expressed by cells.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1245" length="5"></location><text>cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="70" length="31"></location><text>lung fibroblast cell line WI-38</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="859" length="15"></location><text>WI-38 cell line</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="453" length="34"></location><text>diploid fibroblast cell line WI-38</text></annotation></passage></document><document><id>PMID-20563198</id><passage><offset>0</offset><text>Yellow-green 52.3W laser at 556nm based on frequency doubling of a diode side-pumped Q-switched Nd:YAG laser.
We demonstrate a high-power 556nm yellow-green laser generated by intracavity frequency doubling of a diode side-pumped Nd:YAG laser at 1112nm. A symmetrical L-shaped flat-flat cavity was employed to implement efficient operation of the low-gain 1112nm transition and to achieve good power scalability. The coatings of the cavity mirrors were carefully designed to optimize the performance of the laser, and a 92W continuous wave laser output at 1112nm was achieved when the pumping power of the laser diodes reached 960W. By intracavity frequency doubling of the fundamental laser in a lithium triborate crystal, the maximum power of the frequency-doubled output at 556nm was found to be as high as 52.3W with a pulse repetition frequency of 10kHz. This corresponds to an optical-to-optical conversion efficiency of about 5.4%.
</text></passage></document><document><id>PMC-3003518-sec-05</id><passage><offset>0</offset><text>Introduction
Adipose tissue, once viewed as simply a storage and release depot for lipids, is now considered an endocrine tissue [1,2] that secretes various substances (adipokines), including tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, leptin, adiponectin, resistin, visfatin, and omenetin [3,4]. Among these adipokines, much attention has been paid to adiponectin's relationship with insulin sensitivity and glucose and lipid metabolism in the past 10 years. In addition, adiponectin is known to exhibit potent anti-inflammatory [5], atheroprotective [6], and antidiabetic [7] effects.
Recent findings suggest that adiponectin may be involved in the pathogenesis of rheumatoid arthritis (RA). Levels of adiponectin in synovial fluid and sera were elevated in patients with RA [8,9]. Adiponectin also induces the production of proinflammatory cytokines, IL-6, matrix metalloproteinase (MMP)-1, and IL-8 from RA synovial fibroblasts in vitro [10,11]. Thus, it was suggested that adiponectin can also exert significant proinflammatory and matrix-degrading effects. However, the role of adiponectin in the pathogenesis of RA is still controversial because of conflicting reports about its function [10,12-15]. In particular, adiponectin seems to play an anti-inflammatory role because it significantly inhibited IL-1beta-stimulated synovial cell proliferation in collagen-induced arthritic mice, despite increased IL-6 expression [16]. In contrast, high-grade inflammation in RA patients was negatively correlated with circulating adiponectin concentrations [17]. Rather, it was suggested that circulating adiponectin may be involved in cardiovascular disease in RA patients. Although this contradiction was partly explained by the induction of tolerance to inflammatory stimuli by adiponectin [18], the pro- or anti-inflammatory effects of adiponectin on the pathogenesis of RA remain unknown.
With regard to adiponectin's proinflammatory effects, we wondered whether adiponectin might stimulate the production of vascular endothelial growth factor (VEGF) and MMPs as well as proinflammatory mediators like IL-1beta and TNF-alpha do. In this study, we investigated the stimulatory effect of adiponectin on the production of IL-6, IL-8, prostaglandin E2 (PGE2), VEGF, and MMPs. In addition, the correlation between adiponectin and VEGF or MMPs was investigated by measuring the levels of these three proteins in the joint fluid of patients with RA or osteoarthritis (OA).
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="928" length="20"></location><text>synovial fibroblasts</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1346" length="13"></location><text>synovial cell</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="736" length="14"></location><text>synovial fluid</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="2430" length="11"></location><text>joint fluid</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="755" length="4"></location><text>sera</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1651" length="14"></location><text>cardiovascular</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="13" length="14"></location><text>Adipose tissue</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="112" length="16"></location><text>endocrine tissue</text></annotation></passage></document><document><id>PMID-2275272</id><passage><offset>0</offset><text>[Biotechnological and biomedical aspects of production and study of metal cation-phospholipid complexes].
Problems relating to the technology of a phospholipid preparation from natural materials, liposome production, and studies into the mechanisms of interaction between metal (trace elements) cations and model bilayer lipid membranes are discussed. The proposed technology of extraction allows for preparation of phospholipids utilizable for liposome formation. The cation specificity of lipid bilayers is found to be determined by the presence of anionic phosphate adsorption sites on their surface.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="313" length="23"></location><text>bilayer lipid membranes</text></annotation></passage></document><document><id>PMID-6198387</id><passage><offset>0</offset><text>Role of interleukin 1 in antigen-specific T cell proliferation.
The role of interleukin 1 (IL 1) in human antigen-specific T cell proliferation was examined. Nylon wool-purified T cells proliferated in the presence of autologous monocytes (Mo.) pulsed for 18 h with tetanus toxoid (TT) antigen (Mo.TT). Irradiation of Mo.TT with ultraviolet (UV) light (72 J/m2) abolished their capacity to support T cell proliferation and drastically reduced their capacity to secrete IL 1 after stimulation with Staphylococcus albus. The defect in antigen presentation induced by UV irradiation of Mo.TT was reversed in a dose-dependent manner by the addition of two different preparations containing human interleukin 1 (IL 1). The first preparation consisted of supernatants of Mo. stimulated with Con A for 18 hr and in which Con A activity was blocked by alpha-D-methyl-mannoside (Mo.-Con A-Sup). The second preparation consisted of human IL 1 partially purified from supernatants of human peripheral blood mononuclear cells stimulated with S. albus. This IL 1 copurified with human leukocyte pyrogen (LP) and was termed IL 1/LP. Both IL 1-containing preparations enhanced the response of C57BL/6 mouse thymocytes to phytohemagglutinin. A rabbit antibody to human IL 1/LP inhibited the capacity of T cells to proliferate in response to Mo.TT and inhibited the capacity of Mo.-Con A-Sup to reconstitute the T cell response to UV-irradiated Mo.TT. IL 1/LP was not necessary for T cells to recognize the immunogenic moiety presented by Mo., because monolayers of UV-irradiated Mo.TT were equivalent to monolayers of unirradiated MO.TT in their capacity to adsorb TT-reactive T cells specifically. Furthermore, the addition of rabbit antibody to IL 1/LP did not interfere with the capacity of UV-irradiated Mo.TT to adsorb TT-reactive T cells. The results obtained in this study indicate that IL 1 is involved in optimal antigen-driven proliferation of human T lymphocytes.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="318" length="2"></location><text>Mo</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="398" length="6"></location><text>T cell</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="218" length="20"></location><text>autologous monocytes</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="240" length="2"></location><text>Mo</text></annotation><annotation id="T27"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="765" length="2"></location><text>Mo</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="583" length="2"></location><text>Mo</text></annotation><annotation id="T26"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="870" length="2"></location><text>Mo</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="979" length="34"></location><text>peripheral blood mononuclear cells</text></annotation><annotation id="T25"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="295" length="2"></location><text>Mo</text></annotation><annotation id="T24"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1944" length="13"></location><text>T lymphocytes</text></annotation><annotation id="T23"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1820" length="7"></location><text>T cells</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1792" length="2"></location><text>Mo</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1661" length="7"></location><text>T cells</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1615" length="2"></location><text>MO</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="42" length="6"></location><text>T cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="178" length="7"></location><text>T cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="123" length="6"></location><text>T cell</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1072" length="9"></location><text>leukocyte</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1192" length="10"></location><text>thymocytes</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1287" length="7"></location><text>T cells</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1325" length="2"></location><text>Mo</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1361" length="2"></location><text>Mo</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1395" length="6"></location><text>T cell</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1428" length="2"></location><text>Mo</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1465" length="7"></location><text>T cells</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1522" length="2"></location><text>Mo</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1563" length="2"></location><text>Mo</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T4" role=""></node><node refid="T5" role=""></node></relation></passage></document><document><id>PMID-16927570</id><passage><offset>0</offset><text>[The prevalence of ADHD and attention problems in preschool-aged children. A comparison of two diagnostic instruments].
OBJECTIVES:
In order to analyse the prevalence of ADHD and attention problems in preschool-aged children, mothers were asked to rate their children using two measuring instruments.
METHODS:
The analysis is part of a prospective, randomised control study of N = 280 children aged three to six years, whose mothers rated them using the Child Behaviour Checklist/CBCL 1 1/2-5 and the Parent Rating Scale for Attention-Deficit Hyperactivity Disorder (ADHD).
RESULTS:
The prevalence rates ranged from 2.7% to 9.9%. There was no significant gender effect in this age group.
CONCLUSIONS:
The study delivers initial findings and provides support for decisions to implement in Germany new assessment methods for preschool-aged children with ADHD or hyperkinetic syndrome. Finally, the different rates of prevalence and the implications of the findings for epidemiology and the prevention of ADHD and attention problems among preschool-aged children are discussed.
</text></passage></document><document><id>PMID-10644902</id><passage><offset>0</offset><text>Obstructive nephropathy: lessons from cystic kidney disease.
Obstructive nephropathy is one of the most important causes of renal failure in infants and children, while polycystic kidney disease (PKD) is a major cause of renal failure in the adult population. This review summarizes the evidence that there may be a number of mechanisms common to the pathophysiology of both conditions. In animal models of obstructive nephropathy and PKD, the renal tubular expression of epidermal growth factor is suppressed, and expression of clusterin is increased, both of which suggest arrested maturation or dedifferentiation of the tubular cell. There is a marked increase in apoptosis of epithelial cells in dilated tubules, associated with an increase in apoptotic stimuli. The renin-angiotensin system is activated in both obstructive nephropathy and PKD, which may contribute to tubular atrophy and interstitial fibrosis, which characterize the progression of both conditions. Focal cystic dilatation of the tubule is found in obstructive nephropathy, while tubular obstruction is present in cystic kidney disease. It is therefore likely that elucidation of the effects of mechanical stretch on renal tubular epithelial cells will contribute to our understanding of both conditions.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="45" length="6"></location><text>kidney</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="444" length="13"></location><text>renal tubular</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="180" length="6"></location><text>kidney</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="708" length="7"></location><text>tubules</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1003" length="6"></location><text>tubule</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="623" length="12"></location><text>tubular cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="680" length="16"></location><text>epithelial cells</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1190" length="30"></location><text>renal tubular epithelial cells</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="124" length="5"></location><text>renal</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="221" length="5"></location><text>renal</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="874" length="7"></location><text>tubular</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1053" length="7"></location><text>tubular</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="894" length="12"></location><text>interstitial</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1094" length="6"></location><text>kidney</text></annotation></passage></document><document><id>PMC-1716863-sec-01</id><passage><offset>0</offset><text>Background
HIV-1 infectivity depends on free cholesterol incorporated into the viral envelope. Here, we analyze HIV infectivity in the presence of drugs that stimulate cholesterol efflux.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="85" length="8"></location><text>envelope</text></annotation></passage></document><document><id>PMID-14981916</id><passage><offset>0</offset><text>Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk.
BACKGROUND:
The estrogen receptor plays a critical role in breast cancer development and progression. So the genetic polymorphism of ER-alpha gene could affect cancer risk and phenotype.
MATERIALS AND METHODS:
We fully sequenced the ER-alpha gene to investigate its single nucleotide polymorphisms (SNPs) in 100 breast cancer patients and 100 controls.
RESULTS:
Six novel polymorphism in the control and 11 in cancer patients were found. The G/G genotype at C975 G and A/A genotype at G1782 A had a protective effect against breast cancer when compared to other genotypes (OR = 0.3 and 0.3, respectively). 975G allele was associated inversely with the p53 expression and positively with the bcl-2 expression in cancer with borderline significance. Combining this result with our previous study, these associations became more significant (p = 0.005 and 0.019, respectively).
CONCLUSION:
Polymorphisms in ER-alpha gene can affect the breast cancer susceptibility and may be related to other protein expression, such as p53 and bcl-2.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="640" length="13"></location><text>breast cancer</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="826" length="6"></location><text>cancer</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="427" length="13"></location><text>breast cancer</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="525" length="6"></location><text>cancer</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1048" length="13"></location><text>breast cancer</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="95" length="13"></location><text>breast cancer</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="275" length="6"></location><text>cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="174" length="13"></location><text>breast cancer</text></annotation></passage></document><document><id>PMID-521790</id><passage><offset>0</offset><text>Regulation of glucosyl- and fructosyltransferase synthesis by continuous cultures of Streptococcus mutans.
Streptococcus mutans strains Ingbritt, and its derivative B7 which had been passaged through monkeys, have been used to investigate how the synthesis of extracellular glucosyl- and fructosyltransferases is regulated. The most active enzyme from carbon-limited continuous cultures was a fructosyltransferase; enzymes catalysing the formation of water-insoluble glucans from sucrose were relatively inactive. Dextransucrase (EC 2.4.1.5), which catalyses soluble glucan synthesis, was most active in the supernatant fluid from cultures grown with excess glucose, fructose or sucrose, but full activity was detected only when the enzyme was incubated with both sucrose and dextran. Little dextransucrase activity was detected in carbon-limited cultures. It is concluded that glucosyl- and fructosyltransferases are constitutive enzymes in that they are synthesized at similar rates during growth with an excess of the substrate or of the products of the reactions which they catalyse. Although the Ingbritt strain was originally isolated from a carious lesion, it is now a poor source of glucosyltransferase activity. Glucosyltransferases were extremely active in cultures of a recent clinical isolate, strain 3209, and were apparently induced during growth with excess glucose.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1148" length="14"></location><text>carious lesion</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="260" length="13"></location><text>extracellular</text></annotation></passage></document><document><id>PMC-2374931-sec-01</id><passage><offset>0</offset><text>Aim
This study reports the results of a large prospective single-blinded clinical trial of 3 SSRI (paroxetine, fluoxetine and escitalopram) in PE using a validated questionnaire.
</text></passage></document><document><id>PMID-6327760</id><passage><offset>0</offset><text>Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy.
One possible mechanism for Graves' ophthalmopathy is that the progressive orbital inflammation is initiated by formation of thyroglobulin (Tg)-anti-Tg immune complexes at sites of Tg binding to extraocular muscle membranes. In this study monoclonal antibodies (MCAB) against human Tg were used as probes (1) to identify Tg in eye muscle membranes prepared from normal subjects and (2) to measure binding of human Tg and Tg-anti-Tg immune complexes to eye muscle membranes. Reactivity of anti-Tg MCAB with Tg, thyroid, and eye muscle membranes was determined by binding of [125I]anti-Tg monoclonal antibody, an enzyme-linked immunosorbent assay (ELISA), and the indirect immunofluorescence technique. Seven membrane fractions, prepared by differential sucrose gradient centrifugation, were used. Whereas [125I]anti-Tg MCAB bound to all thyroid membrane fractions tested, no [125I]anti-Tg bound to eye muscle membranes. Similarly, reactivity of anti-Tg MCAB with eye muscle membranes was not demonstrated in ELISA or immunofluorescence tests. Although Tg-anti-Tg immune complexes bound to thyroid membranes, such complexes did not bind to eye muscle membranes. Significant binding of [125I]human Tg to eye muscle or thyroid membranes was not demonstrated for any membrane preparation. On the other hand moderate, but significant, binding to skeletal muscle was shown. Similar results were found using an ELISA. Binding of [125I]anti-Tg-Tg complexes of [125I]Tg to thyroid and eye muscle membranes was not affected by the presence of normal human serum, phosphate ions, pH, or incubation temperature, conditions claimed by others to be critical for Tg and Tg-anti-Tg immune complex binding. Since Tg is not present in normal human eye muscle a major role of Tg, or Tg-anti-Tg immune complexes, in the pathogenesis of Graves' ophthalmopathy appears to have been excluded by these findings.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Immaterial_anatomical_entity</infon><location offset="198" length="7"></location><text>orbital</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="450" length="20"></location><text>eye muscle membranes</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="318" length="28"></location><text>extraocular muscle membranes</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="830" length="18"></location><text>membrane fractions</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1085" length="20"></location><text>eye muscle membranes</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="575" length="20"></location><text>eye muscle membranes</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="646" length="20"></location><text>eye muscle membranes</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1324" length="10"></location><text>eye muscle</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1338" length="17"></location><text>thyroid membranes</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1385" length="20"></location><text>membrane preparation</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1211" length="17"></location><text>thyroid membranes</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1020" length="20"></location><text>eye muscle membranes</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1261" length="20"></location><text>eye muscle membranes</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1463" length="15"></location><text>skeletal muscle</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1598" length="20"></location><text>eye muscle membranes</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1586" length="7"></location><text>thyroid</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1668" length="5"></location><text>serum</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="633" length="7"></location><text>thyroid</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1852" length="10"></location><text>eye muscle</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="959" length="26"></location><text>thyroid membrane fractions</text></annotation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T17" role="Arg1"></node><node refid="T16" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T21" role="Arg1"></node><node refid="T5" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T10" role="Arg1"></node><node refid="T11" role="Arg2"></node></relation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T12" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T20" role=""></node></relation></passage></document><document><id>PMC-2918592-sec-06</id><passage><offset>0</offset><text>Breast cancer
The incidence of breast cancer is no higher than in the rest of the population. Tamoxifen should not be used as it may worsen symptoms [43].
Women need also specific management for treatment of HAE.
Short term prophylaxis: three options are available: attenuated androgens, tranexamic acid or C1Inh concentrate. There is no specific problem for the use of theses drugs for short course in female patients. In case of short term prophylaxis with attenuated androgens, no virilisation has been observed [44,45].
Acute attack treatment: there is no specific problem for the use of C1inh concentrate, tranexamic acid, icatibant; or ecallantide in female patients.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="0" length="13"></location><text>Breast cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="31" length="13"></location><text>breast cancer</text></annotation></passage></document><document><id>PMC-3088328-sec-10</id><passage><offset>0</offset><text>Etymology.
Professor Stephen Lane Wood worked extensively on collections of Scolytinae preserved in Indian museums, and described a number of new Scolytinae species from India. In this paper we describe one more new bark-beetle species from India kept in the Natural History Museum in Vienna (NHMW) and dedicate this species to the late Professor Stephen Lane Wood.
</text></passage></document><document><id>PMC-2768104-sec-03</id><passage><offset>0</offset><text>Results:
In the total population (N=95), median OS was significantly longer in patients with baseline CA 19-9 values at or below the median than in those with values above it (12.2 months [95% confidence interval (CI), 8.6-16.6%] vs 5.0 months [95% CI, 3.9-5.7%]; P&lt;0.0001). This also reached significance in the Gem+A arm (median OS, 12.5 months [95% CI, 8.6-16.6%] vs 4.9 months [95% CI, 3.6-5.6%]; P&lt;0.0001). Patients with any dBP&gt;90 mmHg had significantly longer OS than those who did not. However, there was no predictive significance of CA 19-9.
</text></passage></document><document><id>PMC-2767981-sec-02</id><passage><offset>0</offset><text>Methods
Therefore, we developed a reciprocal system of a full-length HIV packaging cell line and a shortened HI-viral shuttle vector. The Tat-deficient packaging construct is stably integrated in a VSVG-pseudotyped cell line and transactivated by the shuttle vector by expression of TATGFP from a heterologous promoter which also indicates positive cells. Expression of the HI-viral structure proteins is driven by a natural 5' LTR promoter and a 3' polyadenylation signal, whereas the envelope expression out of the shuttle vector is achieved by an IRES. This system of two vectors is tightly controllable and bypasses the problem of limited packaging capacity into HIV-1 virions.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="486" length="8"></location><text>envelope</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="57" length="35"></location><text>full-length HIV packaging cell line</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="349" length="5"></location><text>cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="198" length="26"></location><text>VSVG-pseudotyped cell line</text></annotation></passage></document><document><id>PMC-3141469-caption-02</id><passage><offset>0</offset><text>Details of treatment programs A and B in respect to visits to different health care professionals and treatment activities
</text></passage></document><document><id>PMC-3087566-caption-11</id><passage><offset>0</offset><text>Representative time histories of the estimated SatO2 levels of normal cortex (black) and tumor (grey) from all six patients.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="70" length="6"></location><text>cortex</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="89" length="5"></location><text>tumor</text></annotation></passage></document><document><id>PMID-8643685</id><passage><offset>0</offset><text>Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
The observed in vitro and in vivo benefit of combination treatment with anti-human immunodeficiency virus (HIV) agents prompted us to examine the potential of resistance development when two protease inhibitors are used concurrently. Recombinant HIV-1 (NL4-3) proteases containing combined resistance mutations associated with BMS-186318 and A-77003 (or saquinavir) were either inactive or had impaired enzyme activity. Subsequent construction of HIV-1 (NL4-3) proviral clones containing the same mutations yielded viruses that were severely impaired in growth or nonviable, confirming that combination therapy may be advantageous. However, passage of BMS-186318-resistant HIV-1 (RF) in the presence of either saquinavir or SC52151, which represented sequential drug treatment, produced viable viruses resistant to both BMS-186318 and the second compound. The predominant breakthrough virus contained the G48V/A71T/V82A protease mutations. The clone-purified RF (G48V/A71T/V82A) virus, unlike the corresponding defective NL4-3 triple mutant, grew well and displayed cross-resistance to four distinct protease inhibitors. Chimeric virus and in vitro mutagenesis studies indicated that the RF-specific protease sequence, specifically the Ile at residue 10, enabled the NL4-3 strain with the triple mutant to grow. Our results clearly indicate that viral genetic background will play a key role in determining whether cross-resistance variants will arise.
</text></passage></document><document><id>PMC-2858731-caption-14</id><passage><offset>0</offset><text>Additional file 3
Primers used in this study. All of the primers used for generating PCR products for microinjection and site-direct mutagenesis are listed.
</text></passage></document><document><id>PMID-12312519</id><passage><offset>0</offset><text>On the relationship between the population structure and national economic development in China.
The authors examine the relationship between population reproduction and the production of material goods, with particular reference to the effect of changes in the age composition of the population on the national economy and national income.  An analysis of the population structure of China is presented, with consideration given to age characteristics, occupation, and urban and rural population.  Suggestions for improving the population structure to achieve maximum rates of economic development are presented.  Regional differences in population structure are also discussed.
</text></passage></document><document><id>PMC-2474864-sec-28</id><passage><offset>0</offset><text>Authors' contributions
MP prepared the first draft with the assistance of JLdR. Other authors reviewed the manuscript, provided further contributions and suggestions. All of the authors worked collectively to develop the algorithms and methods described in this paper.
</text></passage></document><document><id>PMID-18657078</id><passage><offset>0</offset><text>Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography.
BACKGROUND:
The Thrombelastograph (TEG; Haemoscope Corp.) analyzes clot formation in whole blood (WB) and treatment based on this analysis has been shown to reduce transfusion requirements in liver and cardiac surgery when compared to conventional coagulation analysis. Implementing TEG as a routine laboratory-based analysis, however, requires validation of the activators employed and the effect of storage of the WB sample in citrate before analysis.
STUDY DESIGN AND METHODS:
The effect of kaolin, tissue factor (TF) 1:17,000, or TF 1:42,500 on TEG clotting time (R), Angle (velocity of clot formation), and maximum clot strength (amplitude [MA]) were evaluated, together with day-to-day variation, the coefficient of variance (CV%), and the effect of citrate storage time.
RESULTS:
Clot formation variables were equally affected by TF 1:17,000 and kaolin activation, whereas R was significantly longer when TF 1:42,500 was used. The CV for the different variables varied from 3 to 13 percent with no significant differences between assays. Storage of citrated WB significantly affected the TEG variables in a hypercoagulable direction. Only the R, however, was significantly affected (12%) when samples rested for 0 and 30 minutes were evaluated with kaolin as the activator.
CONCLUSION:
The TEG assays evaluated were reproducible and present with an acceptable CV% for routine clinical practice. Kaolin and TF 1:17,000 equally affected the clot formation variables. Storage of WB for up to 30 minutes in citrate did not, except for R, affect clot formation variables when kaolin was used as activator allowing for immediate analysis when the sample arrives in the laboratory.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="42" length="6"></location><text>tissue</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="91" length="4"></location><text>clot</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="75" length="11"></location><text>whole blood</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="250" length="2"></location><text>WB</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="344" length="5"></location><text>liver</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="219" length="4"></location><text>clot</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="237" length="11"></location><text>whole blood</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="743" length="4"></location><text>clot</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="772" length="4"></location><text>clot</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="939" length="4"></location><text>Clot</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1217" length="2"></location><text>WB</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="354" length="7"></location><text>cardiac</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1598" length="4"></location><text>clot</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="568" length="2"></location><text>WB</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1635" length="2"></location><text>WB</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1700" length="4"></location><text>clot</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="654" length="6"></location><text>tissue</text></annotation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T5" role=""></node><node refid="T6" role=""></node></relation></passage></document><document><id>PMID-537829</id><passage><offset>0</offset><text>Differences between the arterial and the venous pathomorphology in Buerger's disease.
Morphological lesions were found to be different in arteries and in veins, in 9 cases of Buerger's disease. The arterial lesions were not characteristic and consisted of non-specific inflammation, thrombosis and obliteration which also occur in many other disease. In contrast, in addition to wall infiltration and thrombosis, the veins showed microabscesses and giant cell granulomas, which we believe to be absent in all other known diseases. The affected venous segment exhibited a variety of lesions. In the earliest period, the morphological aspect of inflammation in arteries and veins was fairly similar. In a late periods, that is those of vascular obliteration, the arteries and veins did not show any distinguishing morphological differences.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="24" length="8"></location><text>arterial</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="100" length="7"></location><text>lesions</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="41" length="6"></location><text>venous</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="198" length="16"></location><text>arterial lesions</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="417" length="5"></location><text>veins</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="138" length="8"></location><text>arteries</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="154" length="5"></location><text>veins</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="544" length="6"></location><text>venous</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="582" length="7"></location><text>lesions</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="659" length="8"></location><text>arteries</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="672" length="5"></location><text>veins</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="430" length="14"></location><text>microabscesses</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="734" length="8"></location><text>vascular</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="449" length="21"></location><text>giant cell granulomas</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="761" length="8"></location><text>arteries</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="774" length="5"></location><text>veins</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="379" length="4"></location><text>wall</text></annotation></passage></document><document><id>PMC-1281265-sec-06</id><passage><offset>0</offset><text>Conclusions
Only after careful consideration of the biological underpinnings of a truly beneficial response can an exposure be considered for the general population, such as the addition of folic acid to cereals. If a toxic or hazardous pollutant were found to have truly beneficial effects at low dose, then that agent should be tested clinically, go through the U.S. Food and Drug Administration (FDA) approval process, and be regulated as a pharmaceutical for those who might benefit from its use. Certainly, the general population should not be exposed to chemotherapeutic agents that benefit cancer patients. For pharmaceuticals, it is understood that there are trade offs between benefits and risks. For example, although aspirin is a generally well-tolerated pain reliever and is increasingly advocated as a preventative tool for heart attacks and colorectal cancer (Vainio and Miller 2003; Werner et al. 2004), it is also linked to increased risk of gastrointestinal bleeding, cerebral hemorrhage (Werner et al. 2004), and asthma attacks (Jenkins et al. 2004). In addition, aspirin is not recommended for children or teenagers who have or are recovering from chicken pox or flulike symptoms because it can cause debilitating and sometimes lethal Reyes syndrome (U.S. FDA 2003). Individual risks to pharmaceutical agents can be controlled with proper usage; however, increased exposure to environmental toxins presents additional involuntary risks for the general population. Under the latter condition, exposure is inadequately controlled, and there is no mechanism to correct for individual circumstances (e.g., medical condition or age) that may result in harm.
Although hormetic effects may occur in some instances, it is indeed rare that exposures to toxic, mutagenic, teratogenic, and carcinogenic chemicals, even at low exposure levels, would be risk free and provide health benefits for the general public. Portraying chemicals with numerous adverse effects as having benefits while ignoring their hazards is irresponsible and does not provide full and objective disclosure. In the 1950s doctors prescribed DES to pregnant women to prevent miscarriage and premature births and to produce "bigger and stronger babies" even though DES had been shown to cause damage to reproductive tissues in animals (Dinusson et al. 1948; Dunn and Green 1963; Takasugi and Bern 1964). Human use of DES was banned in the United States in 1971 after the discovery of high rates of rare, clear-cell adenocarcinomas of the vagina and cervix in DES-exposed daughters (Herbst 1981), and later studies showed elevated breast cancer risk in women who took DES during pregnancy (Titus-Ernstoff et al. 2001). Certainly, health policy decisions should be based on scientific evidence and not on speculation of health benefits in order for the general population to avoid repeating the mistakes of the past similar to that of the DES tragedy.
The claims and projections of health benefits from exposures to environmental toxicants and carcinogens are based on untested assumptions and disregard numerous well-established scientific principles that underpin a public health-protective approach to regulating exposure to toxic substances. If hormesis were used in the decision-making process to allow higher exposures to toxic and carcinogenic agents, this would substantially increase health risks for many, if not most, segments of the general population.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="2295" length="7"></location><text>tissues</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="958" length="16"></location><text>gastrointestinal</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2528" length="6"></location><text>cervix</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="985" length="8"></location><text>cerebral</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2609" length="13"></location><text>breast cancer</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="2494" length="15"></location><text>adenocarcinomas</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="2517" length="6"></location><text>vagina</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="597" length="6"></location><text>cancer</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="855" length="17"></location><text>colorectal cancer</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="837" length="5"></location><text>heart</text></annotation></passage></document><document><id>PMID-12344153</id><passage><offset>0</offset><text>Act No. 16.045  of 2 June 1989 prohibiting all discrimination that violates the principle of equality of treatment and opportunities for both sexes in all sectors of labor activity.
This Uruguayan Act prohibits discrimination in employment with respect to the following areas, among others: 1) advertising for the provision of positions; 2) selection criteria; 3) recruitment and hiring; 4) evaluation of performance criteria; 5) the right to advancement and promotion; 6) labour stability; 7) social benefits; 8) suspension and dismissal, particularly in cases involving a change of civil status, pregnancy, or nursing; 9) possibilities for professional and technical education or retraining; and 10) remuneration criteria. Reserving places for one sex because of the presence of activities in which the sex of the employee is essential for performance or to comply with international labor treaties does not constitute discrimination.  Nor do compensatory acts designed to promote equality of opportunities and treatment of both sexes in concrete situations. In cases where the provisions of this Act have been violated, specially designated judges will call the parties together and may adopt measures designed to end the situation complained of.  If they deem it necessary, the judges may institute more formal proceedings.  If the measures adopted are not carried out, the person violating the law is subject to a daily fine, as well as administrative penalties set out in Act 15.903 of 10 November 1987.  Adverse decisions may be appealed.  The state is also to undertake educative campaigns to create interest in and understanding of the problems affecting women workers, thus promoting awareness in such workers and their employers of their situation.
</text></passage></document><document><id>PMID-20621240</id><passage><offset>0</offset><text>Listerine: past, present and future--a test of thyme.
Listerine, a mouthrinse composed of a mixture of essential oils, was created in 1879 and was originally formulated as a surgical antiseptic. In spite of its known antimicrobial properties it was thought of as a product in search of a use and promoted as a deterrent for halitosis and as a floor cleaner. In the last several years Listerine has emerged as a bona fide therapeutic agent for reduction of plaque induced oral diseases. In contrast to the inconsistent history of Listerine, systemic antibiotics discovered in the 1940's were heralded as miracle drugs. However, the value of prophylactic usage of antibiotics has come under scrutiny as a result of increasing resistance and adverse reactions. Moreover, reports by both American and British professional societies have led to a re-evaluation of the relative risks associated with plaque induced bacteremia when twice-yearly visits to dental professionals are compared to daily activities. These new recommendations and revelations open the door for local antimicrobial approaches to reduce the challenge of plaque-induced bacteremias. These issues will be discussed in the context of Listerine, its intricate and complicated past, and its connection to current uses in oral health and beyond.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1121" length="6"></location><text>plaque</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="1283" length="4"></location><text>oral</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="456" length="6"></location><text>plaque</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="894" length="6"></location><text>plaque</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="471" length="4"></location><text>oral</text></annotation></passage></document><document><id>PMC-3068582-sec-06</id><passage><offset>0</offset><text>SUMMARY
Both the innate and adaptive immune subsystems are necessary to provide an effective immune response whether to an actual pathogenic agent or to an immunization. Further, effective immunizations must induce long-term stimulation of both the humoral and cell-mediated arms of the adaptive system by the production of effector cells for the current infection and memory cells for future infections with the pathogenic agent. At least seven different types of vaccines are currently in use or in development that produce this effective immunity and have contributed greatly to the prevention of infectious disease around the world.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="369" length="12"></location><text>memory cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="37" length="17"></location><text>immune subsystems</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="324" length="14"></location><text>effector cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="261" length="4"></location><text>cell</text></annotation></passage></document><document><id>PMID-9165485</id><passage><offset>0</offset><text>The effects of oxidative stress on in vivo brain GSH turnover in young and mature mice.
Glutathione (GSH) synthetase activities and GSH turnover rates were examined during severe oxidative stress in the mouse brain as induced by t-butylhydroperoxide (t-BuOOH). Brain GSH synthetase activities in 8-mo-old mice in the cortex, striatum, thalamus, hippocampus, midbrain, and cerebellum were found to increase following t-BuOOH treatment. The effect of GSH synthesis on brain GSH turnover rates for 2- and 8-mo-old mice were determined after intracerebroventricular (icv) injection of [35S]cysteine. Rate constants for GSH turnover were determined by least-squares iterative minimization from the specific activity data from 20 min to 108 h after [35S]cysteine administration. GSH and glutathione disulfide (GSSG) specific activities were determined after separation by high-pressure liquid chromatography (HPLC). The half-life of GSH in the 2-mo-old mouse was 59.5 h and in the 8-mo-old mouse was 79.1 h. In summary, defense mechanisms against oxidative stress in the brain differ with age. Young mice can increase the cellular availability of GSH, whereas mature mice can increase GSH synthetase activity during oxidative stress. These differences make mature mice more susceptible to brain oxidative damage.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="43" length="5"></location><text>brain</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="261" length="5"></location><text>Brain</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="209" length="5"></location><text>brain</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="335" length="8"></location><text>thalamus</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="345" length="11"></location><text>hippocampus</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="317" length="6"></location><text>cortex</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="325" length="8"></location><text>striatum</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="466" length="5"></location><text>brain</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1065" length="5"></location><text>brain</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1116" length="8"></location><text>cellular</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1283" length="5"></location><text>brain</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="358" length="8"></location><text>midbrain</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="372" length="10"></location><text>cerebellum</text></annotation></passage></document><document><id>PMID-12360110</id><passage><offset>0</offset><text>No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors.
This study investigated the hypothesis that the human platelet antigen-1 (HPA-1) polymorphism may influence the antiplatelet effects of glycoprotein (GP)IIb/IIIa inhibitors. Adenosine diphosphate (30 micro mol)-induced fibrinogen binding was measured by flow cytometry. Abciximab (0.03-3 micro g/ml), tirofiban (0.3-30 nmol/l) or eptifibatide (0.01-1 micro g/ml) were incubated for 15 min with the samples prior to stimulation. IC(50) values for the inhibition of fibrinogen binding were determined from each experiment. All subjects were genotyped by GALIOS and automated fluorescence correlation spectroscopy. Although a marked variability in the inhibitory effects of all three GPIIb/IIIa inhibitors was confirmed, there were no significant differences between the genotypes with respect to the inhibition of fibrinogen binding. Thus, the present study does not provide evidence for an effect of HPA-1 polymorphism on the inter-individual variability in the platelet inhibitory effects of the three GPIIb/IIIa inhibitors approved for clinical use.
</text><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1100" length="8"></location><text>platelet</text></annotation></passage></document><document><id>PMC-2900753-caption-02</id><passage><offset>0</offset><text>Water emerging from the yoke adapter of the nitrous oxide hose
</text></passage></document><document><id>PMID-11278466</id><passage><offset>0</offset><text>A pancreatic beta -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta ), HNF-1alpha, and SPs transcription factors.
The PDX-1 transcription factor plays a key role in pancreas development. Although expressed in all cells at the early stages, in the adult it is mainly restricted to the beta-cell. To characterize the regulatory elements and potential transcription factors necessary for human PDX-1 gene expression in beta-cells, we constructed a series of 5' and 3' deletion fragments of the 5'-flanking region of the gene, fused to the luciferase reporter gene. In this report, we identify by transient transfections in beta- and non-beta-cells a novel beta-cell-specific distal enhancer element located between -3.7 and -3.45 kilobases. DNase I footprinting analysis revealed two protected regions, one binding the transcription factors SP1 and SP3 and the other hepatocyte nuclear factor 3beta (HNF-3beta) and HNF-1alpha. Cotransfection experiments suggest that HNF-3beta, HNF-1alpha, and SP1 are positive regulators of the herein-described human PDX-1 enhancer element. Furthermore, mutations within each motif abolished the binding of the corresponding factor(s) and dramatically impaired the enhancer activity, therefore suggesting cooperativity between these factors.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="677" length="5"></location><text>beta-</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="687" length="14"></location><text>non-beta-cells</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="341" length="9"></location><text>beta-cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="473" length="10"></location><text>beta-cells</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="710" length="9"></location><text>beta-cell</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="2" length="21"></location><text>pancreatic beta -cell</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="270" length="5"></location><text>cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="222" length="8"></location><text>pancreas</text></annotation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T6" role="Arg1"></node><node refid="T7" role="Arg2"></node></relation></passage></document><document><id>PMID-2028342</id><passage><offset>0</offset><text>Posterior stabilization of the cervical spine with hook plates.
Hook-plate fixation is designed for posterior cervical stabilization from C2 to C7. Indications remain the same as for standard posterior fixations. The prime indications are discoligamentous injuries. The plates are hooked under the lower laminas and attached to the articular masses of the upper vertebra by oblique screws. An H-graft is placed between the spinous processes. The vertebrae are compressed together by the plates at three points, the facet joints, and graft. The resulting pre-stressed system is stable in all directions. A protocol for safe reduction of cervical dislocations is observed. Of 70 patients treated from 1979 to 1986, 51 were examined 12-54 months after surgery. All fusions consolidated. Two neurologic complications not attributable to the fixation occurred. Other major complications were not seen.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="110" length="8"></location><text>cervical</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="332" length="16"></location><text>articular masses</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="446" length="9"></location><text>vertebrae</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="636" length="8"></location><text>cervical</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Anatomical_system</infon><location offset="788" length="10"></location><text>neurologic</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="31" length="14"></location><text>cervical spine</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="362" length="8"></location><text>vertebra</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="298" length="13"></location><text>lower laminas</text></annotation><relation id="R1"><infon key="relation type">Part-of</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T7" role="Arg1"></node><node refid="T3" role="Arg2"></node></relation></passage></document><document><id>PMID-5101344</id><passage><offset>0</offset><text>Tropical splenomegaly syndrome in Zambia: further observations and effects of cycloguanil and proguanil.
Nineteen Zambian patients with the tropical splenomegaly syndrome and sinusoidal lymphocytosis on liver biopsy were studied. The association of macrobulinaemia with the tropical splenomegaly syndrome has again been confirmed. Sixteen patients were treated with antimalarials-12 with cycloguanil pamoate alone, 3 with cycloguanil and proguanil, and 1 with proguanil alone. Twelve patients were observed for periods of sufficient length for the drug effect to be assessed, and in 11 there was a good response in terms of decrease in spleen size.Cycloguanil pamoate may be of value both for prophylaxis and treatment in areas where tropical splenomegaly syndrome is endemic.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="175" length="10"></location><text>sinusoidal</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="636" length="6"></location><text>spleen</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="203" length="5"></location><text>liver</text></annotation></passage></document><document><id>PMID-11781057</id><passage><offset>0</offset><text>Phonology: a review and proposals from a connectionist perspective.
A parallel distributed processing (PDP) model of phonological processing is developed, including components to support repetition, auditory processing, comprehension, and language production. From the performance of the PDP reading model of Plaut, McClelland, Seidenberg, and Patterson (1996), it is inferred that the acoustic-articulatory motor pattern associator that supports repetition provides the basis for phonological sequence knowledge. From the observation that many patients make phonemic paraphasic errors in language production, as in repetition, it is argued that there must be a direct link between distributed concept representations (lexical semantic knowledge) and this network representation of sequence knowledge. In this way, both lexical semantic and phonotactic constraints are brought to bear on language production. The literature on phonological function in normal subjects (slip-of-the-tongue corpora) and in patients with aphasia is critically reviewed from this perspective. The relationship between acoustic and articulatory motor representations in the process of phonetic perception is considered. Repetition and reproduction conduction aphasia are reviewed in detail and extended consideration is given to the representation of auditory verbal short-term memory in the model. Finally, the PDP model is reconciled with information processing models of phonological processing, including that of Lichtheim, and with current knowledge of the anatomic localization of phonological processing. Although no simulations of the model were run, a number of simulation studies are proposed.
</text></passage></document><document><id>PMID-20157600</id><passage><offset>0</offset><text>Further Characterization of Activin A-induced IgA Response in Murine B Lymphocytes.
We have recently shown that activin A, a member of TGF-beta superfamily, stimulates mouse B cells to express IgA isotype but other isotypes. In the present study, we further characterized effects of activin A on B cell growth and IgA expression. We found that activin A did not have effect on LPS-stimulated cell viability. In parallel, CFSE staining analysis revealed that activin A did not alter cell division. An increase of IgA secretion by activin A was completely abrogated by anti-activin A Ab but not by anti-TGFbeta1 Ab. In the same conditions, no other isotypes are significantly affected by each antibody treatment. Finally, activin A, as similar to TGF-beta1, increased IgA secretion by mesenteric lymph node cells. These results suggest that activin A can specifically stimulate IgA response, independent of TGF-beta in the gut.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="794" length="16"></location><text>lymph node cells</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="921" length="3"></location><text>gut</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="392" length="4"></location><text>cell</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="482" length="4"></location><text>cell</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="69" length="13"></location><text>B Lymphocytes</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="296" length="6"></location><text>B cell</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="174" length="7"></location><text>B cells</text></annotation></passage></document><document><id>PMID-19744262</id><passage><offset>0</offset><text>Cognitive function and number of teeth in a community-dwelling elderly population without dementia.
Although the number of sound or decayed teeth has been reported to be associated with cognitive function in elderly populations with dementia, little is known about this association in elderly populations without dementia. We evaluated this relationship, with adjustment for confounding factors, in Japanese populations of 60-year-old (n = 270; 120 males and 150 females) and 65-year-old (n = 123; 57 males and 66 females) individuals residing in Fukuoka Prefecture of Japan. Dental examinations were performed in all subjects, along with the Mini-mental state examination (MMSE) for assessing cognitive function. Among the total of 393 subjects, the mean MMSE score was 27.9 +/- 1.9, and 391 subjects scored 24 or higher. The mean numbers of sound and decayed teeth were 12.0 +/- 6.3 and 0.5 +/- 1.2, respectively. Associations were found between the numbers of sound and decayed teeth and MMSE in total subjects and males, but not in females, by multiple regression analysis adjusted for gender, age, level of education, marital status, smoking, alcohol drinking, working status, systolic blood pressure and blood glucose. An association was also found between MMSE and the number of sound teeth in a logistic regression analysis. In conclusion, associations were found between normal-range cognitive function and the numbers of sound and decayed teeth, after adjustment for various confounding factors, in an elderly Japanese population.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1210" length="5"></location><text>blood</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1292" length="5"></location><text>teeth</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="981" length="5"></location><text>teeth</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organism_substance</infon><location offset="1191" length="5"></location><text>blood</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="1449" length="5"></location><text>teeth</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="33" length="5"></location><text>teeth</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="861" length="5"></location><text>teeth</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="140" length="5"></location><text>teeth</text></annotation></passage></document><document><id>PMID-11171752</id><passage><offset>0</offset><text>Focal congenital alveolar proteinosis associated with abnormal surfactant protein B messenger RNA.
Two siblings presented with typical clinical features of congenital pulmonary alveolar proteinosis (PAP). Necropsy of one sibling revealed scattered foci of the diagnostic histologic changes in the lung tissue. In contrast to infantile and adult PAP, focal distribution is uncommon in congenital PAP. Defective expression of the granulocyte-macrophage colony-stimulating factor receptor was ruled out. The surfactant protein B (SP-B) content in the lung tissue of the autopsied patient was low, and a deletion in the SP-B messenger RNA was detected. We speculate that the PAP in our patients was related to the reduced quantity and/or to the altered quality of SP-B.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="548" length="11"></location><text>lung tissue</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="248" length="4"></location><text>foci</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="350" length="5"></location><text>focal</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="17" length="8"></location><text>alveolar</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="297" length="11"></location><text>lung tissue</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="167" length="18"></location><text>pulmonary alveolar</text></annotation></passage></document><document><id>PMID-20631994</id><passage><offset>0</offset><text>Ventral and dorsal striatal dopamine efflux and behavior in rats with simple vs. co-morbid histories of cocaine sensitization and neonatal ventral hippocampal lesions.
UNLABELLED:
RATIONAL: Exposing animal models of mental illness to addictive drugs provides an approach to understanding the neural etiology of dual diagnosis disorders. Previous studies have shown that neonatal ventral hippocampal lesions (NVHL) in rats produce features of both schizophrenia and addiction vulnerability.
OBJECTIVE:
This study investigated ventral and dorsal striatal dopamine (DA) efflux in NVHL rats combined with behavioral sensitization to cocaine.
METHODS:
Adult NVHL vs. SHAM-operated rats underwent a 5-day injection series of cocaine (15 mg/kg/day) vs. saline. One week later, rats were cannulated in nucleus accumbens SHELL, CORE, or caudate-putamen. Another week later, in vivo microdialysis sampled DA during locomotor testing in which a single cocaine injection (15 mg/kg) was delivered.
RESULTS:
NVHLs and cocaine history significantly increased behavioral activation approximately 2-fold over SHAM-saline history rats. DA efflux curves corresponded time dependently with the cocaine injection and locomotor curves and varied significantly by striatal region: Baseline DA levels increased 5-fold while cocaine-stimulated DA efflux decreased by half across a ventral to dorsal striatal gradient. However, NVHLs, prior cocaine history, and individual differences in behavior were not underpinned by differential DA efflux overall or within any striatal region.
CONCLUSION:
Differences in ventral/dorsal striatal DA efflux are not present in and are not required for producing differential levels of acute cocaine-induced behavioral activation in NVHLs with and without a behaviorally sensitizing cocaine history. These findings suggest other neurotransmitter systems, and alterations in striatal network function post-synaptic to DA transmission are more important to understanding the interactive effects of addictive drugs and mental illness.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="0" length="7"></location><text>Ventral</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="130" length="36"></location><text>neonatal ventral hippocampal lesions</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="12" length="15"></location><text>dorsal striatal</text></annotation><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="577" length="4"></location><text>NVHL</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="653" length="4"></location><text>NVHL</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="370" length="36"></location><text>neonatal ventral hippocampal lesions</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="408" length="4"></location><text>NVHL</text></annotation><annotation id="T10"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="994" length="5"></location><text>NVHLs</text></annotation><annotation id="T11"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1241" length="15"></location><text>striatal region</text></annotation><annotation id="T12"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1402" length="5"></location><text>NVHLs</text></annotation><annotation id="T13"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1540" length="15"></location><text>striatal region</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="794" length="17"></location><text>nucleus accumbens</text></annotation><annotation id="T14"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1584" length="7"></location><text>ventral</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="828" length="15"></location><text>caudate-putamen</text></annotation><annotation id="T15"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1592" length="15"></location><text>dorsal striatal</text></annotation><annotation id="T16"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1883" length="8"></location><text>striatal</text></annotation><annotation id="T17"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="525" length="7"></location><text>ventral</text></annotation><annotation id="T22"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="1742" length="5"></location><text>NVHLs</text></annotation><annotation id="T18"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="537" length="15"></location><text>dorsal striatal</text></annotation><annotation id="T21"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="292" length="6"></location><text>neural</text></annotation><annotation id="T19"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1356" length="7"></location><text>ventral</text></annotation><annotation id="T20"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="1367" length="15"></location><text>dorsal striatal</text></annotation><relation id="R4"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T19" role="Arg1"></node><node refid="T20" role="Arg2"></node></relation><relation id="R2"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T14" role="Arg1"></node><node refid="T15" role="Arg2"></node></relation><relation id="R3"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T17" role="Arg1"></node><node refid="T18" role="Arg2"></node></relation><relation id="R1"><infon key="relation type">frag</infon><infon key="file">ann</infon><infon key="type">Relation</infon><node refid="T1" role="Arg1"></node><node refid="T2" role="Arg2"></node></relation><relation id="Equiv"><infon key="file">ann</infon><infon key="type">Equiv</infon><node refid="T4" role=""></node><node refid="T5" role=""></node></relation></passage></document><document><id>PMC-3155394-sec-04</id><passage><offset>0</offset><text>Discussion
The two most important factors leading to the development of hypoxia are biological processes that determine the amount of organic matter available to be degraded and physical factors creating stratification. Stratification in most areas of the coastal zone of the Baltic Sea is due to seasonal temperature changes, although stratification by occasional inflowing saltier water does occur in some estuaries.(14) Hypoxia is common in estuaries located in the Danish Straits due to the large load of nutrients sustaining algal production and the strong stratification caused by large differences in surface and bottom water salinity.(5) Hypoxia in the Swedish and Finnish archipelagos are influenced by phytoplankton growth stimulated by nutrient loads from urban and agricultural sources, but also by restricted water circulation. The Finnish Archipelago Sea is impacted by drifting algal mats that consume oxygen during their decomposition when they sink to the bottom.(15) By contrast, hypoxia is rare in the northern Baltic Sea estuaries located in the Bothnian Sea coastal zone where nutrient loads are lower. Hypoxia is uncommon along the eastern shore from Estonia to Poland due to enhanced circulation of water in open areas along the coastline (Figure 1).
There are very limited data available to examine how far back in time hypoxia has occurred. A key question in this ecosystem affected daily by over 85 million people could be "Is hypoxia a natural phenomenon?".(16) The large numbers of enclosed areas, in many cases with shallow sills that restrict the exchange of bottom water and often in combination with large irregular changes in salinity, might mean that hypoxia has always been present in the coastal zone. However, sediment laminations from Stockholm Archipelago, an indicator of past hypoxia,(17) have been shown to be a recent phenomenon with very few areas with laminated sediments prior to 1900.17,18 The long-term millennial trends in coastal hypoxia remain unknown, although hypoxia has occurred intermittently throughout the last 8000 years in offshore deep waters of the Baltic Sea.(10) Further sediment studies are necessary, similar to those carried out in the open Baltic Sea,(10) to ascertain how far back in time hypoxia was observed in the coastal zone. Key uncertainties remain including how have the driving forces for hypoxia, e.g., climate(19) and nutrient loading, changed through time in the Baltic Sea coastal zone, and do they vary during the same time periods that hypoxia varies in the open waters?(16)
An important consideration in determining the number of ecosystems experiencing hypoxia is the size of the assessment unit. We combined numerous monitoring points and sites to form a coherent coastal unit when bottom waters were physically connected to each other. This means that assessment units considered hypoxic might occur in the same geographical region and could be in close proximately to each other, if their bottom waters were physically disconnected. The Baltic Sea archipelagos have a complex topography with many basins disjoined by shallow sills resulting in many distinct sites, although they are all affected by similar mechanisms. In fact, the Stockholm and Finnish archipelagos contributed 21% of the total assessment units, a relatively large share compared to the total Baltic Sea coastal zone, but &gt;40% of the hypoxic sites. The coastal stretches of the Western Gotland Basin and Gulf of Finland that have a substantial number of hypoxic sites are also archipelagos, which are more prone to hypoxia because of the complex topography, proximity to development, and consequently more sensitive to enhanced nutrient inputs from land.
Surprisingly only 4.0% of all sites were classified as seasonally hypoxic according to our definition when &gt;50% and &lt;80% of profiles during the stratified period have oxygen concentrations less than 2 mg L-1. A statistically rigorous definition of what constitutes seasonal hypoxia does not currently exist and in fact should be linked to ecological consequences for it to be ecologically relevant and not just connected to absolute concentrations.(3) Currently coastal marine ecosystems that experience hypoxia for a period of days to months every year are often considered to be seasonally hypoxic, although we have categorized them here as being episodic, because we required the monitoring units to be hypoxic for most of the stratified period. However, in Limfjorden, Denmark, bottom water oxygen concentrations can vary greatly between weekly samplings (SI Figure S6), although nearly every year hypoxic conditions are observed somewhere in the Limfjorden. Our statistical estimation is that Limfjorden is episodically hypoxic. Diaz and Rosenberg(1) would classify Limfjorden as periodically hypoxic, although we have found it difficult to create a statistically robust indicator that would classify systems as periodically hypoxic. Periodic hypoxia is problematic because it never allows for re-establishment of benthic communities.(20)
Currently, there are 416 areas in the world with reported coastal hypoxia with about 30 previously reported sites in the Baltic Sea region, which includes both coastal zone hypoxia and deep water sites in the Baltic Sea.(1) We have identified an additional 96 sites that have experienced hypoxia, increasing the global total to nearly 500 sites. Of all the known sites around the world, around 20% of the sites are found in the Baltic Sea region. Most sites experienced episodic hypoxia, which is a precursor to development of seasonal hypoxia.(20) The large number of sites partially reflects the fact that the Baltic Sea is one of the most data rich regions of the world with no tidal mixing and complex bottom topography creating conditions favorable for hypoxia, although these are only the "monitored areas" and many more hypoxic sites probably exist in the Baltic Sea coastal zone. In contrast, there was no evidence of hypoxia at 95 stations in estuarine and coastal waters around Ireland due to sufficient tidal mixing.(21) If such detailed data existed for other coastal regions around the world, it is likely that the number of areas would increase globally.
Oxygen is an important parameter in water quality assessments since sufficient oxygen is essential to aquatic life and is necessary to support healthy biological communities.(3) For example, oxygen concentration is a supporting element to the biological quality elements in the European Water Framework Directive,(21) is one of the ecological objectives in the Helsinki Commission's (HELCOM) eutrophication assessment of the Baltic Sea, and is included in the European Marine Strategy Framework Directive as an effect parameter of eutrophication. Accurate data for the concentration of dissolved oxygen are essential for documenting environmental changes in water resources resulting from natural phenomena and human activities.
Reports of hypoxia globally are increasing1,22 both due to the recognition of the seriousness of hypoxia on ecosystem functioning and as decades-long monitoring records become available in databases. How the large number of newly identified hypoxic areas influences nutrient biogeochemical cycles and ecosystem services in the coastal zone in the Baltic Sea is currently unknown, although the functioning of the coastal filter certainly plays an important role in how adjacent marine systems respond to changes in nutrient loading. Presently about 40% of the world's population lives within 100 km of the coastal zone strongly impacting ocean health,(24) including increasing the occurrence of hypoxic areas.1,2 What is currently lacking is the link to the driving factors of hypoxia including nutrient enrichment, organic carbon loading and climate change,(25) and a determination of appropriate nutrient loading targets for guidance to managers to ameliorate the devastating impact of hypoxia.(24)
</text></passage></document><document><id>PMID-1970332</id><passage><offset>0</offset><text>Mapping of the L-methylmalonyl-CoA mutase gene to mouse chromosome 17.
In humans, methylmalonyl acidemia is caused by a deficiency of L-methylmalonyl-CoA mutase (MUT) controlled by a gene that has been mapped to chromosome 6. The mouse homolog of this gene has now been mapped to mouse chromosome 17. Recombinant inbred and congenic strains place the mouse Mut locus 1.06 cM distal to H-2, between Pgk-2 and Ce-2. The relative order of syntenic probes flanking H-2 on mouse chromosome 17 and HLA on human chromosome 6 is shown to be different.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="474" length="13"></location><text>chromosome 17</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="505" length="12"></location><text>chromosome 6</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="56" length="13"></location><text>chromosome 17</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="286" length="13"></location><text>chromosome 17</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="212" length="12"></location><text>chromosome 6</text></annotation></passage></document><document><id>PMID-17617824</id><passage><offset>0</offset><text>Rapid mixing between old and new C pools in the canopy of mature forest trees.
Stable C isotope signals in plant tissues became a key tool in explaining growth responses to the environment. The technique is based on the fundamental assumption that the isotopic composition of a given unit of tissue (e.g. a tree ring) reflects the specific C uptake conditions in the leaf at a given time. Beyond the methodological implications of any deviation from this assumption, it is of physiological interest whether new C is transferred directly from sources (a photosynthesizing leaf) to structural sinks (e.g. adjacent stem tissue), or inherently passes through existing (mobile) C pools, which may be of variable (older) age. Here, we explore the fate of (13)C-labelled photosynthates in the crowns of a 30-35 m tall, mixed forest using a canopy crane. In all nine study species labelled C reached woody tissue within 2-9 h after labelling. Four months later, very small signals were left in branch wood of Tilia suggesting that low mixing of new, labelled C with old C had taken place. In contrast, signals in Fagus and Quercus had increased, indicating more intense mixing. This species-specific mixing of new with old C pools is likely to mask year- or season-specific linkages between tree ring formation and climate and has considerable implications for climate reconstruction using stable isotopes as proxies for past climatic conditions.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="612" length="11"></location><text>stem tissue</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Organism_subdivision</infon><location offset="786" length="6"></location><text>crowns</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="367" length="4"></location><text>leaf</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="571" length="4"></location><text>leaf</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="892" length="12"></location><text>woody tissue</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1283" length="9"></location><text>tree ring</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="113" length="7"></location><text>tissues</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="307" length="9"></location><text>tree ring</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="292" length="6"></location><text>tissue</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T1" role=""></node></relation><relation id="A4"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T4" role=""></node></relation><relation id="A3"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation><relation id="A6"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T6" role=""></node></relation><relation id="A5"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A8"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T9" role=""></node></relation><relation id="A7"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T8" role=""></node></relation><relation id="A9"><infon key="file">ann</infon><infon key="attribute type">Plant</infon><infon key="type">Attribute</infon><node refid="T7" role=""></node></relation></passage></document><document><id>PMID-1639185</id><passage><offset>0</offset><text>Recent advances in minisatellite biology.
Highly polymorphic tandemly repeated 'minisatellite' loci are very abundant in the human genome, and of considerable utility in human genetic analysis. This review describes the use of an ordered-array Charomid library in the systematic and efficient cloning of these regions, and in the analysis of the relative overlap between the different probes used to screen for hypervariable loci. Recent work on the process of mutation leading to the generation of new-length alleles is also discussed, including the observation that at least some mutations may be due to unequal exchanges.
</text></passage></document><document><id>PMC-2998423-sec-17</id><passage><offset>0</offset><text>Real time RT-PCR
RNA extraction and real-time RT-PCR were performed as we described previously [22]. The sequences of ABCG2 primers are 5'-GGCTTTCTACCTGCACGAAAACCAGTTGAG-3' (forward) and 5'-ATGGCGTTGAGACCAG-3' (reverse). The sequences of GAPDH primers are 5'-AAGGACTCATGACCACAGTCCAT-3' (forward) and 5'-CCATCACGCCACAGTTTCC-3' (reverse). The relative ABCG2 RNA level (2DeltaCT) treated with inhibitors was expressed as percentage of the control (in the presence of 0.1% DMSO) where DeltaCT (threshold cycle) = (CTABCG2-CTGAPDH).
</text></passage></document><document><id>PMID-7000775</id><passage><offset>0</offset><text>Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli.
Only one of the sulfhydryl groups from Cys-32 and Cys-35 in the active center of native Escherichia coli thioredoxin-(SH)2 was alkylated by excess iodoacetic acid at pH values below 8.0. Both groups reacted in the protein denatured with 4.5 M guanidine hydrochloride. The second order rate of alkylation of thioredoxin-(SH)2 with 1 eq of iodoacetic acid was pH-dependent and showed independent initial reactions of one thiolate ion with a pK value of 6.7 and a second with a pK value close to 9.0. The same pH dependence was observed for alkylation with iodoacetamide but the apparent rate constant, 107 M-1 S-1 at pH 7.2, was about 20-fold higher than the corresponding rate with iodoacetate. The sulfhydryl group with a pK value of 6.7 was shown to belong to Cys-32 by labeling thioredoxin with [14C]iodoacetic acid followed by complete alkylation with [3H]iodoacetate and amino acid sequence analysis of peptides from the active center. The abnormally low pK value of Cys-32 is suggested to arise by electrostatic influence from a positive charge on the amino group of Lys-36. A mechanism of action for thioredoxin-(SH)2 as a protein disulfide reductase has been formulated. This is based on an initial nucleophilic attack by the thiolate of Cys-32 with the formation of an unstable transient mixed disulfide involving Cys-32 and one of the sulfurs in the substrate. This is followed by a conformational change and a nucleophilic attack of Cys-35 to give the 14-membered disulfide ring in thioredoxin-S2 and the dithiol of the substrate.
</text></passage></document><document><id>PMC-2707607-sec-10</id><passage><offset>0</offset><text>Implications for Psychological Models of Interval Timing
Several models have been previously applied to interpret data obtained in interval-timing experiments involving gaps (retention-intervals). A switch model, assuming that during the gap time fails to accumulate due to the opening of a stimulus-controlled switch, predicts that, irrespective of gap and criterion durations, subjects should use a stop rule [14], [15], [30], [31]. In contrast, the present data indicate that rats flexibly change their behavior with both gap and criterion duration. An instructional-ambiguity model proposing that subjects perceive the gap as an ambiguous, ITI-like event, predicts that manipulations that render the gap similar to the ITI should reset the clock, while manipulations that render the gap dissimilar from the ITI should stop the clock [37]. Because in our experiment the gap and ITI were identical (dark) this hypothesis predicts the use of the same rule (reset) at all gap and criteria durations, in contrast to the current data showing the use of different rules for different temporal criteria. To account for the flexible use of the run/stop/reset rules by rats and pigeons, Cabeza de Vaca et al. [38] proposed a passive memory-decay model which assumes that subjective time--stored in WM--decays passively during the gap. This model predicts that the effect of a gap should depend solely on absolute gap duration, but not on criterion duration, as found here (Fig. 1B-D). These models can not account for the differential effects of gaps on multiple intervals.
In contrast to these alternatives, the present resource allocation model assumes that during the gaps resources are re-allocated (diverted away from timing), each clock is unable to maintain its current subjective time in WM, and the response is delayed [16], [17], [27] in proportion to the perceived salience of the distracter relative to the times signal [34], [35]. Indeed, the effect of a gap is affected by the contrast in intensity between the gap and the timed signal [27], [34], [39] and by the perceptual acuity of the subjects [27]. Importantly, the predictions of this resource re-allocation model are not restricted to retention-intervals (i.e., gaps), but extend to distracters presented during the continuous presentation of a timed signal. Previous data were quantitatively accounted for by assuming that during a gap and/or distracter the accumulated time decays at a rate that varies with the relative salience of the distracter to the timed signal [25], [26], [35]. Here we found that the comparison between the gap and the (multiple) timed signal(s) extends to the temporal domain. Simulations indicate that both the differential effect of the gap on multiple durations, and the gradual hierarchical reset due to increasing gap duration can be quantitatively accounted for assuming that the three clocks have separate resources re-allocated independently during a gap at a rate proportional to the ratio g/Tk between the duration of the gap and each criterion duration (Fig. 2A:D-Model).
</text></passage></document><document><id>PMC-3041749-sec-13</id><passage><offset>0</offset><text>MoClo cloning protocol
Restriction-ligations were set up by pipetting in one tube approximately 40 fmol (~100 ng of DNA for a 4 kb plasmid) of each DNA component (PCR product or plasmid), 10 U of the required restriction enzyme (BsaI or BpiI) and 10 U T4 DNA ligase (using high concentration ligase, 20 U/microl) in Promega ligation buffer in a final reaction volume of 20 microl. The reaction was incubated in a thermocycler for 5 hours at 37degreesC, 5 min at 50degreesC and 10 min at 80degreesC. The reaction mix was then added to 100 microl chemically competent DH10b cells, incubated for 15-30 min on ice and transformed by heat shock. 800 microl of liquid LB was then added to the transformation, and the cells were let to recover 45 min at 37degreesC. Different aliquots of the transformation were plated on LB plates containing the appropriate antibiotic. The number of colonies was counted for one or two selected plates (containing countable number of colonies), or from a section of the plates when very high number of colonies were obtained even for the lowest volume plated. The number of colonies was then extrapolated for the entire transformation.
For level 2-2 cloning, two type IIS enzymes were required, BpiI and BsaI. The same protocol was used as described above except that 10 U and 2.5 U were used for the enzymes BpiI and BsaI, respectively. To optimize efficiency of the restriction-ligation for the final construct containing 11 transcription units (cL2-13*), a variation of this protocol was used as follows. The reaction mix was set up containing 20 U ligase, 5 U BpiI and 5 U BsaI, in a total reaction volume of 20 microl. The mix was incubated in a thermocycler with the following parameters: incubation for 2 minutes at 37degreesC, 5 minutes at 16degreesC, both steps repeated 45 times, followed by incubation for 5 minutes at 50degreesC and 10 minutes at 80degreesC. The reaction mix was transformed in E. coli chemically competent cells as described above.
</text><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="566" length="11"></location><text>DH10b cells</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="1954" length="15"></location><text>competent cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="711" length="5"></location><text>cells</text></annotation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Processed</infon><infon key="type">Attribute</infon><node refid="T3" role=""></node></relation></passage></document><document><id>PMC-3100324-sec-10</id><passage><offset>0</offset><text>Statistics
The survival of mice was analyzed using Kaplan-Meier survival analysis. All other data were analyzed by one-way ANOVA, followed by the Student-Newman-Keuls test for all pairwise comparisons. Prior to ANOVA, Levene's Test for Equality of Variances was performed. All statistical analyses were performed using MedCalc software, version 11.2.1.0.
</text></passage></document><document><id>PMID-9421512</id><passage><offset>0</offset><text>Effect of a mutation in the anticodon of human mitochondrial tRNAPro on its post-transcriptional modification pattern.
Although the gene sequences of all 22 tRNAs encoded in the human mitochondrial genome are known, little information exists about their sequences at the RNA level. This becomes a crucial limitation when searching for a molecular understanding of the growing number of maternally inherited human diseases correlated with point mutations in tRNA genes. Here we describe the sequence of human mt-tRNAPropurified from placenta. It shows absence of editing events in this tRNA and highlights the presence of eight post-transcriptional modifications. These include T54, never found so far in an animal mt-tRNA, and m1G37, a modification known to have fundamental functional properties in a number of canonical tRNAs. Occurrence of m1G37 was further investigated in an analysis of the substrate properties of in vitro transcripts of human mt-tRNAProtowards pure Escherichia coli methylguanosine transferase. This enzyme properly methylates G37 in mt-tRNA and is sensitive to the presence of a second G at position 36, neighboring the target nucleotide for methylation. Since mutation of nt 36 was shown to be correlated with myopathy, the potential consequences of non-modification or under-modification of mt-tRNA nucleotides in expression of the particular myopathy and of mitochondrial diseases in general are discussed.
</text><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="1386" length="13"></location><text>mitochondrial</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="47" length="13"></location><text>mitochondrial</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="532" length="8"></location><text>placenta</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cellular_component</infon><location offset="184" length="20"></location><text>mitochondrial genome</text></annotation></passage></document><document><id>PMID-479303</id><passage><offset>0</offset><text>Cardiac gap junction configuration after an uncoupling treatment as a function of time.
Rabbit ventricle either was fixed in glutaraldehyde without injury (control) or was injured before fixation, presumably causing electrical uncoupling of the gap junctions. All tissue was then processed for freeze-fracture. Replicas of control gap junctions exhibited irregular packing of the P-face particles and E-face pits. Average center-to-center spacing of the particles was 10.5 nm. Tissue fixed 1-5 min after injury showed clumping of gap junctional particles and pits. Within the clumps, the particles and pits were hexagonally packed and the center-to-center spacing of the particles averaged 9.5 nm. In tissue fixed 15-30 min after injury, the clumps of gap junctional particles had coalesced into a homogeneous structure in most junctions. The packing of the particles and pits was hexagonal and the spacing of the particles averaged 9.5 nm. A few pieces of rabbit atrium were frozen without prior fixation or cryoprotection to try to assess the effect of glutarldehyde fixation on gap junction structure. In this tissue the gap junctional particles were irregularly packed and their spacing averaged 10.0 nm.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="477" length="6"></location><text>Tissue</text></annotation><annotation id="T7"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="964" length="6"></location><text>atrium</text></annotation><annotation id="T8"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="1113" length="6"></location><text>tissue</text></annotation><annotation id="T9"><infon key="file">ann</infon><infon key="type">Organ</infon><location offset="0" length="7"></location><text>Cardiac</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Multi-tissue_structure</infon><location offset="95" length="9"></location><text>ventricle</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="264" length="6"></location><text>tissue</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Tissue</infon><location offset="701" length="6"></location><text>tissue</text></annotation></passage></document><document><id>PMC-3013756-sec-09</id><passage><offset>0</offset><text>FUNDING
National Institutes of Health grants, National Institute of Environmental Health Sciences and the National Library of Medicine (R01 ES014065 and R01 ES014065-04S1 to CTD); INBRE program of the National Center for Research Resources (P20 RR016463). Funding for open access charge: NIEHS grant (R01 ES014065).
Conflict of interest statement. None declared.
</text></passage></document><document><id>PMID-12049815</id><passage><offset>0</offset><text>In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines.
This study determined the selective cytotoxicity of eight coumarin compounds to human renal carcinoma cells, relative to non-carcinoma proximal tubular cells. Selectivity cytotoxicity was observed following exposure to 6-nitro-7-hydroxycoumarin (6-NO(2)-7-OHC) and 7,8-dihydroxycoumarin (7,8-OHC). 6-NO(2)-7-OHC induced cytotoxicity was irreversible in both cell lines, unlike 7,8-OHC, which was reversible in the carcinoma cells only. Mobility shift and BrdU incorporation assays showed that both compounds did not intercalate DNA but had a concentration-dependent inhibitory effect on its synthesis. All coumarins studied were found to be non-mutagenic using the standard Ames test. These results would suggest that 6-NO(2)-7-OHC and 7,8-OHC might have a therapeutic role to play in the treatment of renal cell carcinoma.
</text><annotation id="T6"><infon key="file">ann</infon><infon key="type">Pathological_formation</infon><location offset="908" length="20"></location><text>renal cell carcinoma</text></annotation><annotation id="T4"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="464" length="10"></location><text>cell lines</text></annotation><annotation id="T5"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="520" length="15"></location><text>carcinoma cells</text></annotation><annotation id="T1"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="88" length="16"></location><text>renal cell lines</text></annotation><annotation id="T3"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="227" length="36"></location><text>non-carcinoma proximal tubular cells</text></annotation><annotation id="T2"><infon key="file">ann</infon><infon key="type">Cell</infon><location offset="192" length="21"></location><text>renal carcinoma cells</text></annotation><relation id="A2"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T5" role=""></node></relation><relation id="A1"><infon key="file">ann</infon><infon key="attribute type">Pathological</infon><infon key="type">Attribute</infon><node refid="T2" role=""></node></relation></passage></document></collection>